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Background: Intermittent claudication (IC) is ischaemic leg pain associated with reduced 
walking ability. Walking is a recommended but underused treatment for IC. The Theory of 
Planned Behaviour (TPB) and Common Sense Model of Illness Representations (CSM) are 
frameworks for understanding and changing health behaviours, such as walking, through 
appropriate behaviour-change techniques (BCTs). This research evaluated cognitions about 
walking treatment and illness defined by the TPB and CSM, respectively, to inform the 
development and evaluation of a behaviour-change intervention (BCI) in people with IC. 
Methods: Medical Research Council guidelines for developing and evaluating complex 
interventions informed five studies, including people with IC: a) a systematic review of 
randomised-controlled trials (RCTs) of interventions applying BCTs targeting walking; b) a 
qualitative exploration of experiences of and beliefs about walking and IC; c) a cross-sectional 
observational evaluation of TPB and CSM constructs for explaining walking intention and 
objective walking ability (6 Minute Walk Distance [6MWD]); d) a feasibility study of an RCT 
evaluating a physiotherapist-led BCI targeting objective walking behaviour (pedometer step 
count) and ability (6MWD); and e) a nested qualitative study evaluating the acceptability of the 
RCT and BCI to participants and a physiotherapist. 
Results: a) The systematic review identified 6 RCTs, which reported 11 BCTs. Barrier 
identification and problem solving, self-monitoring, and feedback on performance were 
included in effective interventions. b) In the qualitative study (n=19), two themes (and five 
subthemes) emerged: 1) Walking is an overlooked self-management opportunity (IC is benign 
and leg pain can be overcome; IC is severe and there is nothing I can do); and 2) Tailored 
walking guidance is desired (Varied outcome expectations of walking; Barriers to walking to 
intensity; and Limited purposeful walking for exercise) among people with IC. c) A cross-
sectional study (n=142) explained 73% and 28% of variance in walking intention and 6MWD. 
TPB constructs (β=0.23, 0.35, and 0.34 for attitude, subjective norm and perceived behavioural 
control) and perceived consequences (β=0.15) contributed to walking intention, whereas CSM 
constructs (β=-0.20, 0.32, 0.22, and 0.18 for treatment control, personal control, coherence, 
and risk factor attributions) contributed to 6MWD, beyond past walking behaviour. 
d) Feasibility of an RCT evaluating a home-based BCI was demonstrated (n=24): intervention 
adherence (71%), study retention (92%), and treatment fidelity evaluation methods met 
feasibility criteria, and a moderate treatment effect (Hedges g=0.39, 95% CI -0.47, 1.25) on 
objective walking behaviour, but not 6MWD, was found. e) Feasibility and acceptability of the 
protocol and interventions was confirmed by narrative accounts of participants and the 
physiotherapist in a nested qualitative study. 
Conclusions: The TPB and CSM were evaluated and applied in the systematic development of a 
walking BCI for people with IC. Few high-quality RCTs were identified which evaluate BCTs 
targeting walking for IC, walking is overlooked as a self-management opportunity among 
people with IC who desire tailored walking guidance, and walking treatment cognitions explain 
walking intention, whereas illness cognitions explain objective walking ability. An RCT 
evaluating a home-based physiotherapist-led BCI targeting BCTs was feasible, and acceptable 
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 Intermittent claudication (IC): Chapter 1.
epidemiology, impact, and treatment 
Lower-extremity peripheral arterial disease (PAD) is a long-term atherosclerotic condition, 
characterised by narrowing or calcification of the arteries supplying oxygenated blood to the 
legs, and leading to impaired circulation (Haas et al., 2012). This age-related condition (Selvin 
and Erlinger, 2004) affects up to 20% of the adult population, more than 50% of whom 
experience associated symptoms of ischaemic exertional leg pain, called intermittent 
claudication (IC) (Hirsch et al., 2001). 
1.1 Pathophysiology of atherosclerotic peripheral arterial disease 
(PAD) 
The initiation of an atherosclerotic lesion involves the recruitment of mononuclear leucocytes 
(e.g., monocytes and lymphocytes) to the intima of the artery, a process mediated by adhesion 
molecules (e.g., vascular cell adhesion molecule-1) and inflammatory cytokines 
(e.g., macrophage chemoattractant protein-1) (Libby, 2000). Mononuclear leucocytes collect in 
the intima as macrophages, accumulate lipids, and evolve into foam cells, which are indicators 
of the fatty streak and precursors of atherosclerotic plaque. The atheroma progresses, in 
particular via the proliferation of smooth muscle cells, which accumulate macromolecules and 
minerals (e.g., calcium) within their extracellular matrix, contributing to the formation of a 
fibrous plaque, and clinical atherosclerosis (Hiatt et al., 2001; Ouriel, 2001; Libby, 2000).  
Atherosclerotic plaque tends to develop at sites where blood vessels branch, curve, or are 
irregular, and where sudden changes in velocity and direction of blood flow might occur. 
Primary conduit vessels frequently affected by PAD include the common iliac, external iliac, 
common femoral, superficial femoral and popliteal arteries, and disease can be localised or 
multilevel and diffuse. The location and extent of atherosclerosis has implications regarding 
the manifestation of symptoms and opportunity for successful revascularisation 




In addition to localised effects of atherosclerotic lesions on blood flow, PAD is associated with 
reduced systemic endothelial function, including flow-mediated dilation and nitric oxide 
responsiveness, which may contribute to IC and walking impairment (Yang et al., 2008). 
Chronic inflammation is implicated in the process of endothelial dysfunction, and is associated 
with IC and with progression of PAD (Silvestro et al., 2002; Belch et al., 2002). 
1.2 Classification of PAD and IC 
Classifications of PAD help to describe the extent and severity of disease and symptoms. 
Fontaine et al. (1954) described five stages based on subjective criteria for defining IC (e.g., 
disability based on self-reported walking distances) (Table 1.1):  
 stage I: asymptomatic PAD;  
 stage IIa: mild claudication (pain-free walking distance >150 metres);  
 stage IIb: moderate to severe claudication (pain-free walking distance ≤150 metres);  
 stage III: ischaemic pain at rest; and  
 stage IV: PAD with ulceration or gangrene.  
Rutherford et al. (1997) expanded the Fontaine classification to include seven categories, 
subdividing IC into three levels based upon objective treadmill walking distances, including 
“severe claudication”; in addition, end-stage PAD was broadened to include two levels based 
on severity and the possibility of salvaging tissue (Table 1.1).  
Both classification systems remain widely used, and provide clinical descriptions and criteria 
for defining PAD severity. However, individual cases which approach category thresholds may 
be difficult to define, and the classifications might be more applicable in research than in 
clinical settings, where more detailed haemodynamic assessment would be required to 











Clinical description Objective criteriaa 
I 0 Asymptomatic (no 
haemodynamically significant 
occlusive disease) 
Normal treadmill or reactive 
hyperaemia test  
IIa 1 Mild claudication Completes treadmill exerciseb; 
post-exercise AP>50 mmHg but 
at least 20 mmHg lower than 
resting value  
IIb 2 Moderate claudication Between categories 1 and 3 
 3 Severe claudication Cannot complete standard 
treadmill exerciseb and post-
exercise AP<50 mmHg 
IIIc 4 Ischaemic rest pain Resting AP<40 mmHg, flat or 
barely pulsatile ankle or 
metatarsal PVR; TP<30 mmHg  
IVc 5 Minor tissue loss: non-healing 
ulcer, focal gangrene with diffuse 
pedal ischaemia 
Resting AP<60 mmHg, ankle or 
metatarsal PVR flat or barely 
pulsatile; TP<40 mmHg  
 6 Major tissue loss: extending above 
TM level, functional foot no longer 
salvageable 
Same as category 5 
Reproduced from Norgren et al. (2007) with permission from Elsevier. aRutherford 
classification. bFive minutes at 3.2 kilometres/hour on a 12% incline. cGrades III and IV 
(Rutherford categories 4–6) describe critical limb ischaemia. AP, ankle pressure; PVR, pulse 
volume recording; TM, trans-metatarsal; TP, toe pressure.  
1.2.1 Classic and atypical IC 
The Fontaine and Rutherford classifications describe symptoms in terms of objective or 
haemodynamic severity; however, IC can be defined further by its location and manifestation. 
Two broad categories exist: classic IC and atypical exertional leg pain (i.e., atypical IC). Classic 
IC, is described as exertional pain, located in the calf, that requires the individual to stop 
walking and resolves within 10 minutes of rest, but does not begin at rest or resolve during 




PAD (Wang et al., 2005). Up to 50% of individuals with PAD experience atypical IC, which 
includes pain in muscle groups other than the calves (i.e., the buttock or thighs), or pain that 
individuals are able to continue walking through (Hirsch et al., 2001; McDermott et al., 2001). 
In both classic and atypical IC, the imbalance of blood flow and metabolic demands generate 
ischaemic pain or discomfort in the lower extremities that affects walking.  
Many research studies, including the studies in this thesis do not differentiate between classic 
and atypical symptoms, and utilise the generic term “IC”. 
1.3 Detection and diagnosis of PAD and IC 
PAD can be detected and diagnosed by non-invasive markers. Palpation of arm, leg, and pedal 
pulses is used to identify and locate abnormalities. Alongside palpation, the presence of IC can 
aid detection. However, pedal pulses are variable and can overestimate the presence of 
disease, whereas reliance on the presentation of symptoms alone leads to under-diagnosis, so 
reliability of these methods is limited (Norgren et al., 2007; Criqui et al., 1985).  
A sensitive, non-invasive test is the ankle–brachial pressure index (ABPI), which provides a 
simple haemodynamic measure of blood flow capacity. The ABPI is calculated as the ratio of 
maximum blood pressure measured at the dorsalis pedis and/or posterior tibial arteries 
compared with the maximum blood pressure at the left or right brachial artery. Large-vessel 
PAD is defined as a resting ABPI≤0.90 in either leg (Norgren et al., 2007) (Table 1.2). 
Table 1.2 Interpretation of the ankle–brachial pressure index for defining PAD 
Resting ankle–brachial pressure index  Definition 
≥1.30 Non-compressible vessel 
1.00–1.29 Normal blood flow 
0.91–0.99 Borderline peripheral arterial disease 
0.41–0.90 Mild to moderate peripheral arterial disease 





Specificity of a resting ABPI≤0.90 for detecting moderate PAD (e.g., ≥50% stenosis) is 83–99%, 
although sensitivity is lower (15–79%) (Dachun Xu et al., 2010), and so the ABPI might not be 
sufficient for detecting PAD that is mild or located in calcified vessels (Stein et al., 2006). 
Additional tests are recommended for symptomatic and at-risk individuals in clinical settings, 
and include pulse volume recordings (arterial waveforms detected by plethysmograph, which 
detects and graphically records changes in pulse contour and amplitude), post-exercise ABPI 
measurements or post-occlusive reactive hyperaemia (a decrease from resting or baseline 
ABPI indicates PAD), and resting blood flow velocity (detected by continuous wave Doppler, 
with triphasic waveforms indicating normal blood flow, and biphasic and monophasic 
waveforms indicating PAD) (Stein et al., 2006). For individuals with PAD being considered for 
revascularisation, angiography, duplex ultrasound, magnetic resonance imagery, or computed 
tomographic angiography are methods used to assess the degree and suitability of 
atherosclerotic lesions for intervention. Duplex ultrasonography enables the quantification of 
stenoses based on waveform analysis and peak systolic velocity (Table 1.3) (Norgren et al., 
2007; Begelman and Jaff, 2006).  
Table 1.3 PAD severity based on stenosis grade obtained by duplex ultrasound 
Pattern of peak systolic velocity Stenosis grade Interpretation 
Normal waveform, no change in peak systolic 
velocity 
0% Normal (no stenosis) 
Change in waveform, no change in peak systolic 
velocity 
1–19%  Mild stenosis 
Increase in peak systolic velocity of 30–100% 
relative to proximal normal segment 
20–49% Moderate stenosis 
Increase in peak systolic velocity of >100% relative 
to proximal normal segment 
50–99% Severe stenosis 





A low ABPI diagnoses PAD, and is associated with greater walking impairment, but not with the 
type of symptom manifestation (McDermott et al., 2010). Given the subjective nature of pain 
presentation, IC is diagnosed primarily by self-report and combined with objective criteria 
(described above) to determine health status and treatment approach. Clinically, individuals 
are asked to describe their symptoms and the extent of functional limitations in their own 
words. Validated questionnaires that systematically screen for symptoms (Schorr and Treat-
Jacobson, 2013), and standardised treadmill- or corridor-based protocols that induce or 
quantify symptoms, are more commonly used in the research setting (Section 1.6.1; Chapter 
3). The San Diego Claudication Questionnaire (SDCQ; Chapter 3) is a validated survey for 
identifying and categorising PAD symptoms, and is sensitive (69.9–96.1%) and specific (46.5–
81.8%) for detecting PAD compared with the ABPI, history of revascularisation, or post-tibial 
and tibial-peroneal blood pressures (Schorr and Treat-Jacobson, 2013). In many instances, 
confirmation of IC requires differential diagnosis, particularly to exclude neuropathic pain 
related to diabetes or spinal degeneration (Schorr and Treat-Jacobson, 2013). 
1.4 Prevalence of PAD and IC 
Due to discrepancies in criteria and methods for detecting PAD (Reed et al., 2009), alongside 
differences in population characteristics, the total prevalence of PAD is not well established 
(Mohler and Giri, 2008), and rates vary between approximately 1.5–20% (Cimminiello et al., 
2011; Diehm et al., 2004). Among individuals with PAD, approximately 50% experience IC 
(Hirsch et al., 2001). The location of atherosclerosis might affect the manifestation of leg pain, 
with the highest prevalence of IC occurring when disease is present in multiple vessels in either 
one leg or both (Hiatt et al., 1995).  
The Prevalence of Peripheral Arterial Disease in Patients with a Non-High Cardiovascular 
Disease Risk, with no Overt Vascular Diseases nor Diabetes Mellitus (PANDORA) study enrolled 
9,816 adults with at least one cardiovascular disease risk factor from primary care practices 




(Cimminiello et al., 2011), suggesting that PAD may be largely underdiagnosed. However, 
97.4% of participants were White, and ethnicity is an important risk factor for PAD not 
captured by that study.  
1.5 PAD and IC risk factors and comorbid conditions 
PAD is linked to modifiable risk factors common with systemic atherosclerosis, including 
dyslipidaemia, diabetes, hypertension, and tobacco smoking (Murabito et al., 1997). PAD is 
associated with a two- to threefold increased risk of cardio- and cerebrovascular morbidity and 
mortality (Leng et al., 1996; Diehm et al., 2004; Criqui et al., 1997), and risk factor 
management is a focus of PAD treatment (Norgren et al., 2007). Compared with asymptomatic 
PAD, the risk of cardiovascular morbidity and mortality is heightened among those who 
experience IC (Criqui et al., 1997).  
Physical inactivity increases cardiovascular risk among individuals with IC. People with IC are 
less active compared with healthy individuals, and less than one-half achieve public health 
physical activity guidelines for general cardiovascular health (Department of Health, 2011), or 
for improving IC (Lauret et al., 2014; McDermott et al., 2002). Lower daily physical activity is 
associated with a higher rate of decline in IC symptoms (Garg et al., 2009), and up to 2.1-fold 
and 3.5-fold increased risk of a cardiovascular event or all-cause mortality, respectively (Garg 
et al., 2006). 
Age and ethnicity are additional, non-modifiable risk factors for PAD. The prevalence of PAD 
increases from approximately 3–4% in adults aged ≥40 years (Murabito et al., 2002) to 15–20% 
in individuals aged >70 years (Selvin and Erlinger, 2004; Criqui et al., 1997). The age-dependent 
prevalence of PAD among women may be lower than for men, although the total prevalence of 
PAD, and that of borderline PAD (i.e., ABPI 0.90–1.00), is equal or higher among women 
(Hirsch et al., 2012; Hiramoto et al., 2014); however, it is unclear whether there are gender 
differences in the onset, progression and outcome of PAD (Walker and Hiramoto, 2012). Black 




including increased hypertension, diabetes, and body mass index (BMI) (Meadows et al., 2009; 
NHS Health and Social Care Information Centre, 2005), and a higher prevalence of PAD. Among 
an observational sample of 2343 participants in The San Diego Population Study, 4.4% had 
PAD, with a 2.3-fold increased risk among Black individuals, which was only partly attributable 
to cardiovascular risk factors (Criqui et al., 2005). The Multi-Ethnic Study of Atherosclerosis, 
including 6653 individuals in the United States, reported an odds ratio (OR) of 1.47 (95% 
confidence interval [CI] 1.07, 2.02) for Black ethnicity, after controlling for atherosclerotic risk 
factors, and interleukin-6, fibrinogen, and D-dimer, which suggests potential mechanisms 
underpinning ethnic differences (Allison et al., 2006).  
1.6 The impact of PAD and IC 
The direct impact of IC on individuals with PAD includes impaired walking ability, physical 
function and health-related quality of life (Treat-Jacobson et al., 2002; McDermott et al., 
2001), and places a significant cost on the National Health Service (NHS) and burden to 
individuals and society (Michaels et al., 2000). 
1.6.1 The impact of PAD and IC on walking ability and physical function 
Frequently used objective assessments used to quantify the impact of IC on walking ability 
include standardised treadmill- and corridor-based walking tests. Treadmill protocols 
(e.g., initial 3.2 kilometres/hour and 0% grade, increasing grade by 2% every 2 minutes) 
(Gardner et al., 1991) are used to elicit two self-reported disease-specific parameters: 1) the 
pain-free walking ability (PFWA), which reflects the distance or time walked before the 
perceived onset of IC; and 2) the maximal walking ability (MWA), which is the distance or time 
walked before IC causes the individual to stop and rest. The 6 Minute Walk Test (6MWT) is a 
corridor-based assessment that provides a valid and reliable measure of walking ability, 
reported as the 6 Minute Walk Distance (6MWD; Chapter 3), and can be used to obtain the 
PFWA and MWA, although some individuals with IC may not achieve these parameters at a 




Individuals with PAD walk shorter distances (up to 136 metres less in a 6MWT) and more 
slowly (by 0.13 metres/second over 4 metres, or 12% slower at usual pace) compared with 
healthy controls (McDermott et al., 1998). 6MWD declined by up to 80 feet (25 metres) over 
12 months in a sample of 417 individuals with PAD (McDermott et al., 2006). Adjusting for age 
and gender, individuals with PAD had a higher rate of self-reported mobility loss (defined as 
inability to walk 400 metres or up and down one flight of stairs; hazard ratio 1.63, 95% CI 1.03, 
2.56) and an increased risk (hazard ratio 2.17, 95% CI 1.42, 3.32) of achieving their MWA 
during a 6MWT compared to individuals without PAD over a median 50 month follow-up 
period (McDermott et al., 2007). These data include people with IC and asymptomatic PAD, 
and as a result it is difficult to discern the degree to which walking impairment is associated 
with IC alone.  
There is an inconsistent association between PAD symptomology and walking ability among 
people with or without IC. There were no differences in objective ambulatory measures (400 
metre walk time and 4 metre walk speed) between people with IC (n=77) or asymptomatic 
PAD (n=143), controlling for age, sex, smoking, BMI, self-reported physical activity, and 
common comorbidities. However, only older adults (aged 70–89 years) were included, and so 
findings might not reflect younger people with PAD (McDermott et al., 2013a). Associations 
are also inconsistent for perceived walking ability, reported on the self-administered Walking 
Impairment Questionnaire (WIQ), a 14-item validated disease-specific measure, including 
walking shorter distances, slower speeds, and having greater difficulty climbing stairs 
(McDermott et al., 1998). Individuals with IC reported shorter walking distances than 
individuals with asymptomatic PAD on the WIQ, but similar walking speeds and stair climbing 
abilities (Collins et al., 2005). However, only 67 participants were included, comparisons did 
not control for key sociodemographic variables (e.g., age, sex, ethnicity) or comorbidities, and 
the WIQ may be less accurate for moderate walking impairment compared with extreme 




Among individuals with symptomatic PAD, the impact of symptom type is also equivocal. One 
study found individuals with classic IC (n=150) walked shorter distances (328.5 versus 391.6 
metres) and were more likely to stop (16% versus 6.8%) during a 6MWT compared with 
individuals reporting atypical IC (n=131) (McDermott et al., 2001). However, there were no 
significant differences in 4 metre walk speed, tandem stand, or chair raises. While 
150 participants with classic IC were included, subgroups of atypical IC were explored (e.g., 
individuals who reported carrying-on versus stopping walking due to IC), so that study may 
have been underpowered to detect differences between groups across multiple comparisons. 
Among 715 participants with IC, there were no differences in distances walked during treadmill 
and corridor walking tests, self-reported walking ability (measured by the WIQ), self-reported 
and accelerometer-based physical activity, and health-related quality of life between 
individuals who reported classic or atypical IC (Gardner et al., 2007). However, that study 
included mostly men (80%), and participants who reported atypical IC presented symptoms 
consistent with classic IC on a graded treadmill test, suggesting participants were inaccurately 
classified on study enrolment.  
While the evidence reviewed indicates that PAD reduces walking ability compared with healthy 
individuals, the impact of symptom presence and type (i.e., classic versus atypical IC) is 
unclear. 
1.6.2 The impact of PAD and IC on health-related quality of life 
Compared with age- and sex-adjusted norms, people with PAD report lower overall health-
related quality of life (Pell, 1995; Regensteiner et al., 2008). The impact of PAD on quality of 
life is comparable to that of other cardiovascular diseases (e.g., coronary artery disease), in 
particular with regard to aspects of physical functioning; however, PAD has an additive effect 
on impairment, with individuals who have combined cardiovascular disease and PAD reporting 




Measures of walking ability (e.g., derived from treadmill or corridor tests) tend to better reflect 
the impact of symptomatic PAD on quality of life, compared with clinical parameters reflecting 
disease severity (e.g., ABPI) (Izquierdo-Porrera et al., 2005; Spronk et al., 2007). For example, 
in 80 people with IC, ABPI was associated with pain-related and physical functioning (r=0.30 
and 0.42, respectively), whereas 6MWD was associated with broader aspects of quality of life 
including physical, mental, and general health, and vitality (r=0.28–0.42) (Izquierdo-Porrera et 
al., 2005) measured by the Medical Outcomes Survey Short Form-12 (SF-12), a brief, 
standardised, and valid measure of mental and physical functioning over the past 7 days (Ware 
et al., 1996). However, that study included mostly male participants (87%) and may not reflect 
women with IC, and reported only Pearson correlation coefficients, therefore results do not 
indicate agreement or explore multivariate effects.  
Two qualitative investigations aid in further understanding the impact of IC. Treat-Jacobson et 
al. (2002) interviewed 38 individuals with PAD (n=25 men, mean age 65 years) to explore the 
effect of their diagnosis and treatment on health-related quality of life. Pain and walking 
impairment were central to the experience of PAD, and participants described limitations and 
avoidance of physical activities, altered social and recreational activities, feelings of 
uncertainty or fear, and compromised self-identity including feeling aged, abnormal, or 
ashamed by symptoms. Participants included individuals with IC, and with a range of disease 
severities, including critical limb ischaemia (e.g., Fontaine stage III-IV) in the United States. 
However participant ethnicity and previous treatment were not reported, so whether the 
sample represented these characteristics of the IC population is unclear, and findings may not 
be generalisable to individuals in the United Kingdom (UK). A qualitative investigation 
conducted in Sweden, and including 15 individuals with IC (n=7 women, mean age 73 years), 
reported a need for individuals to adjust to a restricted life, which was illustrated by 
perceptions of burdening others when having to stop during a walk, longing for one’s previous 
lifestyle, the need to incorporate IC into daily life, and leading a strenuous life with IC (Egberg 
et al., 2012). Participants described frustration, fury, and exasperation as a result of their IC. 




range of individuals with IC, and while authors reported sampling purposively for duration of 
symptoms, data are not reported on this clinical characteristic so it is unclear whether a 
representative sample was achieved. 
Given the profound impact of PAD, and particularly IC, on walking ability, physical function, 
and quality of life, efficient management, which targets symptoms, is a healthcare priority 
(NICE, 2012). 
1.7 Management of IC 
1.7.1 Treatment aims for individuals with IC 
Management of IC addresses systemic atherosclerosis as well as lower-limb disease and 
symptoms (Norgren et al., 2007). Specifically, treatment targets include the following: 
a) IC, aiming to alleviate leg pain in order to improve walking performance and daily 
functional ability;  
b) PAD, aiming to improve blood flow to the lower extremities, preventing tissue damage 
and limb loss; and  
c) systemic disease, aiming to modify risk factors for cardiovascular disease and halt the 
progression of atherosclerosis. 
1.7.2 The pathway of care for individuals with IC 
Management of IC includes supervised exercise therapy, primarily consisting of walking, as the 
initial approach (Norgren et al., 2007; NICE, 2012) (Figure 1.1), which aims to improve walking 
ability (e.g., MWA, PFWA). Naftidrofuryl oxalate, a vasodilator licensed in the UK for treating 
IC, is recommended only after supervised exercise therapy is trialed (NICE, 2012). If these 
strategies are unsuccessful, revascularisation (i.e., angioplasty or bypass surgery) may be 
considered; in selected individuals with a proximal occlusion and progressing, debilitating 
symptoms, invasive procedures may be considered as a first-line treatment in order to address 
IC and restore blood flow to the limb (Norgren et al., 2007). However, elective invasive 
procedures demonstrate only short-term improvements in walking ability compared with 
conservative management (Murphy et al., 2011), and carry greater risk for the individual 




Figure 1.1 Pathway for management of intermittent claudication (IC) recommended by the 
UK National Institute for Health and Care Excellence 
 
National Institute for Health and Care Excellence (2015). Adapted from “Managing intermittent 
claudication in people with peripheral arterial disease”. Reproduced with permission. 
Risk-factor modification is recommended for all individuals with PAD, to prevent a 
cardiovascular event and progression of lower-limb atherosclerosis. Recommendations include 
referral to smoking cessation services, weight reduction among individuals with a 
BMI≥25 kg/m2, lipid control through dietary changes or statin therapy, aggressive glycaemic 
control with a glycated haemoglobin goal of <7%, blood pressure control to <140/90 mmHg or, 
for people with diabetes or renal insufficiency to <130/80 mmHg, and antiplatelet therapy 
(SIGN, 2006; Norgren et al., 2007). The overall effect of cardiovascular risk reduction on IC has 
not been described; however, the use of statins for cholesterol management is associated with 
improved IC and walking ability. Hypothesised mechanisms for the effect of statins on IC 
include changes in endothelial function, plaque stabilisation, and attenuation of the 

















1.7.3 Guidelines for walking treatment for IC 
Supervised exercise therapy is currently endorsed as initial treatment for individuals with IC by 
the American College of Cardiology Foundation/American Heart Association (ACC/AHA) and 
the Trans-Atlantic Inter-Society Consensus (TASC)-II Group (Norgren et al., 2007; Hirsch et al., 
2006). The ACC/AHA recommends a minimum of 30–45 minutes of supervised walking exercise 
≥3 times per week for ≥12 weeks (Hirsch et al., 2006). Similarly, TASC-II guidelines advise 
supervised track or treadmill walking for 30–60 minutes per session conducted 3 times per 
week for 3 months (Norgren et al., 2007). To maximise the training response (e.g., increased 
walking ability), walking should be performed at a speed or grade that induces claudication 
within 3–5 minutes, and the individual should walk beyond the onset of pain to the point when 
claudication is perceived as moderate in intensity (Norgren et al., 2007).  
Consistent with these guidelines, the National Institute for Health and Care Excellence (NICE) 
identifies the provision of supervised exercise therapy as a priority for implementation within 
the NHS. Specifically, it recommends 1) offering 2 hours per week of supervised exercise 
therapy for a 3 month period and 2) encouraging people to exercise to the point of maximal 
pain (NICE, 2012). Quality Standards issued in 2014 by NICE suggest poor guideline 
implementation nationally, and identify variation in the provision of supervised exercise 
therapy across the UK and a need both for new provision and improvement in existing care 
(NICE, 2014a). A key quality statement recommends that all individuals with IC are offered 
supervised exercise therapy, and suggests that greater use of conservative strategies, including 
advice on risk factor modification and exercise, could reduce the need for more invasive 
treatment and improve outcomes.  
The focus of this thesis will be on individuals with Fontaine stages IIa and IIb (Rutherford 
categories 1–3), as evidence underpinning walking treatment guidelines for PAD includes 





1.7.4 Effectiveness of walking treatment for IC 
Walking ability in people with IC consistently improves with supervised exercise therapy. In a 
meta-analysis of 21 exercise interventions, Gardner and Poehlman (1995) reported an increase 
of 179% and 122% in PFWA and MWA in people with IC, respectively. A Cochrane review 
including 30 randomised controlled trials (RCTs) found similar results, with a mean difference 
(MD) favouring supervised exercise therapy over usual care of 108.99 metres (95% CI 38.2, 
179.8) and 82.29 metres (95% CI 71.86, 92.7) in PFWA and MWA, respectively (Lane et al., 
2014). In both reviews, however, the components and dosage of exercise interventions varied, 
and incorporated strength training or cycle ergometry, making it difficult to isolate the effect 
of walking exercise on outcome. However, walking exercise was identified as a feature of 
interventions associated with the greatest improvements, alongside a duration of ≥6 months, 
and exercise intensity reaching near-maximal pain (Gardner and Poehlman, 1995). In addition, 
while cycle ergometry, arm ergometry, and lower-extremity aerobic exercises demonstrate at 
least moderate effects on walking ability, treadmill walking exercise produces comparatively 
greater effects on PFWA and MWA according to findings of a systematic review including 
36 studies (n=1644 participants) (Parmenter et al., 2011). However, study quality was modest 
due to limited blinding of assessors, allocation concealment, or intention-to-treat analyses, 
and few trials (11%) evaluated modes of therapy other than lower-limb aerobic exercise (e.g., 
walking). In addition, women and older adults with IC were under-represented by included 
studies. 
Supervised exercise therapy may be more effective in improving MWA and PFWA when 
compared to standard pharmaceutical therapy (Murphy et al., 2011; Gardner et al., 2011) and 
revascularisation (Murphy et al., 2011; Watson et al., 2008). Gains in walking ability are 
associated with increases in daily physical activity and improvements in overall ambulatory 
function, including stair climbing (Gardner et al., 2001; Gardner et al., 2000). Improvements in 
health-related quality of life following supervised exercise therapy  are inconsistent and limited 




surveys (e.g., Vascular Quality of Life Questionnaire), and because health-related quality of life 
is often reported as a secondary outcome, so studies are not powered to detect a change 
(Gardner et al., 2005; Tsai et al., 2002; Watson et al., 2008).  
1.7.5 Mechanisms for benefits of walking treatment for IC 
Key hypothesised mechanisms for the effects of walking on IC include microvascular changes 
affecting the skeletal muscle (i.e., angiogenesis), macrovascular changes to the arterial tree 
(i.e., arteriogenesis). Additional factors that may support walking improvements include 
reduced systemic inflammation, central adaptations, changes to blood rheology, and gait 
alterations. 
Angiogenesis. Exercise, including walking, increases capillary density and mitochondrial 
enzyme activity in people with IC, allowing greater oxygen extraction by the muscle (Lundgren 
et al., 1989). Metabolic, hypoxic and/or mechanical factors are implicated in the stimulation of 
angiogenic processes (Figure 1.2).  
Metabolic processes include the production of extracellular adenosine by adenosine 
triphosphate released during exercise. Compared with healthy populations, people with PAD 
experience a prolonged initial anaerobic phase with the onset of exercise, and might not reach 
aerobic glycolysis, leading to a need for rest (Schocke et al., 2008). However, lactic acid and 
low intracellular pH during anaerobic exercise are associated with adenosine release from 
skeletal muscle or endothelial cells, which, with persistent challenge, could lead to increased 
vascular endothelial growth factor (VEGF) production, endothelial cell proliferation, and 
capillary number, contributing to increased microcirculation and improved walking ability 
(Haas et al., 2012).  
Hypoxia facilitates greater responsiveness to adenosine. Hypoxia inducible transcription factor 
1, in particular, but also hypoxia inducible transcription factor 2 and peroxisome 
proliferator-activated receptor  coactivator 1 regulate the adaptive response to hypoxia, 




which could lead to proliferation of endothelial cells, mobilisation of circulating angiogenic 
cells, and microvascular changes. However, the degree to which hypoxia stimulates 
angiogenesis is unclear, and varies between tissue types, suggesting that local or intracellular 
factors (which may be substantially altered in chronic ischaemic conditions, like PAD) affect 
capillary endothelial responsiveness (Haas et al., 2012). There is limited evidence that exercise 
can increase circulating endothelial progenitor cells in people with IC (Schlager et al., 2011; 
Sandri et al., 2005), which could facilitate capillary growth or enhanced endothelial cell 
function.  
Figure 1.2 Proposed pathway of angiogenic changes in response to exercise-induced hypoxia 
 
VEGF, vascular endothelial growth factor. 
Evidence for the development of angiogenic pathways is largely based on animal models, and 
there is limited research on humans, particularly people with IC. Following an acute bout of 
exercise, individuals with IC demonstrate higher angiostatic factors (e.g., thrombospondin-1) 
that inhibit VEGF-induced capillary growth, and limited increase in extracellular VEGF and 
messenger RNA expression of angiogenic factors compared with healthy age-matched 
controls, which could limit the angiogenic potential (Hoier et al., 2013). 
Arteriogenesis. The enlargement of existing collateral blood vessels in response to increased 
blood flow, which is redistributed due to reduced downstream pressure, relies on increased 
shear stress combined with upregulation of key enzymes (e.g., nitric oxide, VEGF, vascular cell 
adhesion molecule, and fibroblast growth factor-2) that alter paracrine factors, which induce 
remodelling (Yang et al., 2008) (Figure 1.3). Preclinical mouse models demonstrate increased 
collateral blood flow, which is directly related to the intensity and duration of exercise training, 
and increased vessel luminal diameter in the presence of an isolated arterial occlusion (Prior et 

















al., 2013; De Vivo et al., 2005), possibly due to the impact of multilevel disease, which might 
reduce the development of an effective collateral circuit, insufficient exercise stimuli required 
to elicit vascular remodelling, and limitations of measures available to detect changes in 
collateral development and blood flow (Yang et al., 2008).  
Figure 1.3 Proposed pathway of vascular remodelling resulting from changes in blood flow 
during exercise 
 
FGF, fibroblast growth factor; NO, nitric oxide; VCAM, vascular cell adhesion molecule; VEGF, 
vascular endothelial growth factor. 
Endothelial function and inflammatory markers. An important factor related to both micro- 
and macrovascular adaptation to exercise is endothelial function. Exercise at intensities that 
induce IC coincides with an acute inflammatory response and endothelial damage, but, over 
the long-term, may curb inflammation (Tisi and Shearman, 1998) and stimulate vascular 
growth factor expression, potentiating angiogenesis (Palmer-Kazen et al., 2009). A recent study 
including 67 individuals with IC reported a 43% improvement in flow-mediated dilation, and 
reduced high-sensitivity C-reactive protein concentration following 12 weeks of supervised 
exercise therapy (Januszek et al., 2014). However, improvement in MWA was not associated 
with endothelial and inflammatory markers. An RCT including 156 participants reported a MD 
in flow-mediated dilation of 1.5% (95% CI 0.35–2.70%) following a 24 week supervised exercise 
programme compared to a control group, however participants in that study had 
asymptomatic PAD only (McDermott et al., 2009). 
Acute, ischaemia-inducing exercise is associated with increased inflammatory markers and the 
accumulation of reactive oxidative species in people with PAD, which may damage 
mitochondrial function, reduce energy production and increase apoptosis and sarcopenia. 
However, daily walking activity is associated with lower high-sensitivity C-reactive protein 
(Gardner et al., 2014) and ischaemic-reperfusion injury, including neutrophil activation and 
Exercise induced 
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free radical damage, was reduced following 3 months of treadmill exercise therapy in people 
with PAD (Turton et al., 2002), suggesting adaptations to exercise which curb the inflammatory 
response.  
Blood rheology. Macro- and microcirculatory blood flow is affected by properties of blood 
rheology, including haematocrit, blood and plasma viscosity, red cell aggregation, and 
filterability, which are compromised in individuals with PAD compared with controls, and 
normalised following walking exercise therapy (Ernst and Matrai, 1987). However, the data are 
quasi-experimental, and included a small sample size, and the prescribed exercise therapy 
exceeded guidelines at two bouts of graded treadmill walking per day, on 5 days of the week 
over 3 months. By contrast a randomised controlled trial comparing a standard treadmill 
exercise programme of 3 sessions per week to pain onset found no differences in haematocrit 
compared with a control group, although blood lipid profiles including high- and low-density 
lipoprotein levels improved among those in the exercise therapy group (Mika et al., 2011).  
Central cardiorespiratory fitness. Upper-limb arm ergometry exercise programmes 
demonstrate improvements in MWA and PFWA, suggesting a contribution of central 
cardiorespiratory adaptations to walking improvements, and not just local vascular and muscle 
adaptations to ischaemia-inducing lower-limb training (Parmenter et al., 2011). Both upper- 
and lower-limb exercise induced similar changes in cardiorespiratory fitness (i.e., oxygen 
consumption at pain onset and ventilator equivalent for oxygen uptake) which were 
significantly different from an inactive control, but not haemodynamic variables (e.g., blood 
pressure and heart rate) after 12-weeks of training, which were associated with MWA and 
PFWA (Bronas et al., 2011). 
Skeletal muscle adaptations. In addition to increased blood flow and circulating metabolic 
enzymes, skeletal muscle adaptations include improvements in strength and endurance 
following walking exercise. Wang et al. (2006) demonstrated increased calf muscle peak force, 




changes in peak force correlated with increased MWA (r=0.63, p<0.01) and PFWA (r=0.53, 
p<0.05).  
Gait alterations and walking economy. People with IC demonstrate greater variability in gait, 
longer stance time, and increased ground reaction force compared with healthy controls 
before and after the onset of symptoms during walking (Myers et al., 2011; Scott-Pandorf et 
al., 2007). Reduced walking speed and efficiency in people with PAD leads to increased oxygen 
demand. There is limited evidence for changes in gait kinematics following walking exercise 
(King et al., 2012), although reduced oxygen consumption at submaximal workload following 
training suggests improvements in overall walking economy (Milani and Lavie, 2007).  
1.7.6 Supervised versus home-based exercise therapy  
Evidence supporting walking treatment for IC is largely drawn from research on supervised 
exercise therapy, which is typically centre-based, structured and conducted on treadmills or a 
walking track (Watson et al., 2008). While supervised exercise therapy is a cost-effective 
treatment for IC (Treesak et al., 2004; Ambrosetti et al., 2004; Bermingham et al., 2013), 
programmes can be resource- and time-intensive, and are not widely available (Stewart and 
Lamont, 2001; Norgren et al., 2007). The estimated cost for initiating a physiotherapist-led 
supervised exercise programme in the NHS is £255 per person, and is a key barrier to 
implementation (NICE, 2014b). Only 24% of vascular surgeons in the UK have access to 
programmes which they could refer individuals with IC to, and the majority of available 
programmes are available only on 1 day per week, and so do not meet recommendations for 
IC management (Shalhoub et al., 2009).  
Due to the limited availability of supervised exercise therapy, individuals with IC often receive 
simple “go home and walk” advice (Makris et al., 2012) from a clinician (Stewart and Lamont, 
2007; Shalhoub et al., 2009). Content and detail of walking advice varies between vascular 
specialists (Makris et al., 2012; Bartelink et al., 2004); in a survey including 378 vascular 
surgeons, predominantly from the UK, 30% reported provision of general advice to people 




walking (Makris et al., 2012). Individuals with IC who recall walking advice are more likely to 
report walking; however, fewer than one-half and one-quarter achieved the optimal walking 
intensity and duration, respectively (Bartelink et al., 2004). Participants report a lack of specific 
walking advice as a barrier to initiating self-directed walking (Bartelink et al., 2004). Other 
barriers to walking identified among individuals with IC include a perceived lack of time, feeling 
tired, the need to stop and rest, and uneven walking terrain (Galea et al., 2008). Over 
6 months, walking advice is less effective than supervised exercise therapy in improving 
walking ability (Fokkenrood et al., 2013). 
Structured home-based exercise programmes could bridge the gap between supervised 
exercise therapy and walking advice. A narrative systematic review of 17 studies (10 RCTs and 
7 observational) including 1457 participants, supported structured home-based exercise for 
improving walking ability compared with baseline performance (n=7 studies) or usual care (n=5 
studies), although supervised exercise therapy was superior (n=6 studies) (Al-Jundi et al., 
2013). However, components of interventions varied and were poorly reported, so the 
mechanisms underpinning effective interventions cannot be determined. Also, treatment 
fidelity was not reported, including adherence to home-based exercise, which may impact 
intervention effectiveness. Finally, programmes were typically delivered by a researcher, 
although some reported delivery by a vascular specialist (e.g., nurse), exercise physiologist, or 
psychologist, but none described the training or experience of the professional delivering the 
intervention in behaviour-change methods. By contrast with clinical practice, few interventions 
were delivered by a physiotherapist, despite exercise prescription, health promotion, and an 
understanding of psychosocial factors that influence health behaviour, forming the scope of 
practice of physiotherapists (Health and Care Professions Council, 2013).  
A Cochrane review including 14 RCTs (n=1002 participants with IC) found greater effects of 
supervised exercise therapy on maximal (0.48, 95% CI 0.32 to 0.64) and pain-free walking 
ability (0.52, 95% CI 0.35 to 0.69) at 6-month follow-up compared with walking advice and 
structured home exercise (Fokkenrood et al., 2013). Rik of bias was generally low across 




were reported, and so a training effect favouring supervised exercise therapy cannot be ruled 
out, and only four studies evaluated adherence (i.e., the dose of exercise completed), which 
could affect walking ability.  
Gommans et al. (2014) also demonstrated superior effects for supervised exercise therapy, 
when compared with home-based exercise therapy, walking advice or a no-exercise control on 
maximal and pain-free walking ability at 6 weeks and 3 months in a meta-analysis of 30 studies 
(n=1406 participants with PAD). However, there was no difference between supervised 
exercise therapy and home-based exercise therapy at 6-month follow-up suggesting that 
either any effects of supervised, treadmill-based therapy were lost following programme 
discontinuation or that maintenance of home-based exercise therapy was superior or its 
effects occurred at a slower rate. 
In summary, home-based exercise therapy results in improvements in walking ability from 
baseline and greater improvements compared with walking advice alone. The effectiveness of 
supervised exercise therapy compared with other treatments may be diminished over the 
long-term. 
1.8 Conclusions 
 IC is a prevalent symptom of atherosclerotic PAD, associated with reduced walking 
ability, physical function, and health-related quality of life. 
 Supervised centre-based exercise therapy is an effective recommended treatment for 
IC, but is limited in availability, and relies on adequate attendance and adherence to 
self-directed walking post-discharge, which has not been demonstrated. 
 Home-based exercise therapy may be a viable, low-cost alternative to supervised 
exercise therapy, but evidence is based on low quality data, including poorly defined 





 Theory-based behaviour change and Chapter 2.
adherence to walking with IC 
Participation in both supervised and home-based exercise programmes require the individual 
to change their behaviour, for example by adopting a new regimen or changing their current 
exercise volume or intensity. Initial and continued behaviour change is crucial to the 
effectiveness of all exercise programmes for IC. Yet adherence to supervised centre-based 
exercise programmes is variable and short-lived (Lane et al., 2014), and individuals with IC do 
not maintain self-directed activity (i.e., walking behaviour) following discharge from a 
programme (Menard et al., 2004). While guidelines recommend supervised exercise therapy 
for IC, in practice, home-based walking is frequently advised (Norgren et al., 2007; Stewart and 
Lamont, 2001; Stewart and Lamont, 2007), and may present different challenges to short- and 
long-term behaviour change.  
Without intervention, walking behaviour and walking ability progressively declines among 
individuals with IC (Gardner et al., 2004), contributing to an increased risk of cardiovascular 
morbidity and mortality (Garg et al., 2006). While structured home-based walking may provide 
a viable alternative to supervised exercise therapy, adherence rates as low as 34% (Makris et 
al., 2012) could compromise the cost-effectiveness and commissioning of programmes 
(Bermingham et al., 2013). Despite being a significant problem, little is known about the 
factors associated with uptake or adherence to self-directed walking behaviour and improved 
walking ability among individuals with IC (Buck and Ciccone, 2004).  
Adherence to treatment, such as walking for IC, is a complex interplay between the individual, 
provider, and context, which is centred on behaviour (Miller, 2012). Within the NHS (provider), 
an important aspect of a walking programme is “supervision”; however, the type of instructor 
and volume of contact varies and is not accounted for in RCTs comparing supervised and 
home-based walking programmes; therefore, the role and degree of supervision required, 




and Koelemay, 2007; Watson et al., 2008). Sources of behaviour change related to the 
individual include capability (e.g., physical and psychological), opportunity (e.g., physical and 
social), and motivation (e.g., reflective and automatic processes) (Michie et al., 2011b), which 
should be targeted during interventions that promote walking for IC. Even once a regimen of 
walking is established, unexpected disruptions can interrupt or end previous routines 
(Dishman, 2001), so interventions are needed that equip individuals with the necessary skills 
and resources to adapt or adjust their behaviour.  
Factors that may contribute toward an understanding of behaviour change and adherence to 
walking among individuals with IC include 1) consistent reporting of intervention components 
that could contribute to increased walking and 2) the use of behaviour-change theory in the 
development and evaluation of interventions in order to facilitate walking uptake and 
adherence.  
2.1 Behaviour-change techniques and the systematic reporting of 
theory-based interventions  
A standardised format and language for reporting complex interventions, such as walking 
programmes for IC, could support syntheses of data, facilitate replication and adoption of 
novel treatments, and contribute to identification of intervention components, or 
combinations of components, that are producing an effect (Abraham and Michie, 2008). To 
address the need for standardised reporting, Abraham and Michie (2008) developed a 26-item 
taxonomy of theory-linked behaviour change techniques (BCTs) relevant to diet and physical 
activity, which was subsequently expanded and refined to include 40 distinct items (Michie et 
al., 2011a), and again to include 93 items (Michie et al., 2013).  
Items in the taxonomy target individual motivation, and range from simple tasks such as 
keeping a diary in order to monitor walking or setting behavioural goals, to complex 
psychological techniques including motivational interviewing (discussing and exploring with 
the individual ways to minimise resistance and ambivalence toward walking) (Rollnick and 




will engage in walking) (Gollwitzer, 1999). While the taxonomy is not exhaustive, it provides a 
standardised classification to assist in the reporting and synthesis of data from complex 
interventions.  
The 40-item taxonomy was applied in a review of 25 behaviour-change interventions targeting 
self-efficacy and physical activity (primarily walking) in healthy older adults (French et al., 
2014). Overall, 29 BCTs were identified, and interventions included, on average, 8 BCTs. 
Treatment effects on self-efficacy (d=0.37, 95% CI 0.22, 0.52) and physical activity (d=0.14, 95% 
CI 0.09, 0.20) were small to medium, and large effects were moderated by the inclusion of 
barrier identification with problem solving, providing rewards contingent on successful 
behaviour, and modelling or demonstration of the behaviour. However, 10 BCTs were 
associated with smaller physical activity effects, and 6 with both decreased self-efficacy and 
physical activity. High variability across data limits the interpretation of findings, and it is 
impossible to determine whether BCTs were delivered consistently and with fidelity to the 
treatment, or to discern whether effects were dependent upon combinations of BCTs.  
A review of behaviour-change interventions targeting physical activity in people with coronary 
artery disease identified 23 studies (Ferrier et al., 2011). Follow-up prompts, general 
encouragement, goal setting, and self-monitoring were techniques most frequently associated 
with increased physical activity following home-based programmes (n=7 studies). However, 
participants were mostly male, measures of physical activity varied and included non-validated 
tools, and study quality was low.  
To date, BCTs applied to walking interventions for IC have not been systematically identified or 
evaluated. 
2.2 Identifying and applying theory to behaviour-change interventions 
Identifying and understanding factors that predict and explain behaviour change might provide 
targets for interventions, and inform the selection of appropriate BCTs to facilitate home-




adherence (Michie et al., 2011b), which can be understood by exploring theory-based 
psychosocial variables that are proposed to influence health behaviour (Buckworth, 2000); 
evidence for predictive and causal links can then be applied in the design, implementation, and 
evaluation of interventions (Buckworth, 2000; Sutton, 2011; NICE, 2007). Both the Medical 
Research Council (MRC) and NICE endorse a theory-guided approach to behaviour-change 
interventions, and recommend the identification and assessment of psychosocial variables 
targeted by a programme (NICE, 2007; Craig et al., 2008). In particular, NICE proposes that 
interventions address individual beliefs, attitudes, intentions, skill, and knowledge associated 
with the target behaviour (NICE, 2007). However, there are multiple theories supporting 
behaviour change, considerable overlap among constructs between theories, and theories are 
limited in their description of the processes whereby behaviour change occurs (Abraham et al., 
2009). Therefore, identifying a relevant theory and strategies for implementing the theory can 
be a challenge during the early stages of intervention design. Criteria for selecting a theory to 
underpin an intervention include the following (Sutton, 2011):  
1) clearly defined constructs and causal relationships between constructs;  
2) substantial empirical support, including evidence that proposed determinants 
influence behaviour; and  
3) specification of how behavioural determinants can be modified.  
Few theories meet all criteria, and so the process of selection relies on a degree of 
compromise (Sutton, 2011). Two theoretical models, with clearly defined constructs and 
robust empirical support, are potential frameworks for underpinning an intervention to 
increase walking in people with IC: 1) the Theory of Planned Behaviour (TPB); and 2) the 
Common Sense Model of Illness Representations (CSM). 
2.3 The Theory of Planned Behaviour (TPB) 
The TPB (Ajzen, 1985; Ajzen, 1991) is a social cognitive model of the proximal determinants of 




(TRA) (Ajzen and Fishbein, 1980; Fishbein and Ajzen, 1975). The TPB proposes that human 
behaviour is inherently goal-directed, and implicit or explicit plans are prerequisites both for 
conscious and non-conscious behaviour enactment (Ajzen, 1985). Accordingly, intention is a 
proximal determinant of behaviour in the TPB framework. Intention represents a person’s 
motivation, goal, or conscious plan to perform (or attempt to perform) a behaviour, and 
provides an indication of the willingness and effort that is likely to be applied when attempting 
to engage in a behaviour (Ajzen, 1988). Within the TPB literature, intention has been 
conceptualised as a behavioural intention (e.g., “I will”), desire (e.g., “I want”), or behavioural 
expectation (e.g., “I am likely to”). Behavioural intention tends to be the strongest predictor of 
behaviour (Armitage and Conner, 2001), and is conceptually more distinct from other 
constructs within the model, whereas desire and expectation may be accounted for by attitude 
or perceived behavioural control (Sheeran, 2002).  
Figure 2.1 Schematic diagram of the Theory of Planned Behaviour (TPB) 
 
 
Intention is the function of a person’s attitude toward the behaviour and subjective norm, 
which account for volitional behaviour, consistent with the TRA (Ajzen and Fishbein, 1980; 
Fishbein and Ajzen, 1975). However, according to Ajzen (1985), “every intended behaviour is a 
goal whose attainment is subject to some degree of uncertainty” (pp. 24). Moreover, a 




















and behavioural goal attainment is contingent on the person’s perception of (and actual) 
control over the various factors that may prevent it (Ajzen, 1985). Therefore, perceived 
behavioural control is a key variable which distinguishes the TPB framework, and enables the 
model to account for non-volitional behaviour, such as engaging in walking treatment for IC. 
Attitude, subjective norm, and perceived behavioural control are constructs defined by 
expectancy-value conceptualisations, which form underlying behavioural, normative, and 
control beliefs, respectively. The strength and saliency of these underlying beliefs are products 
of anticipated outcomes of performing the behaviour and the value placed by the individual on 
those outcomes. The constructs and their underlying beliefs are conceptually and empirically 
associated and, with the exception of elicitation studies, direct measures of attitude, 
subjective norm, and perceived behavioural control constructs are typically reported (Ajzen, 
1985; Armitage and Conner, 2001).  
Attitude represents an individual’s positive or negative evaluation of a behaviour, and reflects 
the perceived likelihood of a salient outcome of performing the behaviour and the perceived 
value of that outcome. A person who anticipates mostly positive, valued outcomes of 
performing a behaviour will hold a favourable attitude toward the behaviour, and will be more 
likely to intend to perform the behaviour.  
Subjective norm is defined as the perceived social pressure regarding whether or not to 
perform a behaviour. This construct reflects the perceived approval or disproval by salient 
referents regarding the behaviour, and the individual’s motivation to behave consistently with 
those referents. Individuals who believe that others with whom they are motivated to comply 
(e.g., a close family member, healthcare professional, or group of friends) endorse their 
behaviour are more likely to intend to perform the behaviour. 
Perceived behavioural control represents the perceived ease or difficulty of performing a 




opportunities to perform the behaviour and potential obstacles, and the perceived power of 
each of those factors to facilitate or inhibit the behaviour. Individuals take into account 
internal and external influences of behaviour when forming control beliefs (Ajzen, 1988; Ajzen, 
1985). The predictive accuracy of perceived behavioural control hinges on the extent to which 
an individual’s assessment of internal (e.g., information, skills, emotions) and external (e.g., 
environmental barriers, cost) control factors is realistic and approaches actual control (Ajzen, 
1985). 
Perceived behavioural control has been compared to the construct self-efficacy, defined as an 
individual’s confidence in their ability to perform a task in order to achieve a defined outcome 
(Bandura, 1997; Bandura, 1986). Perceived behavioural control and self-efficacy are 
correlated; however, TPB studies applying both constructs suggest that they are empirically 
distinct, and independently predict exercise and physical activity behaviour (Hagger et al., 
2002b; Rodgers et al., 2008; Motl et al., 2005), although evidence is based largely on healthy 
populations, and may not reflect walking in people with IC. Despite their conceptual 
distinction, measures of perceived behavioural control frequently include items assessing 
confidence and controllability, potentially accounting for a degree of self-efficacy.  
The relative importance of attitude, subjective norm, and perceived behavioural control in the 
formation of a behavioural intention can vary depending on the context and behaviour (Ajzen, 
1991). In instances where volition is compromised (for example, due to personal or 
environmental barriers), perceived behavioural control also acts as 1) a direct determinant of 
behaviour wherein perceived behavioural control increases in predictive strength, relative to 
intention, as the extent of volitional control over the behaviour decreases; and 2) a moderator 
of the intention–behaviour relationship, such that greater perceived behavioural control is 
associated with a stronger intention–behaviour relationship (Ajzen, 1991). Meta-analyses of 




interactive effect of intention and perceived behavioural control has not been consistently 
demonstrated (Armitage and Conner, 2001; Ajzen, 1991).  
2.3.1 The TPB as a framework for explaining exercise and physical activity  
A comprehensive review and meta-analysis including 185 tests of the TPB reported an 
explained variance of 27% and 39% in intention and behaviour, respectively, with medium to 
large sample-weighted univariate effects of TPB constructs (Armitage and Conner, 2001). 
Perceived behavioural control added 2% of variance in behaviour, when controlling for 
intention. However, high variability was reported around the main effects, and findings 
reflected a range of behavioural outcomes including those not related to health.  
The TPB has been applied extensively to health-related behaviour, and in particular to exercise 
and physical activity (Hausenblas et al., 1997; Hagger et al., 2002b; Godin and Kok, 1996; 
McEachan et al., 2011). In an early review, including 31 studies, attitude (r=0.39) and perceived 
behavioural control (r=0.45) demonstrated the largest correlations with intention, followed by 
subjective norm (r=0.09); intention (r=0.47) and perceived behavioural control (r=0.45) both 
demonstrated large associations with exercise or physical activity behaviour (Hausenblas et al., 
1997). However, most (n=18) studies evaluated the TRA, and so did not report data on 
perceived behavioural control, and just four studies reflected clinical samples (i.e., individuals 
with cardiovascular disease). Also, zero-order effects of predictor variables on intention and 
behaviour were evaluated, ignoring the shared statistical variability across TPB constructs.  
In a subsequent review, Hagger et al. (2002b) applied multivariate techniques to data from 
72 studies evaluating the relationship between TPB constructs and physical activity behaviour, 
correcting for statistical artefacts including measurement error, sampling, and inter-
correlations between variables. Path analyses demonstrated a good fit of the TPB models 
predicting intention (2[3]=246.6, p<0.01) and behaviour (2[2]=15.57, p<0.01). Overall, 45% of 
the variance in intention was explained, with the greatest contributions by attitude and 




norm (β=0.05, p<0.01). Intention (β=0.43, p<0.01) and perceived behavioural control (β=0.15, 
p<0.01) together accounted for 24% of the variance in physical activity behaviour. However, 
most data reflected younger, healthy subjects (e.g., student samples), and so findings might 
not reflect older adults with long-term conditions, like IC. In addition, there was high variation 
and heterogeneity of distributions of the correlations across studies, suggesting that there may 
be factors which affect the consistency of associations between studies. 
McEachan et al (2011) meta-analysed data from 237 prospective tests of the TPB applied to 
health behaviour, including 103 reflecting physical activity. Results were adjusted for measures 
of past-behaviour, type of behaviour, participant age and duration of follow-up. Attitude 
(r=0.51), subjective norm (0.32), and perceived behavioural control (0.47) were associated 
with physical activity intention, after adjusting for sampling error. The model predicted 24% of 
variance in physical activity behaviour (β=0.42 and 0.11 for intention and perceived 
behavioural control, respectively). The inclusion of past behaviour (section 2.3.2) explained an 
additional 10% variance (adjusted R2=0.34), was the strongest predictor (β=0.038) of physical 
activity behaviour, and attenuated the effect of perceived behavioural control (β=0.07), but 
not intention (β=0.22). Overall, the TPB was best at predicting physical activity behaviour, 
improved when the duration of follow-up was <5 weeks, and was not affected by participant 
age. 
The systematic reviews described above evaluate a range of exercise and physical activity 
behaviours, and might not apply to decisions to engage in walking. French et al. (2013) 
identified seven reports of the TPB (n=1228) evaluating walking intention, including one study 
of individuals with IC (Galea and Bray, 2006). Sample weighted mean correlations for attitude, 
subjective norm, and perceived behavioural control were r=0.33, 0.30 and 0.47 (all p<0.001), 
respectively, and suggest that control beliefs might be particularly influential when planning 
walking. However, data on behaviour were not reported, and only one study reported a 




Overall, systematic reviews of studies applying the TPB to exercise, physical activity, and 
walking, suggest that perceived behavioural control may be just as important as attitude in 
accounting for behavioural intention. Subjective norm is frequently the weakest predictor of 
intention, however this could be due to the use of less reliable single-item measures. Intention 
is consistently the strongest predictor of behaviour, with perceived behavioural control 
demonstrating small but significant direct effects on behaviour when controlling for intention; 
applications of the TPB to walking in particular suggest perceived behavioural control may be 
especially salient.  
2.3.2 The role of past behaviour in the TPB 
Past behaviour provides an approximation of the degree to which a behaviour is routine, or 
habitual. Routine behaviour, formed through context-dependent repetition, shifts behavioural 
enactment from conscious, effortful, and goal-driven actions, toward automatic non-conscious 
processes that are reliant on situational cues and implicit cognitions (Sheeran et al., 2013). 
Past behaviour demonstrates large associations with current or future behaviour and is 
frequently the strongest predictor of intention or behaviour in TPB studies (Hagger et al., 
2002b). There is disagreement on how past behaviour should be defined within the TPB (Ajzen, 
2002b); however, the following proposals have been evaluated: 1) past behaviour, particularly 
behaviour frequency, is defined as an indicator of habit and has a direct causal influence on 
behaviour, independent of TPB variables; 2) other unmeasured variables exist which mediate 
the effect of past behaviour on intention and behaviour, and reported effects are therefore a 
result of common residual variance; or 3) past behaviour reflects temporal stability of 
behaviour and has no causal influence on behaviour, and should be statistically controlled to 
provide a true approximation of the effects of TPB variables on subsequent behaviour (Rhodes 
and Courneya, 2003). There is limited evidence comparing the various pathways for past 
behaviour to impact cognitions and behaviour within in the general TPB literature, and 




however, data from the wider TPB literature demonstrate the importance of accounting for 
past behaviour when evaluating and applying the TPB model.  
2.3.3 The intention–behaviour gap: proximal determinants of behaviour  
The basic tenets of the TPB have been widely supported; however, systematic reviews 
demonstrate that the model is consistently better at explaining intention than behaviour. This 
lack of correspondence, in particular where positive intentions to engage in a behaviour lead 
to subsequent inaction, has been termed the “intention–behaviour gap” (Orbell and Sheeran, 
1998). Evidence of the intention–behaviour gap is drawn primarily from observational studies; 
however, a report of 11 RCTs of interventions targeting physical activity (Rhodes and Dickau, 
2012a) demonstrated that a large effect of behaviour-change interventions on intention 
(d=0.45, 95% CI 0.30, 0.60) translated into a small effect on behaviour (d=0.15, 95% CI 0.06, 
0.23), and suggests an important challenge for the development of effective walking 
programmes.  
Research has sought to identify potential moderators or mediators which might improve the 
intention–behaviour relationship. Rhodes and Dickau (2012b) identified 57 cross-sectional and 
prospective observational studies evaluating intention moderation in the domain of physical 
activity behaviour. The most consistent moderators were intention stability, anticipated regret, 
and conscientiousness; however, data were limited and heterogenous, with small numbers of 
studies evaluating each moderator, and a meta-analysis could not be performed. Additionally, 
outcomes included self-reported measures of behaviour which could inflate the intention–
behaviour relationship (Scott et al., 2007), and studies included healthy individuals only 
limiting the applicability of findings to people with IC.  
2.3.4 Self-regulatory processes and volitional control of behaviour 
Research addressing the intention–behaviour gap has explored self-regulatory processes as 
proximal determinants of behaviour. Behaviour may be conceptualised as including two 
distinct and sequential processes: a motivational phase and volitional phase (Schwarzer, 2014). 




based on salient beliefs (e.g., behavioural, normative, and control beliefs). The volitional phase 
encompasses planning, action and maintenance of behaviour and requires specific strategies 
for execution not described within the TPB, and which reflect self-regulatory processes. 
According to Ajzen (2011), the ability to self-regulate represents an aspect of actual control 
over behaviour, and could therefore improve the accuracy of perceived behavioural control 
and the likelihood of performing a behaviour. Self-regulatory processes which have been 
described and evaluated within the TPB include action planning and action control.  
Action planning is a BCT that involves detailed planning of a behaviour, including when (e.g., 
frequency and duration), where, and/or the situation in which a behaviour will be enacted 
(Michie et al., 2011a; Leventhal et al., 1965). This prospective, self-regulatory process  involves 
activation of a mental representation of a behaviour, prompting the individual to consider the 
sequence of actions required in order to achieve a complex behaviour, such as walking, and to 
recognise opportunities to act (Sniehotta et al., 2005b; Gollwitzer, 1999). Action planning may 
be particularly salient when initiating a behaviour (Gollwitzer, 1999), and increases the 
likelihood of a behaviour by automatising behaviour, and thereby reducing deliberation when 
an opportunity to engage in the behaviour arises. Thus, a shift is made from conscious, 
effortful control over behaviour toward automatic control determined by situational cues 
(Gollwitzer, 1999). Interventions targeting action planning demonstrate a small to medium 
effect (standardised MD=0.31, 95% CI 0.11, 0.51) on physical activity, and a maintained effect 
over 12 weeks (standardised MD=0.24, 95% CI 0.13, 0.35) (Belanger-Gravel et al., 2013). In an 
extended TPB model, action planning independently (OR=3.37, 95% CI 1.04, 10.95) 
distinguished attenders from non-attenders of community-based cardiovascular rehabilitation 
(R2=0.36, p<0.001), alongside intention and perceived behavioural control (Sniehotta et al., 
2010). Action planning predicted self-reported exercise (β=0.28, p<0.01) at 4 months following 
outpatient cardiovascular rehabilitation, and fully mediated the effect of intention on exercise 
in a sample of 307 individuals (Sniehotta et al., 2005a). However, the model did not account 




contribution to 4-month self-reported physical activity (total R2=0.20) among 352 individuals 
with coronary artery disease, controlling for age, physical activity, and intention (Sniehotta et 
al., 2005b). However, participants reported high levels of physical activity, and action planning 
is proposed to be most salient when initiating behaviour. Findings therefore may not 
generalise to populations who are physically inactive, such as those with IC.  
Action control is the conscious self-regulation of behaviour change comprising three distinct 
processes: awareness of standards, self-monitoring and self-regulatory effort (Karoly, 1993; 
Sniehotta et al., 2006). Two longitudinal studies provide evidence that self-regulatory 
processes may support the translation of intention to behaviour. de Bruin et al. (2012) 
employed bootstrapping to demonstrate that self-monitoring and self-regulatory effort at least 
partially mediated the relationship between intention and 3-month self-reported vigorous 
physical activity in 499 healthy adults. The mediating effect was maintained after controlling 
for significant covariates, including past behaviour, self-efficacy, and gender. However, 
awareness of standards was not assessed, and the sample was biased to participants who 
were more educated, younger, and had higher self-efficacy at baseline compared with those 
who were lost to follow-up, limiting the external validity of findings. Action control predicted 
change in intention and self-reported physical activity over 6 weeks in 122 individuals 
discharged from an outpatient cardiovascular rehabilitation programme (Sniehotta et al., 
2006). In particular, self-monitoring and self-regulatory effort were modifiable constructs, 
whereas awareness of standards was unchanged over the assessment period. Findings may be 
particularly relevant when facilitating home-based exercise following a supervised centre-
based programme. 
The TPB is a viable behaviour-change framework, which has been evaluated in the context of 
exercise, physical activity, and walking. Attitude, subjective norm, and perceived behavioural 
control explain intention, whereas factors bridging the intention–behaviour relationship, 




pertaining to a behaviour (e.g., engaging in walking treatment for IC). Among individuals with 
long-term conditions, such as PAD, cognitions reflecting their illness may also contribute to an 
understanding of behaviour-change, and are defined by the CSM.   
2.4 The Common Sense Model of Illness Representations (CSM) 
The CSM (Leventhal et al., 1980; Leventhal et al., 1984) (Figure 2.2) was developed from 
research describing the interaction between a health threat, which evoked fear or a perception 
of danger and an action plan, which outlined a behavioural coping strategy to reduce that 
threat. Individuals who were exposed to a health threat and provided with an action plan for 
coping with the threat were more likely to engage in the coping behaviour compared with 
individuals who were not exposed to the threat (Leventhal et al., 1965). Assumptions 
underlying the evolving theory were: a) that people are motivated to avoid and reduce health 
threats and b) that people are active, self-regulating problem solvers with regard to their 
health.  
A health threat is established and shaped by at least three sources: a) somatic stimuli (i.e., 
symptoms); b) information based on past experience of illness; and c) information provided by 
various media and social sources, including family, friends and healthcare professionals 
(Leventhal et al., 1980). Information forming a health threat is processed cognitively as 
perceived representations of danger and emotionally as representations of fear. The 
integration of information is hierarchical, occurring at both concrete and abstract levels, such 
that individuals identify their illness by symptoms (e.g., leg pain) and by labels for those 
symptoms (e.g., “intermittent claudication”) through an iterative process to form an implicit, 





Self-regulation is a key process underlying the CSM, and comprises the processes of action 
planning and action control (Section 2.3.4). According to Leventhal et al. (2003), in the context 
of a health-related behaviour, such as walking treatment for IC, what is being regulated is the 
physical being and functional resources of the self, in the pursuit of identified goals.  An illness 
representation is essential to the self-regulation of behaviour as it comprises the goals for 
danger or fear control, strategies for control, the criteria for appraising success and ongoing 
perceptions of response efficacy (Leventhal et al., 2003; Leventhal et al., 1984). For example, 
an individual with IC might reduce walking to avoid or minimise pain, or seek further advice or 
treatment.  
The CSM is a parallel processing model, wherein cognitive and emotional processes can be 
developed simultaneously and independently, but can interact with one another such that 
emotional reactions can impact perceived symptoms, coping, and the evaluation of coping 
responses (Leventhal et al., 1984). Cognitive representations of the illness can generate an 
emotional response, based on the abstract label of the illness (e.g., narrowed arteries) and the 
concrete features (e.g., leg pain, cold feet) (Leventhal et al., 1984). Throughout the self-





















strategies and incorporate this information to their illness representation, which may 
therefore develop and change over time.  
2.4.1 Components of illness representations 
Leventhal et al. (1984) described at least four attributes which comprise an illness 
representation, and which mediate the relationship between a health threat and coping 
response (Figure 2.2). These include identity (i.e., the abstract label given to the disease and 
concrete symptoms that define the illness, such as “IC” or “leg pain”), timeline (i.e., the extent 
to which the illness is perceived as acute, episodic [recurrent] or chronic), consequences (i.e., 
the perceived severity of the illness and possible impact on physical, social and psychological 
functioning), and cause (i.e., the extent to which the cause of illness is attributed to personal 
or external factors). The components of an illness representation have been refined 
psychometrically to incorporate illness coherence (i.e., a meta-cognition representing the 
individuals understanding of their illness and the plausibility of their illness representation), 
and perceptions about control and cure of illness, initially reflected by a single construct 
(“control/cure”), then distinguished as personal control (i.e., the perceived confidence in one’s 
ability to control their condition), and treatment control (i.e., the perceived efficacy of health 
advice or treatment), respectively (Moss-Morris et al., 2002). 
2.4.2 The CSM, coping responses, and illness outcomes 
Research on the CSM has focused on the relationship between illness representations and 
coping responses, and has explored a range of psychosocial, functional and behavioural health 
outcomes associated with illness.  
In a meta-analysis of 45 observational studies of illness representations reflecting 23 illnesses, 
higher illness identity, perceived consequences and chronic timeline were associated (range 
r=0.12 to 0.23, p<0.05) with maladaptive coping strategies (e.g., avoidance/denial and 




0.27, p<0.05) with adaptive coping strategies (e.g., cognitive reappraisal, problem-focused 
coping and seeking social support) (Hagger and Orbell, 2003). Identity and consequences were 
inversely associated (r=0.18 to 0.67, p<0.05) with health outcomes (e.g., physical functioning, 
psychological well-being, role functioning, social functioning, vitality, and lower psychological 
distress), while chronic timeline and control/cure were positively related (r=0.11 to 0.24, 
p<0.05). Few studies evaluated exercise or physical activity as a behavioural coping strategy, or 
objective measures of physical functioning, and no studies included people with IC. 
Additionally, high error variance could not exclude the possibility that moderating variables 
accounted for many of the associations observed. Finally, causal attributions, coherence, and 
emotional illness representations were not evaluated. 
2.4.3 The CSM as a framework for explaining exercise and physical activity 
The CSM has been applied in the context of supervised exercise therapy for cardiovascular and 
cardiopulmonary diseases. A systematic review of eight cross-sectional and prospective 
correlational studies, including 906 individuals with newly diagnosed coronary artery disease, 
suggested a greater illness identity, and more positive beliefs about consequences, cure or 
control, and coherence predicted attendance at cardiovascular rehabilitation (French et al., 
2006). Effect estimates were small (range r=0.084 to 0.160), and only cure or control had a 
significant effect on attendance after correcting for measurement error and unequal numbers 
of attenders versus non-attenders. Causal attributions were not evaluated due to 
measurement inconsistencies and lack of data, and attendance at rehabilitation, which 
provides a surrogate measure of exercise adherence, was defined as “at least one session” in 
seven studies and “at least 50% of sessions” in one study, and thus may not reflect regular 
exercise participation that achieves the recommended dose for health benefits (Department of 
Health, 2011). 
A prospective, observational study including 96 individuals with chronic obstructive pulmonary 
disease (COPD) explored the effect of baseline illness cognitions on 6MWD following 




evaluated, and reflected the sum of scores obtained for illness perception constructs on the 
Revised Illness Perception Questionnaire (IPQ-R) (Chapter 3), a 70-item scale which 
demonstrates test-retest reliability up to 6 months, and is validated in populations with acute 
and chronic illness (Moss-Morris et al., 2002). Baseline illness representations explained 12% 
of variance in 6MWD (β=-0.43, p<0.05), after controlling for age, gender, depressive 
symptoms, anxiety, COPD severity, and baseline 6MWD (R2 adjusted=0.77, p<0.01). 
Perceptions of COPD as cyclical and acute, and a negative emotional response were correlated 
with shorter 6MWD, but no associations with positive illness perceptions were found. Causal 
attributions and illness identity were not evaluated, which are important constructs defined by 
the CSM, and although the composite illness representation scale had good internal 
consistency (Cronbach’s a=0.82), further psychometric properties were not reported, and the 
small sample size meant the study may not have been powered to evaluate effects of 
independent constructs.   
2.5 The TPB and CSM applied to interventions targeting exercise and 
physical activity 
Despite its utility for explaining and predicting exercise and physical activity, the TPB lacks 
explicit instruction on how to modify variables and change behaviour, and therefore its 
suitability for intervention development has been questioned (Sutton, 2002). However, a 
review identified 24 TPB interventions across a range of health behaviours, which 
demonstrated small effects on intention and behaviour. Among studies which applied the TPB 
during the intervention development, 42% and 33% reported an effect on intention and 
behaviour, respectively (Hardeman et al., 2002). BCTs included providing information, 
persuasion, goal setting, skill rehearsal, modelling, planning and implementation, and social 
support. Most studies included TPB variables as outcomes, but did not apply the TPB to 
develop the intervention or assess change in TPB cognitions. In addition, few studies targeted 
individuals with or at risk for long-term illness, among which none addressed exercise or 




Two subsequent trials draw on the TPB systematically to develop exercise or physical activity 
interventions. The ProActive trial evaluated a behaviour-change intervention targeting TPB 
cognitions and volitional processes (Williams et al., 2004) that aimed to bridge the intention–
behaviour gap in order to increase physical activity among sedentary individuals at risk for type 
II diabetes mellitus. BCTs included goal setting and review, action planning, self-monitoring, 
follow-up prompts, and reinforcement. Compared with a brief information leaflet promoting 
physical activity, both face-to-face and telephone-delivered versions of the intervention were 
unsuccessful at increasing 12-month physical activity measured by objective heart rate 
monitoring (Kinmonth et al., 2008). In addition, the intervention arms demonstrated only small 
effects on attitude, perceived behavioural control, and intention to increase physical activity at 
6 months (Hardeman et al., 2009). Data on fidelity of treatment delivery indicated that only 
one-half of BCTs were applied by intervention facilitators, which may explain these results.  
Darker et al. (2009) evaluated a TPB intervention including a motivational phase that targeted 
control beliefs and self-efficacy to engage in walking, and a volitional phase applying goal 
setting, action planning, and coping planning strategies in a cross-over waiting list study. The 
intervention had a large effect (d=0.90; mean 19.8 to 32.2 minutes/day of walking) on 
pedometer walking 1 week post-intervention, and behaviour was higher at 6 weeks versus 
baseline in sedentary adults. The effect of the intervention on intention was mediated in part 
by perceived behavioural control and attitude, and the effect on behaviour was mediated by 
perceived behavioural control, but not intention or action planning. However the study design 
limits the between-group comparisons at follow-up. 
Both studies demonstrate the feasibility of applying the TPB to interventions, but draw on 
multiple theories to enlist behaviour-change strategies. For example, Darker et al. (2009) 
incorporated self-efficacy, and used BCTs described by Social Cognitive Theory, including past 
performance and mastery experiences. The ProActive trial was underpinned by the Self-




Finally, both studies targeted sedentary at-risk populations, and conclusions cannot be drawn 
about the application of TPB interventions in individuals with established, long-term 
conditions, such as IC.  
The CSM has been applied less extensively to interventions targeting exercise and physical 
activity. A brief inpatient intervention, comprising four individual 30 minute sessions based on 
the CSM, and delivered by a health psychologist increased return to work, illness coherence, 
accuracy of causal attributions, intention to attend cardiovascular rehabilitation, and self-
reported strenuous physical activity at 3 and 6 months among participants following a 
cardiovascular event (n=52) compared with a usual care group (n=51) (Broadbent et al., 2009). 
However, physical activity was not measured by a validated tool nor was it explicitly targeted 
by the intervention, and so the effect on physical activity may be attributable to processes 
other than those proposed by the CSM.  
While research has evaluated TPB- or CSM-based interventions for increasing exercise or 
physical activity, findings are equivocal, and there is limited research specifically evaluating 
their effects on walking, and particularly among individuals with IC, described below.  
2.6 The TPB and CSM applied to walking among individuals with IC 
The TPB has been applied to two studies evaluating walking among individuals with IC. In both 
studies, attitude, subjective norm, and perceived behavioural control predicted 67% of 
variance in walking intention (Galea and Bray, 2007; Galea and Bray, 2006). However, the 
utility of the model for predicting walking behaviour was mixed. In one study perceived 
behavioural control explained 8% of variance in prospective self-reported walking behaviour 
during the upcoming week with no contribution by intention (Galea and Bray, 2006), 
suggesting an intention–behaviour gap. Potential mediators of the intention–behaviour 
relationship were not explored in these participants who were predominantly conservatively 




In the second study, 34% of variance in self-reported walking behaviour during the upcoming 
4 weeks was explained by both intention and perceived behavioural control, providing support 
for the full TPB model. The increase in variance explained may be because the measure of 
walking frequency and duration was obtained from a validated physical activity scale (Physical 
Activity Scale for the Elderly [PASE]) (Washburn et al., 1993) and combined with a longer 
measurement period, which may have provided more accurate data on walking. However, past 
walking behaviour was not assessed, which could attenuate the effect of TPB variables on 
future behaviour (McEachan et al., 2011).  
The CSM might further explain walking, but has not been widely researched among people 
with IC. Cunningham (2010) assessed illness cognitions using the Brief Illness Perceptions 
Questionnaire, a 9-item measure which demonstrates 6 week test-retest reliability and 
concurrent validity with the IPQ-R (Broadbent et al., 2006; Moss-Morris et al., 2002), walking 
personal control, and outcome expectations in 71 individuals with IC. Participants completed a 
single item evaluating their average frequency of walking for at least 30 minutes. Walking and 
illness cognitions were accurate in distinguishing those who met walking guidelines (i.e., 
reported walking for 30 minutes on at least 3 days of the week) from those who did not in 
93.4% of cases. However, only walking personal control, a variable devised for this particular 
study, and akin to perceived behavioural control as defined by the TPB, emerged as a 
significant determinant among variables included in that model (OR 22.3, 95% CI 1.34, 369.50, 
p=0.030), and there was insufficient evidence for the utility of illness cognitions in further 
explaining walking behaviour. Modifications to questionnaire items to reflect participants’ 
beliefs about their IC symptoms (i.e., “cramping leg pain”), rather than their illness may explain 
these findings. According to the CSM, symptoms act as a cue, leading to illness 
representations, coping responses and outcome evaluations of coping (Leventhal et al., 1984; 
Leventhal et al., 1980). Therefore, perceptions of symptoms (i.e., IC) might not capture 
participants’ wider illness representations (i.e., PAD). Additionally, a non-validated single-item 




of its psychometric properties, which may not provide an accurate estimate of physical activity 
(Ainsworth et al., 2012).  
The CSM has been applied to one pilot RCT to promote walking behaviour in individuals with IC 
(Chapter 4). A brief individual intervention comprising two 60 minute sessions and two booster 
telephone calls delivered by a researcher increased pedometer walking behaviour at 4, 12 and 
24 months (MD at 24 months 1,630 steps, 95% CI 495, 2,765), and reduced the likelihood of 
angioplasty or surgery (OR over 24 months 3.09, 95% CI 1.06, 9.04) compared with usual care 
among 58 individuals newly diagnosed with IC (Cunningham et al., 2012; Cunningham et al., 
2013). However, revascularisation moderated the effect of the intervention on daily walking 
behaviour, suggesting that long-term effects may be dependent upon subsequent 
revascularisation. While the intervention improved illness identity and personal control at 
4 months compared with the control group, there were no changes in other illness 
perceptions, and treatment fidelity was not evaluated, therefore the processes of change are 
unclear. 
2.7 Comparison and integration of theoretical models 
The TPB and CSM are widely supported models for understanding and explaining health-
related behaviour. Most research on individual health behaviour change has been informed by 
a single theoretical model; however, observational and interventional studies have increasingly 
applied multiple theoretical frameworks (Noar and Zimmerman, 2005). Studies of multiple 
theories, allowing comparisons between models, and enabling synthesis of or differentiation 
between constructs across models may contribute to the progress of health behaviour 
research, leading to identification of the best conceptualisation of constructs and of how 
constructs combine and result in behaviour change (Noar and Zimmerman, 2005).  
Both the TPB and CSM describe implicit and explicit cognitive processes that drive health 
behaviour. However, the CSM describes thoughts and beliefs pertaining to an illness, and in 




behaviour, but does not explicitly account for the illness or health threat.  Among individuals 
with long-term conditions, such as IC, both illness and walking treatment cognitions could play 
a role in determining health behaviour change, such as increasing walking. Existing theories 
incorporating illness and treatment cognitions reflecting exercise or physical activity (e.g., 
Health Belief Model, Protection Motivation Theory, Health Action Process Approach) are less 
robust compared with the TPB (Plotnikoff and Trinh, 2010) and lack evidence supporting their 
utility for understanding walking motivation among individuals with IC. In addition, theories 
define illness cognitions as perceived severity or susceptibility only, potentially failing to 
account for the range of illness cognitions that determine behaviour change among individuals 
with IC (Chapter 6). By contrast, the CSM defines illness cognitions as perceptions regarding 
symptomology, causality, control or cure, timeline, consequences, and coherence, and 
accounts for the emotional response to an illness threat, which determine a coping response, 
such as walking as treatment for IC. Therefore, evaluating walking treatment cognitions 
defined by the TPB alongside illness cognitions defined by the CSM could provide a powerful 
model for understanding walking among individuals with IC. 
Sneihotta et al. (2010) tested a combined TPB and CSM model in people with coronary artery 
disease, wherein the effect of illness representations on coping was mediated by an “extended 
TPB model” comprising proximal TPB variables (i.e., intention, perceived behavioural control) 
and action planning. Cognitions were measured in the final weeks of hospital-based outpatient 
cardiovascular rehabilitation, and their utility to predict self-reported physical activity and 
attendance at a community-based cardiovascular rehabilitation programme 2 months later 
was examined in a series of linear and logistic regression models. Individually, both the TPB 
and CSM were weak predictors of physical activity, rendering the full hypothesis untenable; in 
a regression analysis combining constructs from both models, only perceived behavioural 
control (from the TPB) and timeline cyclical (from the CSM) made independent contributions 
to the overall model, adding just 5% of explained variance in physical activity beyond past 




at least 1 session) to community-based cardiovascular rehabilitation in a binary logistic 
regression, with intention and action planning providing significant independent contributions. 
However, the sample was small (n=95), and predominantly (73%) male, and a short version of 
the Illness Perceptions Questionnaire was used, which exhibited poor reliability for two 
subscales assessing personal and treatment control.  
Leventhal (2010) suggested that both treatment and illness beliefs should be targeted in order 
to change behaviour; however, to date, few studies have applied the TPB and CSM together to 
develop and evaluate interventions. The present research will build on previous evidence, 
evaluating walking treatment and illness cognitions defined by the TPB and CSM, respectively, 
to inform the development and evaluation of a behaviour-change intervention targeting 
walking in people with IC. 
2.8 Conclusions 
 BCT taxonomies may contribute to the systematic reporting, evaluation, and 
development of walking interventions among individuals with IC. 
 The TPB and CSM are widely supported models for understanding and explaining 
health behaviour, including walking behaviour and ability. 
 To date, the TPB and CSM have not been applied together to explain, evaluate, or 






The purpose of the current research is to develop and evaluate a physiotherapist-led 
behaviour-change intervention targeting self-directed walking in people with IC. MRC 
guidelines identify four key elements of the development and evaluation process for complex 
interventions (Craig et al., 2008) (Figure 3.3). Acknowledging that the process can vary in its 
sequence, and in the emphasis placed on various elements, the current research focuses on 
a) development (e.g., identifying the evidence base, identifying and developing theory) and 
b) feasibility and piloting (e.g., testing procedures for a definitive trial). 
Figure 2.3 Key elements of intervention development and evaluation processes according to 
Medical Research Council guidelines 
 
Reproduced from Craig et al. (2008) with permission from the BMJ Publishing Group, Ltd. 
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The objectives of this thesis are:  
a) to identify and evaluate evidence for theory-based behaviour-change techniques 
that have been applied walking interventions for people with IC;  
b) to explore of the experiences of and beliefs about illness and treatment among 
individuals with IC;  
c) to evaluate constructs defined by the TPB and CSM as determinants of walking 
intention and objective walking ability; and 
d) to develop and assess the feasibility and acceptability of an RCT of a 
physiotherapist-led home-based behaviour-change intervention targeting walking 





 Selection and evaluation of methods and Chapter 3.
measures 
3.1 Introduction 
MRC guidelines outlining the development and feasibility testing of complex interventions, 
such as walking interventions for IC, recommend combining qualitative and quantitative 
methods to identify the evidence base, develop appropriate theory, and model processes and 
outcomes in advance of a definitive trial (Craig et al., 2008). This research employs a mixed-
methods approach, and follows a pragmatic epistemology, wherein the method for a single 
study is matched to the research question, and qualitative or quantitative methods are distinct 
but corresponding in their overarching goal (Yardley and Bishop, 2015). A strength of using 
mixed-methods is the plurality of approaches, which accommodates complex research 
questions, and encourages creativity and adaptability in research conductance (Hesse-Biber 
and Johnson, 2013).  
Qualitative methods applied during this thesis include: 
 the Framework Method. 
Quantitative methods evaluate three areas relevant to the research question and individuals 
with IC:  
 Walking; 
 Theory-based constructs; and 
 Descriptive clinical variables.  
Qualitative methods can be applied at all stages of intervention development and evaluation 
(Nastasi and Schensul, 2005; Craig et al., 2008), and can illuminate processes underpinning 
intervention effects, and redirect or reframe future research (Sandelowski, 2004; Speller et al., 
1997). Data on the lived experiences and beliefs of individuals with IC, pertinent to walking, 




be targeted by interventions (Chapter 5). During intervention evaluation, qualitative research 
may reveal the processes underpinning intervention effects, determine the acceptability of the 
study protocol and intervention, and identify areas to address before further research or 
implementation (Chapter 8) (Craig et al., 2008).  
Qualitative studies exploring walking in individuals with IC have applied Thematic methods to 
analyse and interpret data (Galea et al., 2008; Gorely et al., 2015; Cunningham et al., 2014). 
Thematic analysis identifies consistencies and contradictions within data, elucidates 
relationships across data, and draws descriptive or explanatory conclusions that cluster around 
themes (Braun and Clarke, 2006; Gale et al., 2013). Strengths of this approach include its 
parsimony and flexibility, including applicability across epistemologies and theoretical 
frameworks, and a balance of inductive and deductive methods. However, it has frequently 
been applied and reported inconsistently, and while Thematic analysis permits the use of a 
priori theory-driven codes, the guidelines for this approach are unclear (Braun and Clarke, 
2006).  
One approach, which has not yet been applied to research involving people with IC, is the 
Framework Method, which is underpinned by Thematic analysis and characterised by a 
systematic procedure of organising data (Ritchie and Spencer, 1994; Gale et al., 2013). The 
early stages of data management may be largely deductive, and permit a priori codes, making 
the Framework Method suitable for theory-driven research with predefined objectives (Pope 
et al., 2000), such as the current thesis. The overall process relies on rigorous interpretation to 
extract meaning and explanations inductively (Ritchie and Spencer, 1994). This is achieved 
through a reflexive process acknowledging the empirical basis of the research and the 
emerging, inductive outcomes of the qualitative process (Nastasi and Schensul, 2005; Gale et 
al., 2013).  
Quantitative studies seek to understand and evaluate walking, defined as walking behaviour 




report using validated questionnaires. Demonstrating that a theoretical model explains 
behaviour is important for theory testing and development, and therefore self-reported 
measures are frequently employed in that context, which are correspondent with measures of 
theoretical constructs (Armitage and Conner, 2001; McEachan et al., 2011). However, in 
applied research, generating understanding of the cognitions driving behaviour change might 
be better achieved by employing valid and reliable objective outcome measures. Objective 
measures of walking behaviour include monitoring devices, such as pedometers, which 
capture activity data in real time, and show better criterion validity than self-reported 
measures when compared with accelerometer-derived physical activity (Prince et al., 2008).  It 
is important also to consider disease-specific and broader health outcomes of an intervention, 
including symptoms and health-related quality of life.  
3.1.1 Aims 
This chapter aims to describe and evaluate qualitative and quantitative methods and 
measures, including self-reported constructs and objective outcomes, applied in this research 
to establish a body of evidence informing a theory-based behaviour-change intervention 
targeting walking in people with IC. 
3.2 Research Governance and Good Clinical Practice 
This research recruited participants with IC from two NHS sites. The investigator (MGH) 
received NIHR training in Good Clinical Practice, and all research involving NHS patients was 
carried out in accordance with guidelines to ensure participant safety and confidentiality. 
Approval from a Research Ethics Committee and local Research & Development Departments 
across sites was received prior to studies commencing (Appendix 1). Participant Information 
Sheets, Participant Consent Forms, and a sample letter informing General Practitioners of their 




3.3 The Framework Method for qualitative research 
3.3.1 Topic guide development 
Qualitative topic guides were developed following recommendations consistent with the 
Framework Method (Ritchie and Spencer, 1994; Gale et al., 2013) and used to guide semi-
structured audio-recorded interviews. Topics established a priori were addressed (e.g., 
treatment and illness beliefs, acceptability of treatment), which were consistent with the 
theoretical objectives of the research, but questions were open to enable new topics and 
themes to emerge from participant accounts (e.g., “What is it like having PAD?”). Topic guides 
were pilot tested, and refined iteratively following early interviews. 
3.3.2 Procedure 
Participants were invited to individual semi-structured interviews conducted by one researcher 
(MGH). Interviews took place at King’s College London (London, UK) (Chapters 5 and 8) or at 
participants’ homes (Chapter 5) if they preferred. Interviews were audio-recorded and 
followed a topic guide.  
3.3.3 Qualitative data analyses 
Key stages of the Framework Method for analysing qualitative data were applied (Table 3.1). 
Interviews were transcribed verbatim and analysed using NVivo 9 (QSR International Ltd, 
Southport, UK). Accuracy of transcripts was checked against the original recordings. 
Familiarisation took place during transcription, reading, and review of transcripts. Recurrent 
themes, including those reflecting a priori topics (i.e., illness and treatment beliefs) and 
emergent topics raised by participants (i.e. pain beliefs) were recorded and incorporated to 
the thematic framework, which is a hierarchical index of themes and subthemes used to code 
data. The thematic framework was then used to index, or code, the transcribed data. Results 
were charted in a case-by-category grid used to summarise, view, and analyse the data. 
Descriptive and explanatory patterns were identified and used to develop a thematic map 





Table 3.1 Stages of the Framework Method for analysing qualitative data 
Stage Description 
Transcription A verbatim transcription of the audio-
recorded data is produced, allowing initial 
immersion of the researcher with the data. 
Familiarisation Further immersion in the raw data by 
listening to audio-recordings, reading 
transcripts and studying notes taken during 
interviews. Key ideas and recurrent themes 
are listed. 
Coding  Line-by-line coding of transcripts by applying 
open (e.g., emerging from the data) or 
predefined (e.g., based on existing theory or 
research question) categories to data to 
facilitate systematic comparisons across the 
data set. 
Development of the analytical framework A coding system, or tree, is developed from 
initial transcripts. This should include a 
category “Other”, to accommodate data that 
do not “fit” the evolving framework. Several 
iterations may be required and continued 
development may take place when applying 
the analytical framework. 
Application of the analytical framework The analytical framework is applied to all 
subsequent transcripts, to index data into 
existing categories and codes. The framework 
is only complete once the final transcript is 
coded. 
Charting data into the framework matrix A matrix is generated (typically arranged as 
code  participant), and charted data are 
reduced from verbatim text to distilled 
summaries retaining the meaning of 
participants’ views and experiences. 
Interpretation of data Charted data are explored, to define 
concepts, and map the range and nature of 
phenomena. Typologies, descriptions, 
relationships and causal explanations may be 
generated from themes identified in the data.  
Adapted from Gale et al. (2013). 
3.3.4 Qualitative data validation 
Data were member-checked with participants to support the resonance of findings, by 
summarising key topics discussed with the participant immediately upon completion of the 
interview. Reflexive diaries and field notes were maintained for each interview. Transcripts 




application of the analytical framework, charting, and interpretation of data were conducted 
by one investigator, and reviewed and discussed by at least one other investigator in order to 
reach a consensus. A third researcher was available to resolve disagreements. Interpretation 
was considered until agreement was reached that the final themes accurately and 
meaningfully reflected the interview data. 
3.4 Quantitative methods and measures 
Measures included in this thesis are listed in Table 3.2.  
Table 3.2 Outcome measures included in the thesis, reflecting walking, theory-based 
constructs, and descriptive clinical variables of individuals with intermittent claudication (IC) 
Parameter Measure 
Objective walking ability  
6 Minute Walk Distance (6MWD) 6 Minute Walk Test (6MWT) 
Pain-Free Walking Ability (PFWA) 6MWT 
Maximal Walking Ability (MWA) 6MWT 
Walking behaviour  
Objective walking behaviour Pedometer step count  
Self-reported walking behaviour  Baltimore Activity Scale for Intermittent Claudication 
(BASIC) 
Past walking behaviour International Physical Activity Questionnaire (IPAQ) 
Theory-based constructs  
Walking treatment cognitions Theory of Planned Behaviour (TPB) Questionnaire 
Illness cognitions Revised Illness Perception Questionnaire (IPQ-R) 
Barrier self-efficacy Barrier Self-Efficacy Scale for Intermittent Claudication 
(BSES) 
Action Planning Action Planning Questionnaire 
Action Control Action Control Questionnaire 
Descriptive clinical variables  
Lower-limb symptom classification San Diego Claudication Questionnaire (SDCQ) 
Health-related quality of life Medical Outcomes Survey Short Form-12 version 2      
(SF-12v2) 
Perceived activity intensity Borg Rating of Perceived Exertion (RPE) 
Perceived pain intensity Borg Category–Ratio 10 Scale for Pain (CR10) 




3.4.1 Objective walking ability 
6 Minute Walk Test  
The 6MWT is a submaximal exercise test, and was carried out according to a standardised 
protocol, including a script for instructions and feedback (Montgomery and Gardner, 1998; 
American Thoracic Society, 2002) (Appendix 2). Two cones were placed 30.48 metres (100 
feet) apart, creating a 60.96 metre (200 foot) circuit in a straight corridor located at King’s 
College London (London, UK). Participants were asked to walk along the corridor around the 
cones, and were instructed that the aim was to cover the greatest distance possible in 6 
minutes. They were instructed to stop and rest if needed, but to resume walking after a self-
determined rest break if there was time remaining. The researcher (MGH) stood at one end of 
the corridor with a stopwatch, clipboard, and 6MWT worksheet (Appendix 2). Instructions and 
feedback (provided every minute) followed a standardised script (Appendix 2). A marker was 
placed at the point along the corridor where the participant stopped walking, and the distance 
was obtained using a tape measure (Figure 3.1). 
Figure 3.1 Participants completing the 6 Minute Walk Test 
 
Images acquired and used with participant permission. 
To optimise coordination and stride length, minimise anxiety, and to address the possibility of 
a learning effect (American Thoracic Society, 2002), the 6MWT was repeated during the cross-




second test were used for analyses. A minimum of 20 minutes duration was maintained 
between tests, to allow rest from fatigue and IC, which is the primary limiting factor of walking 
performance and is typically relieved within 10 minutes of rest. 
The 6MWT provided three outcomes: the 6MWD, PFWA, and MWA. 
6 Minute Walk Distance (6MWD) 
The 6MWD is the total distance walked in metres during the 6MWT (Lipkin et al., 1986), and 
measures objective walking ability. The 6MWD has demonstrated test–retest reliability up to 
2 weeks among individuals with IC (r=0.94, coefficient of variation 10.4%; intraclass correlation 
coefficient [ICC] 0.90, p<0.001), and concurrent validity with the ABPI (r=0.55, p<0.001) 
(Montgomery and Gardner, 1998; McDermott et al., 2008). Criterion validity of the 6MWD 
against accelerometer-derived physical activity level and a standardised graded treadmill test 
was demonstrated by linear trends across quartiles of both measures (both p<0.001) in 
156 individuals with IC, controlling for age, gender, and race (McDermott et al., 2008). The 
6MWD was sensitive to change following 6 months of combined supervised and home-based 
walking exercise therapy among people with IC (MD 53.5 metres compared with a control 
group) (McDermott et al., 2013b). The minimal clinically important difference (MCID) for the 
6MWD has not been established in people with IC; however, among individuals with coronary 
artery disease and COPD, MCIDs are 23 and 25 metres, respectively, following exercise 
rehabilitation (Holland et al., 2010; Gremeaux et al., 2011). 
Pain-Free Walking Ability (PFWA) 
The PFWA is the distance or duration of walking before the perceived onset of IC. During the 
6MWT, participants were asked to indicate the onset of leg pain either verbally or by raising 
one hand, whichever they preferred, and the time elapsed (in seconds) was recorded. PFWA 
demonstrated good test–retest reliability during corridor and treadmill walk tests (ICC 0.68–
0.90, coefficient of variation 19.8–31.3%) (Zwierska et al., 2004), and the PFWA achieved 
during a treadmill test was moderately correlated with 6MWD (r=0.35, p=0.007) (Montgomery 




Maximal walking ability (MWA) 
The MWA represents the distance or duration of walking before IC causes the individual to 
stop and rest. During the 6MWT, MWA was recorded as the time elapsed (in seconds) when 
the participant stopped to rest for any reason before 6 minutes. MWA demonstrated good 
test–retest reliability during corridor and treadmill walk tests (ICC 0.81–0.87, coefficient of 
variation 16.4–22.4%) (Zwierska et al., 2004). During treadmill testing, the MWA was more 
reliable compared with the PFWA, and demonstrated greater reliability at higher workloads 
(Degischer et al., 2002). The MWA achieved during a graded treadmill test was moderately 
correlated (r=0.53, p<0.001) with 6MWD (Montgomery and Gardner, 1998). 
3.4.2 Walking behaviour 
Objective walking behaviour 
Mean daily step count over a period of 6 days was assessed by pedometer (Omron Walking 
Style Pro 2.0; HJ-322U-E, Omron Healthcare UK, Ltd., Milton Keynes, UK) (Figure 3.2). The 
model employed uses a tri-axial accelerometer sensor as a mechanism for detecting 
movement. The device does not indicate periods of non-wear, which is associated with the 
validity of step counts, and therefore limits the interpretation of data. Data could be coupled 
with participant-reported wear time or a minimal acceptable wear time or step-count 
established as a threshold for including and analysing data (Schmidt et al., 2007). 
Figure 3.2 The Omron Walking Style Pro pedometer 
 
HJ-322U-E; Omron Healthcare UK, Ltd., Milton Keynes, UK. 
Participants were instructed to wear the pedometer on their hip, on either side, ensuring it 
was fitted horizontally. Individual data reflecting height (centimetres), weight (kilograms), and 
stride length (centimetres) were input to the activity monitor for each participant to ensure 




steps along a corridor, and the distance walked was marked and measured in order to 
compute the stride length in cm: 
𝑆𝑡𝑖𝑑𝑒 𝑙𝑒𝑛𝑔𝑡ℎ (𝑐𝑚) =




The test–retest and criterion reliability of the Omron Walking Style Pro (HJ-720IT0-E2) was 
evaluated by determining the agreement between consecutive measures around a 
60.96 metre level circuit and against visual step counts, respectively. 
Methods 
Participants. 12 Participants with IC from a larger, cross-sectional study were recruited 
(Chapter 5). Sociodemographic and clinical characteristics are listed in Table 3.3. 
Table 3.3 Sociodemographic and clinical characteristics of participants in a reliability study of 
the Omron Walking Style Pro pedometer 
Variable Value, n (%) 
Age, yearsa 65 (59–71)a 
Male gender 11 (92) 
White ethnicity 9 (75) 
Body mass index, kg/m2a 29 (24–33)a 
Current or previous smoker 5 (42) 
Classic intermittent claudication 7 (58)b 
n=12. aData are median (interquartile range).  bDetermined by the San Diego Claudication 
Questionnaire. 
Procedure. A pedometer was fitted onto participants left hip, attached to the waist of their 
trousers, and perpendicular to the ground. Participants were asked to complete one circuit 
around two cones placed 30.48 metres apart, covering a total distance of 60.96 metres. They 
were seated for 2 minutes, after which time they repeated the walking circuit. During both 




walk and recorded a visual step count taken in real-time during the walk. Data from the 
pedometer were recorded after each test and used for analyses. 
Analyses. Analyses were carried out using SPSS Statistics Software version 21.0 (IBM SPSS 
Statistics, Inc., Armonk, NY, USA). ICCs were calculated to explore test–retest reliability 
(repeatability) between steps recorded by pedometer for each walk, and agreement between 
pedometer and visual step count determined using two-way fixed models, determined for 
consistency and agreement, respectively (Weir, 2005; Shrout and Fleiss, 1979).  
Bland–Altman  plots were used to evaluate agreement between steps measured by pedometer 
and by visual count during participants’ second walk (Bland and Altman, 1986). The second 
walk was selected as this would account for any learning effect regarding the walking protocol 
and to ensure that pedometers had been positioned correctly. According to guidelines for 
determining agreement (Bland and Altman, 1986), the following procedure was followed: 
a) the difference between scores obtained by pedometer and visual step count was 
computed; 
b) the mean of scores for each participant was computed;  
c) the mean (Mean[difference]) and standard deviation (SD[difference]) of the difference 
between scores was computed; 
d) limits of agreement were computed  
e) the coefficient of reproducibility was computed. 
A scatterplot was generated displaying the mean scores obtained using the two measures 
against the difference between pedometer and visual step count. A random pattern of data 
points on the scatter plot indicated low risk of systematic error or bias in scores obtained by 





One outlier was identified during Bland-Altman analyses, which was removed.  
Test–retest reliability. There was good test–retest reliability between step count on the first 
and second walks (ICC 0.95, 95% CI 0.83, 0.98; p<0.001).  
Agreement between pedometer and visual step count. There was good reliability between 
pedometer step count and visual step count during the first (ICC 0.97, 95% CI 0.89, 0.99; 
p<0.001) and second (ICC 0.99, 95% CI 0.98, 0.99; p<0.001) walks. These findings indicate that 
in both trials <3% of variance between scores was due to random error. 
A scatterplot of mean scores and difference between scores revealed no clear relationship 
between the mean scores and difference in means on the scatterplot (Figure 3.3). Limits of 
agreement indicated that for 95% of samples, step count obtained by pedometer would fall 
within -3.16 and 3.16 steps measured by visual count (Table 3.4).  
Figure 3.3 Bland–Altman Plot illustrating agreement between pedometer and visual step count 








Table 3.4 Calculations required to generate a Bland–Altman plot for testing agreement 
between pedometer and visual step count over a 60.96 metre circuit  
Variable Value 
Mean(difference) ±SD(difference) 0.0 ±1.61 
Limits of agreement -3.1556, 3.1556 
Width of limits of agreement 6.3112 
n=11. 
Conclusions 
Test–retest reliability over consecutive walks around a 60.96 metre level walking circuit was 
demonstrated. There was high agreement between pedometer and visual step count, 
demonstrating low variance due to error.  
Self-reported walking behaviour 
The Baltimore Activity Scale for Intermittent Claudication (BASIC) (Gardner and Montgomery, 
2006) is a five-item disease-specific questionnaire assessing walking, and provides an estimate 
of daily physical activity level. Items are presented with three ordinal multiple choice 
responses, and ask participants to estimate their pain-free walking distance (0=“less than 1 
block”, 1=“between 1 and 2 blocks”, or 2=“more than 2 blocks”), their behavioural response to 
pain during walking (0=“stop walking”, 1=“slow down”, or 2=“continue walking at the same 
pace”), and their frequency of walking at a fast pace, up and down stairs, and up and down 
hills (0=“rarely/never”, 1=“sometimes”, or 2=“frequently”). The response scale for the item 
reflecting pain-free walking distance was modified to reflect the estimated equivalent of 
walking distance in metres (0=“less than 100 metres”, 1=“between 100 and 200 metres”, or 
2=“more than 200 metres”) rather than city street blocks (A Gardner, personal 
communication, 8 December 2011), to improve its relevance for participants based in the UK. 
Responses for the five items are summed to allow for scores ranging from 0 to 10, with 10 
reflecting increased walking. From the total score, a continuous measure of physical activity 
represented in units of energy expenditure can be obtained using the following equation:  




The BASIC predicts accelerometer-based daily physical activity, was sensitive to change in 
physical activity following a 6-month supervised exercise programme (Gardner and 
Montgomery, 2006), and demonstrated moderate test–retest reliability over 1 week (=0.60, 
p=0.21) in a small sample (n=38) of individuals with stable IC (Barbosa et al., 2012).  
Past walking behaviour  
The International Physical Activity Questionnaire (IPAQ) is a 7-item measure of daily physical 
activity. The self-administered short form asks participants to recall the frequency (days) and 
duration (minutes) of moderate and vigorous activities, walking for ≥10 minute bouts, and 
sitting over the last 7 days.  
A continuous total score reflecting MET-minutes/week of physical activity is computed based 
on weighted durations and frequencies of reported activity per category using the following 
formula: 
𝑇𝑜𝑡𝑎𝑙 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 = (3.3 × 𝑤𝑎𝑙𝑘𝑖𝑛𝑔 𝑑𝑢𝑟𝑎𝑡𝑖𝑜𝑛 × 𝑤𝑎𝑙𝑘𝑖𝑛𝑔 𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦) 
+ (4.0 × 𝑚𝑜𝑑𝑒𝑟𝑎𝑡𝑒 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑑𝑢𝑟𝑎𝑡𝑖𝑜𝑛 × 𝑚𝑜𝑑𝑒𝑟𝑎𝑡𝑒 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦)  
+ (8.0 × 𝑣𝑖𝑔𝑜𝑟𝑜𝑢𝑠 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑑𝑢𝑟𝑎𝑡𝑖𝑜𝑛 × 𝑣𝑖𝑔𝑜𝑟𝑜𝑢𝑠 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦) 
where units of duration and frequency were minutes and days, respectively.  
Scores for a single item reflecting walking frequency (“During the last 7 days, on how many 
days did you walk for at least 10 minutes at a time?”) were used in analyses to reflect past 
walking behaviour.  
A large-scale cross-cultural study representing 12 countries including adults aged between 18 
to 65 years, and including 250 participants from the UK, demonstrated test–retest reliability of 
the IPAQ over 1 week (Spearman’s =0.75, n=292) and moderate criterion validity against 
accelerometer-based physical activity measured over 1 week (Spearman’s =0.40, n=151) 
(Craig et al., 2003). Most (85%) participants in that sample were active, reporting 




who are less active, such as those with IC. However, criterion validity of the IPAQ subscales 
was demonstrated against accelerometer-based activity in 122 men and women aged 62 to 
70 years, although test–retest reliability was low (Kolbe-Alexander et al., 2006). The IPAQ has 
been used in intervention studies including people with IC, and the subscale reflecting 
sedentary time was sensitive to change following a home-based walking programme 
(Cunningham, 2010). 
3.4.3 Theory-based constructs 
Walking treatment cognitions  
A 23-item TPB questionnaire was used to assess participants’ beliefs about walking treatment. 
The questionnaire was adapted from a previous measure administered to individuals with IC 
(Galea and Bray, 2007; Galea and Bray, 2006). Instructions to participants recommended 
walking guidelines for people with IC to complete at least 30 minutes of walking exercise on 
3 or more days per week (Gardner and Poehlman, 1995; Norgren et al., 2007). The 
questionnaire assesses participants’ attitude (8 items), subjective norm (4 items), perceived 
behavioural control (7 items), and intention (4 items) regarding “the recommended walking 
exercise”.  
Items reflecting attitude toward walking treatment are presented on 7-point bipolar adjective 
scales reflecting instrumental and affective attitudes, including the following anchors: wise–
foolish (reverse scored), good–bad (reverse scored), beneficial–harmful (reverse scored), 
useless–useful, unpleasant–pleasant, enjoyable–unenjoyable (reverse scored), boring–
interesting, and stressful–relaxing.  
Items reflecting subjective norm are presented on 7-point Likert scales ranging from 
1=completely disagree to 7=completely agree, and reflect injunctive norms. One global item 
asks participants about important others (i.e., “Most people who are important to me think I 
should do the recommended walking”), whereas the remaining three items target normative 




member) identified in previous elicitation studies on individual cognitions about exercise 
behaviour (Downs and Hausenblas, 2005).  
Items reflecting perceived behavioural control regarding walking treatment are assessed on 7-
point Likert scales, and include one item reflecting perceived ease or difficulty (e.g., “For me to 
do the recommended walking exercise would be…” 1=extremely easy, 7=extremely difficult 
[reverse scored]), three items reflecting perceived control (e.g., “How much personal control 
do you believe you have over whether or not you do the recommended walking exercise?” 
1=complete control, 7=absolutely no control [reverse scored]) and three items reflecting 
perceived confidence (e.g., “How confident are you that you will be able to do the 
recommended walking exercise?” 1=completely unconfident, 7=completely confident).  
Items reflecting behavioural intention are presented on 7-point Likert scales (1=completely 
disagree to 7=completely agree) preceded by the statements, “I will do the recommended 
walking exercise”; “My goal is to do the recommended walking exercise”; and “I intend to do 
the recommended walking exercise”. For one item (“Do you plan to do the recommended 
walking exercise?”), corresponding anchors were 1=definitely not and 7=definitely so. 
Scores for items representing each scale are summed and their total used for analyses. Higher 
scores represent more positive walking treatment cognitions.  
In observational studies including people with IC, the TPB scales demonstrated internal 
consistency (Cronbach’s α>0.70), and were associated with self-reported walking behaviour 
(r=0.37–0.56, p<0.05) (Galea and Bray, 2007). 
Illness cognitions  
The Revised Illness Perception Questionnaire (IPQ-R) (Moss-Morris et al., 2002) is a three-part 
measure of individuals’ representation of their illness as defined by the CSM.  
The first part of the questionnaire quantifies symptom identity, defined as the extent to which 




they have experienced since having their illness from a list of 14 (e.g, pain, wheezing, fatigue), 
and which of those symptoms are associated with their illness. Items are scored on 
dichotomised scales (yes/no), and the total sum of affirmative responses used in analyses to 
indicate identity (range from 0 to 14). Higher illness identity is associated with negative 
adjustment and poorer psychological and physical health outcomes (Hagger and Orbell, 2003). 
The second part of the questionnaire includes 38 items assessing seven constructs reflecting 
illness perceptions. Items referring to “illness” were replaced with “PAD”, following guidelines 
for developing the IPQ-R for specific populations: acute timeline (6 items; e.g., “My PAD will 
last for a long time”), cyclical timeline (4 items; e.g., “I go through cycles in which my PAD gets 
better and worse”), consequences (6 items; e.g., “My PAD is a serious condition”), personal 
control (6 items; e.g., “I have the power to influence my PAD”), treatment control (5 items; 
e.g., “There is nothing which can help my PAD”), coherence (5 items; e.g., “I have a clear 
picture or understanding of my PAD”), and emotion (6 items; e.g., “My PAD makes me feel 
afraid”). Each item is evaluated on a 5-point scale (1=strongly disagree, 2=disagree, 3=neither 
agree nor disagree, 4=agree, and 5=strongly agree). Scores for relevant items (i.e., items 1, 4, 
8, 15, 17–19, 23–27, 36) were reversed, and scores for items reflecting each construct were 
summed, and the total used for analyses. Higher scores for personal control, treatment 
control, and coherence reflect positive, adaptive illness perceptions, whereas higher scores for 
acute timeline, cyclical timeline, consequences, and emotion reflect negative, maladaptive 
illness perceptions.  
Using the same 5-point scale and anchors, the third part of the IPQ-R includes 18 items 
assessing four constructs reflecting the following causal attributions: psychological attributions 
(6 items; stress or worry, mental attitude, family problems or worries, emotional state, 
personality, and overwork), risk factors (7 items; heredity, diet or eating habits, poor medical 
care, my own behaviour, ageing, alcohol, smoking), immunity (3 items; a germ or virus, 




injury) (Moss-Morris et al., 2002). The scale also includes an open-ended question inviting 
participants to list the three most important causes they believe contributed to their PAD. 
Scores for items reflecting each causal attribution construct were summed and the total used 
for analyses. Psychological and risk factor attributions reflect modifiable causes that are 
internal to the individual, so higher scores were defined as positive causal attributions. 
Immunity and accident/chance attributions reflect causes that are external to the individual, 
so higher scores were defined as negative causal attributions. Frequencies of each causal 
attribution were reported as the number and percentage of participants who responded 
affirmatively (i.e., “agree” or “strongly agree”) to a causal attribution item.  
Summary scores for all seven IPQ-R variables and causal attributions were computed using 
recommended syntaxes and used for analyses. Syntaxes allow up to 2 missing scores for 
variables with 6 items, and 1 missing score for variables with fewer than 6 items (Weinman et 
al., 2000; Moss-Morris et al., 2002). 
IPQ-R subscales demonstrated test–retest reliability over 3 weeks (r=0.46 to 0.88) and 
6 months (r=0.35 to 0.82), with the greatest stability demonstrated for causal attributions and 
identity; however, data were limited to a small sample of 28 renal dialysis patients for the 
3 week assessment and 75 individuals with rheumatoid arthritis for the 6 month assessment 
(Moss-Morris et al., 2002). Internal reliability (Cronbach’s α=0.75) and discriminant validity 
between the scale reflecting somatisation (i.e., symptoms experienced since having the illness) 
and the scale reflecting beliefs about symptoms associated with the illness (paired samples t-
test [15.94], p<0.001) was reported in 711 individuals representing eight different illnesses, 
including rheumatoid arthritis, type II diabetes mellitus, asthma, chronic and acute pain, 
multiple sclerosis, myocardial infarction and human immunodeficiency virus (Moss-Morris et 
al., 2002). Internal reliability was demonstrated for scales reflecting the seven illness 
perception constructs (Cronbach’s α ranging from 0.79 to 0.89) and four causal attributions 




discriminated between individuals with acute (n=35) versus chronic (n=63) pain across each 
subscale.  
Barrier self-efficacy  
The Barrier Self-Efficacy Scale for Intermittent Claudication (BSES) is a 7-item disease-specific 
measure of individuals’ confidence in their ability to engage in walking when faced with 
specific barriers, and was developed from elicitation interviews with eight individuals newly 
diagnosed with IC (Cunningham, 2010). Items are presented on 11-point Likert scales (0=not at 
all confident, 10=extremely confident) and follow a common stem, “How confident are you 
that you can do a walk of at least 30 minutes, at least 3 times a week, walking until the 
claudication is almost unbearable before resting”, and include the following 7 scenarios: bad 
weather, walking uphill, walking alone, having a partner who walks quickly, walking up a flight 
of steps, feeling tired, having nowhere to stop and rest. Two items from the original scale, 
walking in good weather and on flat terrain, were omitted in the current research because 
they reflect facilitators, not barriers. Scores across the remaining 7 items were summed and 
the total used in analyses to reflect barrier self-efficacy, with higher scores reflecting more 
positive self-efficacy. The original 9-item scale demonstrated good internal consistency 
(Cronbach’s α=0.97), and distinguished adherers from non-adherers to walking 
recommendations in a sample of 71 individuals with established IC (OR 22.3, 95% CI 1.34, 
369.50, p=0.030). These findings suggest that the barriers identified by eight individuals with 
recently diagnosed IC who took part in elicitation interviews were generalisable to a wider 
group of individuals with established IC. Also, items are consistent with disease-specific 
barriers identified in focus groups of individuals with established IC (Galea et al., 2008).  
Action planning 
Action planning was assessed using a 4-item scale (Luszczynska and Schwarzer, 2003; Sniehotta 
et al., 2005a). In order to ensure relevance and specificity to walking, items on the original 
scale reflecting “exercise” were modified to “walking exercise”. Four items assessed the extent 




their walking exercise. Each item was measured on a 4-point Likert scale (1=not at all true to 
4=exactly true). Scores across the 4 items were summed and the total score used to reflect 
action planning, with higher scores reflecting greater action planning. A principal components 
analysis demonstrated factor loading of the original four items (r=0.78–0.85) and conceptual 
distinction from items assessing behavioural intentions in 352 individuals with coronary artery 
disease (Sniehotta et al., 2005b), and internal reliability of the scale (Cronbach’s α=0.95).  
Action control 
Action control was assessed using a 6-item measure (Sniehotta et al., 2005a). The original scale 
was modified from “exercise” to “walking exercise”. Two-items each reflected the following 
self-regulatory processes: self-monitoring (e.g., “I have constantly monitored myself to ensure 
I walked frequently enough”), awareness of standards (e.g., “I have always been aware of my 
agreed walking action plan”), and self-regulatory effort (e.g., “I tried my best to follow through 
with my walking action plan”), and were measured on a 4-point Likert scales (1=not at all true 
to 4=exactly true). Scores across the 6 items were summed and the total score used to reflect 
action control, with higher scores reflecting more positive action control. The 6-item scale 
demonstrated good internal reliability (Cronbach’s α=0.91), and factor loading of items 
reflecting each of the three self-regulatory processes: self-monitoring (r=0.86), awareness of 
standards (r=0.77), and self-regulatory effort (r=0.88) (Sniehotta et al., 2005a).  
3.4.4 Descriptive clinical variables 
Health-related quality of life 
The Medical Outcomes Survey Short Form-12 version 2 (SF-12v2) measures health-related 
quality of life over a 4 week recall period. The SF-12v2 includes 12 items reflecting general 
health, physical functioning, physical role, emotional role, bodily pain, vitality, mental health, 
and social functioning. Quality Metric Health Outcomes Scoring Software (version 4.5; 
OPTUMInsight, Lincoln, RI, USA) was used to compute Physical Component Summary (PCS) and 
Mental Component Summary (MCS) scores based on weightings for each item. Scores range 




±SD 2009 United States adult population normal score of 50 ±10 which is equivalent to the 
population normal score derived among a UK sample (Gandek et al., 1998). PCS and MCS 
scores demonstrated good test–retest reliability over 2 weeks (r=0.89 and 0.76, respectively), 
and known group discriminant validity between individuals with a mental or physical condition 
ranging in severity (Ware et al., 1996). The SF-12v2 was evaluated in the Claudication: Exercise 
Versus Endoluminal Revascularization (CLEVER) trial (Murphy et al., 2011), which compared 
26 week supervised exercise therapy to angioplasty or optimal medical management alone for 
IC. The PCS, but not the MCS, was sensitive to change from baseline (MD 5.9 ±10.1, p=0.047 
versus usual care) following supervised exercise therapy (Murphy et al., 2011).  
Lower-limb symptom classification  
The San Diego Claudication Questionnaire (SDCQ) is a disease-specific measure used to 
categorise PAD symptoms and distinguishes classic IC and atypical IC (McDermott et al., 1999; 
Criqui et al., 1996). The standardised 8-item survey is administered by a researcher, and used 
to define symptoms as 1) asymptomatic, defined as having no symptoms upon exertion or 
rest; or as having 2) atypical exertional leg symptoms, defined as symptoms that occur upon 
exertion and that do not meet the criteria for IC; 3) IC, defined as exertional calf pain that 
requires the individual to stop walking, resolves within 10 minutes of rest, and which does not 
begin at rest or resolve during walking; or 4) leg pain on exertion and rest. A categorical score 
from 1–4 was used to reflect symptoms. Sensitivity of the SDCQ compared with resting and 
post-exercise ABPI or history of revascularisation ranged from 69.9% to 96.1%; specificity for 
detecting PAD ranged from 46.5% to 81.8% compared with ABPI, history of revascularisation, 
or post-tibial and tibial-peroneal blood pressures (Schorr and Treat-Jacobson, 2013).  
Perceived activity intensity 
The Borg (1998) Rating of Perceived Exertion (RPE) assessed perceived activity intensity. 
Participants were asked to rate their perceived activity intensity before and after the 6MWT on 
a categorical scale ranging from 6=“no exertion at all” to 20=“maximal exertion”. In a meta-




common physiological markers of activity intensity, mean sample-size-weighted coefficients 
ranged from r=0.61 (against ventilation as the criterion) to r=0.72 (against respiration rate as 
the criterion) (Chen et al., 2002). Borg RPE scores of 13–16 were correspondent with exercise 
training at 80–90% of maximal ventilator oxygen uptake in individuals with IC (Zwierska et al., 
2005), consistent with ratings of moderate to vigorous activity in healthy older adults (Panton 
et al., 1996) and individuals with cardiovascular disease (Whaley et al., 1997). 
Perceived pain intensity 
The Borg (1998) Category–Ratio 10 Scale for Pain (CR10) assesses perceived pain intensity 
before and after the 6MWT. Participants were asked to rate the intensity of pain or discomfort 
in their legs before and after the 6MWT on a scale from 0=“nothing at all” to 10=“maximal”. 
The CR10 demonstrated large associations with RPE (r=0.91), heart rate (r=0.82), and blood 
lactate (r=0.76) among healthy male participants during a progressive cycle ergometry test 
(Borg et al., 1985). Among individuals with IC, the scale demonstrated good internal 
consistency (Cronbach’s α=0.88) over four administrations repeated weekly (Galea and Bray, 
2006). CR10 score corresponded with MWA during a shuttle walk test and was sensitive to 
change from baseline in 71 individuals with IC who underwent 24 weeks of supervised exercise 
therapy (Zwierska et al., 2005). The CR10 distinguished IC during peak exercise tolerance 
achieved by lower-limb ergometry (mean 6.8, 95% CI 6.3, 7.3) versus upper-limb ergometry 
(mean 4.5, 95% CI 3.8, 5.2; p<0.001), controlling for perceived exertion and blood lactate 
between groups (Zwierska et al., 2006). 
Body mass index 
BMI (kg/m2) was obtained from height and weight estimates (fully clothed and wearing shoes) 
using standard scales.  
3.5 Discussion 
This research employs a mixed-methods approach, combing qualitative and quantitative 
evidence to inform the development and evaluation of a behaviour-change intervention 




therefore, the Framework Method was applied, which is a qualitative approach that 
acknowledges existing theory and enables the exploration of theorised concepts (e.g., CSM 
and TPB constructs) alongside novel themes.  
Qualitative evidence is considered alongside quantitative data derived from measures 
pertinent to this thesis and which include: walking, psychosocial constructs, and descriptive 
clinical variables. Walking, the primary outcome of this research, includes self-reported and 
objective measures of walking behaviour and ability. Self-reported measures of walking 
behaviour are easily implemented, and correspond with self-reported measures of theory-
based cognitions, but can be subject to recall and social desirability bias (Ainsworth et al., 
2012) and may lead to inflated covariances between constructs, compromising the 
generalisability and validity of findings (Kaiser et al., 2007; Podsakoff et al., 2003). In addition, 
few questionnaires assess walking exclusively, and those evaluated in general populations 
might not be appropriate or sensitive among people with IC (Gardner and Poehlman, 1998). 
Therefore, validated objective measures including a 6MWT and pedometer provided the 
primary outcomes reflecting objective walking ability and behaviour, respectively. 
The 6MWT is a standardised assessment frequently used in research and clinical practice 
among people with long-term conditions, including IC, and is feasible to implement and 
acceptable to participants. Compared with treadmill assessments of walking ability, corridor-
based measures, such as the 6MWD derived from the 6MWT, better reflect walking achieved 
in daily life (Nordanstig et al., 2014; McDermott et al., 2008), and are preferred by individuals 
with IC (Zwierska et al., 2004).  
Test–retest reliability of the Omron Walking Style Pro pedometer and agreement against visual 
step count was demonstrated, and indicated that <3% of variance between pedometer and 
visual step count was due to random error. Most participants were male, and one participant 
was an outlier, who had a slow walking gait and high BMI, factors which could compromise the 




this participant were removed from analyses, and limits of agreement were acceptable 
suggesting the robustness of findings. Pedometers are widely used, acceptable to participants, 
and validated among older adults with long-term conditions, such as IC (Tudor-Locke et al., 
2011).   
ABPI readings were not obtained as standard practice at participating sites in this research, 
and were not available from medical records. Due to resource limitations, the ABPI was not 
assessed as an outcome of this research; therefore information on disease severity is limited to 
data on the location and extent of stenosis assessed by Duplex sonography, where available in 
participants’ medical records.  
Psychosocial constructs defined by the TPB and CSM were assessed by self-report, including a 
TPB questionnaire and the IPQ-R. To improve the saliency and resonance of the 
questionnaires, items were modified to reflect walking treatment and illness cognitions 
pertinent to IC, consistent with guidelines for developing the measures (Moss-Morris et al., 
2002; Ajzen, 2002a). Adapted scales were also included assessing barrier self-efficacy for 
walking with IC, and constructs which have not previously been assessed in people with IC, 
including and action planning and action control, and therefore psychometric properties are 
not established in this population. However, validity and reliability of the scales were 
demonstrated in other populations with long-term conditions, including people with 
cardiovascular disease (Sniehotta et al., 2005b; Sniehotta et al., 2005a).  
3.5.1 Conclusions 
 A series of valid and reliable tests provide a balance of objective and self-reported 
measures, capturing the individual perspective on walking treatment and illness. 
 Quantitative data considered alongside qualitative evidence provides rich evidence can 
be applied in the systematic development and evaluation of a complex intervention 




 Do behaviour-change techniques Chapter 4.
increase walking in individuals with IC? A 
systematic review1 
4.1 Introduction 
Walking is recommended as a first-line treatment strategy for individuals with IC. Yet there is a 
lack of available supervised centre-based programmes, and adherence to simple walking 
advice from a healthcare professional is low.  
Walking uptake and adherence might be enhanced by theory-driven behaviour-change 
interventions (Chapter 2). Past reviews of structured home-based walking therapy do not 
identify or evaluate theory-based components of interventions (i.e., BCTs) that could facilitate 
walking uptake and adherence (Al-Jundi et al., 2013; Makris et al., 2012). 
Systematic reviews identify and synthesise primary research, assess the quality of evidence, 
and evaluate consistency of findings across studies (Chalmers, 2005). This method underpins 
evidence-based medicine, guiding quality improvement while providing objective criteria to 
inform decision making about healthcare practice and policy (Davidson et al., 2003). Within the 
context of complex intervention development, such as walking programmes for people with IC, 
the MRC guidelines encourage a systematic review of the literature to identify the best 
available evidence underpinning a new intervention (Craig et al., 2008). The Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement provides a 
checklist for conducting and reporting systematic reviews of healthcare interventions, which 
aim to ensure consistent, transparent, and robust conclusions to be drawn (Moher et al., 
2009). 
However, systematic reviews of complex healthcare interventions, such as behaviour-change 
interventions for IC, present a number of methodological issues. Defining the intervention 
                                                          
1 This review is published. Galea M, Weinman J, White C, et al. (2013) Do behaviour-change 
techniques contribute to the effectiveness of exercise therapy in patients with intermittent 




under review, searching for and locating relevant evidence, standardising the selection of 
included studies, and synthesising the data are among these (Shepperd et al., 2009). A key 
element of the Consolidated Standards of Reporting Trials (CONSORT) statement on reporting 
complex healthcare interventions is the description of intervention components (Boutron et 
al., 2008; Shepperd et al., 2009). For behavioural interventions, recommendations include 
qualitative data on session content, delivery mode, supervision and materials, and quantitative 
data on the number and duration of sessions, and the Template for Intervention Description 
and Replication (TIDieR) checklist provides the minimum recommended data required for an 
intervention to be replicated (Hoffmann et al., 2014).  Taxonomies of theory-based BCTs can 
be applied when reporting the content of complex interventions, in order to facilitate 
consistent, systematic, and explicit reporting of the active ingredients of complex theory-based 
interventions. 
To date, evidence from interventions employing BCTs targeting walking among individuals with 
IC has not been synthesised and evaluated. If it is possible to identify techniques, or 
combinations of techniques, that have been successfully utilised to increase walking in people 
with IC, then these could be applied in addition to walking prescriptions (i.e., walking advice or 
supervised exercise therapy) in order to achieve greater outcomes.  
4.1.1 Aims 
This study aims to systematically identify and review the existing literature evaluating BCTs 
targeting walking in people with IC. 
4.1.2 Objectives 
This objectives of this study are: 
a) to identify and quantify BCTs that have been applied in walking interventions among 
people with IC; 
b) to evaluate whether BCTs improve MWA, PFWA, self-reported walking ability, and 
walking behaviour; and 





4.2.1 Study design 
A systematic review of RCTs was conducted. 
4.2.2 Eligibility criteria 
Studies met the following inclusion criteria: 
1) RCTs including individuals with IC; 
2) a group which received an intervention incorporating at least one BCT, as defined by 
Michie et al. (2011a), that explicitly targeted walking; 
3) a group which received usual care (walking advice alone and/or optimised medical 
management) or an attention-control, but no administration of BCTs; and 
4) MWA, PFWA, self-reported walking ability, or walking behaviour reported at least 3 
months following intervention initiation. 
Exclusion criteria were: 
1) non-RCT designs; 
2) studies including participants without IC; 
3) active control or comparison groups (e.g., supervised or home-based exercise 
therapy); 
4) publications in languages other than English.  
4.2.3 Outcome variables 
All outcome variables were evaluated at least 3 months following treatment initiation, with the 
longest follow-up assessment reported (Table 4.1). The primary outcome was MWA assessed 
by a standardised treadmill or corridor walk test. Secondary outcomes included PFWA, self-




Table 4.1 Outcomes evaluated in a systematic review of behaviour-change interventions 
targeting walking among people with IC 
Outcome Measure 
Primary outcome  
Maximal walking ability (MWA) Standardised treadmill or corridor walk test 
Secondary outcomes  
Pain free walking ability (PFWA) Standardised treadmill or corridor walk test 
Self-reported walking ability Walking Impairment Questionnaire (WIQ) or other 
validated measure 
Walking behaviour Self-report or activity monitor 
 
4.2.4 Data sources and search strategies 
An electronic database search (Appendix 3) was conducted using Medline, PsychINFO, Embase, 
CINAHL, and Web of Science and by cross-checking reference lists of retrieved full-text articles. 
The OpenSINGLE database was searched for any appropriate grey literature and the active 
register of the metaRegister of Controlled Trials was searched for in-progress and unpublished 
trials. No language restrictions were imposed and databases were searched from their earliest 
records to December 2012. Search results were downloaded into bibliographic software 
(EndNote X6; Thompson Reuters, New York, NY, USA). 
Search terms included MeSH, keyword, and wild-card terms located in the title or abstract for 
three broad concepts reflecting the disease (e.g., “intermittent claudication”, “peripheral 
arterial disease”), psychological interventions or variables (e.g., “behaviour modification”, 
“motivation”, “intervention”) and outcome (e.g., “walking”, “exercise”).  
4.2.5 Study selection 
Titles and abstracts of records were screened for eligibility, and the full texts of retained 
articles reviewed by two investigators (MGH and LMB) independently using a screening tool 
that was designed and piloted a priori (Appendix 3). Disagreement between reviewers was 




4.2.6 Data collection and computation 
A data extraction tool was developed based on a template from the Cochrane Peripheral 
Vascular Diseases Review Group. This was pilot-tested on a selection of studies and refined. 
Data were collected on methods, study design, participants, intervention components, and 
outcome variables. At least two of four reviewers (MGH, CW [Academic Physiotherapist], LMB 
and SJB [Health Psychologist]) extracted data from all included studies. Disagreement was 
resolved by discussion. 
MD scores and 95% CIs were calculated for data on MWA, PFWA, and walking behaviour, 
where possible, using Review Manager version 5.0 (RevMan 5.0; The Cochrane Collaboration, 
Copenhagen, Denmark). If available data were insufficient to calculate MDs, percentage 
change scores were calculated. Scores for self-reported walking ability were converted from 
ratio or percentage values to reflect a range from 0–100 on the WIQ (Regensteiner et al., 
1990). 
4.2.7 Evaluation of risk of bias and quality of evidence in individual studies 
Study quality was evaluated using The Cochrane Collaboration (2011) Tool for Assessing Risk of 
Bias. Individual RCTs were rated as having high risk of bias (i.e., “low-quality” trials) or low to 
moderate risk of bias (i.e., “high-quality” trials) if there was evidence for the presence of ≥3 or 
<3 sources of bias, respectively. In addition, RCTs were appraised using a 27-item checklist 
(Downs and Black, 1998; Deeks et al., 2003), which provided a broader evaluation of study 
quality, including reporting, internal and external validity, and power. The scale provides a 
Quality Index, ranging from 0–31, with higher scores reflecting lower risk of bias. The 
cumulative level of evidence from multiple studies, defined as “strong”, “moderate”, “limited”, 
“conflicting”, or “none”, was determined for each outcome variable in accordance with 






4.3.1 Study selection 
Six studies were identified for inclusion in the review (Collins et al., 2011; Cheetham et al., 
2004; Gardner et al., 2011; Christman, 2003; Cunningham et al., 2012; Quirk et al., 2012). The 
initial database search resulted in 3575 identified records. After duplicates were removed, 
2328 records remained, of which 2200 studies were excluded based on the content of their 
titles and abstracts. Full texts of the remaining 128 articles were reviewed, of which a further 
122 articles were excluded (Figure 4.1). 
Due to the heterogeneity of behaviour-change interventions, exercise prescriptions and 
outcome measures used, a narrative synthesis of the six included studies was conducted 
without meta-analysis. 
4.3.2 Characteristics of included studies 
Study design and participants  
Six RCTs evaluating BCTs to increase walking in IC included a total of 461 participants (Table 
4.2). Two RCTs were pilot studies (Cunningham et al., 2012; Quirk et al., 2012) and one was a 
PhD thesis (Christman, 2003). The number of participants ranged from 19 (Quirk et al., 2012) 
to 145 (Collins et al., 2011). Mean age was 67.3 years and 64% (n=274/430) were male, 
reflecting the age and gender distribution of IC in the general population (Diehm et al., 2004). 
Baseline clinical measures were similar between control and intervention groups in all included 
studies, with the exceptions that one study reported a significantly higher MWA (Christman, 
2003) and one reported greater medication use for IC (Collins et al., 2011) among the control 
group participants. 
Outcomes 
Three studies evaluated walking ability (MWA or PFWA) by treadmill protocol using a graded 
progressive treadmill test (Gardner et al., 2011; Collins et al., 2011; Christman, 2003), and one 
used a constant load treadmill test (Cheetham et al., 2004). Two RCTs included data on self-
reported walking ability using the WIQ (Collins et al., 2011; Gardner et al., 2011). Three studies 
reported walking behaviour, two which used step activity monitors (i.e., accelerometers and 
pedometers) (Gardner et al., 2011; Cunningham et al., 2012), and one which used a standard 





aNo records were identified from the OpenSINGLE database or metaRegister of Controlled 
Trials. bUnavailable through a national library catalogue. BCT, behaviour-change technique; IC, 
intermittent claudication; RCT, randomised controlled trial. 
Intervention compositions and settings 
BCTs were administered in conjunction with walking advice in four studies (Quirk et al., 2012; 
Christman, 2003; Cunningham et al., 2012; Gardner et al., 2011) and with walking advice plus 
supervised exercise therapy in two studies (Cheetham et al., 2004; Collins et al., 2011). 
Interventions ranged in the number of BCTs applied from one (Cheetham et al., 2004; Quirk et 
al., 2012) up to seven (Collins et al., 2011). Two interventions were delivered through group 
sessions administered by a researcher or under medical or physiotherapist supervision 
(Cheetham et al., 2004; Christman, 2003) and four during individual consultation with a 
3575 records identified 
through database searcha 
 Embase 1748 
 Medline 904 
 Web of Science 745 
 CINAHL 133 
 PsychINFO 45 
0 additional records 
identified through other 
sources 
2328 records after 
duplicates (1247) removed 
2328 records of titles and 
abstracts screened 2200 records excluded  
128 full-text articles 
assessed for eligibility 
6 studies included 
122 full-text articles excluded 
 No BCT 72 




 Non-RCT 23 
 Not translated 4 
 Same cohort 3 
 Non-IC sample 1 
 Active control group 1 
Figure 4.1 Flow diagram illustrating the process of study selection for inclusion in a 





researcher or exercise physiologist (Gardner et al., 2011; Collins et al., 2011; Cunningham et 
al., 2012; Quirk et al., 2012). Among the interventions delivered on an individual basis, two 
were delivered at a research centre or hospital (Quirk et al., 2012; Gardner et al., 2011), one 
included a baseline consultation plus telephone follow-up (Collins et al., 2011), and one was 
delivered in participants’ homes (Cunningham et al., 2012).  
Identified behaviour-change techniques 
Overall, 11 BCTs (Michie et al., 2011a) were identified in the included studies (Table 4.3). The 
most frequent techniques reported were prompting self-monitoring of behaviour (n=3) 
(Christman, 2003; Gardner et al., 2011; Collins et al., 2011), feedback on performance (n=3) 
(Gardner et al., 2011; Christman, 2003; Collins et al., 2011), and barrier identification and 
problem solving (n=3) (Christman, 2003; Collins et al., 2011; Cunningham et al., 2012). Other 
BCTs included motivational interviewing (n=2) (Quirk et al., 2012; Cunningham et al., 2012), 
providing follow-up prompts (n=2) (Christman, 2003; Collins et al., 2011), information on the 
consequences of the behaviour in general (n=2)(Cunningham et al., 2012; Cheetham et al., 
2004), behavioural goal setting (n=2) (Cunningham et al., 2012; Collins et al., 2011), and 
planning social support (n=2) (Collins et al., 2011; Christman, 2003). Action planning 
(Cunningham et al., 2012), use of a behavioural contract (Christman, 2003), and prompting 
practise of the behaviour (Collins et al., 2011) were each reported once.  
Control groups 
Control groups received walking advice in four studies (Gardner et al., 2011; Christman, 2003; 
Cheetham et al., 2004; Quirk et al., 2012), and walking advice or usual care plus an attention-
control in two studies (Cunningham et al., 2012; Collins et al., 2011). One study (Gardner et al., 
2011) was a three-arm trial comparing home-based exercise therapy with supervised exercise 
therapy or walking advice; for the purposes of this review, results are reported of comparisons 
between home-based exercise therapy and walking advice only, as the home-based exercise 
therapy group were engaged in self-monitoring and received feedback on performance as 











BCTs used BCT delivery Control  Outcome measure 
Cunningham 
(2012) 
n=58 (67% M), 
mean 65.3 years, 
36% current 
smokers, mean 




Information on consequences of 
walking exercise, behavioural goal 
setting, action planning, barrier 
identification/problem solving, 
motivational interviewing.  
Individual consultation with 
a researcher (trainee health 
psychologist; 2 1 hour, 1 






WB (step activity 
monitor) at 
4 months. 
Gardner (2011)a n=119 (48% M), 









Individual consultation with 
an exercise physiologist (7 
15 minutes, 2/month). 
Walking 
advice. 










n=59 (73% M), 
mean 67 years, 





and SET (1 30 
minutes/week 
for 6 months) 
+BCT. 
Information on consequences of 
walking exercise. 
Motivation class (1 5–
10 minutes/week for 
6 months) delivered under 
medical or physiotherapist 

















n=30 (55% M), 










behavioural contract, follow-up 
prompts, planning social support. 
Small group counselling 
delivered by a researcher 




MWA and PFWA 
(graded 
progressive 
treadmill test)d up 
to 6 months. 
Collins (2011) n=145 (69% M), 
mean 66.5 years, 
14% current 
smokers, mean 
ABPI 0.95, DM and 
established IC. 
Walking advice 
and SET (1 50 
minutes/week 
for 6 months) 
+BCT.  
Behavioural goal setting, barrier 
identification/problem solving, 
self-monitoring, performance 
feedback, prompt practise of 
walking, follow-up prompts, 
planning social support. 
Individual consultation (1 
at baseline), practice 
exercise sessions (2 
1 hour), follow-up telephone 
consultation (1 biweekly 
for 6 months) delivered by a 









and SRWA at 
6 months. 
Quirk (2012) n=19 (74% M), 
mean 73.2 years, 
32% current 
smokers, mean 




Motivational interviewing. Individual consultation (up 
to 4 1 hour). 
Walking 
advice. e 
WB (self-report) at 
3 months.f 
aThis was a three-arm trial and included a group receiving supervised exercise therapy (SET) for which data are not presented. bGardner–Skinner treadmill protocol 
(Gardner et al., 1991): 3.2 kilometres/hour (2.0 miles/hour) constant speed, baseline 0% grade, increasing 2% every 2 minutes up to 14% at 16 minutes; maximum 
distance 0.8 kilometres (0.5 miles). c3.0 kilometres/hour at a 12% grade up to 15 minutes (Heidrich et al., 1995). dBaseline 1.6 kilometres/hour (1.0 miles/hour) and 
5% grade, increasing in 5 minute intervals to 4.0 kilometres/hour (2.5 miles/hour) and 10% grade. eConfirmed by personal communication with author. 
fInternational Physical Activity Questionnaire, short form. ABPI, ankle–brachial pressure index; BCT, behaviour-change technique; DM, diabetes mellitus; IC, 
intermittent claudication; M, male; MWA, maximal walking ability; PAD, peripheral arterial disease; PFWA, pain-free walking ability; SDCQ, San Diego Claudication 







4.3.3 Risk of bias and quality of evidence in individual studies 
The mean (range) Quality Index (Downs and Black, 1998) was 20 (12–26). Possible bias 
occurred in several studies because of inadequate allocation concealment (Cheetham et al., 
2004; Quirk et al., 2012; Christman, 2003; Collins et al., 2011) and none of the included studies 
blinded outcome assessment (Table 4.4). 
Table 4.3 Summary of behaviour-change techniques identified in a systematic review of 
behaviour-change interventions targeting walking among people with IC 
Behaviour-change technique Definitiona 
Prompt self-monitoring of 
behaviour 
Individual is asked to keep a record (e.g., diary) of 
behaviour as a method of changing behaviour (excludes 
outcome measures used for research) 
Provide feedback on performance Individual is provided data about their own recorded 
behaviour or receives comments on their behavioural 
performance 
Barrier identification / problem 
solving 
Individual is prompted to think about potential barriers 
(e.g., behavioural, cognitive, emotional, environmental, 
social and/or physical) and identify ways of overcoming 
them 
Use of follow-up prompts Intervention components are gradually reduced in 
intensity, duration and/or frequency over time (e.g., 
letters or telephone calls are used instead of face-to-face 
consultations) 
Provide information on 
consequences of the behaviour in 
general 
Information about the relationship between the 
behaviour and its possible or likely consequences, which 
are not individually personalised (e.g., usually based on 
epidemiological data) 
Goal setting (behaviour) Individual is encouraged to make a behavioural resolution 
(i.e., to decide to change or maintain change)  
Plan social support / social change Individual is prompted to plan how to elicit social support 
to achieve their target behaviour or outcome (e.g., 
support from family, friends, or healthcare professionals) 
Action planning Involves detailed planning of what the person will do, 
including when or how frequently, in which situation 
and/or where to engage in behaviour 
Motivational interviewing A clinical method including specific techniques that 
prompt the individual to engage in change talk in order to 
minimise resistance and resolve ambivalence to change 
Agree behavioural contract A written agreement on the performance of a specified 
behaviour, including a record of the resolution that is 
witnessed by another 
Prompt practise Individual is prompted to rehearse and repeat the 
behaviour, parts of the behaviour, or preparatory 
behaviours numerous times (e.g., building habits or 
routines) 
aDefinitions are according to the taxonomy of behaviour-change techniques defined by Michie 




Table 4.4 Risk of bias in RCTs included in a systematic review of behaviour-change interventions targeting walking among people with IC 
 



















risk of biasb 
Quality 
Indexc 
Cheetham (2004) Yes Yes Yes Yes No No High 21 
Christman (2003) Yes Yes Yes Yes No No High 15 
Collins (2011) No Yes Yes Yes No Yes High 23 
Cunningham (2012) No Yes No Yes No No Low 24 
Gardner (2011) No No Yes Yes No No Low 26 
Quirk (2012) No Yes Yes Yes Yes No High 12 
The presence or potential presence of a source of bias is indicated as “yes”. aSummary risk of bias was determined using The Cochrane Collaboration (2011) tool 
for assessing risk of bias. bStudies were rated as having high risk of bias (i.e., “low-quality” trials) or low to moderate risk of bias (i.e., “high-quality” trials) if there 
was evidence for the presence of ≥3 or <3 sources of bias, respectively. cQuality Index scores range from 0–31, with higher scores indicating higher study quality 







4.3.4 Effects of behaviour-change interventions 
MWA at least 3 months following treatment initiation 
Four studies reported data on MWA (Table 4.5 and Appendix 3) (Gardner et al., 2011; 
Cheetham et al., 2004; Christman, 2003; Collins et al., 2011). One high-quality trial reported 
significantly greater improvements in MWA at 3 months in the intervention versus control 
groups (MD ∆134.0 seconds, 95% CI 39.7, 228.3; p=0.005) (Gardner et al., 2011). That study 
compared an intervention providing BCTs plus walking advice with walking advice alone. 
Among low-quality trials, one study reported improvements in 3 month MWA following BCTs 
plus walking advice and weekly supervised exercise therapy versus walking advice alone 
(median ∆ 130% versus control 70%; p<0.001) (Cheetham et al., 2004). Two low-quality RCTs 
demonstrated no benefit of intervention versus control on MWA. One showed no difference 
3 months following BCTs plus walking advice compared with walking advice alone (MD -3.9 
minutes, 95% CI -8.2, 1.1; p=0.13) (Christman, 2003) and one showed no difference at 
6 months following BCTs plus walking advice and weekly supervised exercise therapy versus a 
non-exercise attention-control group (MD 14.7 metres, 95% CI -69.0, 39.6; p=0.60) (Collins et 
al., 2011).  
PFWA at least 3 months following treatment initiation 
Three studies reported data on PFWA (Table 4.5 and Appendix 3). One high-quality trial 
(Gardner et al., 2011) reported greater improvements in PFWA at 3 months following BCTs 
plus walking advice compared with walking advice alone (MD ∆ 150.0 seconds, 95% CI 65.5,  
234.5; p=0.0005). Among low-quality trials, there was no difference in PFWA at 3 months 
following BCTs plus walking advice compared with walking advice alone (MD -2.0 minutes, 95% 
CI -5.7, 1.7; p=0.29) (Christman, 2003) or at 6 months following BCTs plus walking advice and 
weekly supervised exercise therapy versus an attention-control group (MD 14.4 metres, 95% CI 




Self-reported walking ability at least 3 months following treatment initiation 
Data on self-reported walking ability were available from two studies (Table 4.5 and Appendix 
3). One high-quality trial found no difference at 3 months in self-reported walking ability 
following BCTs plus walking advice (mean ±SD ∆for distance 10.0 ±25.0 and speed 11.0 ±22.0) 
versus walking advice alone (mean ±SD ∆ for distance 1.0 ±34.0 and speed 4.0 ±25.0; both 
p=NS) (Gardner et al., 2011). One low-quality trial reported mixed findings. There was a 
greater improvement in self-reported walk speed (mean ±SE ∆ 5.7 ±2.2 versus control 1.9 ±2.8; 
p=0.034), but not walking distance (mean ±SE ∆5.6 ±3.5 versus control 1.4 ±3.3; p=0.383) 
following BCTs plus walking advice and weekly supervised exercise therapy versus an 
attention-control (Collins et al., 2011).  
Walking behaviour at least 3 months following treatment initiation 
Data on walking behaviour were available from three studies, including two high-quality trials 
(Table 4.5 and Appendix 3). In one high-quality study, change in mean 6 day step count was 
greater following BCTs plus walking advice versus an attention-control plus walking advice (MD 
1674.2 steps, 95% CI 156.0, 3188.4; p=0.03) (Cunningham et al., 2012). In a second high-quality 
study, there was no difference in mean 7 day activity time following BCTs plus walking advice 
versus walking advice alone (MD -1 minutes/day, 95% CI -41.1, 39.1; p=0.96) (Gardner et al., 





Table 4.5 Data extracted from studies included in a systematic review of behaviour-change interventions targeting walking among people with IC reflecting effects 
on MWA, PFWA, self-reported walking ability, and walking behaviour 
 Outcome 
First author 
  Self-reported walking ability  
Maximal Walking Ability Pain-Free Walking Ability Distance Speed Walking behaviour 
Cunningham (2012) – – – – Greater change 
(1358 steps) versus control 
(-227 steps) at follow-up; 
p<0.001 
Gardner (2011)a Greater change in walking 
time (124 seconds ±193) 
versus control (-10 seconds 
±176); p<0.05  
Greater change in walking 
time (134 seconds ±197) 
versus control (-16 seconds 
±125); p<0.05  
p=NS p=NS p=NS 
Cheetham (2004) Greater walking distance 
(median 304 metres) versus 
control (median 175 metres); 
p<0.001 
– – – – 
Christman (2003) p=NS p=NS – – – 






Quirk (2012) – – – – p=NS 
Data are presented as intervention versus control and represent mean ±standard deviation (SD) unless indicated otherwise. aThis was a three-arm trial and 









This systematic review is the first evaluation of BCTs alongside exercise for improving walking 
in individuals with IC. The existing evidence is limited to a small number of mostly low-quality 
trials using 11 BCTs, and there is insufficient evidence to draw conclusions on the effectiveness 
of these strategies for improving MWA. Given that access to supervised centre-based exercise 
therapy and adherence to walking advice is limited among individuals with IC (Bartelink et al., 
2004; Makris et al., 2012), this is an important finding as it highlights the need for more 
rigorous trials of behaviour-change interventions for this population. 
While data from two high-quality trials demonstrate that BCTs supplementary to exercise 
prescription improved MWA and PFWA (Gardner et al., 2011) and increased walking behaviour 
(Cunningham et al., 2012), further evidence from four low-quality trials was conflicting. The 
high-quality trials were more recent publications, and may reflect improvements in study 
design and reporting, and a growing recognition of the need to explicitly support behaviour-
change among individuals with IC. However, findings of both trials were at risk of bias due to 
lack of blinding of the outcome assessor, which may be important given that walk test 
performance could be influenced by interaction with personnel. 
While RCTs are considered the gold standard for synthesising the existing evidence, poor 
design and reporting can introduce bias and reduce the robustness of data (Black, 1996; Kunz 
and Oxman, 1998). In addition, RCTs often lack ecological validity, limiting the implementation 
of findings to practice. For example, three of the included studies reported intervention 
delivery by a researcher, and further evaluation of training and delivery by a suitable 
healthcare professional, such as a physiotherapist, would be required prior to implementation.  
In the current review, 11 BCTs were applied to increase walking in individuals with IC. These 
included self-monitoring, providing feedback on walking performance, and barrier 
identification with problem solving. These techniques are useful for increasing an individual’s 




healthcare professionals when prescribing home-based walking among people with IC. 
However, there were 29 additional theory-based techniques in the applied taxonomy (Michie 
et al., 2011a) and, following the latest update to the taxonomy to include 93 items, many more 
techniques that have not been applied to increase walking among individuals with IC, some 
which may warrant investigation. 
Subsequent to this review, two trials have been reported on group-based behaviour-change 
interventions for people with IC. Structured EDucation for Rehabilitation in Intermittent 
Claudication (SEDRIC) is a pilot trial of a group-based intervention targeting self-directed 
walking (Tew et al., 2015). BCTs included goal setting, action planning, self-monitoring, 
feedback on performance, and prompted follow-up, delivered via one 3 hour workshop and a 
booster follow-up provided by telephone 2 weeks later. Data from 23 participants 
demonstrated significant improvements in objective walking ability (6MWD and treadmill-
derived MWD, MD 44.9 metres [95% CI 6.9, 82.9] and 173 metres [95% CI 23, 322], 
respectively) and self-reported walking ability (WIQ speed, distance, and stair climbing MD 
21.0 [95% CI 8.6, 35.0], 21.0 [95% CI 3.8, 38.1], and 30.7 [95% CI 6.4, 55.0], respectively), but 
not daily walking at 6 week follow-up (MD 400 steps/day [95% CI -827, 1708]). Treatment 
increased self-efficacy to walk and personal control, but not other illness perceptions assessed 
by the Brief Illness Perceptions Questionnaire (Broadbent et al., 2006). While these results are 
promising, this was a small study of mostly male participants, and so statistical comparisons 
must be interpreted with caution. In addition, only a short-term (6 week) follow-up is 
reported.  
The Group-Oriented Arterial Leg Study (GOALS) (McDermott et al., 2012; McDermott et al., 
2013b) is an RCT of group-mediated Cognitive Behaviour Therapy targeting barriers to self-
directed walking in 194 individuals with IC. The intervention comprised a 6 month programme 
of weekly sessions lasting 90 minutes, including a 45 minute facilitator-led discussion and 




goal setting, self-monitoring, feedback on performance, instruction on how to engage in 
walking, instruction on where and when to engage in walking, and general information on the 
consequences of the behaviour. Compared with an attention-control, the intervention 
increased 6MWD (MD 53.5 metres, 95% CI 33.2, 73.8), MWA, PFWA, accelerometer-based 
walking behaviour, and self-reported walking distance and speed (assessed by the WIQ); there 
were no differences in health-related quality of life. Participants in the intervention group also 
reported increased exercise self-efficacy and changes in cognitive-behavioural processes; 
however, changes were independent of improvements in 6MWD (Rejeski et al., 2014). Only a 
per-protocol analysis was reported and participants who did not attend a two-session run-in 
period were excluded (McDermott et al., 2012), so findings may be biased toward adherent 
and highly-motivated individuals. Additionally cost-effectiveness was not reported, and such a 
lengthy and intensive intervention might not be easily implemented or feasible in practice.  
The SEDRIC and GOALS trials corroborate present findings supporting self-monitoring, 
feedback on performance, and barrier identification with problem solving for improving 
walking in IC, through interventions that explicitly address the challenge of exercise adherence. 
In the present review, four (Cunningham et al., 2012; Christman, 2003; Collins et al., 2011; 
Quirk et al., 2012) of the six included studies were designed with the objective of addressing 
the problem of exercise motivation among individuals with IC, by employing BCTs. However, 
only one of these studies (Cunningham et al., 2012) referred to a version of the Behaviour 
Change Taxonomy employed in the present review. The drive for standardised reporting of 
intervention components is relatively contemporary, and the inclusion of studies predating the 
Behaviour Change Taxonomy required a degree of interpretation by the reviewers. Moreover, 
BCTs that were not included in the version of the taxonomy applied may have been 
overlooked. Synthesis of data from recent and future studies that adhere to standardised 




Among the four studies which deliberately employed BCTs, only two were underpinned by a 
theoretical model: Cunningham et al. (2012) applied the CSM (Leventhal et al., 1980; Leventhal 
et al., 1984) and Christman (2003) applied the Transtheoretical Model, which describes 
behaviour-change as a progression across five stages including precontemplation, 
contemplation, preparation, action, and maintenance, and as susceptible to relapse (Prochaska 
and Diclemente, 1983). However, the 40 item Behaviour Change Taxonomy was not explicitly 
informed by either of these two theories, and BCTs identified within these two studies do not 
necessarily map onto the respective theories employed. This finding can be viewed as a 
limitation of the taxonomy itself, which is not exhaustive. While the taxonomy provides a 
useful methodological tool for specifying intervention content, the authors acknowledge that 
BCTs need to be better linked to theories of behaviour change (Michie et al., 2011a). 
4.4.1 Methodological considerations 
Statistical data synthesis could not be performed for this review because of a high degree of 
clinical and methodological heterogeneity, primarily due to variations in intervention protocol 
and setting between studies, and lack of control for these factors within studies. In addition, in 
two studies (Cheetham et al., 2004; Collins et al., 2011), where BCTs were provided alongside 
supervised exercise therapy, it is difficult to distinguish the effects of BCTs beyond the benefits 
of the exercise alone. However, both studies provided only one supervised exercise session per 
week, which is a suboptimal exercise dose that does not meet guidelines for supervised 
exercise therapy for individuals with IC (Norgren et al., 2007; Fakhry et al., 2012). Thus, it is 
possible that the change in walking ability is not solely attributable to supervised exercise 
therapy in these studies, and that BCTs targeting self-directed walking behaviour might 
influence outcomes. Data from the study by Gardner et al. (2011), which applied BCTs to 
increase self-directed walking, demonstrate that BCTs have the potential to increase 
participation such that individuals achieve gains in walking ability that are at least comparable 




BCTs are intended to target and modify known motivational factors, for example, a person’s 
beliefs about walking and the outcome of performing it, or their ability to engage in walking 
treatment for IC. However, included studies did not evaluate treatment effects on the 
psychosocial constructs underpinning the BCTs implemented, so it was not possible to 
determine whether the intervention successfully altered psychosocial variables or if other 
factors influenced walking. Moreover, as most interventions combined multiple BCTs, the 
independent effects of each could not be determined.  
This study demonstrates a need to tailor interventions to the population of individuals with IC, 
and, importantly, to the individual. Interventions that provide a fixed package in order to 
facilitate self-management through walking may not be suitable or effective, and could explain 
the lack of evidence for behaviour-change interventions increasing walking in people with IC. 
4.4.2 Conclusions 
 Eleven BCTs were identified in this review and, in particular, self-monitoring, feedback 
on performance, and barrier identification with problem solving, could be easily 
combined with exercise prescription and walking advice in clinical practice.  
 There is limited evidence from one high-quality RCT supporting BCTs for increasing 
MWA and PFWA, and one high-quality RCT supporting BCTs for increasing walking 
behaviour among people with IC.  
 Recent evidence indicates a growing body of research on theory-driven behaviour 
change interventions targeting walking for IC, which are group-mediated, and suggests 





 Individual experiences of and beliefs Chapter 5.
about walking for IC: a qualitative study  
5.1 Introduction 
While RCTs underpin evidence-based practice in healthcare research (Sibbald and Roland, 
1998), inclusion of broader sources of evidence is endorsed to ensure the context, meaning, 
and purpose behind health behaviour are not overlooked (Snape and Spencer, 2003; Kelly et 
al., 2002). Qualitative health research enables an understanding of behaviour, cognitions, and 
interactions between phenomena to ensure culturally appropriate and tailored interventions 
(Pope and Mays, 1995), and can establish the need for treatment, define key constructs 
(Nastasi and Schensul, 2005), and identify the theoretical targets for an intervention (Craig et 
al., 2008).  
Past qualitative research involving individuals with IC has largely sought to understand 
participants’ lived experiences of the condition, and its impact on quality of life. Findings 
demonstrate broad implications of IC for psychosocial, emotional, and physical functioning 
(Wann-Hansson et al., 2005; Treat-Jacobson et al., 2002), but does not explicitly address the 
experience of walking with IC, or identify targets for intervention. 
Three qualitative studies have explored walking among individuals with IC. Galea et al. (2008) 
reported barriers and facilitators to walking drawn from focus groups involving a sample of 
15 people with IC. General (e.g., lack of time, feeling tired) and disease-specific (e.g., a need to 
take frequent rest breaks, companionship on walks, uneven walking terrain) factors were 
identified and reflected personal, environmental, and behaviour-related variables. While 
identifying and overcoming barriers to walking is an important behaviour-change strategy 
(Michie et al., 2011a), perceived barriers and facilitators to walking do not fully explain walking 
behaviour (Galea and Bray, 2007), and other factors should be explored which could 
contribute to behaviour change. In addition, most participants in that study had attended 




home-based walking therapy might report different experiences and factors that influence 
walking. 
Focus groups with 24 individuals with IC were conducted to inform the development of 
SEDRIC, a self-management programme targeting walking (Gorely et al., 2015). Uncertainty 
and lack of support or empathy were identified as themes illustrating the experience of living 
with IC. Examples of participants’ uncertainty included the possibility of exacerbating 
symptoms by walking, their ability to do enough walking to make a difference, and the best 
dose of exercise for their condition. Benefits and barriers to physical activity, and a lack of 
motivation, were also described, and are consistent with previous research (Galea et al., 2008). 
Participants were mostly male, White, and had been treated conservatively, and may not 
reflect the wider population of people with IC, including those who had undergone 
revascularisation. 
Another qualitative study included only individuals with IC who had undergone 
revascularisation (Cunningham et al., 2014). Participants avoided walking, viewed IC as acute 
and treatable, and reported a limited understanding of the cause and broader consequences 
of IC, suggesting illness beliefs are salient. The use of medical terminology was highlighted as a 
barrier when discussing their condition with a healthcare professional. This research was 
framed within the CSM, however a priori theory-based themes were not reported, which could 
bias results, and there was a lack of explanatory evidence linking illness and treatment beliefs 
with walking, so it is unclear which factors should be targeted in walking interventions for IC.   
The objective of this study is to explore the experience of living with IC, and the role of illness 
and treatment beliefs in understanding walking, to inform the development of a home-based 
intervention to increase walking in IC. This study acknowledges the TPB and CSM as models for 
explaining walking among individuals with IC, and therefore employs the Framework Method 
to elicit and explore salient, theory-based constructs, while allowing new themes to emerge 





The aim of this study is to explore experiences of walking, and cognitions about walking 
treatment and illness, among people with IC, in order to understand and explain walking and 
to inform the development of an acceptable intervention to facilitate walking among 
individuals with IC.  
5.1.2 Objectives 
According to the Framework Method, the functions of qualitative research are contextual, 
explanatory and generative (Ritchie, 2003); therefore, the objectives of this study are: 
a) to describe and understand the experience of walking with IC (contextual); 
b) to identify and explain beliefs held by individuals with IC regarding their illness and 
walking (explanatory); and 
c) to develop an thematic map of walking behaviour among people with IC (generative). 
5.2 Methods 
5.2.1 Study design 
A qualitative study using semi-structured in-depth individual interviews and applying the 
Framework Method was conducted.  
5.2.2 Ethical approval 
Ethical approval was obtained on 30 August 2011 from the National Research Ethics Service 
(NRES) Committee London – London Bridge (reference 11/LO/0871; Appendix 1) and approval 
from the Departments of Research and Development, Guy’s & St Thomas’ NHS Foundation 
Trust was confirmed on 12 September 2011 and from King’s College Hospital NHS Foundation 
Trust on 31 January 2013 (CSP reference 73416). 
5.2.3 Eligibility criteria 
Participants met the following inclusion criteria:  
1) adults aged ≥18 years; and  
2) IC diagnosed by a vascular clinician, and based on results of established methods (e.g., 
ABPI, duplex ultrasound, computed tomography, magnetic resonance imaging) against 




Reasons for exclusion were:  
1) revascularisation (e.g., endovascular treatment or bypass surgery) scheduled in the 
upcoming 3 months; 
2) the presence of a comorbidity other than IC (e.g., knee osteoarthritis, back pain) self-
reported as the primary limitation of walking;  
3) the presence of a condition for which it is unadvisable to increase walking (e.g., 
unstable angina); and/or 
4) inability or refusal to provide informed consent.  
5.2.4 Sampling and recruitment 
A purposive sample of eligible participants was recruited from vascular outpatient clinics at 
Guy’s & St Thomas’ NHS Foundation Trust between 1 September 2011 and 31 May 2014. 
Sampling aimed to achieve a range of age, gender, and duration of symptoms (i.e., ≤2 years or 
>2 years). The initial target sample size was 12, and the stopping criterion was defined as no 
new information obtained from three consecutive interviews (Francis et al., 2009). 
Medical records of attendance at an outpatient clinic for a scheduled appointment were 
screened and eligible individuals were identified and informed of the study by the direct 
healthcare team. If interested, potential participants were provided with verbal and written 
information about the study and met with the researcher (MGH) who answered any questions 
and obtained the participants’ contact details. One week later, the potential participant was 
telephoned and invited to enrol onto the study. If they agreed to take part, then a letter was 
delivered to the participant’s home address confirming details of the scheduled appointment 
and directions to the site. Participants received a reminder telephone call within 2 days of their 
scheduled appointment.  
5.2.5 Outcome measures 
Sociodemographic and clinical characteristics. Sociodemographic characteristics (age, gender, 




conditions) were assessed by self-report (Appendix 4). Data on previous revascularisation were 
obtained from medical records. 
Self-reported walking behaviour. The walking subscale of the Physical Activity Scale for the 
Elderly (PASE), a valid and reliable measure (Washburn et al., 1993; Dinger et al., 2004), was 
used to assess walking behaviour. Participants reported their average walking frequency 
(0 days=never, 1–2 days=seldom, 3–4 days=sometimes, or 5–7 days=often) and duration (less 
than 1 hour, 1 but less than 2 hours, 2–4 hours, or more than 4 hours) over the past 7 days 
(Appendix 4). 
5.2.6 Topic guide development  
A topic guide was developed which reflected the theory-based objectives of the study, and 
addressed cognitive processes related to illness and walking treatment for IC (Appendix 4). 
Advice on content and structure of the topic guide was provided from an experienced 
qualitative researcher (B Grunfeld, personal communication, 17 March 2011) in the Institute of 
Psychiatry, Psychology & Neuroscience, King’s College London. The topic guide was pilot tested 
during a mock interview with a clinical researcher and refined iteratively after interviews with 
participants with IC (Table 5.1). 
5.2.7 Procedure  
A 75 minute appointment was arranged either at the participant’s home or at King’s College 
London (London, UK), depending on participant preference. Following informed consent, 
sociodemographic information and clinical characteristics were obtained by self-report, 
participants completed the PASE questionnaire, and the SDCQ was administered. Interviews 
followed the topic guide (Appendix 4) and were audio-recorded.  
5.2.8 Analyses 
Interviews were transcribed verbatim by one researcher (MGH) and analysed using NVivo 9 
(QSR International Ltd, Southport, UK). Key stages of the Framework Method were applied, 
including transcription, familiarisation, coding, development, and application of the analytical 




Table 5.1 Topic guide exploring illness and treatment experiences and beliefs among people 
with intermittent claudication 
Introduction Nature of project, confidentiality, duration of interview, any questions.  
Opening 
question 
How did you realise you had PAD? What has your experience been since your 
diagnosis? 
Illness beliefs Can you tell me about PAD?  
 Can you describe your condition? 
 Complications? Symptoms?? 
 What is it like having PAD? 
 How do you feel having PAD?  
 Tell me about your symptoms.  
 How do your symptoms affect you?  
 How do you address the pain?  
 What do you think it means? 
 Is there anything that you can do about your PAD? 
 Does your condition change over time?  
 What caused your PAD?  
Treatment 
beliefs 
What can be done for your condition? 
 Do you know very much about walking exercise?  
 Could walking exercise affect your PAD? How? 
Have you tried walking or currently walk? What is it like? 
 What do you think about walking as a way of treating PAD?? 
 Do other people feel you should be walking? 
 Are their opinions important to you?  
Do you know anyone else with PAD? 
 How do you feel about starting/continuing walking?  
 Barriers? Facilitators?  
Closing remarks Any additional comments?  






5.3.1 Participant characteristics 
Nineteen participants (n=6 women; mean ±SD age 66 ±9 years) were included. The study 
stopping criterion was not met by the initial target sample of 12, and a further 7 participants 
were recruited to attain data saturation. As the initial 12 participants identified themselves as 
White, individuals from ethnic minorities were purposively sampled among the 7 latter 
participants. More men than women were sampled, reflecting the higher prevalence of IC 
among men (Diehm et al., 2004). Over half (53%; n=10) had experienced IC for ≥2 years and 16 
(84%) participants reported walking on ≥3 days/week (Table 5.2). 
Table 5.2 Sociodemographic and clinical characteristics of participants in a qualitative study 
exploring individual experiences of and beliefs about walking with IC 
Variable Value, n (%) 
Age, years 66 ±8.9a 
Male gender 13 (68) 
Married 11 (58) 
White ethnicity 17 (90) 
Current smoker 7 (37) 
Cardiovascular risk factors  
Diabetes mellitus 6 (32) 
Cardiovascular disease 12 (63) 
Renal disease 2 (11) 
Heart attack 3 (16) 
Stroke 2 (11) 
Duration of symptoms >2 years 10 (53) 
Past revascularisation 5 (26) 
Past supervised exercise therapy 8 (42) 
Walking frequencybc  
Never 0 (0) 
Seldom (1–2 days)  1 (5) 
Sometimes (3–4 days)  7 (37) 
Often (5–7 days)  9 (47) 
Walking durationb  
<1 hours 10 (53) 
1–2 hours 5 (26) 
2–4 hours 2 (11) 
>4 hours 2 (11) 
n=19. aData are mean ±SD. bBased on the walking subscale of the Physical Activity Scale for the 




5.3.2 Descriptive and explanatory themes 
Two superordinate themes were identified: 1. Walking is an overlooked self-management 
opportunity and 2. Tailored walking guidance is desired. Five subthemes further illustrate 
these findings (Table 5.3).  
Table 5.3 Explanatory themes and subthemes emerging from qualitative interviews exploring 
individual experiences of and beliefs about walking with IC 
Theme/subtheme Summary 
1. Walking is an overlooked self-management 
opportunity 
Walking is not understood as 
treatment, or as a first-line 
management option. A medical 
model is the predominant approach 
to illness. 
1.1 IC is benign and leg pain can be overcome IC is an isolated, harmless symptom, 
not warranting surgery, and leading 
to varied beliefs about the necessity 
of walking treatment. 
1.2 IC is severe and there is nothing I can do A high impact of IC on lifestyle and 
work, leading to hopelessness, lack 
of control, and attempted coping 
strategies, although walking is 
overlooked. 
2. Tailored walking guidance is desired Lack of awareness of walking 
guidelines, and concern regarding 
necessary and appropriate self-
management.  
2.1 Varied outcome expectations of walking Uncertainty about the realistic 
consequences of regular walking 
exercise, or mechanisms of benefits. 
2.2 Barriers to walking to intensity Uncertainty about walking through 
pain, inability to feel exhilarated by 
symptom-limited walking exercise. 
2.3 Limited purposeful walking for exercise Descriptions of incidental bouts of 
walking incorporated into daily life 
and activities, and not deliberately 
for achieving exercise. 





Walking is an overlooked self-management opportunity 
Most participants had discussed the role of walking with a healthcare professional but did not 
consider it a first-line treatment strategy for IC, or did not regard walking as a treatment for IC 
at all: 
“There’s no treatment. I’m getting no treatment, not for this. I’m 
getting advice, and the advice is ‘try to walk through it’. That’s the 
only advice I’ve ever had.” (007A, male, 69 years) 
Other participants believed that walking could slow the progression of their symptoms, or 
delay or replace higher-risk interventions, such as revascularisation:  
“I’m hoping that I can stave off this operation because, from what I’ve 
heard, I don’t really want that. And hopefully I can improve my 
lifestyle by strengthening these vessels up and feeding my calf muscle 
more. I mean, I don’t know whether that’s possible.” (001A, male, 
67 years) 
Individuals who had undergone revascularisation, but still experienced IC, anticipated another 
bypass or angioplasty to alleviate their symptoms, not recognising walking as a treatment 
option. One participant, who was prepared to undergo a second revascularisation, was 
surprised when told instead to try walking:  
“They told me, ‘We’re sending you home. We’re going to ask you to 
walk through the pain of claudication in your left calf’. I said, ‘You’re 
joking! You can’t walk with cramp!’ I was quite willing for them to do 
the operation …and if they had done that straight away, I would have 




The overlooked role of walking for IC is explained by two subthemes, which illustrate how 
treatment beliefs were framed around the perceived consequences of IC: 1.1 IC is benign and 
leg pain can be overcome; and 1.2 IC is severe and there is nothing I can do. 
IC is benign and leg pain can be overcome 
Most participants viewed their IC as benign and as having minimal impact on their day-to-day 
lives, and frequently did not recognise a need for walking or the potential for walking to 
improve their function.  
Among these individuals, pain was not viewed as harmful, and IC was described as “a 
nuisance” (128B, female, 78 years) and something that “you just get on with” (001A, male, 
67 years), or as an “inconvenience” (007A, male, 69 years). Leg pain was considered an 
isolated minor symptom:  
“Ninety percent of the time I don’t even think of it because I’m not 
doing something that makes it hurt.” (010A, male, 64 years) 
Despite the belief that IC was benign, some participants linked their condition with systemic 
comorbidities, and considered walking and other exercise as potentially useful for maintaining 
their general health. However, these beliefs were not consistently reflected in descriptions of 
walking behaviour. One individual expressed concern about systemic atherosclerosis, which 
hampered her walking efforts:  
“I’m not thinking that my legs are going to cause me to collapse. I’m 
thinking, ‘because I have blockages in my legs, have I got blockages 
elsewhere, which could cause me to collapse?’” (002A, female, 
79 years). 
IC is severe and there is nothing I can do 
Some participants viewed IC as severe and described a considerable impact on their lifestyle 




strategy. They expressed strong negative emotions, such as anger, frustration, humiliation and 
embarrassment, stress, fear, apathy, depression, and loneliness:  
“I just get so frustrated, I cancelled plans. I was going to Germany to 
look at castles… I was going to go down the Rhine. But where’s the 
castle? Oh, it’s on top of the hill. And that means walking up hill, and 
that’s a no-no.” (003A, male, 52 years) 
Functional limitations influenced participants’ sense of identity. For example, some 
participants felt old because they linked walking impairment with ageing. Participants 
dissociated from the term “disease” and did not like to be perceived as “old” or “disabled” by 
their IC: 
“If I was to say ‘something disease’, [my family] would think it is 
something serious, so I just don’t say anything at all. I think they 
would start treating me as an old person, and I don’t want to be 
treated as an old person.” (012A, female, 68 years) 
Participants who felt disabled by IC also described a lack of control over their condition and 
helplessness. They failed to recognise walking as a self-management opportunity, yet 
expressed concern about the possibility of a life- or limb-threatening treatment. Participants 
coped with IC by adapting their activities or planning ahead to minimise symptoms (e.g., 
choosing sedentary activities or hobbies).  
One participant (005A, male, 62 years), with longstanding IC, described extensive coping 
strategies, including stress-avoidance, relaxation, following familiar walking routes, and goal 
setting. He was the only participant who reported a high impact of IC on his life, and described 





Tailored walking guidance is desired  
All participants described engaging in walking; however, most were unaware of and did not 
achieve walking guidelines for IC (Norgren et al., 2007), regardless of the duration of their IC. 
The lack of guidance meant participants were uncertain about the appropriate walking dosage 
(both duration and intensity), and were worried about doing enough, as well as the possibility 
of “overdoing it” (005A, male, 62 years).  
This conflict was partially alleviated in participants who had completed a supervised centre-
based exercise programme, which provided structure and reassurance that they were 
exercising safely and effectively. In addition, these participants increased their understanding 
of IC, enabling them to cope with and manage their condition: 
“I’m not mystified any more, about what can happen and all that, and 
I’ve come to accept that and I’m very grateful. The understanding of 
why I have peripheral [arterial] disease, what causes it – it means 
that when it comes on, I’m not confused or baffled or muddled.” 
(025B, male, 73 years) 
However, attending supervised exercise therapy did not facilitate independent walking, and 
participants described barriers such as comorbidities, leg pain, lack of motivation, and time. 
Overall, participants wanted definitive tailored guidance and support to achieve the walking 
recommendations: 
“If there was an exercise programme that could help people like me, I 
think that would be fantastic. Even if it were only one we had to do on 
our own at home, but knowing we were doing the right things at the 
right time at the right pace and frequency, I think, would be 




This is further explained by three subthemes, which describe the consequences of a lack of 
tailored walking guidance: 2.1 Varied outcome expectations of walking; 2.2 Barriers to walking 
to intensity; and 2.3 Limited purposeful walking for exercise.  
Varied outcome expectations of walking 
A lack of clear instructions meant participants held mixed beliefs about the possible outcomes 
of walking for IC. Those who recognised the potential for walking to improve or stabilise their 
condition did not necessarily report engaging in the recommended walking.  
Some participants understood that walking was superior to other forms of exercise for IC, 
believing that walking would “open vessels”, whereas gardening “burns calories” (128B, 
female, 78 years). In some instances, there was a sense that walking was helpful, despite 
confusion about the cause of IC:  
“I think being on my feet is a help, because I think the more I walk the 
blood is flowing... I don’t understand the pain, but maybe it’s not 
flowing as it should when I’m walking. I don’t know.” (012A, female, 
68 years) 
Other participants believed walking is good for their general health, and not harmful but were 
sceptical about walking to improve their IC: 
“I think walking helps generally, actually. Whether it could specifically 
help my condition now, I don’t know. But I think that if you can walk 
and the more you walk you’re better all around.” (002A, female, 
79 years). 
Some individuals had attempted walking but either found no improvement or were perplexed 
by the notion that walking would get easier despite the pain, suggesting that advice to walk 
was counterintuitive:  
 “Well, the more I walk, the more pain I get. It doesn’t get any easier 
by walking. What you’re implying is that if I walk more, then my 





Barriers to walking to intensity  
A lack of tailored guidance, and specifically instructions on “walking through pain”, led to 
uncertainty about the appropriate walking intensity. Most individuals believed they ought to 
“walk through pain”, but were uncertain what this meant. The notion of “walking through 
pain” was often inconceivable, and attempts at walking had produced discouraging, or 
perplexing, results:  
“Everyone seems to be keen on the medical side of telling you to walk 
through it, and I thought, ‘Why’? And it only ever works very rarely. 
Occasionally, you go for a fairly long walk, you just keep going 
through the agony, and then it does ease off… Is that it?” (007A, 
male, 69 years). 
Few participants conveyed the importance of exercise intensity, or an understanding of how to 
modify or monitor their walking intensity in order to improve their IC and cardiovascular 
health. One individual who had longstanding IC had considered but not attempted to increase 
his walking intensity: 
“I have got to learn to pace myself, do a bit more pace work, as 
opposed to just strolling around.” (001A, male, 67 years)  
 Others who considered walking to intensity described IC as a key factor hampering their 
attempts: 
 “When you exercise, you feel as if your heart rate should go a bit, and 
you kind of feel almost that refreshed feeling, that exhilarated. I never 
get that. I just meander along with the pain beginning and getting 
worse and worse until I have to stop.” (008A, female, 44 years) 
Limited purposeful walking for exercise 
A lack of tailored walking guidance, including the potential outcomes of walking and 




for exercise. Participants instead engaged in incidental walking, often incorporated into daily 
errands or tasks:  
“I wouldn’t choose walking as a form of just simple exercise. I would 
rarely, maybe occasionally, I would go out for a walk... it’s either 
shopping, going to see somebody, in a form of transport getting 
somewhere.” (008A, female, 44 years) 
Some participants held a “more is better” attitude toward walking, encompassing the notion 
that the body was a “machine” that needed movement to “avoid seizing up” (128B, female, 
78 years). Consequently, individuals who engaged in purposeful walking were uncertain of how 
much was enough: 
“I’m doing an hour’s walk. I used to do 2 hours, but I’m doing that and 
I feel that, like, I’m pushing it each day… If a doctor says to me, you 
know, ‘look, you should do 2 hours, 3 hours a day,’ I would do it. But I 
don’t know, you see.” (005A, male, 62 years) 
Most individuals preferred incorporating walking to their daily lives. Five participants (001A, 
093B, 005A, 010A, and 011A) who described purposeful walking understood that walking could 
improve circulation, and viewed walking as a means of symptom management. Some 
individuals were inclined to try purposeful walking, and recognised barriers to doing so. One 
individual drew on planning and social support as potential strategies when attempting 
purposeful walking: 
“I’ve got to try and get myself organised so that I go out on my own 
or with the wife, and so we say, ‘Alright, we’re going to have an 





5.3.3 Thematic map 
From the present findings a thematic map was developed (Figure 5.1) suggesting that past 
experiences and treatment beliefs about walking were proximal to the fulfilment of walking 
guidelines. Illness beliefs about the consequences of IC resulted in walking being overlooked as 
a self-management opportunity, and a predominant medical model of treatment, which 
contributed to treatment beliefs about the role of walking. Uncertainty about walking 
treatment was expressed as a lack of tailored walking guidance, which resulted in varied 
outcome expectations of walking, barriers to walking to intensity and, as a consequence, 
limited purposeful walking.  
Figure 5.1 Thematic map illustrating explanatory themes identified in a qualitative study 
exploring the experiences of and beliefs about walking and illness among 19 individuals with IC 
 
 
5.3.4 Reflexive diary 
MGH is an academic researcher with an educational background in exercise medicine and 
health psychology, and has conducted quantitative studies and qualitative focus group 
research involving people with IC. Clinically, she is trained in diagnosis and monitoring of PAD 
using Doppler ultrasound, and administered a supervised exercise programme for people with 
IC. A social constructivist epistemological approach was maintained during this research, which 
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interpretation. The researcher acknowledges the influence of her past experiences and 
theoretical frameworks underpinning this body of work (i.e., TPB and CSM) in the design of this 
study, interaction with participants during interviews, and interpretation of data. 
5.4 Discussion 
This qualitative study identified two superordinate themes that help explain walking beliefs 
and behaviour among people with IC. First, walking is overlooked by people with IC as a self-
management opportunity. Two subthemes demonstrate that self-management strategies were 
framed around perceived consequences of IC as relatively benign or severe, and that neither 
instance was resolved through walking. Second, people with IC express a desire for tailored 
walking guidance. Three subthemes demonstrated cognitive (e.g., uncertainty regarding the 
outcome of walking for IC) and experiential (e.g., tendency for incidental walking, attempts at 
engaging in moderate to vigorous walking) explanations for the finding that participants were 
not achieving guidelines for walking. 
Walking is a first-line strategy for treating stable IC (NICE, 2012). However, participants did not 
consider walking as a treatment, centring their management options on the perceived 
consequences of IC and the likelihood and risk of revascularisation, thereby adhering to a 
medical model of treatment. These findings are consistent with a previous study, which 
reported prevailing beliefs that revascularisation could cure IC among individuals interviewed 
post-operatively (Cunningham et al., 2014). This suggests that the optimal time point for 
intervening to change walking behaviour may be upon diagnosis, and before individuals 
undergo revascularisation. However, there is no evidence that illness and walking treatment 
beliefs following revascularisation are particularly resistant to change, and it may be that 
individuals who undergo revascularisation receive greater exposure to advice from healthcare 
professionals regarding treatment for IC and may be better informed. For example, 
participants in the current study who had undergone a bypass or angioplasty recognised their 
role – or duty of self-care – alongside the care of their vascular specialist, in order to optimise 




Wann-Hansson et al. (2008) reported a desire to prevent disease progression following 
revascularisation as a factor influencing behaviour change among people with IC. Together, 
these findings suggest a wider scope for successfully intervening to facilitate a change in 
walking behaviour among people with IC.  
Another factor explaining why many people with IC do not adopt walking as a treatment 
strategy might be a lack of awareness of walking guidelines. Participants in the current study 
reported receiving advice to walk, but none were aware of specific walking guidelines and 
expressed a desire for tailored instructions. Individuals adopted walking advice in the form of 
incidental walking that was structured around daily activities or errands. This pattern of 
behaviour was also reflected in responses to the physical activity questionnaire, wherein 
nearly half (48%) of participants reported walking for several hours a day, on most days of the 
week. Participants also described barriers to achieving moderate to vigorous walking, 
indicating they were not walking at an appropriate intensity. Daily activity level is positively 
associated with physical function and reduced cardiovascular morbidity among people with IC 
(McDermott et al., 2002; Garg et al., 2009; Garg et al., 2006), but improvements in PFWA and 
MWA may require progressive challenges to the vascular system as demonstrated following 
structured walking therapy (Lane et al., 2014). It is possible that current guidelines for walking, 
which are based on supervised centre-based programmes do not translate easily or realistically 
to home-based walking. Indeed, among participants in the current study who had previously 
attended supervised exercise therapy, none reported currently engaging in walking, and they 
identified barriers to walking including comorbidities, a lack of motivation, time constraints, 
and leg pain, which had not been adequately addressed in supervised programmes or by 
healthcare professionals. As healthcare resource limitations are likely to preclude the 
implementation of supervised exercise therapy, interventions which help participants to 




Participants largely underestimated the potential for walking to improve their symptoms, and 
frequently suggested general health benefits of walking as more plausible. The TPB and CSM 
recognise outcome expectation and treatment efficacy, respectively, as important factors 
driving health behaviour. Outcome expectation reflects the behavioural belief underpinning 
attitude within the TPB, and is an important determinant of intention, whereas the CSM 
includes treatment control (i.e., the perceived efficacy of a treatment) as a key aspect of the 
illness representation. Therefore, ensuring positive and realistic beliefs about treatment 
options, including walking, might facilitate self-management among individuals with IC.  
5.4.1 Methodological considerations 
This study has several strengths. It includes participants with long-standing IC (>2 years), which 
allowed the exploration of a range of illness and treatment experiences. Participant 
experiences of walking as a treatment were explicitly elicited in order to broaden our 
understanding of the links between illness and walking treatment in this population. The study 
was theoretically underpinned, and adhered to a robust and systematic procedure using the 
Framework Method. Measures were taken to validate data, including researcher validation 
and member-checks with participants.  
Researcher bias is an important consideration in qualitative research, and can limit the 
interpretation of findings where transparency is lacking; this study employed the use of 
reflexive diaries and field notes following interviews to recognise and acknowledge biases, and 
a reflexive statement is reported indicating the researcher’s training, experience, and pre-
existing knowledge of the theoretical frameworks and population. Transparency is facilitated 
by the use of the Framework Method, which permits the deductive development of themes 
that are informed by existing theory. 
There are some limitations to this study. Participants were recruited from a vascular surgery 
outpatient clinic, and it is possible that people newly diagnosed with IC, and those not yet 




treatment, which were not captured. In addition, participants predominantly (90%) identified 
themselves as White despite attempts to recruit people from a range of ethnicities. This is 
similar to other clinical studies, which have identified challenges of recruiting a representative 
ethnically diverse sample (Sheikh et al., 2009; Heiat et al., 2002). Future research exploring the 
beliefs of individuals from different cultural background could enrich our understanding of the 
experience of IC in these populations. 
5.4.2 Conclusions 
 People with IC report uncertainty regarding their PAD, IC, and the role of walking 
treatment, which may contribute toward a lack of engagement in walking behaviour. 
 Walking is not perceived as treatment, and therefore not adopted as a self-
management strategy for IC. 
 Beliefs about the severity (i.e., perceived consequences) of IC contribute to inactivity, 
either by an associated negative emotional response, including feelings of fear and 
helplessness, or via a lack of perceived need for walking treatment for IC. 
 Individuals with IC report a high volume of incidental walking and limited purposeful 
walking for exercise, which is inconsistent with existing walking treatment guidelines 
for IC. 
 Tailored walking guidance from a healthcare professional, which explicitly addresses 
perceived barriers to moderate and vigorous walking (i.e., perceived behavioural 
control) and beliefs about the outcome of walking treatment for IC (i.e., attitude 






 Explaining walking intention and Chapter 6.
objective walking ability in individuals with IC: the 
role of walking treatment and illness cognitions 
6.1 Introduction 
People with IC engage in lower levels of walking behaviour compared with healthy, age-
matched controls (Garg et al., 2009; Lauret et al., 2014), and do not achieve walking treatment 
guidelines for improving IC. Over an 18 month observational follow-up, Gardner et al. (2004) 
demonstrated that, without further intervention (e.g., medication, exercise therapy, or 
revascularisation), walking ability (6MWD) declines among individuals with IC by 9%, and 
PFWD declines by 22%. Corresponding decreases in daily walking behaviour suggest that, 
beyond age-related decline, changes in walking ability may be attributable to changes in 
walking behaviour (McDermott et al., 2006).  
Psychosocial factors related to illness and walking treatment are barriers to self-management 
reported by people with IC, and theory-defined constructs, in particular those consistent with 
the TPB and CSM, are salient (Chapter 5).  
To date, three studies evaluated TPB or CSM variables as determinants of walking among 
people with IC (Chapter 2). Walking treatment cognitions defined by the TPB explained walking 
intentions among individuals with IC (Galea and Bray, 2007; Galea and Bray, 2006), but the 
model did not consistently explain walking behaviour, and is therefore incomplete. In addition, 
studies did not control for past walking behaviour, an important determinant of future 
behaviour within the TPB (McEachan et al., 2011), which could bias responses toward current 
judgements about walking (Hagger et al., 2002a; Bagozzi, 1981). Illness cognitions defined by 
the CSM did not explain adherence to guidelines reflecting the frequency and duration of 
walking for IC; however, causal attributions were not evaluated, and walking was assessed 




To strengthen our understanding of salient psychosocial variables that influence walking 
intention and behaviour in people with IC, past walking behaviour should be taken into 
account, and objective walking behaviour assessed. While behaviour change (e.g., programme 
attendance or increased self-directed walking) is a prerequisite for successful walking 
interventions for people with IC, the primary treatment aim includes improvements in walking 
ability (Norgren et al., 2007). Walking ability, ideally quantified using a validated objective 
measure (e.g., treadmill or corridor walk tests), provides a valuable clinical outcome, and an 
approximation of daily walking behaviour (McDermott et al., 2008). However, to date, no 
studies have explored constructs defined by the TPB or CSM, alone or in combination, as 
determinants of objective walking ability among people with IC.  
6.1.1 Aims 
The aim of this study is to evaluate the TPB and CSM together to test the utility of their 
constructs for explaining walking intention and objective walking ability, defined as the 6MWD, 
in people with IC.  
6.1.2 Objectives 
The objectives of this study are: 
a) to evaluate whether illness cognitions explain variance in walking intention above and 
beyond past walking behaviour, attitude, subjective norm, and perceived behavioural 
control;  
b) to evaluate whether walking intention and perceived behavioural control explain 
variance in 6MWD beyond past walking behaviour; and  
c) to evaluate whether illness cognitions explain variance in 6MWD beyond past walking 







Hypotheses evaluated in this study are listed in Table 6.1. 
Table 6.1 Null and alternative hypotheses tested in a cross-sectional study evaluating walking 
treatment and illness cognitions as determinants of walking intention and 6 Minute Walk 
Distance (6MWD) 
Null hypotheses Alternative hypotheses 
H01: Illness cognitions will not explain 
variance in walking intention beyond 
past walking behaviour, and attitude, 
subjective norm, and perceived 
behavioural control regarding walking 
treatment. 
H11: Illness cognitions will explain variance 
in walking intention beyond past 
walking behaviour, and attitude, 
subjective norm, and perceived 
behavioural control regarding walking 
treatment. 
H02: Perceived behavioural control and 
walking intention will not explain 
variance in 6MWD beyond past walking 
behaviour. 
H12: Perceived behavioural control and 
walking intention will explain variance 
in 6MWD beyond past walking 
behaviour. 
H03: Illness cognitions will not explain 
variance in 6MWD beyond past walking 
behaviour, perceived behavioural 
control, and walking intention. 
H13: Illness cognitions will explain variance 
in 6MWD beyond past walking 
behaviour, perceived behavioural 
control, and walking intention. 
6.2 Methods 
6.2.1 Study design 
A cross-sectional observational study was conducted. 
6.2.2 Ethical approval 
Ethical approval was obtained on 30 August 2011 from NRES Committee London – London 
Bridge (reference 11/LO/0871) (Appendix 1). Approval from the Department of Research and 
Development, Guy’s & St Thomas’ NHS Foundation Trust was confirmed on 12 September 
2011 and from King’s College Hospital NHS Foundation Trust on 31 January 2013 (CSP 




6.2.3 Eligibility criteria 
Participants met the following inclusion criteria:  
1) adults aged ≥18 years; and 
2) IC diagnosed by a vascular clinician, and based on results of established methods (e.g., 
ABPI, duplex ultrasound, computed tomography, magnetic resonance imaging) against 
recommended criteria (Norgren et al., 2007).  
Exclusion criteria were:  
1) revascularisation (e.g., endovascular treatment or bypass surgery) scheduled in the 
upcoming 3 months; 
2) the presence of a comorbidity other than IC (e.g., knee osteoarthritis, back pain) self-
reported as the primary limitation of walking;  
3) the presence of a condition for which it is unadvisable to increase walking (e.g., 
unstable angina); and/or 
4) inability or refusal to provide informed consent.  
6.2.4 Sampling and recruitment 
Sample size calculation 
Sample size was calculated a priori by a standard power calculation. Using G*Power software 
(version 3.1.9.2) (Faul et al., 2009), a medium effect (f2=0.15, equivalent to R2=0.13) in variance 
of 6MWD with =0.05, a power of 0.80, and including 15 predictor variables required 
139  participants. To account for a maximum rate of missing data of 10% (Roth, 1994), the 
target sample size was increased to 153 participants. 
Participant recruitment 
Participants were identified from vascular outpatient clinics at Guy’s & St Thomas’ NHS 
Foundation Trust between 1 September 2011 and 15 July 2014 and from King’s College 




Medical records of individuals attending vascular outpatient clinic appointments were 
screened for eligibility by the direct healthcare team, and potential participants were identified 
and informed of the study. Eligible individuals who expressed an interest in the study were 
provided with further verbal and written information by the researcher (MGH), and contact 
details were obtained. After at least 24 hours, the potential participant was telephoned and 
invited to attend a single appointment at a mutually convenient time. If they agreed to attend, 
a confirmation letter provided details of the scheduled appointment and directions to the site, 
or of transportation provided. Participants received a reminder telephone call within 2 days of 
their scheduled appointment.  
6.2.5 Outcome measures 
Sociodemographic and clinical characteristics. The following variables were assessed by self-
report: age, gender, marital status (never married, married, separated, divorced, or widowed) 
ethnicity (White, mixed/multiple ethnic background, Asian/Asian British, 
Black/African/Caribbean/Black British, or other), smoking status (current, previous, or never), 
presence of comorbidities (diabetes mellitus, cholesterol, hypertension, cardiovascular 
disease, renal disease, previous heart attack, or stroke), current medication for IC (yes/no), 
other mobility-limiting symptoms or conditions (yes/no), and participation in an exercise 
programme in the past 3 years (yes/no) (Appendix 5). 
Walking, theory-based constructs, and descriptive clinical variables were assessed and are 





Table 6.2 Outcome measures included in a cross-sectional study evaluating walking treatment 
and illness cognitions as determinants of walking intention and 6MWD 
Variable Measure 
Objective walking ability  
6 Minute Walk Distance (6MWD)  6 Minute Walk Test (6MWT) 
Pain-Free Walking Ability (PFWA)  6MWT 
Maximal Walking Ability (MWA)  6MWT 
Walking behaviour  
Self-reported walking behaviour  Baltimore Activity Scale for Intermittent Claudication 
(BASIC) 
Past walking behaviour International Physical Activity Questionnaire (IPAQ) 
Theory-based constructs  
Walking treatment cognitions Theory of Planned Behaviour Questionnaire (TPB) 
Illness cognitions Revised Illness Perception Questionnaire (IPQ-R) 
Descriptive clinical variables  
Lower-limb symptom classification San Diego Claudication Questionnaire (SDCQ) 
Health-related quality of life Medical Outcomes Survey Short Form-12 version 2 
(SF-12v2) 
Perceived activity intensity Borg Rating of Perceived Exertion (RPE) 
Perceived pain intensity Borg Category–Ratio 10 Scale for Pain (CR10) 






Participants were invited to attend a 1.5 hour session at the Division of Health and Social Care 
Research, King’s College London (London, UK). Upon arrival, participants were seated in a quiet 
meeting room, asked if they had read the information letter and invited to ask any questions. 
Participants were asked to read, complete and sign three copies of the consent form, one 
which was retained by the researcher, one which was filed in the participants’ medical records, 
and the other provided to the participant for their own reference. Questionnaires assessing 
sociodemographic variables, the BASIC, and the IPAQ were completed in that order. The 
researcher then administered the SDCQ and measured participants’ BMI.  
Next, participants received standardised instructions on the 6MWT and completed the CR10 
and RPE scales prior to commencing the 6MWT (Chapter 3). At the end of the 6MWT the CR10 
and RPE were re-administered. Participants rested for at least 20 minutes, during which they 
completed the IPQ-R and TPB questionnaires. Finally, the second 6MWT was repeated with 
pre- and post-test administrations of the Borg CR10 and RPE (Figure 6.1).  
Figure 6.1 Flow diagram illustrating procedure of a cross-sectional study evaluating walking 
treatment and illness cognitions as determinants of walking intention and 6 Minute Walk 
Distance (6MWD) 
 
BASIC, Baltimore Activity Scale for Intermittent Claudication; BMI, body mass index; CR10, 
Category–Ratio 10 Scale for Pain; IPAQ, International Physical Activity Questionnaire; IPQ-R, 
Revised Illness Perception Questionnaire; RPE, Rating of Perceived Exertion; SDCQ, San Diego 
Claudication Questionnaire; TPB, Theory of Planned Behaviour; 6MWD, 6 Minute Walk 
Distance. 
6.2.7 Analyses 
Statistical analyses were carried out in SPSS Statistics Software version 21.0 (IBM Statistics Inc., 




Data preparation and scale exploration 
Internal consistency of all self-reported measures was evaluated by using Cronbach’s α. Scores 
were interpreted as ≥0.70=good, 0.60–0.69=acceptable, 0.50–0.59=poor, and 
<0.50=unacceptable reliability (Cronbach, 1951). 
Data were examined for missing values. Participants missing >10% of data at the item level 
were excluded from analyses. For all scales, except the IPQ-R, mean substitution was used to 
derive missing data before summary scores were computed (Roth, 1994). For scales reflecting 
IPQ-R variables, summary scores were computed as recommended (Chapter 3) (Weinman et 
al., 2000; Moss-Morris et al., 2002).  
Descriptive analyses 
Sociodemographic and clinical characteristics are presented as means ±SD or 95% CIs for 
continuous variables, and frequencies (%) for categorical variables. MD scores (95% CI) are 
presented for pre- and post-test reports of perceived pain intensity (CR10) and perceived 
activity intensity (RPE) obtained during the second 6MWT, and for the 6MWD obtained during 
the first and second 6MWTs. 
Distributions of outcome measures were explored for normality by visual inspection of 
histograms and normal Q-Q plots, and calculating standardised scores for skewness (𝑧𝑠) and 
kurtosis (𝑧𝑘). Scores for 𝑧𝑠 and 𝑧𝑘 >1.96 or <-1.96 were defined as departures for normality 
(Field, 2013). Log10 and square root transformations were applied to raw or reflected scores 
for data that were positively or negatively skewed, respectively. The method producing the 
best approximation of normality for a given variable was retained for analyses of that variable 
(Tabachnick and Fidell, 2013).  Non-normal data were transformed to their original scales to 
aid the interpretation of results. 
Bivariate relationships between past walking behaviour, CSM, and TPB variables, and the 
criterion variable for each model (i.e., walking intention or 6MWD) were explored using two-





Hypotheses were evaluated using two hierarchical multiple linear regression analyses. Each 
regression model included three blocks. The adjusted multiple regression coefficient (R2adj) for 
the final model, and R2 change (R2Δ) for each block of the model are reported. Standardised 
βcoefficients are reported for the independent variables. In each model, past behaviour was 
controlled for in the first block of the regression analyses because it reflects a variable that 
temporally precedes the main TPB constructs, and has been shown to independently 
contribute toward explaining physical activity intention and behaviour (McEachan et al., 2011; 
Sutton, 2005). TPB variables were entered in the second block, before illness cognitions, 
because 1) past research has demonstrated a large effect of TPB variables on walking intention 
in individuals with IC (Galea and Bray, 2007; Galea and Bray, 2006); and 2) it is recommended 
that research on health behaviour explore the utility of general theories of behaviour change 
initially (e.g., TPB), and apply health-specific theories (e.g., CSM) only if they improve our 
understanding of behaviour change (Sutton, 2005). In block three, illness cognitions were 







The first three-block multiple linear regression model tested the first hypothesis (H11) 
(Table 6.3).  
Table 6.3 Structure of a hierarchical multiple linear regression model evaluating past walking 
behaviour, walking treatment cognitions, and illness cognitions as determinants of walking 
intention 
Block (Enter) Variables 
 1. Past walking behaviour 7-Day walking frequency 




Perceived behavioural control 













The second three-block multiple linear regression model tested the second (H12) and third 
(H13) hypotheses (Table 6.4). Blocks 1 and 2 tested H12, and Block 3 tested H13. 
Table 6.4 Structure of hierarchical multiple linear regression model evaluating past walking 
behaviour, walking treatment cognitions, and illness cognitions as determinants of 6MWD 
Block (Enter) Variables 
 1. Past walking behaviour 7-Day walking frequency 
 2. Walking treatment cognitions Perceived behavioural control 
Intention 











Risk factors attributions 





Criteria for meeting the assumptions of multiple linear regression analyses 
Multicollinearity. Criteria for absence of multicollinearity required bivariate correlations 
between predictor variables <0.80, variance inflation factors <10.0, and tolerance statistics 
<0.10 (Tabachnick and Fidell, 2013). 
Homoscedasticity. Constant variance between predicted dependent variable scores and errors 
of prediction required a random distribution of scores based on visual examination of a 
scatterplot of standardised residual values against standardised predicted values of the 
dependent variable.   
Normality of the error distribution. A normal distribution of the frequency of standardised 
residual scores around the predicted dependent variable scores was determined by visual 
evaluation, a mean of the distribution approaching zero, and no deviations from normality 
based on Normal P–P plots of standardised residuals. 
Independent errors. The criterion for independent residual terms between observations was a 
Durbin–Watson statistic <1 or >3. 
Absence of outliers in the model. Univariate outliers were defined as Studentised residual 
values ±3 SD. Multivariate outliers were defined as a Mahalaonobis distance (Mahal D2) 
greater than the critical value of 2 for the degrees of freedom of the final model at p=0.01 
(Field, 2013). 
6.3 Results 
6.3.1 Participant characteristics 
Overall, 152 individuals with IC were enrolled onto the study. One participant (022B, male, age 
not reported) withdrew from the study during questionnaire completion, 6 participants had 
>10% missing data at the item level (range 17.3–22.2%) and were excluded from analyses, and 
3 participants were identified as outliers (Section 6.3.6). Therefore, data for 142 individuals 
were included in the analyses. Sociodemographic and clinical characteristics of excluded 




The majority of included participants were male (80%) and White (80%) (Table 6.5). Just over 
one-third (35%) of participants were currently smoking, and nearly one-quarter (24%) had 
attended a supervised exercise programme for IC within the previous 3 years. Classic IC was 
the most common symptomology (48%), followed by atypical exertional leg symptoms (37%). 
One-half (50%) of participants with available data had been managed conservatively. 
Table 6.5 Sociodemographic and clinical characteristics of participants in a cross-sectional 
study evaluating walking treatment and illness cognitions as determinants of walking intention 
and 6MWD 
Variable Value, n (%) 
Age, years 66.9 ±10.2a 
Body mass index, kg/m2 28.2 ±5.0a 
Male gender  116 (80.0) 
Married  61 (42.1) 
White ethnicity 116 (80.0) 
Current smoker  51 (35.2) 
Cardiovascular risk factors  
Diabetes mellitus 50 (34.5) 
Cardiovascular diseaseb 63 (43.8) 
Hypertension 105 (72.4) 
Hyperlipidaemia 101 (69.7) 
Renal diseaseb 14 (9.7) 
Past heart attack 31 (21.4) 
Past strokeb 22 (15.2) 
Comorbid pain 53 (36.6) 
Pharmacological IC management 44 (30.3) 
Past supervised exercise therapy 35 (24.1) 
Past revascularisationc  
None 72 (49.6) 
Angioplasty (with or without stent) 21 (14.5) 
Bypass surgery 9 (6.2) 
Endarterectomy 2 (1.4) 
Multiple procedures 2 (1.4) 
Lower-limb symptom classification  
No pain 2 (1.4) 
Pain at rest 20 (13.8) 
Classic IC 69 (47.6) 
Atypical IC 54 (37.2) 
n=142.  aData are mean ±SD. bData are missing for one participant. cData are missing for 39 




6.3.2 Scale reliability 
Inter-item reliability was demonstrated by Cronbach’s α scores ranging from 0.63–0.91, except 
for accident/chance attributions (IPQ-R), which had a Cronbach’s α score of 0.34. This is 
consistent with previous research (Moss-Morris et al., 2002) and attributable to a 2-item scale, 
so despite the low reliability, the scale was retained for further analyses (Table 6.6). 
Table 6.6 Inter-item reliability of psychometric scales of the Theory of Planned Behaviour and 
Revised Illness Perception Questionnaires 
Questionnaire and scale Cronbach’s α 
Theory of Planned Behaviour Questionnaire  
Attitude  0.83 
Subjective norm 0.82 
Perceived behavioural control 0.74 
Walking intention 0.91 
Revised Illness Perception Questionnaire  
Personal control 0.64a 
Treatment control 0.69 
Consequences 0.65b 
Coherence 0.79c 
Acute timeline  0.76c 
Cyclical timeline 0.76 
Emotion 0.83c 
Psychological attributions 0.83d 
Risk factor attributions 0.64a 
Immunity attributions 0.76e 
Accident/chance attributions 0.36c f 
Data reflect n=142 with the following exceptions: an=139; bn=140; cn=141; dn=134; and en=135. 
fLow internal consistency was attributed to a 2-item scale, and the variable was retained in the 
model. 
6.3.3 Missing value analyses and treatment 
There was a high frequency of item-level missing data across participants for the IPAQ, ranging 
from 1 (0.7%, item 1, days of vigorous physical activity) to 17 (11.3%, item 4, duration of 
moderate physical activity). There was also a high frequency of responses coded as “don’t 




moderate physical activity), and item 6 (duration of walking). There were no missing data for 
item 5, reflecting walking frequency, which was used in regression analyses to reflect past 
walking behaviour.  
Among variables included in the regression models, the rate of missing data was <5% 
(Appendix 5). Overall, 29 participants were missing data (all <10% at the item level). There 
were no clear patterns across missing data, with the exception of one item reflecting 
subjective norm (n=5 missing, “My spouse/significant other approves of me doing the 
recommended walking exercise”) and four items reflecting causal attributions (pollution in the 
environment [n=2 missing], family problems or worries [n=2 missing], my own personality [n=4 
missing], and altered immunity [n=5 missing]).  
6.3.4 Data distributions and transformations 
All data were normally distributed except variables reflecting past walking behaviour (IPAQ), 
subjective norm (TPB), walking intention (TPB), accident/chance attributions (IPQ-R), and 
identity (IPQ-R), which were transformed (Table 6.7) 
Table 6.7 Summary of data transformations for non-normally distributed variables included in 
a cross-sectional study evaluating walking treatment and illness cognitions as determinants of 
walking intention and 6MWD 
Variable Distribution Transformation Formula 





















Square root SQRT(AC)=SQRT(AC) 





6.3.6 Descriptive results 
Objective walking ability  
Mean 6MWD was 365.0 metres (95% CI 347.3, 382.7; range 62.2–581.2). Pain intensity scores 
increased by mean 3.7 (95% CI 3.3, 4.0) and perceived exertion by mean 5.02 (95% CI 4.5, 5.5). 
Post-test scores reflect pain intensity that is “somewhat severe to severe” and a perceived 
exertion that is “light to somewhat hard”.  
Overall, 75 (52%) participants reported their PFWA (mean 128.4 seconds [95% CI 114.0, 143.0]) 
and 36 participants stopped to rest during the walk test (MWA; mean 185.9 seconds, 95% CI 
154.8, 216.9) (Table 6.7).  
Table 6.7 Data reflecting objective walking ability and descriptive clinical variables measured 
during the 6 Minute Walk Test (6MWT) in a cross-sectional study evaluating walking treatment 
and illness cognitions as determinants of walking intention and 6MWD 
Variable Mean ±SD 95% CI 
6 Minute Walk Distance, metres 365.0 ±107.8  347.3, 382.7 
Pain-Free Walking Ability, seconds 128.4 ±63.0 114.0, 143.0 
Maximal Walking Ability, seconds 185.9 ±91.8 154.8, 216.9 
Pre-test perceived activity intensity 7.7 ±2.7 7.3, 8.2 
Post-test perceived activity intensity 12.8 ±3.1 12.3, 13.3 
Pre-test perceived pain intensity 0.8 ±1.2 0.6, 1.0 
Post-test perceived pain intensity 4.5 ±2.3 4.1, 4.9 
n=142 except Pain Free Walking ability (n=75) and Maximal Walking Ability (n=36). 
Participants walked 12.94 metres (95% CI 7.30, 18.6) further during the second 6MWT 
compared with the first, which suggested a small learning effect (3.5%) (American Thoracic 
Society, 2002).  
Perceived causal attributions 
Overall, risk factors were the predominant causal attributions (assessed using the IPQ-R), and 




of participants also agreed that ageing, their own behaviour, dietary behaviour, alcohol, and 
heredity were likely causes of their PAD. Stress was the only other causal attribution reported 
by more than 25% of the sample (Figure 6.2 and Appendix 5) 
Figure 6.2 Frequencies of perceived causal attributions of PAD reported by participants in a 
cross-sectional study evaluating walking treatment and illness cognitions as determinants of 
walking intention and 6MWD 
 
 
Descriptive statistics and bivariate correlations for psychosocial predictors and criterion 
variables are presented in Table 6.8. Mean scores were positive for all TPB variables, and for 
personal control, treatment control, coherence and risk factor attribution regarding PAD. PAD 
was perceived as acute, and with high consequences and emotional impact. Bivariate 
associations were, overall, in the anticipated directions. 6MWD was positively associated with 
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factor attribution (0.18), and negatively associated with acute timeline (r=-0.16), consequences 
(r=-0.26), and emotion (r=-0.22).  Walking intention was positively associated with other TPB 
variables (r=0.67-0.75), and with treatment control (r=0.20), personal control (r=0.19) and 
coherence (r=0.21), and negatively associated with acute timeline (r=-0.23) and 
accident/chance attributions (r=-0.17). Treatment control and personal control were positively 
associated with all TPB variables (r=0.16–0.25), whereas high and low scores for coherence 
(r=0.21–0.23) and consequence (r=-0.22–-0.30), respectively, were associated with attitude 
and perceived behavioural control, but not subjective norm. Acute timeline was associated 
with low scores for attitude (r=-0.29) and subjective norm (r=-0.20), and accident/chance 
attributions were associated with low scores for subjective norm (r=-0.14) and perceived 




Table 6.8 Descriptive statistics and bivariate correlations between past walking behaviour, walking treatment cognitions, illness cognitions, walking intention, and 
6MWD  
Variable 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 M SD 
1. Attitude 0.57a 0.65a 0.13 -0.29a -0.10 0.21a 0.29a 0.21b -0.30a -0.02 -0.05 -0.10 0.05 0.14 0.37a 0.67a 0.38a 44.9 9.7 
2. Subjective norm  0.58a 0.04 -0.20b -0.10 0.25a 0.21b 0.18 0.02 -0.10 0.01 -0.11 -0.16b 0.11 0.25a 0.75a 0.17b 23.0c 10.0c 
3. PBC   0.11 -0.14 -0.18 0.16a 0.25a 0.23b -0.22a -0.16 0.04 -0.19 -0.22a -0.12 0.43a 0.72a 0.27a 31.9 7.2 
4. Identity    -0.19a -0.26a 0.17 0.12 0.17 -0.40a -0.32a -0.15 -0.18b 0.14 -0.45b 0.11 0.03 0.16 3.0c 4.0c 
5. Acute timelineb     0.4 -0.44a -0.31a -0.11 0.33a 0.01 0.29a -0.08 -0.08 0.18b -0.07 -0.23a -0.16b 19.9 4.3 
6. Cyclical timelineb      -0.06 -0.06 -0.50a 0.08 0.32a 0.04 0.30a -0.27a 0.17 -0.04 -0.08 -0.11 11.6 3.5 
7. Treatment control       0.49a 0.14 -0.16b 0.02 0.07 0.08 0.04 -0.12 -0.11 0.20b 0.05 17.5 3.7 
8. Personal control        0.25a -0.35a 0.02 0.17b 0.01 0.14 -0.31a 0.09 0.19b 0.38a 20.1 3.7 






 0.04 -0.29a 0.22b -0.26a 0.10 0.21b 0.32
a
 16.9 4.0 
10. Consequencesb          0.24a 0.20b 0.14 -0.17b 0.64a -0.13 -0.01 -0.26a 19.4 4.3 
11. Psychological attributionsa        
 
0.28a 0.69a -0.42a 0.39a -0.11 -0.08 -0.12 13.7 4.6 
12. Risk factor attributions           0.25a -0.08 0.20b 0.08 -0.02 0.18b 20.5 4.5 
13. Immunity attributionsb            -0.53a 0.19b -0.06 -0.13 0.01 6.5 2.2 
14. Accident/chance attributionsb           -0.17b 0.07 -0.17b -0.06 4.0c 2.0c 
15. Emotionb               -0.08 0.09 -0.22a 17.4 5.6 
16. Past walking behaviour               0.41a 0.33a 5.0c 5.0c 
17. Walking intention                0.26a 25.0c 9.0c 
18. 6MWD, metres                  367.0 107.0 
n=142. ap<0.01. bp<0.05. cData are median (IQR) for variables transformed to their original scales. bA lower score indicates a more positive or accurate illness perception. M, 








6.3.7 Hierarchical multiple linear regression analyses 
Tests of assumptions of multiple linear regression 
Assumptions for the absence of multicollinearity, and for normality, linearity and 
homoscedasticity between predicted dependent variable scores and errors of prediction were 
met for both regression models (Appendix 5). There were no univariate outliers. Three 
multivariate outliers were detected and were removed from analyses: case 14 Mahal D2=22.67 
(walking intention) and 22.25 (6MWD), case 71 Mahal D2=22.76 (6MWD), and case 83 Mahal 
D2=29.20 (walking intention), all p<0.01. 
H11: Illness cognitions will explain variance in walking intention beyond past walking 
behaviour, and attitude, subjective norm, and perceived behavioural control 
regarding walking treatment 
Intention was regressed onto past walking behaviour (Block 1), attitude, subjective norm, and 
perceived behavioural control (Block 2), and identity, acute timeline, cyclical timeline, 
treatment control, personal control, coherence, consequences, and causal attributions 
reflecting psychological factors, risk factors, immunity, and accident/chance (Block 3) (Table 
6.9). Past walking behaviour accounted for 17% of the variance in walking intention, F(1, 
140)=27.56 (p<0.001). The addition of the TPB variables in block two explained an additional 
55% of the variance, F(3, 137)=89.54 (p<0.001), with attitude, subjective norm and perceived 
behavioural control all making significant contributions. Past walking behaviour became non-
significant in this block. The addition of illness cognitions in block three accounted for an 
additional, but nonsignificant, 4% of variance, F(12, 125)=1.633 (p=0.090). The final 
regression model explained 73% of variance in walking intention, F(16, 125)=24.21 (p<0.001). 
Attitude, subjective norm, and perceived behavioural control were significant predictors, as 





Table 6.9 Results of a hierarchical multiple linear regression evaluating past walking behaviour, 
walking treatment cognitions, and illness cognitions as determinants of walking intention 
Variables entered R2adj R2∆ β t p-value 
Block 1 0.16 0.17   <0.001 
Past walking behaviour    0.41 5.25 <0.001 
Block 2 0.71 0.55   <0.001 
Past walking behaviour   0.09 1.81 0.059 
Attitude   0.18 2.90 0.004 
Subjective norm   0.45 7.68 <0.001 
Perceived behavioural control    0.30 4.63 <0.001 
Block 3 0.73 0.04   0.090 
Past walking behaviour   0.10 1.92 0.074 
Attitude   0.23 3.42 0.001 
Subjective norm   0.35 5.61 <0.001 
Perceived behavioural control    0.34 5.16 <0.001 
Identitya   0.01 0.20 0.845 
Acute timelinea   -0.06 -1.12 0.267 
Cyclical timelinea   0.09 1.62 0.107 
Treatment control   0.02 0.33 0.742 
Personal control   -0.02 -0.30 0.763 
Coherence   0.09 1.64 0.104 
Consequencesa   0.15 2.37 0.020 
Psychological attributions   -0.01 -0.09 0.929 
Risk factor attributions   -0.06 -1.18 0.240 
Immunity attributionsa   0.01 0.19 0.852 
Accident/chance attributionsa   0.06 1.12 0.266 
Emotiona   0.08 1.24 0.218 
n=142. aA lower score indicates a more positive or accurate illness perception. 
H12: Perceived behavioural control and walking intention will explain variance in 
6MWD beyond past walking behaviour  
6MWD was regressed onto past walking behaviour (Block 1), intention, and perceived 
behavioural control (Block 2). Past walking behaviour accounted for 11% of variance in 6MWD, 




additional, but non-significant, 2% of variance, F(2, 138)=1.95 (p=0.147). The final regression 
model explained 11% of the variance in 6MWD, F(3, 138)=7.040 (p<0.001). Only past walking 
behaviour was a significant predictor (Table 6.10). 
Table 6.10 Results of a hierarchical multiple linear regression analysis evaluating past walking 
behaviour, walking treatment cognitions, and illness cognitions as determinants of 6MWD 
Variables entered R2adj R2∆ β t p-value 
Block 1 0.10 0.11   <0.001 
Past walking behaviour    0.33 4.12 <0.001 
Block 2 0.11 0.02   0.147 
Past walking behaviour   0.25 2.81 0.006 
Perceived behavioural control   0.10 0.88 0.387 
Walking intention    0.09 0.75 0.453 
Block 3 0.28 0.23   <0.001 
Past walking behaviour   0.15 1.81 0.073 
Perceived behavioural control   -0.03 -0.30 0.768 
Walking intention   0.17 1.48 0.144 
Identitya   0.04 0.52 0.607 
Acute timelinea   -0.10 -1.02 0.308 
Cyclical timelinea   0.02 0.17 0.868 
Treatment control   -0.23 -2.45 0.015 
Personal control   0.31 3.28 0.001 
Coherence   0.19 2.08 0.040 
Consequencesa   -0.10 -0.95 0.345 
Psychological attributionsa   -0.18 -1.59 0.114 
Risk factor attributions   0.19 2.21 0.029 
Immunity attributionsa   0.17 1.48 0.140 
Accident/chance attributionsa   0.05 0.52 0.607 
Emotiona   -0.03 -0.28 0.780 





H13: Illness cognitions will explain variance in 6MWD beyond past walking behaviour, 
perceived behavioural control, and walking intention 
Illness cognitions were added to the model testing H12 (Block 3). CSM variables accounted for 
an additional 23% of variance in 6MWD, F(12, 126)=3.72 (p<0.001) Past walking behaviour 
became non-significant in this block. The final regression model explained 28% of the variance 
in 6MWD, F(15, 126)=4.71 (p<0.001). Treatment control, personal control, coherence, and risk 
factor attributions were significant predictors (Table 6.10). Unstandardised beta coefficients 
indicated that for every 1 unit increase in scores reflecting treatment control, personal control, 
coherence, and risk factor attributions, 6MWD decreased by 7.8 metres (95% CI -14.0, -1.5), 
and increased by 9.0 metres (95% 3.6, 14.5), 5.0 metres (95% CI 0.2, 9.7), and 4.6 metres (95% 






This study demonstrated that illness and walking treatment beliefs defined by the CSM and 
TPB contributed differently to walking intention and objective walking ability (6MWD) among 
individuals with IC. Attitude, subjective norm, and perceived behavioural control regarding 
walking (TPB) explained intention, but not walking ability. By contrast, treatment control, 
personal control and coherence regarding PAD, and risk factor attributions (CSM) explained 
objective walking ability, however, illness cognitions made no significant overall contribution 
to variance in walking intention beyond TPB constructs.  
This is the first study to evaluate constructs from both the TPB and CSM to explain walking 
intention in people with IC, and the first to evaluate their relative and combined contributions 
to an objective measure of walking. It builds on the existing literature (Galea and Bray, 2007; 
Galea and Bray, 2006) by including a larger sample size and controlling for past walking 
behaviour. This study confirmed that TPB cognitions and past walking behaviour account for 
most (71%) of the variance in walking intention. The contribution of past walking behaviour on 
intention was reduced to a small, non-significant effect (β=0.09 p=0.073) with the addition of 
TPB variables. While this study did not aim to evaluate the mechanism for effects of past 
walking behaviour (e.g., mediation or moderation via TPB variables), findings suggest that 
participants’ walking intention was influenced by reasoned, prospective cognition, and so 
individuals with IC might benefit from interventions that facilitate deliberate walking plans.  
Among TPB cognitions, subjective norm accounted for the largest independent effect on 
walking intention, followed by perceived behavioural control and then attitude. This is 
consistent with other work exploring the TPB in IC (Galea and Bray, 2007), but contrary to 
research on exercise and physical activity in healthy individuals, wherein subjective norm is 
consistently the weakest predictor of intention (Hagger et al., 2002b). The relative importance 
of TPB variables can vary depending on the context, population, or behavioural outcome 
(Ajzen, 1991), and it may be that, among people with IC, perceptions about key referents are 
particularly important. Findings from this study suggest that injunctive norms regarding one’s 




salient among people with IC, and that these individuals could form a network providing 
support that could be harnessed by interventions to facilitate walking.  
This is the first study to explore illness cognitions defined by the CSM as determinants of 
walking intention in people with IC. CSM constructs explained only approximately 4% 
additional variance in walking intention beyond past walking behaviour and TPB constructs. 
While CSM constructs collectively did not explain walking intention, perceived consequences 
of PAD emerged as an independent illness cognition that contributed to walking intention 
alongside attitude, subjective norm, and perceived behavioural control. Findings suggest that 
this particular aspect of the illness representation may be salient when forming plans to 
engage in walking, but conflict with qualitative evidence suggesting that individuals do not 
consider walking as a self-management opportunity regardless of the perceived consequences 
of their IC (Chapter 5). However, the bivariate association between perceived consequences 
was small and inverse (r=-0.007), and suggests that a degree of multicollinearity may account 
for the effect noted in the multivariate model, although criteria for this assumption were met. 
Illness cognitions were associated with walking ability and explained 24% of variance in 
6MWD. Personal control, coherence, and risk factor attributions were independent 
determinants of 6MWD. Treatment control was inversely associated with 6MWD, suggesting 
that individuals who perceived their treatment could cure their IC were less likely to engage in 
walking. Qualitative evidence suggests that people with IC do not perceive walking as 
treatment, and frame their treatment options around medical or surgical management 
(Chapter 5), so it may be that individuals considered revascularisation, but not walking, when 
responding to items on treatment control in the IPQ-R. This suggests that individuals who 
believe that revascularisation could improve or cure their IC, are less likely to engage in 
walking.  
Perceived behavioural control and walking intention explained only 2% (p=0.147) of variance in 
6MWD. Findings are consistent with the “intention–behaviour gap”, wherein positive intention 




incompatibility between intention, which explored participants’ self-reported plans to walk, 
and the outcome, which approximated walking behaviour using an objective assessment, could 
explain these findings. However, the 6MWD provides a validated, clinically relevant 
assessment of objective physical activity in people with IC (McDermott et al., 2008), and might 
better reflect their actual walking behaviour than self-reported measures.  
Perceived behavioural control is an important predictor of self-reported walking among 
individuals with IC (Galea and Bray, 2007; Galea and Bray, 2006), but did not explain 6MWD. 
Participants might have held inaccurate control and confidence beliefs regarding walking, or 
anticipated general barriers to walking (e.g., lack of time or motivation), regardless of their 
walking ability. Perceived behavioural control best predicts behaviour when it approximates 
actual control. One strategy for better approximating actual control could be to prompt 
individuals to consider potential barriers to walking. Rejeski et al. (2008) reported a linear 
trend between scores reflecting barrier self-efficacy and the 6MWD among 205 people with IC. 
A significant difference was reported between those with poorest walking ability (<976 feet) 
and those who walked furthest (>1,285 feet; p=0.0005). However, items on the barrier self-
efficacy scale used in that study reflect common challenges to being physically active, and not 
barriers specific to IC, nor beliefs about treatment (i.e., walking for IC) per se. Disease-specific 
measures might provide a better understanding of the impact of perceived barriers on walking. 
Nevertheless, findings suggest that measures of perceived behavioural control that include 
explicit prompts of barriers to walking might improve the explained variance in 6MWD. 
6.4.1 Methodological considerations 
This study has several strengths. It is the first study to evaluate constructs from the TPB and 
CSM together using regression analyses to explain objective walking ability, and the first to do 
so in people with IC. The 6MWD is a valid and reliable measure of walking, and a clinically 
relevant outcome for people with IC. A large, diverse, and representative sample of 
145 individuals was included, which enabled fully powered hypothesis testing.  
This study identifies salient cognitions that explain walking intention and objective walking 




between variables, and it is possible that greater walking ability leads to more positive beliefs 
about walking and PAD. The order of outcome measurement was carefully considered to 
minimise participant burden (e.g., interspersing questionnaire completion between 6MWTs to 
reduce questionnaire fatigue and total assessment time). However, the initial 6MWT was 
carried out before completing surveys about illness and walking treatment cognitions, and 
might have primed individuals to consider their perceived walking ability when responding to 
subsequent surveys. However, it is unlikely that this would introduce a methodological bias 
(e.g., inflated covariance between predictor and criterion variables) because the initial 6MWD 
was not evaluated as the criterion and the context and source of 6MWD data (e.g., objective, 
rated by investigator) differed from that of the survey completion (e.g., subjective, self-
reported) (Podsakoff et al., 2003). A standardised protocol was followed, and a baseline 6MWT 
was conducted to control for a learning effect, which typically ranges between 0% and 17% 
(American Thoracic Society, 2002). The difference (3.5% between the two 6MWTs) was small, 
and unlikely to be clinically meaningful.  
6.4.2 Conclusions 
 Illness cognitions did not explain variance in walking intention beyond past walking 
behaviour, and attitude, subjective norm, and perceived behavioural control regarding 
walking treatment. 
 Perceived behavioural control and walking intention did not explain variance in 6MWD 
beyond past walking behaviour.  
 Illness cognitions explained variance in objective walking ability beyond past walking 
behaviour, perceived behavioural control and walking intention. 
 Taking into account past walking behaviour, attitude, subjective norm and perceived 
behavioural control regarding walking treatment, and perceived consequences, illness 
coherence, personal and treatment control, and risk factor attributions are 
psychosocial variables that should be targeted when developing and evaluating 




 Feasibility of a randomised controlled Chapter 7.
trial of a physiotherapist-led behaviour-change 
intervention targeting walking in people with IC  
7.1 Introduction 
Qualitative and quantitative evidence support the TPB and CSM as viable frameworks for an 
intervention to facilitate walking in people with IC (Chapters 5 and 6). To date, the TPB has not 
been applied in the development of walking interventions for people with IC; however, a pilot 
trial of a brief home-based intervention that was informed by the CSM, and which increased 
walking behaviour in people with IC, suggests that illness cognitions might be important 
targets for intervention (Cunningham et al., 2012; Cunningham et al., 2013). While these 
findings demonstrate a promising way forward for supporting walking behaviour change, only 
individuals newly diagnosed with IC and who were managed conservatively were included 
(Cunningham et al., 2013; Cunningham et al., 2012). Qualitative data highlight a need for 
interventions suitable for the wider population of people with IC (Chapter 5), and suggests that 
many individuals with IC, including those with longstanding symptoms (i.e., >2 years) or who 
had undergone revascularisation, are not achieving walking guidelines and desire further 
support to self-manage their IC.  
Interventions that increase walking behaviour should also demonstrate improvements in 
clinical outcomes for IC, to determine whether behaviour has been changed sufficiently to 
improve health. A primary treatment aim of walking for IC is improved walking ability (Norgren 
et al., 2007); however, there is a dearth of research exploring the effectiveness of behaviour-
change interventions to increase clinical outcomes for IC (Chapter 4), despite the availability of 
validated measures that are easy to administer, low-cost and acceptable to participants, such 
as the 6MWT (Montgomery and Gardner, 1998). Cunningham et al. (2013; 2012) reported 
increased daily walking behaviour, but did not measure objective walking ability, so 




Alongside outcome (i.e., effectiveness) evaluation, there is a growing drive to evaluate and 
report processes underpinning the delivery and uptake of complex interventions, including 
treatment integrity (i.e., the extent to which an intervention has been delivered as intended by 
the protocol), causal mechanisms, and contextual factors, which could support 
implementation to practice (Craig et al., 2008; Moore et al., 2014). Previous studies did not 
detect a treatment effect on theory-based beliefs proposed as mechanisms of change 
(Cunningham et al., 2013; Cunningham et al., 2012). One explanation for this finding was the 
use of non-validated measures of walking treatment beliefs (e.g., walking personal control and 
walking consequences), which were framed by the authors within the CSM, but which are 
conceptually defined and operationalised within the TPB. Measures with demonstrated 
psychometric properties might better assess theory-based cognitive variables targeted by the 
intervention. Additionally, only pre-randomisation and follow-up assessment was carried out, 
and an interim post-intervention assessment would enable longitudinal evaluation of change 
in targeted variables and mediational analyses in a full-scale trial. Finally, data on treatment 
integrity might have supported the reliability and validity of results (Perepletchikova and 
Kazdin, 2005; Borrelli, 2011). 
An important stage in intervention development and evaluation, in particular to understand 
processes underlying intervention effects and treatment outcomes, involves replication of the 
core components of the intervention (Michie et al., 2009). Therefore, the study evaluates core 
components (e.g., BCTs) of a previously reported intervention (Cunningham, 2010; 
Cunningham et al., 2012), while developing and refining the methods to address key 
limitations, including those described above, through feasibility testing.  
Feasibility research enables evaluation of the likelihood that the intervention will be effective 
and whether it is worth continued testing (Bowen et al., 2009). In addition, it identifies where 
and how the protocol or intervention requires modification for a definitive trial, focusing on 




modifications to an intervention), and expansion (e.g., building on results of an effective 
intervention for delivery to a new population or setting) (Bowen et al., 2009).  
An important adaptation of the intervention delivery in the current study explores the 
feasibility of intervention delivery by a physiotherapist. As specialists in exercise rehabilitation 
and prescription, physiotherapists have a central role in changing exercise and physical activity 
behaviour, such as walking for IC. According to the Health and Care Professions Council (2013), 
physiotherapists’ scope of practice includes an understanding of psychosocial factors that 
influence health behaviour and responses to physiotherapy treatment. Physiotherapy 
enhanced by psychological behaviour-change interventions can increase patient self-efficacy 
and physical functioning (McGrane et al., 2015). However, interventions are frequently 
delivered by other healthcare professionals alongside physiotherapy, and physiotherapists 
express a desire to develop their delivery of psychological techniques (Alexanders et al., 2014). 
Therefore, the role of the physiotherapist in supporting increased walking among individuals 
with IC, employing psychological BCTs, needs further exploration. 
7.1.1 Aims 
This study aims to refine and evaluate the feasibility of an RCT comparing a brief 
physiotherapist-led behaviour-change intervention targeting walking to an attention-control 
among people with IC. 
7.1.2 Objectives and feasibility criteria 






Table 7.1 Study objectives and criteria used to evaluate the feasibility of an RCT of a 
physiotherapist-led home-based behaviour-change intervention targeting walking among 
individuals with IC 
Feasibility objectives Feasibility criteria 
a) to evaluate study retention of 
participants 
Study retention at 16 week follow-up will be at least 
60% (n=14/24) based on retention rates of past trials of 
home-based walking interventions in individuals with IC 
(Al-Jundi et al., 2013; Galea et al., 2013)  
b) to evaluate participant 
compliance with the treatment 
and attention-control protocols 
At least 60% (n=14/24) of participants will complete all 
treatment and attention-control sessions  
c) to evaluate the suitability of the 
proposed outcome measures of 
objective walking ability, walking 
behaviour and theory-based 
constructs 
Missing data at each time point will be less than 10% 
for each outcome, based on evidence that this is the 
threshold below which data missing at random will not 
be affected by the choice of treatment (Roth, 1994) 
d) to explore the variability of 
proposed objective walking 
outcomes in order to estimate 
the treatment effect 
Sufficient data will be collected to estimate the effect 
size (Hedges, 1981) of the treatment on 6MWD and 
walking behaviour compared with the attention-
control, and to explore the precision of measurement 
across a range of CIs 
e) to explore the suitability of 
proposed methods for evaluating 
treatment integrity 
A consensus score using the Motivational Interviewing 
Treatment Integrity (MITI) across audio-recorded 




7.2.1 Study design 
An acceptance and feasibility study of a two-arm single-blinded RCT was conducted. 
7.2.2 Ethical approval 
Ethical approval was obtained on 18 February 2013 from NRES Committee North West – 
Greater Manchester West (reference 14/NW/0089) (Appendix 1). Approval from the 
Departments of Research and Development, Guy’s & St Thomas’ NHS Foundation Trust was 




2014 (CSP reference 143466). The trial is registered on the ISRCTN database 
(ISRCTN55465549).  
7.2.3 Development of treatment and attention-control scripts 
Materials (Appendix 6) for the behaviour-change intervention targeting walking (treatment) 
were adapted from previous research (Cunningham, 2010). The intervention was expanded 
based on findings of Chapters 4 and 5, and refined following consultation with individuals with 
PAD and healthcare professionals. 
Incorporating the views of individuals with PAD  
A purposive sample of eight participants (n=6 male, n=3 classic IC, mean age 69.8 years, [range 
56–82], mean 6MWD 338.43 metres [range 237.11–466.20]) in the cross-sectional study 
(Chapter 6) was invited to comment on the intervention structure and material. Participants 
felt that home and telephone delivery was convenient, although they would also be willing to 
attend clinic. Medical terms (e.g., atherosclerosis) and illustrations (e.g., image of vascular 
tree) presented in the intervention script required clarification. Some participants felt the 
content was helpful, although familiar, and so could be expanded to provide more depth and 
tailored information. Overall, participants felt the intervention was acceptable and relevant 
(Appendix 6).   
Incorporating the views of healthcare professionals 
A health psychologist and two physiotherapists were invited to comment on the intervention 
structure and material. To comply with the CSM and a patient-centred approach, aspects of 
the intervention script which implied a cognitive or emotional response were modified in order 
to elicit participants’ illness representation (e.g., the text “You may worry that walking will 
harm your legs…” was replaced with a prompt to elicit the impact of IC on the individual and 
reassurance that walking does not cause harm). Treatment experiences and appraisals were 
elicited in order to elicit participants’ attitude, subjective norm and perceived resources and 




their wider treatment history, to support the resonance among individuals with longstanding 
PAD and who had considered or undergone revascularisation. A walking prescription was 
framed within the recommendations for IC and tailored to individuals’ current walking 
behaviour. Finally, aspects of the script, and particularly the booster telephone sessions, were 
developed to provide more structure and detail with suggestions on how to manage resistance 
to change, and support patients who are both successful and unsuccessful in carrying out their 
action plans and achieving behavioural goals.     
Incorporating the findings of qualitative and cross-sectional data  
Key adaptations to the intervention based on findings from Chapters 4 and 5 sought to a) elicit 
participants understanding and previous experiences of treatment for IC in order to frame 
walking in a relevant context; and b) provide explicit information on the realistic outcomes of 
walking for IC; and c) include explicit instruction on the established guidelines recommending 
walking. For example, participants were invited to discuss any previous treatment they had for 
their IC (Session 1). If walking therapy was not reported, then participants were asked if they 
had heard about walking exercise as a treatment for IC, what current walking activity they 
were engaged in, and what their experiences were of walking. Specific and general benefits of 
walking were provided. Specific benefits of walking including potential improvements in the 
distances walked before pain onset or before needing to stop and rest. General benefits of 
walking included a greater ability to engage in important daily activities, and greater 
maintenance or recuperation of health and mobility if undergoing revascularisation. 
Participants were informed of guidelines for IC to walk for at least 30 minutes on at least 3 
days/week (Session 1). “Walking through pain” was defined as walking to moderate pain 
intensity before stopping to rest, and then continuing on once pain subsided, although some 
people with IC are able to carry on walking without stopping as their pain may not reach a 
moderate level. Walking intensity was further defined as walking at a brisk pace that brings on 
pain within the first 3-5 minutes of walking. Participant were encouraged to think about the 
guidelines, and how much walking they were currently doing, and set a plan to progress 




Table 7.2. Summary of key adaptations to develop a physiotherapist-led home-based 
behaviour-change intervention targeting walking among individuals with IC  
 Cunningham (2010) Extended intervention 
   
Theoretical 
underpinning 
 CSM  CSM and TPB 
Target 
population 
 Newly diagnosed IC  All individuals with stable IC 
(including longstanding PAD and 
previous revascularisation). 





 2 x 60 min face-to-face consultation 
in participant homes and 2 x 20 min 
booster telephone calls 
 2 x 60 min face-to-face consultation 
in participant homes and 2 x 20 min 




Session 1   
Opening  Elicit understanding of IC  Elicit understanding of IC and 
impact on value-based activities 
Introduction 
on IC  
 Provide information on the cause 
of IC (i.e., narrowed arteries and 
lack of oxygenated blood flow) 
 Present illustrations of the vascular 
tree and a narrowed artery 
 Provide information on the cause of 
IC  
 Assure patient that pain is not a 
sign of damage or harm 
 Present simplified illustrations of the 
vascular tree and narrowed artery  
Risk factors 
for IC 
 Provide information on risk factors 
(e.g., cholesterol, smoking, blood 
pressure, physical activity, obesity, 
diabetes) 
 Elicit perceived cause of IC 
 Provide information on risk factors 
and review those relevant to 
participant’s current management 
Treatment 
for IC 
 Provide information on benefits of 
walking, including a) pain-free 
walking ability; b) change in blood 
flow to lower-limb; c) stimulated 
collateral blood flow; d) reduced 
systemic atherosclerotic build-up. 
 
 Elicit previous treatment 
experiences and appraisal of 
treatment 
 Provide information on benefits of 
walking including a) pain-free 
walking ability, b) maximal walking 
ability; c) ability to resume daily 
activities; d) efficacy of walking 
compared with invasive treatments; 
e) general health and mobility. 
 Provide information on mechanisms 
of walking benefits including a) 
oxygen extraction by skeletal 
muscle; b) collateral blood flow; c) 




 Must be done regularly and 
consistently to ensure benefits are 
not lost 
 Elicit current walking regime and 
experiences  
 Provide recommendations of 30 
minutes walking on ≥3 days/week, 
at a “brisk pace” that elicits pain 
within 3-5 minutes, and “walking 






 Elicit experiences of current walking 
and benefits of walking more 
 Utilise 0-10 rating to elicit 
motivation and confidence to 
change walking behaviour 
 Elicit personal strengths and social 
networks which may support 
success  
 Elicit experiences of current walking 
and benefits of walking more 
 Utilise 0-10 rating to elicit 
motivation and confidence to 
change walking behaviour 
 Assure participant that walking may 
progress at an individual rate 
toward achieving recommendations  
Session 2   
Opening  Brief review of key topics discussed 
in previous session 
 Brief review of key topics discussed 




 Elicit individual goals and value-
basis 
 Use worksheet to record walking 
goal 
 Record what, when, where and with 
whom the individual will engage in 
planned walking 
 List up to 3 barriers to achieving 
goal and problem solve 
 Record milestones for participant to 
establish that plan is working 
 Elicit individual goals and value-basis 
 Use worksheet to record walking 
goal 
 Record what, when, where and with 
whom the individual will engage in 
planned walking 
 List up to 3 barriers to achieving goal 
and problem solve 





 Elicit participant attempts at 
achieving walking goal 
 Identify barriers and strategies to 
overcome these 
 Elicit and reinforce participant 
attempts at achieving walking goal 
 Discuss and revise goals, barriers 
and problem solving if necessary 
CSM, Common Sense Model of Illness Representations; TPB, Theory of Planned Behaviour.  
Treatment  
Treatment included two 60 minute individual face-to-face sessions held approximately 1 week 
apart at participants’ homes, and two 20 minute booster telephone calls at 6 and 12 weeks. 
Session 1 was designed to elicit and modify maladaptive illness and treatment beliefs, and was 
supported by illustrations of the lower-limb vascular tree and of an occluded blood vessel. 
Session 2 aimed to establish behavioural and outcome goals, to agree an action plan, and to 
problem solve anticipated barriers with the participant. A work sheet was used to record goals 
and planning, and a copy was provided to participants. The booster telephone call was 
designed to prompt a review of goals and provide feedback on performance. Motivational 
interviewing (social support) was employed as a BCT and as a vehicle for delivering other BCTs 
across all sessions. Targeted BCTs were employed across the sessions as previously defined 




(Michie et al., 2013) (Table 7.3). Complete scripts and materials used during each session are 
provided in Appendix 6. 
Attention-control 
The attention-control was developed to mirror the treatment intervention, but targeted 
dietary behaviour rather than walking. Treatment scripts were maintained, with the exception 
that any content promoting walking exercise was replaced by content that promoted public 
health dietary behaviour, which was sourced from a British Heart Foundation (2013) manual 
(Appendix 6). 
Readability of scripts 
Treatment and attention-control scripts were compared for readability, and respective scores 
for Flesch reading ease were 61.0 and 70.8, and for Flesch-Kincaid grade level were 8.5 and 
7.2. These values indicate that scripts were similar and met standards appropriate for general 
readability. 
7.2.4 Physiotherapist training 
An Agenda For Change Band 6 physiotherapist was recruited to deliver the intervention and 
attention control. The physiotherapist was familiarised with the intervention scripts and 
materials, and attended 1 day (7.5 hours) of training in motivational interviewing through a 
course accredited by the British Psychological Society. Subsequently, five mock sessions with 
feedback, lasting approximately 60–90 minutes were provided with the chief investigator 
(LMB, an academic physiotherapist; 2 sessions), the co-investigator (JAW, an academic and 
clinical psychologist; 1 session), and the researcher (MGH; 2 sessions). The total duration of 
formal training was approximately 15 hours. In addition, ongoing supervision and feedback 




Table 7.3 BCTs included in a physiotherapist-led home-based behaviour-change intervention targeting walking among individuals with IC 





Advise on, arrange, or provide social support, or non-
contingent praise or reward for performance of the 
behaviour, and encouragement and counselling when 
directed at the behaviour (e.g., motivational 
interviewing) 
Physiotherapist trained in motivational interviewing, values-
based goals elicited to support autonomy, change talk facilitated 
through patient-centred dialogue 
Session 1 Information about 
health consequences  
Provide information about health consequences of 
performing the behaviour  
Potential benefits of walking discussed, including ability to walk 
further before pain onset or need to stop and rest.  
Session 2 Goal setting 
(behaviour) 
Set or agree on a goal defined in terms of the behaviour 
to be achieved 
Walking goal defined in terms of frequency, duration, intensity, 
and context in based on current activity with the aim of 
progressing toward recommended walking level  
Goal setting 
(outcome) 
Set or agree on a goal defined in terms of a positive 
outcome of wanted behaviour 
Value-based goal identified which would be facilitated by 
improved walking ability (e.g., work, hobby, social activity) 
Problem solving Analyse or prompt analysis of factors influencing the 
behaviour and generate or select strategies that include 
overcoming barriers and / or increasing facilitators 
Participants encouraged to identify up to three barriers which 
may prevent them achieving their goal, and realistic solutions 
discussed and agreed 
Action planning Prompt detailed planning of behaviour performance, 
including at least one of: context, frequency, duration, 
or intensity 
Action plan worksheet completed, recording details of the 
context, frequency, duration and intensity of walking goal 
Self-monitoring of 
behaviour 
Establish a method for the person to monitor or record 
their behaviour as part of a behaviour-change strategy 
Physiotherapist discussed methods to monitor daily walking 







Review behavioural goals jointly and consider modifying 
goal or behaviour-change strategy in light of 
achievement  
Walking behaviour discussed relative to goals and revised as 
appropriate to be more achievable or challenging  
 Review outcome goals Review outcome goals jointly and consider modifying 
goals in light of achievement 
Value-based goal considered relative to behaviour change 
revised if no longer salient 
 Feedback on 
behaviour 
Monitor and provide informative or evaluative feedback 
on performance of the behaviour 
Reported walking discussed in light of individual goals are 
recommended walking treatment for IC 








7.2.5 Eligibility criteria 
Participants met the following inclusion criteria:  
1) adults aged ≥18 years; and 
2) IC diagnosed by a vascular clinician, and based on results of established methods (e.g., 
ABPI, duplex ultrasound, computed tomography, magnetic resonance imaging) against 
recommended criteria (Norgren et al., 2007), and confirmed by response to the SDCQ. 
Exclusion criteria were:  
1) asymptomatic PAD or rest pain established by the SDCQ;  
2) revascularisation (e.g., endovascular treatment or bypass surgery) scheduled in the 
upcoming 4 months because this could influence walking treatment and illness 
cognitions, and preclude individuals from engaging in walking; 
3) the presence of a comorbidity other than IC (e.g., knee osteoarthritis, back pain) self-
reported as the primary limitation of walking because this could influence walking 
treatment and illness cognitions, and walking outcomes;  
4) the presence of a condition for which it is unadvisable to increase walking (e.g., 
unstable angina) as this could compromise participant safety or influence walking 
treatment and illness cognitions; and/or 
5) inability or refusal to provide informed consent.  
7.2.6 Sampling and recruitment 
Individuals from Guy’s & St Thomas’ NHS Foundation Trust and King’s College Hospital NHS 
Foundation Trust, identified in vascular outpatient clinics, and who completed the cross-
sectional observational study (Chapter 6) and consented to being contacted for future 
research, were informed of the study by post. A convenience sample of 24 participants was 
recruited, based on recommendations for the minimum sample size of 12 per group for pilot 
studies required to ensure feasibility and precision of estimates of variance (Julious, 2005). 




contacted participants by telephone and invited those who were interested to be screened for 
eligibility. 
7.2.7 Outcome measures 
Descriptive variables 
Sociodemographic and clinical characteristics. The following sociodemographic variables and 
clinical characteristics were assessed by self-report at baseline: age, gender, ethnicity (White, 
mixed/multiple ethnic background, Asian/Asian British, Black/African/Caribbean/Black British, 
or other), smoking status (current, currently quitting or cutting down, previous, or never), 
presence of comorbidities (diabetes mellitus, cholesterol, hypertension, cardiovascular 
disease, renal disease, previous heart attack, or stroke), current medication for IC (yes/no), 
duration of symptoms (<1 year, 1–2 years, >2 years), other mobility-limiting symptoms or 
conditions (yes/no), self-reported advice to walk, and participation in supervised exercise 
therapy within the past 3 years (yes/no) (Appendix 6). 
Physical and psychological outcomes. Walking, theory-based constructs, and descriptive clinical 
variables were assessed and are described in full in Chapter 3 (Table 7.4). 
Table 7.4 Outcome measures included in a feasibility study of an RCT evaluating a 
physiotherapist-led home-based behaviour-change intervention targeting walking among 
individuals with IC  
Variable Measure 
Objective walking ability  
6 Minute Walk Distance (6MWD)  6 Minute Walk Test (6MWT) 
Pain-Free Walking Ability (PFWA)  6MWT 
Maximal Walking Ability (MWA)  6MWT 
Walking behaviour  
Objective walking behaviour Pedometer step count  
Self-reported walking behaviour  Baltimore Activity Scale for Intermittent Claudication 
(BASIC) 
Theory-based constructs  
Walking treatment cognitions Theory of Planned Behaviour Questionnaire (TPB) 
Illness cognitions Revised Illness Perception Questionnaire (IPQ-R) 





Action Planning Action Planning Questionnaire 
Action Control Action Control Questionnaire 
Descriptive clinical variables  
Lower-limb symptom 
classification 
San Diego Claudication Questionnaire (SDCQ) 
Health-related quality of life Medical Outcomes Survey Short Form-12 version 2  
(SF-12v2) 
Perceived activity intensity Borg Rating of Perceived Exertion (RPE) 
Perceived pain intensity Borg Category–Ratio 10 Scale for Pain (CR10) 
Body mass index (BMI) Standard scales 
 
Treatment integrity. The Motivational Interviewing Treatment Integrity Code (MITI) is a 
behavioural coding tool designed to assess competence of delivery of motivational 
interviewing (Moyers et al., 2005). It was developed to provide a quick and simple rating for 
the purposes of evaluating treatment integrity or providing feedback to therapists. The MITI 
provides a Global Spirit Score across five dimensions: 1) evocation (extent to which the 
therapist elicits and expands the client’s motivation to change); 2) collaboration (extent to 
which the therapist engages the client as an equal, knowledgeable partner); 3) 
autonomy/support (extent to which the clinician supports and actively fosters the client’s 
perception of choice); 4) direction (the extent to which the clinician maintains focus on a 
targeted behaviour); and 5) empathy (extent to which the clinician understands or aims to 
grasp the client’s perspective and feeling). Each dimension is rated on a 5-point Likert scale, 
with the rater assuming a score of three and rating up or down from that neutral score.  
Global Spirit Scores reflect a holistic evaluation of therapist competence: a score of 3.5 (range 
0–5) demonstrates beginning proficiency, and competency is defined as a score of 4. The MITI 
demonstrates moderate inter-rater reliability (ICC 0.51–0.58) and was validated against the 
Motivational Interviewing Skills Code, which it was derived from, and which is a 




passages (Moyers et al., 2005). The MITI is widely applied because of its ease of use, and is 
suitable for novice raters, although psychometric properties are preliminary.  
For each of the 12 participants in the treatment group, a 10 minute segment of audio 
recordings was randomly selected from Session 1 or Session 2 (Pierson et al., 2007). Two raters 
(MGH and PD [Trainee Health Psychologist]) evaluated a single pass of each segment assigning 
a Global Spirit Score for each dimension. Discrepancies between individual ratings were 
discussed until consensus was achieved. 
7.2.8 Procedure 
Baseline assessment. Participants attended a 1 hour appointment at the Division of Health and 
Social Care Research, King’s College London (London, UK). Participants were asked if they had 
read the information letter and invited to ask any questions. Participants were asked to read, 
complete and sign three copies of the consent form, one which was filed in participants 
medical notes, one which was retained by the researcher, and one which was provided to the 
participant for their own reference. Questionnaires (sociodemographic and clinical 
characteristics, SF-12v2, BASIC, TPB, IPQ-R, BSES, Action Planning, and Action Control) were 
administered and BMI measures obtained. The Borg CR10 and RPE were administered and the 
6MWT was initiated (Chapter 3). At the end of the 6MWT the Borg CR10 and RPE were re-
administered. The participant was invited to rest, either seated or standing, for as long as they 
felt necessary. Stride length was estimated. The participant was then led back to the meeting 
room, seated, and provided instructions on the use of the pedometer and were asked to wear 
the device home and for the upcoming 6 days. They were provided with a letter reminding 
them of the 6 day period they had been asked to wear the pedometer.  
Randomisation. Participants were randomised following baseline assessment to the treatment 
group or the attention-control group. Simple two-way randomisation was carried out by an 
unblinded researcher (LMB) using an online random number generator (www.randomizer.org). 




identification, which was assigned at baseline assessment, to their allocated group prior to 
delivering Session 1. The researcher (MGH) administering baseline and follow-up assessments 
was blinded to participant allocation until study completion. 
Intervention Session 1. At 1 week post baseline assessment, the physiotherapist delivered 
Session 1 of the treatment or attention-control. At the end of Session 1, the physiotherapist 
collected activity monitors and returned these to the researcher in an anonymised envelope. 
Intervention Session 2. At 2 weeks post baseline assessment, the physiotherapist delivered 
Session 2 of the treatment or attention-control. 
Post-intervention assessment. At the end of Session 2, the physiotherapist provided 
participants with a questionnaire pack and postage-paid envelope, and provided instructions 
to complete the questionnaires within 48 hours.  
Booster telephone calls. At 6 and 12 weeks post baseline assessment, the physiotherapist 
delivered booster telephone calls to participants during a prearranged time and date. 
Follow-up assessment. At 16 weeks post baseline assessment, participants attended a 1 hour 
follow-up appointment at the Division of Health and Social Care Research, King’s College 
London (London, UK). Questionnaires were administered, then the 6MWT was conducted, with 
pre- and post-test administrations of the Borg CR10 and RPE. Participants were instructed on 
the use of the pedometer, and given a letter reminding them of the 6 day period they had 
been asked to wear the pedometer, and a pre-paid envelop for returning the device.  
7.2.9 Analyses 
Statistical analyses were carried out in SPSS Statistics Software version 21.0 (IBM Statistics Inc., 
Armonk, NY, USA). Statistical significance was set at p<0.05.  
Descriptive analyses 
Sociodemographic and clinical characteristics are presented as means ±SD or 95% CIs for 




Missing value analyses were completed to identify and describe patterns of item non-response 
by item, scale, and time of measure. The rate of missing data was defined as the proportion 
(percentage) of participants with incomplete data for a variable at a given assessment time 
point. 
Distributions of outcome measures were explored for normality by visual inspection of 
histograms and normal Q–Q plots, and calculating standardised scores for skewness (𝑧𝑠) and 
kurtosis (𝑧𝑘) (Chapter 6) (Field, 2013). Absolute and percentage change scores for all outcome 
variables were computed. 
Associations and effect estimates 
The relationship between targeted cognitions (i.e., TPB, CSM, barrier self-efficacy, and self-
regulatory processes) and walking outcomes (i.e., 6MWD and objective walking behaviour) 
were estimated by determining Spearman rank correlation coefficients (Tabachnick and Fidell, 
2013), and defined as small (r=0.10), medium (r=0.30), and large (r=0.50) (Cohen, 1988). 
Estimates of the magnitude of the effect and variance of the treatment on 6MWD and 
objective walking behaviour were determined by computing Hedges g (Hedges, 1981) and CIs 
for absolute (6MWD) and change (objective walking behaviour) scores. Hedges g was 
calculated using the square root of the pooled variance, with 0.20, 0.50, and 0.80 representing 
small, medium and large effects, respectively (Cohen, 1988). CIs for Hedges g were computed 
for probabilities of alpha=0.05, 0.20, 0.30, 0.40, and 0.50. The corresponding critical values on 
a standardised curve are z=1.96, 1.28, 1.036, 0.841 and 0.674.  
Inter-rater reliability for the MITI scale 
Agreement between two raters applying the MITI was evaluated by calculating weighted 
kappa coefficients. Weightings applied to the 5 point categorical Global Spirit Scores were: 1 
for equivalent ratings, 0.75 for ratings differing by 1 point, 0.5 for ratings differing by 2 points, 






7.3.1 Participant characteristics 
Identification, screening and recruitment 
Of the 94 participants who were sent information letters, 33 could not be contacted, 
15 declined to be screened, and the remaining 46 were screened for eligibility. Among 
46 participants screened for eligibility, 24 met the eligibility criteria and were enrolled onto the 
study. There was no substantial difference in age (mean 65.8 versus 67.4 years) or gender 
(24% of men and 33% of women enrolled) between individuals who were enrolled in the study 
and those who either declined or were ineligible. The complete flow of participants through 
the study is illustrated in Figure 7.1. 
Figure 7.1 Flow of participants through a feasibility study of an RCT of a behaviour-change 







There were no substantial differences between groups on key sociodemographic or clinical 
characteristics at baseline (Table 7.5).  
Table 7.5 Baseline sociodemographic and clinical characteristics of participants in a feasibility 
study of an RCT evaluating a physiotherapist-led home-based behaviour-change intervention 
targeting walking among individuals with IC 
Variable Treatment, n (%) Attention-control, n (%) 
Age 66.3 ±8.8a 67.1 ±11.2a 
Body mass index, kg/m2 28.6 ±5.0a 26.5 ±5.0a 
Male gender 9 (75.0) 10 (83.0) 
Married 6 (50.0) 7 (58.3) 
White ethnicity 11 (91.6) 9 (75.0) 
Current smoker 4 (33.3) 6 (50.0) 
Cardiovascular risk factors   
Diabetes 3 (25.0) 4 (33.3) 
Hypertension 10 (83.3) 8 (66.7) 
Dyslipidaemia 8 (66.7) 5 (38.5) 
Cardiovascular disease 8 (66.7) 4 (33.3) 
Renal disease 2 (16.6) 0 
Past heart attack 4 (33.3) 4 (33.3) 
Past stroke 0 3 (25.0) 
Pharmacological management 2 (16.6) 1 (8.3) 
Comorbid pain 3 (25.0) 3 (25.0) 
Walking advice 6 (50.0) 7 (58.3) 
Past supervised exercise therapy 5 (38.5) 3 (25.0) 
Past revascularisation 1 (8.3) 2 (16.6) 
BASIC, kcal/day 313.0 ±193.9a 317.13 ±99.9a 
Lower-limb symptom classification   
Atypical IC 7 (58.3) 6 (50.0) 
Classic IC 5 (38.5) 6 (50.0) 
Duration of IC<1 year 1 (8.3) 0 
n=24 (12 per group). aData are mean ±SD. BASIC, Baltimore Activity Scale for Intermittent 
Claudication; IC, intermittent claudication. 
 
7.3.2 Descriptive results 
Distribution of walking outcomes 
Change scores for 6MWD and objective walking behaviour were approximately normally 
distributed for both the treatment (6MWD zs=-0.28 and zk=-0.17; objective walking behaviour 
zs=0.35 and zk=-0.28) and attention-control groups (6MWD zs=1.50 and zk=1.28; objective 




Walking change from baseline 
Data for 6MWD and objective walking behaviour were available at baseline and 16 week 
follow-up for 22 and 13 participants, respectively (Section 7.3.3). Among participants in the 
treatment group, 6MWD decreased whereas objective walking behaviour increased. The 
opposite pattern was found in the attention-control (Table 7.6 and Section 7.3.3). At baseline, 
post-test scores for perceived pain intensity were similar between groups and corresponded 
with pain intensity that is “severe”, whereas perceived activity intensity was higher among 
attention-control participants (mean 14.2 ±2.10; “somewhat hard” to “hard [heavy]”) versus 
those in the treatment group (mean 11.5 ±4.0; “light”). By contrast, at follow-up there were no 
substantial differences between groups reflecting perceived pain (“severe”) or activity (“light” 
to “somewhat hard”) intensity following the 6MWT. 
Table 7.6 Baseline, 16 week follow-up, and change scores for 6MWD and objective walking 
behaviour assessed during a feasibility study of an RCT evaluating a physiotherapist-led home-
based behaviour-change intervention targeting walking among individuals with IC 
Parameter Treatment, mean ±SD Attention-control, 
mean ±SD 
6MWD    
Participants 12a 10a 
Baseline, metres 390.44 ±101.81 378.05 ±157.06 
Post-test perceived activity intensity 11.5 ±4.0 14.2 ±2.10 
Post-test pain intensity 5.31 ±3.19 5.75 ±2.37 
Follow-up, metres 381.92 ±113.51 387.93 ±161.84 
Post-test perceived activity intensity 12.82 ±3.60 13.80 ±2.44 
Post-test pain intensity 5.82 ±3.15 4.95 ±2.54 
Change, metres -8.52 ±42.29 9.88 ±42.15 
Change, % -4.23 ±12.56 1.01 ±13.346 
Objective walking behaviour   
Participants 6a 7a 
Baseline, steps/day 2247.02 ±1652.05 4343.28 ±3098.87 
Follow-up, steps/day 3083.94 ±1882.59 4313.80 ±1113.45 
Change, steps/day 836.91 ±625.83 -29.47 ±1471.43 
Change, % 29.98 ±17.57 -2.41 ±40.81 




Quality of life 
The SF-12v2 mental component summary score increased from baseline in the treatment 
group (mean ±SD change 2.76 ±3.56) and decreased in the attention control (mean ±SD change 
-2.07 ±7.90). By contrast physical component summary score decreased from baseline in the 
treatment group (1.16 ±5.09) and increased in the attention-control (mean ±SD change 6.7 
±7.0). Removal of one outlier in the attention-control reflecting physical component summary 
data still yielded a greater but less substantial change from baseline for this group (mean ±SD 
change 4.87 ±4.17) compared with the treatment group. 
Bivariate associations 
Psychosocial outcomes were positive following treatment compared with baseline, with the 
exception of identity and cyclical timeline which were unchanged, and personal control which 
declined. By contrast patterns of change in psychosocial outcomes in the attention-control 
group were variable. The magnitudes of the associations between objective walking behaviour 
and 6MWD were r=0.82 and r=0.59 for the treatment and attention-control, respectively. 
Associations between psychosocial variables and walking outcomes were variable, and are 





Table 7.7 Mean change from baseline in 6MWD and objective walking behaviour, and correlations with change scores of theoretical constructs assessed at 
baseline and 16 week follow-up in a feasibility study of an RCT evaluating a physiotherapist-led home-based behaviour-change intervention targeting walking 
among individuals with IC 
 Treatment group Attention-control group 




behaviour, r (n=5–6) 
Change, mean (SD)  
6MWD, r  
(n=8–10) 
Objective walking 
behaviour, r (n=5–7) 
Attitude 1.50 (5.92) 0.52 0.60 -1.11 (5.23) 0.32 0.02 
Subjective norm 0.33 (5.57) 0.15 0.60 3.11 (5.41) 0.33 -0.69 
Perceived behavioural control 1.58 (6.05) 0.06 0.57 3.75 (7.17) 0.63 -0.33 
Intention 0.83 (3.56) 0.11 0.71 2.33 (3.97) -0.10 -0.75 
Identity
a
 0.00 (1.91) 0.32 0.02 1.20 (2.44) -0.31 -0.27 
Acute timeline
a
 -0.83 (2.64) 0.02 0.01 -0.40 (3.34) -0.19 0.45 
Cyclical timeline
a
 0.00 (2.48) -0.02 0.99 1.30 (2.16) 0.18 -0.74 
Treatment control 1.16 (3.24) 0.05 0.80 -0.60 (2.99) -0.33 -0.46 
Personal control -0.08 (2.35) 0.50 0.82 0.40 (5.17) 0.20 -0.10 
Coherence 1.17 (3.10) -0.07 0.56 -0.40 (3.20) -0.24 0.24 
Consequences
a
 -2.25 (3.22) -0.12 0.27 -1.20 (1.69) -0.72 0.06 
Psychological attributions -1.75 (3.33) 0.20 0.69 1.40 (4.25) -0.08 0.14 
Risk factor attributions -0.67 (2.06) 0.48 0.40 0.33 (3.08) -0.01 0.64 
Immunity attributions
a
 -0.42 (1.51) 0.36 0.81 1.20 (1.35) -0.12 -0.06 
Accident/chance attributions
a
 0.33 (0.78) 0.21 0.01 0.10 (1.20) -0.21 0.32 
Emotion
a
 -1.17 (2.25) 0.02 -0.08 1.50 (4.99) 0.49 -0.35 
Action planning
b
 13.56 (2.55) -0.22 0.16 11.7 (4.29) 0.28 0.44 
Action control
b
 19.00 (2.44) 0.31 NA
c
 16.7 (4.64) 0.14 0.87 
Barrier self-efficacy 2.00 (8.27) 0.71 0.94 7.70 (18.02) 0.47 -0.10 
Valid data (casewise) reflecting associations with 6MWD were available for n=7–12 (treatment) and n=8–10 (attention-control). Valid data (casewise) reflecting 
associations with objective walking behaviour were available for n=5–6 (treatment) and n=5–7 (attention-control). aA decreased score denotes improvement. 








7.3.3 Evaluation of feasibility criteria 
Objective 1: Study retention at 16 week follow-up will be at least 60%  
Study retention at 16 week follow-up was 92% (n=22/24), and therefore the first feasibility 
objective was achieved. All participants in the treatment group completed the study protocol. 
Two participants in the attention-control group were lost to 16 week follow-up. Attempts were 
made to contact both participants in order to determine why they had not completed the 
study. One participant was awaiting test results for cancer screening and reported that his 
attention had turned to this new health issue. The second participant rescheduled his follow-
up appointment twice, but did not attend; no reason was given. Participants lost to follow-up 
were younger than those who completed the study (mean ±SD 57.0 ±2.8 years versus 67.6 
±9.8 years, respectively), and were both male. They did not otherwise differ on 
sociodemographic variables, clinical characteristics, or baseline outcome measures. 
Objective 2: At least 60% of participants will complete all treatment and attention-
control sessions 
In total, 71% (n=17/24) of participants completed all prescribed sessions, therefore the second 
feasibility objective was achieved. Among the treatment and attention-control groups, 67% 
(8/12) and 90% (n=9/10) of participants, respectively, adhered in full. All participants 
completed Sessions 1 and 2 delivered via home visits. However, 4 participants in the treatment 
group and 2 participants in the attention-control group missed one booster telephone call; the 
second booster call was missed in 5 of 6 cases.  
Objective 3: Missing data at each time point will be less than 10% for each outcome 
Rates of missing data at baseline, post-intervention assessment (week 2), and follow-up 
assessment (week 16) were 4–36%, 18–32%, and <5%, respectively (Appendix 6). Item non-
response was <5% for all self-reported variables for surveys returned at each time point. 
Baseline. At baseline, missing survey data was <10% across outcome variables. Two 
participants (9%) had incomplete survey data reflecting TPB and IPQ-R variables. One 
participant (attention-control group) was missing 11 items, including a complete page of the 




intention, and 1 reflecting perceived behavioural control) and 1 item on the IPQ-R (risk factor 
attributions). One participant (attention-control group) was missing 1 item on the TPB 
(perceived behavioural control). Eight participants (36%; 4 treatment and 4 attention-control) 
were missing objective walking behaviour data. Four participants were missing 1 data point, 
three were missing 2 data points, and one participant was missing 4 data points. One 
participant (treatment), who dropped and damaged the pedometer, was missing day 1 and 2 
step counts. That participant was provided with a new pedometer and monitoring continued 
from day 3 to 6. Two participants (one treatment, one attention-control) were missing day 6 
data because their pedometers were collected 1 day early due the physiotherapists’ schedule 
requirements. 6MWD data were complete. 
Post-intervention assessment. At the post-intervention assessment, 9/22 (41%) participants 
had a complete dataset. Four participants (18%; 2 treatment and 2 attention-control) did not 
return their surveys by post.  One participant (treatment) was missing 21 items, including a 
page of data on the IPQ-R (20 items) and 1 item of the IPQ-R causal attributions scale. One 
participant (treatment group) was missing 7 items, including 6 items on the TPB questionnaire 
(1 page) and 1 item on the barrier self-efficacy scale. The remaining seven participants 
(4 treatment, 3 attention-control) were missing 3 or fewer items across the TPB and IPQ-R 
surveys. 
Follow-up. At the 16 week time point, 19/22 (86%) participants had complete datasets. Item 
non-response was <5% across self-reported measures. One participant (treatment) was 
missing day 6 pedometer step count because he posted the pedometer one day early in 
advance of travel plans. Data on objective walking behaviour were missing in entirety for 
one participant at follow-up (attention-control), who returned his pedometer after the 21 day 





Objective 4: Sufficient data will be collected to estimate the effect size of the treatment 
on 6MWD and objective walking behaviour compared with the attention-control and 
to explore the precision of measurement across a range of CIs 
6MWD and objective walking behaviour data presented as means and standard deviations for 
each time point are reported in Table 7.5. In the treatment and attention-control groups, 42% 
and 70% of participants had increased 6MWD, and 82% and 22% had increased their objective 
walking behaviour, respectively (Appendix 6). 
Estimate of the effect: 6MWD 
6MWD decreased among participants in the treatment group (median -6.67, IQR -31.05–17.71) 
and increased in the attention-control group (median 3.34, IQR -15.87–22.75). The estimated 
effect for scores at follow-up favoured the attention-control, Hedges g=-0.04 (95% CI -0.88, 
0.79). The range of CIs suggest no true difference between groups (Figure 7.2).  
Figure 7.2 Confidence intervals corresponding to the treatment effect on change in 6MWD 
compared with the attention-control 
 
 
Sensitivity analysis accounting for missing data. A sensitivity analysis including participants lost 
to follow-up and assuming no change in 6MWD (i.e., last value brought forward) produced 
similar results (median -6.67 metres [IQR -31.05–17.68] change in 6MWD for the treatment 





Sensitivity analysis accounting for outliers. Three participants in the attention-control group 
were identified as outliers. Two participants had change scores falling above the IQR, whereas 
one had a change score falling below (Appendix 6). A sensitivity analysis was conducted with 
these participants removed. Change in 6MWD remained negative for the treatment (median    
-6.7 metres, IQR -31.1–17.7) and positive for the attention-control (median 3.1 metres, IQR      
-6.2–12.4). The treatment effect was reduced and negligible, Hedges g 0.00 (95% CI -0.93, 
0.93). 
Estimate of the effect: objective walking behaviour 
Participants in the treatment group had a greater increase in objective walking behaviour 
(median 857.7 steps/day, IQR 282.6–1432.8) compared with those in the attention-control 
group (median 59.5 steps/day, IQR -942.4–1061.4). A small effect favouring the treatment 
group was detected, Hedges g=0.39 (95% CI -0.47, 1.25). The range of CIs provided evidence 
for a true difference between groups below a probability of α=0.40 (Figure 7.3).  
Figure 7.3 Confidence intervals for the effect of the treatment on objective walking behaviour 
compared with the attention-control 
 
 
Sensitivity analysis evaluating 3 day pedometer data. A sensitivity analysis evaluated objective 




mean 6 and 3 day walking behaviour was demonstrated for baseline (ICC 0.97, 95% CI 0.90, 
0.99) and follow-up (ICC 0.91, 95% CI 0.76, 0.96) scores. Objective walking behaviour increased 
in the treatment group (median 492.33, IQR -256.18–1240.83), and decreased in the attention-
control (median -269.66, IQR -2243.91–1704.59). A small effect favouring the treatment group 
was detected, Hedges g=0.34 (95% CI -0.36, 1.04).  
Objective 5: A consensus score using the MITI across audio-recorded segments of the 
treatment sessions will be achieved by two raters 
The MITI code was feasible and applicable to the brief 10 minute audio-recorded segments of 
the treatment sessions. Global Spirit Scores were achieved by each rater for all five dimensions 
after a single pass, and a final score agreed by consensus. The scale was appropriate and 
meaningful when applied to both Session 1 and Session 2 for the treatment group. Substantial 
inter-rater agreement was achieved overall for MITI scores (=0.73), and ranged across 
dimensions from =0.71 to =0.76 (Table 7.8) (Altman, 1991). 
Table 7.8 Individual scores, consensus scores, and inter-rater agreement among two raters 
using the MITI code to evaluate audio-recorded treatment delivered by a physiotherapist in a 
home-based behaviour-change intervention targeting walking among individuals with IC  
MITI 
dimension 
Session 1  Session 2   
01C 05C  06C 18C 21C 24C 03C  04C  08C  09C  14C  17C  
Evocation             0.74 
Rater 1 2 1 4 2 3 4 4 3 3 2 4 4  
Rater 2 4 2 2 3 4 4 5 4 3 3 4 5  
Final scorea 2 2 4 2 3 4 4 4 3 2 4 4  
Collaboration             0.71 
Rater 1 1 1 4 2 3 4 5 3 3 3 4 5  
Rater 2 4 3 3 3 4 4 4 4 3 4 5 5  
Final scorea 3 2 4 2 3 4 4 3 3 3 4 5  
Autonomy/ 
support 
            0.73 
Rater 1 3 3 3 3 3 4 3 3 4 3 3 3  
Rater 2 3 4 4 3 4 3 4 4 3 3 4 5  
Final scorea 3 3 4 3 3 4 3 3 4 3 3 4  
Direction             0.74 
Rater 1 5 4 4 5 5 5 5 3 5 5 3 5  
Rater 2 5 3 3 5 5 3 4 5 5 4 4 5  
Final scorea 5 3 4 5 4 5 4 4 5 5 4 5  
Empathy             0.76 
Rater 1 2 3 3 2 3 3 3 3 3 4 4 5  
Rater 2 4 4 4 4 4 4 4 5 3 4 4 5  
Final scorea 4 3 4 2 3 3 3 4 3 4 4 5  






This study demonstrated the feasibility of a two-arm randomised trial comparing a behaviour-
change intervention targeting walking to an attention-control among people with IC. This was 
the first study to target constructs from the TPB and CSM together to change objective walking 
behaviour and walking ability in this population, and the first to explore the effects of a theory-
based intervention on objective measures of walking behaviour.  
Objective walking behaviour increased following the walking intervention compared with the 
attention-control. The median 857.7 steps/day (IQR 282.6–1432.8) increase among 
participants in the treatment group corresponds with outcomes of other pedometer-based 
walking interventions (Tudor-Locke et al., 2011). Among older adults and individuals with long-
term conditions, including PAD, 30 minutes of walking is approximately equivalent to 
3000 steps assuming an average cadence of 100 steps/minute (Tudor-Locke et al., 2011; 
Montgomery and Gardner, 1998). Accordingly, participants in the treatment group increased 
walking behaviour by mean 8.6 minutes/day, or the equivalent of approximately 
60 minutes/week.  
By contrast, 6MWD decreased following treatment, and increased in the attention-control 
group. This might be explained by the magnitude of behaviour change described above, which 
was below the threshold for guidelines on frequency and duration of exercise for increasing 
walking ability in people with IC (i.e., 30 minutes on at least 3 days/week, or 90 minutes/week) 
(Norgren et al., 2007), so might not have been sufficient to garner an improvement in the 
clinical outcome (6MWD). In addition, walking intensity was not monitored, and it may be that 
participants were also not achieving this aspect of the walking guidelines. BCTs (Michie et al., 
2013) that were not explicitly incorporated to the current intervention, but which might help 
address the challenge of achieving walking guidelines include the use of graded tasks (e.g., 
increasing the duration of walking by 5 minutes per session until 30 minutes is achieved), 
addressing discrepancies between current behaviour and goals, and providing feedback on the 




Study retention (92%) and treatment compliance (72% overall) were comparable with other 
home-based walking interventions for IC, which report study retention at 12 or 24 weeks 
ranging from 61–100% (Al-Jundi et al., 2013; Galea et al., 2013). In addition, the majority of 
intervention sessions and study assessments were completed within 1 week of the per-
protocol timeframe. However, a high proportion of missing pedometer data reflecting 
objective walking behaviour at baseline assessment meant the feasibility criterion of <10% of 
missing data at each time point was not achieved, and should be addressed in a definitive trial. 
Due to high within- and between-subjects variability in walking behaviour, estimates of missing 
pedometer data comes with a threat to validity. Among healthy adults, 3 day pedometer data 
demonstrates high agreement with 7 day pedometer data (ICC>0.85) (Tudor-Locke et al., 
2005), and, in people with IC, as little as 2 days of pedometer data provided a stable measure 
of walking behaviour (Sieminski et al., 1997). When 3 day pedometer data were analysed, 32% 
(n=7) of the sample data were recovered and results were consistent with 6 day pedometer 
data suggesting that feasibility of this method of data treatment. However, measures could 
also be taken to reduce the volume of missing data, for example by using text-based reminders 
(Sternfeld et al., 2012).  
The proportion of missing pedometer data was lower and within the feasibility criteria at 
follow-up compared with baseline. It may be that participation in the study increased the 
saliency of wearing the pedometer, resulting in a greater likelihood of remembering or 
increased motivation to wear the pedometer. One potential source of participant motivation 
to wear their pedometer, which was not sealed, might have been to monitor walking. 
However, pedometer use was not coupled with explicit self-monitoring (e.g., logging steps in a 
diary), an important factor that increases the effect of pedometer use on behaviour (Bravata 
et al., 2007). Nevertheless, use of sealed pedometers would improve the validity of this 
outcome in future research, reducing the potential for a motivation enhancing effect. 
Alternately, there may be scope for employing pedometers as a low-cost motivational tool to 




deploying this strategy in the context of the current home-based walking intervention would 
need to be explored.  
7.4.1 Methodological considerations 
This study has several strengths. The treatment intervention was based on previous research 
identified in a systematic review, and targeted psychosocial constructs and BCTs in order to 
increase walking. The intervention was developed with a strong theoretical underpinning, and 
evaluated theoretical constructs as process variables for change, addressing the lack of theory-
driven walking interventions for IC (Chapter 4). Validated self-reported and objective measures 
of key variables, including psychosocial constructs and walking were included, and provide 
clinically meaningful outcomes for IC (e.g., 6MWD, PFWD, and MWD).  
An attention-control comparison was an important strength of the methods used in this study. 
However, the fidelity assessment did not include an evaluation of treatment differentiation, 
that is, the extent to which the conditions differed from one another sufficiently to 
demonstrate manipulation of the independent variable as planned (Gearing et al., 2011), and 
may limit the interpretation of findings. The attention-control was modelled on content 
delivered during the walking intervention, incorporated explicit BCTs targeting dietary 
behaviour, and was delivered by the same clinician; therefore, evidence supporting treatment 
differentiation would exclude the possibility of contamination of the attention-control (e.g., by 
inclusion of BCTs targeting walking), or of transfer of learned cognitive or behavioural skills 
(Barnett and Ceci, 2002), and could therefore reduce the possibility of a type-II error. However, 
most research on transfer effects of health behaviours have focused on exercise as a gateway 
for dietary changes (Fleig et al., 2011; Fleig et al., 2014), and not the reverse.  
Treatment integrity was reported for motivational interviewing, but not other BCTs delivered. 
The MITI was available as a validated tool for evaluating motivational interviewing, which was 
a key BCT underpinning treatment. However, measures of treatment integrity related to other 




intervention. Future research should develop and employ appropriate measures of treatment 
integrity which could be used as part of a comprehensive process evaluation.  
Self-reported postal data were not returned by five participants at post-intervention 
assessment, and contributed, alongside objective walking behaviour, to a high proportion of 
missing data. This problem could be overcome by allowing the option to administer surveys 
online, using text or telephone reminders prompting individuals to return surveys, or by 
obtaining missing responses from participants by proxy (e.g., telephone contact). A full-scale 
trial including a larger sample size would permit further exploration of patterns in missing data 
and require robust methods for missing data replacement, if necessary (Roth, 1994). 
Recruitment rates could not be evaluated because participants were identified from the 
previous cross-sectional study (Chapter 6). However, recruitment to the cross-sectional study 
provides some indication of engagement for future studies. Current walking behaviour was not 
an inclusion criteria, and it is possible that, at baseline, some participants were already 
walking, or achieving walking guidelines potentially posing a ceiling effect on the magnitude of 
behaviour change. Self-reported (median BASIC total score 4.0, IQR 2.9–5.1) and objective 
(median step count 2522.3, IQR 1060.8–3983.8) data indicate, however, that baseline physical 
activity was low.  
7.4.2 Conclusions 
 A randomised trial comparing a brief home-based behaviour-change intervention 
targeting walking in people with IC to an attention-control, and delivered by a 
physiotherapist, is feasible.  
 Criteria for feasibility were met and demonstrated study retention at 16 week follow-
up, participant compliance to interventions, low rates of missing data for most 
outcomes, sufficient data to explore treatment effects on objective walking ability and 
behaviour, and suitability of the MITI as a method for evaluating treatment integrity.  
 A definitive trial should incorporate methods for facilitating questionnaire and 





 Acceptability of a randomised Chapter 8.
controlled trial of a physiotherapist-led behaviour-
change intervention targeting walking in people 
with IC: a nested qualitative study 
8.1 Introduction 
The feasibility of an RCT of a physiotherapist-led behaviour-change intervention targeting 
walking for IC was evaluated based on five criteria outlined in Chapter 7. An important aspect 
of the feasibility and piloting of novel interventions involves evaluating their acceptability to 
participants (Bowen et al., 2009; Craig et al., 2008). Understanding the acceptability of the 
study protocol and intervention components to individuals with IC could reveal factors 
underpinning study protocol and intervention adherence, processes of change, and 
intervention effects. In addition, the acceptability of a novel intervention to the 
physiotherapist involved in delivery provides important detail on the feasibility of training and 
potential implementation to practice. 
Qualitative research is a useful approach to understanding processes underpinning an 
intervention and explaining findings, and provides an important means for user involvement 
and feedback in order to refine a study protocol and intervention components (Chapter 3). 
Therefore, a nested qualitative study was conducted to provide an in-depth evaluation of the 
acceptability of the study described in Chapter 7, from the perspective of participants and the 
physiotherapist.  
8.1.1 Aims 
This study aims to explore the experiences of individuals with IC and a physiotherapist who 
took part in a feasibility study of an RCT of a behaviour-change intervention targeting walking 






The objectives of this study are: 
a) to evaluate the acceptability of the study protocol, treatment intervention, and 
attention-control intervention to participants with IC; and 
b) to support and explain findings of the feasibility study. 
8.2 Methods 
8.2.1 Study design 
A qualitative study using semi-structured in-depth individual interviews and applying the 
Framework Method, and which was nested in a feasibility study of an RCT, was conducted 
8.2.2 Ethical approval 
Ethical approval was obtained on 18 February 2013 from NRES Committee North West – 
Greater Manchester West (reference 14/NW/0089) (Appendix 1). Approval from the 
Departments of Research and Development, Guy’s & St Thomas’ NHS Foundation Trust was 
confirmed on 2 April 2014 and from King’s College Hospital NHS Foundation Trust on 15 July 
2014 (CSP reference 143466). 
8.2.3 Eligibility criteria 
Inclusion and exclusion criteria are described in full in Chapter 7 (Section 7.2.5). 
8.2.4 Sampling and recruitment 
A purposive sample of 12 participants from the feasibility study (Chapter 7) and the 
physiotherapist were invited to an interview upon completing the study protocol. Sampling of 
participants was determined by an unblinded investigator (LMB) to reflect a range of 
participants based on the following ordered criteria: group allocation, ethnicity (White versus 
other), gender, past participation in an exercise programme, and median age of sample (<66 
versus ≥66 years). 
8.2.5 Outcome measures  





8.2.6 Topic guide development 
Consistent with the Framework Method (Chapter 3), a topic guide (Table 8.1) was developed 
to reflect participants’ experiences of the study protocol, the treatment or attention-control, 
therapeutic alliance with the physiotherapist, and targeted theoretical constructs. A second 
topic guide (Table 8.2) was developed for an interview with the physiotherapist and reflected 
experiences of training received, study management, delivery of the treatment or attention-
control, understanding of theoretical processes underpinning the treatment, and therapeutic 
relationship with participants. 
8.2.7 Procedure 
Participants were invited to an audio-recorded interview lasting up to 45 minutes at the end of 
their follow-up assessment. The physiotherapist was invited to take part in an interview lasting 
up to 60 minutes following completion of the study. Interviews followed topic guides and were 
audio-recorded. 
8.2.8 Analyses 
Audio-recorded interviews were transcribed verbatim by one researcher (PD) and analysed 
using NVivo 9 (QSR International Ltd, Southport, UK). Key stages of the Framework Method 
were applied, including transcription, familiarisation, coding, development and application of 
the analytical framework, charting, and interpretation (Chapter 3) (Gale et al., 2013). Results 





Table 8.1 Topic guide for participant interviews in a nested qualitative study evaluating the 
acceptability of an RCT of a physiotherapist-led behaviour-change intervention targeting 
walking for IC 
Introduction 
What I’d like to talk with you about are you experiences and views of taking part in this study, 
and the physiotherapist-led treatment you received for your leg pain.  
Brief history 
Before we begin to talk about the study and treatment, could you tell me a bit about the 
problem that you have with your legs from when it first started to your involvement in this 
study? 
What have you tried over the years to improve your leg pain or discomfort? 
 Has this helped at all? 
Research experience 
What were your thoughts when you heard about the research? 
 Introduction letter 
 Information sheet 
 Organisation (location/timing of assessments) 
Could there be any additional information that might have been helpful for you at that point? 
How did you find this study (appointments at KCL)? 
 Assessments 
o 6MWT – is this a suitable way to find out how you are doing? 
 Pedometer – do you think this reflected your actual walking? 
 Questionnaires – were these relevant, appropriate, meaningful? 
 Travel and timing 
Intervention experience 
Can you tell me about your expectations before meeting the physiotherapist? 
What has the treatment with the physiotherapist involved for you? 
What was it like having physiotherapy consultations? 
 Tell me about the home-based sessions? 
o Content (Session 1 versus Session 2) 
o Format (home versus clinic) 
 Tell me about the follow-up phone calls? 
 Dosage (number of sessions, duration, follow-up) 





 Timing – would intervention have been useful at another stage of your 
disease/diagnosis/treatment? 
Outcomes and processes (illness and treatment beliefs) 
How has this intervention affected you? 
 Have you noticed any changes as a result of the treatment (physical) 
 Apart from physical changes, how do you feel in yourself since the treatment 
(emotion) 
 How do you see your leg problem now compared to before the physiotherapy? 
(cognitive/illness perceptions) 
o Do you see your diagnosis / condition differently than before? 
o Has it affected your understanding of your condition? 
o Has it affected your treatment options? 
Therapeutic relationship 
Can you tell me about the relationship you had with the physiotherapist? 
Was this relationship similar or different compared to your relationship with other healthcare 
professionals you have seen about your leg pain? 
Do you think a physiotherapist was the right sort of person to deliver an intervention like this? 
Acceptability 
Would you recommend this sort of treatment to other people with leg pain? 
 What reasons do you think other people might have for not wanting or taking this sort 
of treatment for their leg pain? 
Closing 





Table 8.2 Topic guide for a physiotherapist interview evaluating the feasibility and 
acceptability of an RCT of a home-based behaviour-change intervention targeting walking for 
IC 
Introduction 
What I’d like to talk with you about are you experiences and views about the training you 
received as part of this study, and of delivering the treatment intervention and attention-
control intervention. 
Brief history 
Before we begin can you tell me a bit about your background (training and experiences) as a 
physiotherapist? 
 Have you worked with people who have IC before? With CVD patients?  
 Can you tell me about your experiences in research? 
Training experience 
Tell me about the training you received as part of this intervention (quality, adequacy, 
appropriateness to the task) 
 Background reading on the subject 
 MI Course (Motivational Interviewing and Beyond, Skills Development Centre) 
 Volume and quality of mock sessions/feedback on mock sessions 
 Feedback on ongoing fidelity checks of audio recorded treatment sessions  
 What did you feel about the areas of learning addressed? 
 Too little/too much? 
 Has the training experience changed your practice? 
 If so, how? 
Study Management 
Can you provide any feedback on the day-to-day management of the study?  
 Quality and organisation of materials provided to support day-to-day management 
(e.g., study log, checklists, use of calendar) 
 How might the study management or materials be altered/refined? 
 Tell me about the balance of support you had versus autonomy given in managing 
your work related to this study? 
Intervention delivery 
Tell me about your experiences delivering the treatment intervention (i.e., the walking 
intervention?) 
 What were the barriers and facilitators to delivering this intervention 
 Focus on aspects of Session 1, Session 2, Booster call 
 (Personnel) What band therapist/healthcare professional do you feel should be 





 (Location) What are your thoughts on delivering home-based intervention? 
Attention control 
Tell me about your experiences delivering the intervention to the attention control group 
 What were the barriers and facilitators to delivering this intervention?  
 Did you feel comfortable, knowledgeable? 
 Anything that helped during delivery or that might have been used to improve 
delivery? 
 Any reactions/responses from patients? 
Theoretical processes 
Do you understand the theoretical processes behind this intervention? 
 Yes – what helped 
 No – what more would you like to know? 
Is there anything else you would like to add about the delivery of the intervention? 
Intervention Format 
What do you feel about the intervention format? 
Do you have any suggestions for how this sort of treatment could be refined/altered in the 
future? 
 Timing of sessions/booster 
 Volume and duration of sessions/booster 
 Mode of delivery (face-to-face vs online etc.) 
 Home based versus clinic-based 
 Individual versus group based 
 Physio- versus other-led 
Therapeutic relationship 
Can you tell me about building rapport/the relationship you had with the participants? 
Can you tell me about any good relationships or experiences/challenging relationships or 
experiences 
Closing 
Is there anything else you would like to tell me or you think I should know? 
 
8.3 Results 
8.3.1 Participant characteristics 
Sociodemographic and clinical characteristics of 12 participants (n=6 treatment, 6 attention-




Table 8.3 Sociodemographic and clinical characteristics of participants in a nested qualitative 
study of the acceptability of an RCT evaluating a physiotherapist-led home-based behaviour-
change intervention targeting walking in people with IC 
Variable Value, n (%) 
Age 68.0 ±10.3a 
Body mass index, kg/m2 26.6 ±4.0 a 
Male gender 7 (58.3) 
Married 5 (41.7) 
White ethnicity 10 (83.3) 
Current smoker 2 (16.7) 
Cardiovascular risk factors  
Diabetes mellitus 2 (15.7) 
Hypertension 8 (66.7) 
Dyslipidaemia 5 (41.7) 
Cardiovascular disease 7 (58.3) 
Renal disease 1 (8.3) 
Past heart attack 3 (25.0) 
Past stroke 0 
Comorbid pain 3 (25.0) 
Treatment history  
Pharmacological management of IC 1 (8.3) 
Walking advice 6 (50.0) 
Past supervised exercise therapy 3 (25.0) 
Past revascularisation 0 
Self-reported walking behaviour, kcal/dayb 126.5 ±18.9a 
Lower-limb symptom classificationc  
Classic IC 5 (41.7) 
Atypical IC 7 (58.3) 
Duration of IC<1 year 1 (8.3) 
n=12. aData are mean ±SD. bAssessed by the Baltimore Activity Scale for Intermittent 







8.3.2 Descriptive and explanatory themes 
Narrative accounts by participants and the physiotherapist demonstrated the acceptability of 
the trial and treatment protocol, and included suggestions to improve the programme in 
future. Themes are summarised in Table 8.4.  
Table 8.4 Summary of themes illustrating participant and/or clinician experiences and the 
acceptability of an RCT evaluating a physiotherapist-led home-based behaviour-change 
intervention targeting walking in people with IC 
Theme Description 
Acceptability of the research process 
and protocol 
Participant experiences of assessments and 
appointments, and suggestions for improving the 
study conduct 
Acceptability of the treatment and 
attention-control interventions 
Format and content of the interventions, including 
mode of delivery, information provision, and 
materials  
Perceived expectations and outcomes 
of the treatment and attention-control 
interventions 
Participant expectations prior to the study 
commencing, and outcomes including cognitions, 
behaviour-change, and walking ability  
Physiotherapist role as a person and 
professional 
Participant expectations of physiotherapy, 
individual qualities, professional expertise, 
consistency and relationship building  
Acceptability of the research process and protocol 
Most participants felt they had received enough information prior to joining the study, but had 
little or no expectations of the research for them. One participant expressed initial uncertainty, 
which was relieved with more information, and following the baseline visit: 
“It was a bit new at the time, but gradually getting into it provided 
more information, like an interview; you’re going to a new place or 
something and you’re not sure what is coming to you, and then 






Despite uncertainties or unclear expectations, individuals reported positive experiences after 
taking part: 
“I had only expected that you would study me, and hoped that would 
help other people a little bit. But it has had a positive result for me in 
that I’m actually doing more than I was.” (04C, male, 59 years, 
treatment group) 
Positive experiences included aspects of the research process, including walking and 
questionnaire assessments, which were relevant and appropriate based on participant 
accounts. For example, although participants were not informed of their performance during 
the 6MWT, some individuals viewed this as an opportunity to consider, or evaluate, their 
walking: 
“[The 6MWT] gave me knowledge of how far I could go. When I’m out 
[walking], I’m not stopping to think that I’m really falling behind.” 
(05C, female, 59 years, treatment group) 
Others did not enjoy the 6MWT particularly, but appreciated that it was appropriate in 
the circumstances of the research: 
“It’s not something I enjoyed, but neither do I dislike it. It’s just part of 
the test, if you like, and it’s a function that needs to be done, and it’s 
fine.” (04C, male, 59 years, treatment group) 






“It’s slightly unrealistic because it’s flat… so the impact on the legs 
was fairly marginal.” (02C, male, 75 years, attention-control group).  
Most participants viewed the pedometer as comfortable to wear (13C) and non-intrusive 
(02C), and reported not noticing it while it was worn. One individual in the treatment group, 
and one in the attention control, reported using the pedometer as a self-monitoring or 
motivational tool: 
 “I found it really helpful, almost to the extent to which I wish I had 
one. It really did encourage you on days when I looked at it and saw 
that I had done nothing…[and thought] ‘Oh, wow, I’ve got to go, got 
to do some walking’.” (04C, male, 59 years, treatment group) 
“If you show me, every day, how many miles or how many steps I 
have to do, then I think it could give me a bit more confidence that at 
least I am achieving that goal.” (13C, female, 55 years, attention-
control group) 
Participants were equivocal regarding questionnaire completion, but acknowledged the need 
for questionnaires as an assessment tool: 
“Questionnaires are questionnaires, to be frank. They don’t do 
anything for me. They’re just a necessary part of your process and I’m 
happy to fill them in.” (04C, male, 59 years, treatment group) 
One participant in the treatment group felt the questionnaires were a helpful, reflexive tool: 
“[The questionnaires were] very informative. I’ve never been asked all 
those sorts of questions before, but, you know, they drew from me 





Two participants (05C and 17C), who did not return interim questionnaires by post, did 
not reported reasons or difficulties in completing the questionnaires. Participants 
described no issues related to travel to the study site for assessments, or the 
environment for completing assessments. 
Acceptability of the treatment and attention-control interventions 
The format and delivery of the intervention was acceptable to participants in both groups, who 
enjoyed the home visits and added support through follow-up telephone calls:  
“I think it was better done at home, just in your own surroundings, 
really – [I felt] more relaxed and more secure.” (05C, female, 59 years, 
treatment group) 
 “[The telephone calls] were helpful and important, and it is because 
we had that closeness where [the physiotherapist] has come to my 
home, and we spoke and went through the programme, that, you 
know, the relationship exists where she can call and say, ‘How did you 
get on?’” (21C, male, 56 years, treatment group) 
Participants also reported having ample time with the physiotherapist as crucial to the 
experience, and to building a meaningful therapeutic relationship: 
“There’s more time, she’s more relaxed…and so I’m more relaxed.” 
(02C, male, 75 years, attention-control group) 
“A consultant hasn’t got time to explain all this and you know… she 
comes, sits and talks with no time limit, so I think it’s helpful.” (13C, 
female, 55 years, attention-control group) 
The physiotherapist recommended home delivery as an opportunity to empower participants, 




“By being a guest in someone’s home, you’ve automatically 
empowered them, just through the situation, before you’ve even had 
a conversation. It breaks that pattern of entering the role of the 
clinician dictating, or telling a patient what they ought to do.” 
(physiotherapist) 
However, some participants also welcomed the option of attending intervention sessions at a 
medical centre: 
“I would have gone to the hospital…it’s nice to get out anyway.” (17C, 
male, 69 years, treatment group) 
One individual, who subsequently joined a centre-based exercise programme, felt home-visits 
were acceptable, but suggested a hospital visit might feel more formal, and would add 
significance to the experience, potentially supporting his commitment, and adherence to the 
programme: 
“I think if you do it in a hospital environment, it has more weight. It is 
more official – ‘Right, you’re in a hospital, you’re being treated’.” 
(04C, male, 59 years, treatment group) 
Coupled with the core sessions delivered during home visits, the physiotherapist felt that 
booster follow-up telephone calls were crucial for those participants who might have 
progressed more slowly toward behaviour-change: 
“I do feel that people responded at different rates, which is why the 
booster call is really important for the people who maybe took longer 
to come around to that self-awareness, and a decision that they do 




From participants’ perspectives, booster calls provided reassurance and motivation, and 
helped to maintain a therapeutic relationship with the physiotherapist: 
“I think that was really, really good, and it kind of made you feel a 
little, ‘Yeah, someone’s thinking about me. I’m important.’” (04C, 
male, 59 years, treatment group) 
“It’s a good follow-up in that sense, that makes you pay a bit more 
attention because there can be slippage between the first interview. 
You need a little [prompt] every now and then!” (02C, male, 75 years, 
attention-control group) 
“She reminds me how I’m doing and, you know, so it helps you to 
know she’s going to ring to make sure I stay in control.” (13C, female, 
55 years, attention-control group) 
The clinician felt that the booster follow-up might have been easier to deliver and more 
effective if additional structure had been provided, in the form of a script including BCTs: 
“I felt [the phone calls] could have been expanded… what would be 
nice is, if there was an additional script that you could add in, 
particularly for individuals who were not successful in their attempts 
[at behaviour change], and to be able to refer back to the 
motivational process again.” (physiotherapist) 
Overall, participants across groups reported the intervention content as relevant, and felt they 
had gained positive and useful advice or information from the programme: 
“It turned out to be quite informative and… you know, I’ve learned a 




However, some participants (02C, 05C) felt that the experience might have also been useful 
earlier in their diagnosis, or potentially more suitable for individuals with less healthy lifestyles, 
as they were already actively walking or looking after their diet: 
“Clearly it would have been better seven years ago, when the 
condition was first highlighted by the doctor.” (02C, male, 75 years, 
attention-control group) 
 “I think [the advice] was very good…I mean as far as you know, 
walking. But then again, I knew that I should walk so they didn’t tell 
me anything that I didn’t know.” (08C, female, 73 years, treatment 
group)  
“Because I am aware of my daily lifestyle, I didn’t feel that it was 
totally necessary to follow the plan rigidly so that’s why I suppose I 
didn’t.” (24C, female, 78 years, treatment group) 
The physiotherapist reported the challenge of supporting individuals who described a 
regimen of walking to consider further behaviour change: 
“A challenge I found, particularly in the walking group, was that I 
could sense some individuals thinking, ‘walking is walking’. On the 
surface, they were motivated to walk for their health, and they didn’t 
really grasp that walking was something they needed to do in excess 
of what they were already doing, given that it wasn’t making a 
difference.” (physiotherapist) 
Some participants benefited from this approach and from learning that they could 




“It gets you to think to yourself, ‘Don’t be lazy, you can do more’. And 
the more you do, the better your condition will be, demonstrating 
that the more effort I put in, the better things would turn out.” (03C, 
male, 72 years, treatment group) 
However, the physiotherapist reported a range of participants at varying stages of 
understanding about their condition and motivation for behaviour change, and was able to 
tailor delivery accordingly: 
“There was a wide range of people, some who didn’t need too much 
education, who knew why walking is something they should be doing, 
and that made the job much easier for me. It was just a case of fine-
tuning what they should be doing and it was a very collaborative and 
quite easy process.” (physiotherapist) 
By contrast, the physiotherapist found some individuals required greater encouragement or 
persuasion that walking was beneficial, and took more time during Session 1 to address 
treatment cognitions: 
“There were people who were very focused on the fact the medical 
intervention was needed, and my response to that was…trying [to 
provide information] in a different way, to find different avenues that 
might allow them to get on board the fact that [walking] could be an 
option, even in tandem with medical intervention.” (physiotherapist) 
Participants who reported no or limited previous attempts or experiences of walking also 
frequently reported benefits of receiving the treatment, suggesting that the physiotherapist’s 
attempts at framing the intervention appropriately for these individuals was successful.  
Most participants enjoyed setting and agreeing goals, and found it a useful activity (13C). 




completing the action planning worksheet with the physiotherapist. Another participant, in the 
treatment group, felt that the action planning worksheet was not suitable, and that the 
process of writing down her goals and specific plans was a “total and utter waste of time” 
(08C, female, 73 years, treatment group). 
Another participant found action planning difficult because she was already engaging in a 
degree of routine activity, over and above what the plan entailed: 
“Because I am aware of my daily lifestyle I didn’t feel that it was 
totally necessary to follow the plan rigidly so that’s why I suppose I 
didn’t.” (24C, female, 78 years, treatment group) 
The clinician also reported challenges in goal setting with some participants, and a sense 
that it was initially perceived as somewhat repetitive and unnecessary: 
“I felt almost like I had to apologise for the fact that we were form-
filling…but doing it, and having [goals written] on paper is very 
useful…and I think people actually got on board with the form, once 
we got going.” (physiotherapist) 
However, the physiotherapist felt that the goal setting process was important, and that 
documenting goals in particular helped draw specific and concrete plans from 
participants: 
“Writing [goals] down is almost making them a sort of binding 
contract, and there was certain hesitation, and for people to say, ‘Oh, 
I am actually agreeing to do this’.” (physiotherapist) 
This notion was corroborated by some participants who felt they benefited 




“I think it is a good idea to have a programme, which we set out 
together on how to do walking, and I signed up to.” (03C, male, 
72 years, treatment group) 
Perceived expectations and outcomes of treatment and attention-control  
Participant motivation for joining the study included anticipated benefits to themselves, to 
others with IC, to research in this area, or the individual researcher.  
“I might glean something from being involved that might help me, 
some clarification about the problem, and some knowledge about it.” 
(02C, male, 75 years, attention-control group) 
“I thought, ‘If this is going to lead to something that helps other 
people, because you provide positive advice and a way of doing 
things, then it is well worth doing’.” (03C, male, 72 years, treatment 
group) 
In addition, some participants in the attention-control group reported having “nothing to lose” 
as a reason for deciding to take part:  
“I thought, ‘Well, there’s nothing to be lost and possibly something to 
be gained’.” (02C, male, 75 years, attention-control group) 
By comparison with their expectations, which were general and equivocal, participants 
described specific outcomes, including a positive impact on their psychological and emotional 
well-being, and on the uptake of healthy behaviour, and walking ability. 
Across both the treatment and attention-control groups, the intervention had instilled 




 “I know that what food I take and what I do, it does affect…my whole 
diet affects me, because ‘You are what you eat’, aren’t you?” (15C, 
female, 65 years, attention-control group) 
“Being part of this programme has meant that I’m constantly aware 
that the result of whatever it is that I’m doing goes toward 
something.” (04C, male, 59 years, treatment group) 
Those in the treatment group reported increased self-confidence, knowledge, and motivation: 
“It empowered me, made me think ‘Yes, I have to run with this as the 
next best thing for me and my condition.’ So the advice and what I’ve 
had from you guys, it’s my way forward now.” (21C, male, 56 years, 
treatment group) 
“I had no knowledge of what to do, until I came to see yourself and 
the physiotherapist. I improved mentally and physically. I am getting 
better.” (17C, male, 69 years, treatment group) 
Across both groups, participants reported increased beliefs that they ought to walk more as a 
result of the intervention: 
“It’s highlighted the fact that I do need to exercise. It’s brought that 
home to me a little bit more.” (04C, male, 59 years, treatment group) 
“In my mind, I was saying, “Ah yes, you’re right, I should perhaps do a 
bit more walking, or a bit more of this or less of that.” (02C, male, 
75 years, attention-control group) 
However, participants in the treatment group only reported an understanding of the link 
between walking and their condition, the potential outcome of walking for their IC, and an 




“When the pain is there, I can walk through it now, because I 
understand why it is there. I never knew before.” (17C, male, 
69 years, treatment group) 
“I’m helping the circulation and, in doing so, in walking and 
exercising, I’m helping to keep the blood vessels open.” (24C, female, 
78 years, treatment group)  
Participants across both groups reported increased walking as a result of the intervention. 
However, the treatment group reported specific behaviour change: 
“I’m trying to do one hour per day on most days…I know from past 
experience I expect to have some discomfort after 5 or 10 minutes, 
but just to keep going.” (03C, male, 72 years, treatment group) 
By comparison, those in the attention-control described broad lifestyle changes, or attempts 
to change: 
“I’ve been exercising more, I’ve changed my eating habits, my diet, 
I’ve lost weight, I can walk further and generally speaking, I feel as if 
I’m making a contribution to improving my overall health.” (04C, 
male, 59 years, treatment group) 
Some participants in the treatment group reported the ongoing challenge of walking, despite 
the intervention instilling positive beliefs: 
“Yes, I do agree with what you’ve been saying, sort of thing, telling 
me to walk for 30 minutes, but I find it very difficult.” (05C, female, 




One individual, who joined a supervised centre-based programme following participation in 
the behaviour-change intervention, described the challenge of translating positive beliefs to 
behaviour: 
 “It’s helpful to encourage you and to educate you to the fact you 
need to be doing it, but it doesn’t make you do it.” (04C, male, 
59 years, treatment group)  
Most, but not all, participants in the treatment group reported explicit benefits to their IC and 
improved walking ability: 
“I can walk further, with less discomfort than I could when it all 
started.” (03C, male, 72 years, treatment group) 
“The pain has subsided greatly. It still tingles here and there, but 
nothing to what it was.” (17C, male, 69 years, treatment) 
“It hasn’t got any better for me, and I’m not exactly lazy.” (08C, 
female, 73 years, treatment group) 
By contrast, those in the attention-control group reported physical benefits including weight 
loss or feeling better in themselves generally, with no clear benefits to improved walking 
ability.  
“I feel that, um, my legs are slightly better than they were, but it is 
very subjective. I can’t see it going away, basically.” (02C, male, 
75 years, attention-control group) 
“Hopefully, one day, something might improve. But it hasn’t done so 





Role of the physiotherapist as a person and professional  
Participants reported personal qualities of the physiotherapist, which resulted in a 
positive experience of the intervention. Specifically, they reported the physiotherapist 
as knowledgeable, interested, and friendly, and that these qualities were different from 
other healthcare professionals they had encountered before, and were important to 
benefitting from the programme: 
"She wasn’t like a doctor, she was like, yeah, friendly." (13C, female, 
55 years, attention-control group) 
"She was very sociable, and amenable, which put me at ease. It was 
almost like having a chat with a friend if you like, with some medical 
stuff thrown into it.” (03C, male, 72 years, treatment group) 
“She’s such a positive person, and, she makes you think that she is 
really interested and really cares. I think she’s excellent.” (04C, male, 
59 years, treatment group) 
Participants reported a physiotherapist, in general, as someone who is suited to deliver 
this type of intervention:  
“I don’t think there is anyone better qualified than [a 
physiotherapist], somebody who is clearly interested in making 
people exercise.” (04C, male, 59 years, treatment group) 
“It’s good physiotherapy. I mean, she’s not there to pull me about and 
manipulate my bones and body, because there is nothing she can do 
in that way. So the verbal conversation and the talking and the 
information on how the blood flows around the body – it’s good.” 




From the physiotherapist’s perspective, the intervention was suitable for delivery by an allied 
healthcare professional, and particularly by physiotherapists:  
“Psychologists are going to find that this is a good intervention, but I 
don’t see why physiotherapists shouldn’t have this training. I think 
that physiotherapists are in a good position to be able to deliver this 
kind of information, and need to have the experience of working with 
people, and understanding that there is a psychological role before 
you begin to learn these skills.” (physiotherapist) 
Participants and the physiotherapist described a collaborative relationship, which had positive 
outcomes for individuals with IC: 
“The work that we have done together has made me feel better, and I 
do. The main problem that I went [to the hospital] for has subsided 
since working with [the physiotherapist]. (17C, male, 69 years, 
treatment group) 
In addition, the physiotherapist reported developing a therapeutic stance that 
enabled a collaborative relationship to develop:  
“[The experience] allowed me to give more power to the individual, 
rather than lecturing them on what they should be doing. I felt that I 
could get to know [the participant], and to understand them, and 
develop more of a sort of collaborative or emphatic relationship.” 
(physiotherapist) 
Overall, participants reported enjoying the experience of the study, and the 
intervention. Participants expressed that they would recommend the intervention to 




“I feel very strongly that it, it’s not just a case of recommending it. I 
think it should be a facility that’s available, that, uh, the vascular 
surgeons say to people, ‘Hey, listen, we’ve got a programme I want 
you to join that will help you’, rather than, ‘You need to exercise’.” 
(04C, male, 59 years, treatment group) 
“I think [the programme] should be wider, a bit more known. I’m just 
really happy that I have the knowledge you’ve given me, and I think 
anybody going through this thing should come and have a chat with 
you.” (17C, male, 69 years, treatment group) 
8.4 Discussion 
This study demonstrated the acceptability of a randomised trial evaluating a behaviour-change 
intervention targeting walking to participants with IC and a physiotherapist.  
Participants reported home visits as a convenient alternative to a hospital-based programme, 
and the home environment facilitated a collaborative relationship between the 
physiotherapist and participant. Supervised centre-based programmes are limited in 
availability and challenging to implement (NICE, 2014b), whereas a home-based programme 
reduces the burden of travel required by the patient to attend a centre for exercise (Galea et 
al., 2008), and may improve adherence, in the long-term, to healthy lifestyle choices, such as a 
regimen of self-directed walking (Ashworth et al., 2005). 
In adjunct to home visits, participants and the physiotherapist recommended telephone 
booster calls, which participants anticipated, and which supported their pursuit of agreed goals 
and action plans. Face-to-face contact and booster follow-up telephone calls that reinforce 
previous intervention content, are components of exercise interventions associated with 
adherence following programme completion (Fjeldsoe et al., 2011). Booster follow-up 
telephone calls helped to maintain physical activity and self-reported habit strength 6 months 




including 1166 participants, and the effect of the booster follow-up on physical activity was 
mediated by changes in self-efficacy, action planning, and satisfaction with exercise outcomes 
(Fleig et al., 2013). However, these booster follow-ups were delivered by student researchers, 
and followed a centre-based programme. By contrast, participants in the present research 
reported the importance of establishing a relationship with the physiotherapist prior to 
receiving the booster telephone calls, suggesting a key feature of the current intervention, 
which could enhance the effectiveness of telephone boosters. This is consistent with evidence 
that healthcare professionals are salient normative referents within the social network of 
individuals with IC (Chapter 6). The physiotherapist in the present study recommended greater 
structure to booster telephone calls, including a script to support the dialogue with 
participants, which could incorporate BCTs shown to be effective, including reinforcement, 
review and revision of goals, and problem solving (Fleig et al., 2013). 
Outcomes of the intervention in terms of information, knowledge and improvements in 
psychosocial variables were reported by participants in both the treatment and attention-
control group. While the attention-control participants reported increased healthy behaviour, 
including diet and walking, the treatment group were more specific in detailing walking 
outcomes, both in terms of the volume of activity and perceived walking ability. Findings 
suggest that the attention-control was acceptable to participants, and was perceived as 
credible and potentially beneficial to participants, which are criteria for an attention-control 
(Freedland et al., 2011). However, the possibility of contamination of the attention-control, 
including delivery by the same clinician and transfer effects of dietary behaviour change to 
walking (Chapter 7) cannot be ruled out.  
8.4.1 Methodological considerations 
A strength of this study is the inclusion of a purposive sample of representative participants 
from both the treatment and attention-control groups who provided in-depth, narrative 
accounts of their experiences. However, sampling did not take into account treatment history, 




with IC reflecting a range of treatment histories (e.g., conservative management and/or 
revascularisation) should be included during patient and public involvement for a definitive 
trial. 
The interviewer (MGH), who was blinded during outcome assessment for the feasibility study 
(Chapter 7), was unblinded to group allocation for the purpose of conducting interviews, and 
this may have influenced data collection. However, the investigator followed the same topic 
guide during interviews with participants in the treatment and attention-control groups. In 
addition, data was transcribed and primary analyses conducted by an independent investigator 
(PD), which were validated by the interviewer (MGH) and a third investigator (LMB). 
Data reflect the experiences of only one physiotherapist, and the interactions between 
participants with just one physiotherapist. The transferability of findings across 
physiotherapists is limited, and there may be qualities of the individual identified by 
participants in this study which may differ between clinicians, for example, past clinical 
experience, communication skills, and willingness to engage with counselling-based 
physiotherapy. 
8.4.2 Conclusions 
 The acceptability of a randomised trial comparing a home-based walking programme 
and attention-control targeting dietary behaviour change was reported by participants 
with IC and a physiotherapist. 
 Participants and the physiotherapist reported the importance of establishing a 
collaborative relationship, which was facilitated by delivery within the home 
environment.  
 Booster telephone session were an important aspect to the intervention, although the 





 Thesis discussion  Chapter 9.
Walking is an effective but underused treatment for IC. Consistent and strong evidence 
demonstrates that walking can improve exertional symptoms and increase walking capacity by 
up to 200% (Lane et al., 2014). In addition, walking contributes to overall daily physical activity, 
which is associated with reduced cardiovascular morbidity and mortality, and improved 
physical functioning among individuals with IC (Garg et al., 2009; Garg et al., 2006). However, 
people with IC do not engage in sufficient walking to improve their health (Galea et al., 2008). 
Limited access to supervised centre-based programmes is a barrier to short-term benefits of 
walking, and simple walking advice from a healthcare professional does not increase self-
directed walking (Bartelink et al., 2004; Makris et al., 2012). Long-term health gains require 
adherence to a regimen of walking as a self-management strategy and lifestyle change. 
Theory-driven behaviour-change interventions that are tailored and delivered in the home 
environment could bridge the gap between scarce centre-based programmes and ineffective 
walking advice, and facilitate walking adherence and improvements in walking ability among 
individuals with IC. 
Therefore, this research developed and evaluated a behaviour-change intervention targeting 
theory-based cognitions to facilitate self-directed walking in people with IC. Consistent with 
MRC guidelines (Craig et al., 2008), the programme of work sought to review the existing 
evidence base, identify and develop theory, model processes and outcomes, and test 
procedures for a larger study. These guidelines were implemented through a series of distinct 
but complementary studies incorporating qualitative and quantitative methods: 1) a 
systematic review of the existing literature on theory-based BCTs that have been applied to 
walking interventions for IC; 2) a qualitative exploration of experiences and beliefs about their 




constructs defined by the TPB and CSM as determinants of walking intention and objective 
walking ability; and 4) an acceptability and feasibility study of an RCT of a physiotherapist-led 
home-based behaviour-change intervention targeting walking among individuals with IC.  
9.1 Summary of key findings 
9.1.1 Systematic review of behaviour-change interventions targeting walking in 
people with IC 
A systematic review identified six studies reporting behaviour-change interventions targeting 
walking in people with IC (Chapter 4). Most studies were highly susceptible to bias, and 
reported varied effects on the primary outcome, MWA, and on secondary outcomes including 
PFWA, self-reported walking ability, and walking behaviour. Overall, 11 BCTs (Michie et al., 
2011a) were identified across included studies. Barrier identification and problem solving, self-
monitoring, and feedback on performance were applied frequently, and were included in two 
effective interventions (Cunningham et al., 2012; Gardner et al., 2011). However, most studies 
were not informed by health psychology theory explicitly, and none evaluated theory-based 
mechanisms of change, providing little assurance that BCTs were delivered consistently and 
could explain findings.  
9.1.2 Qualitative study exploring individual experiences of and beliefs about 
walking in people with IC 
A qualitative study (Chapter 5), using the Framework Method, and employing semi-structured 
in-depth interviews including 19 individuals with IC, revealed two key themes. First, walking is 
an overlooked self-management strategy among people with IC, regardless of the perceived 
consequences of their condition. That is, for individuals who reported their IC as benign, 
symptoms could be overcome without the perceived need for any treatment, including 
walking. By contrast, individuals who reported their IC as severe expressed a strong emotional 
response, including feeling helpless, and a lack of personal and treatment control over their 




desire for tailored walking guidance. A lack of clear guidance contributed to findings that 
individuals were not achieving walking guidelines, and to reports of limited purposeful or 
monitored walking, barriers to walking to intensity, and varied outcome expectations of 
walking among participants.  
9.1.3 Cross-sectional observational study evaluating walking treatment and illness 
cognitions as determinants of walking intention and 6MWD in people with IC 
Data from a cross-sectional analysis including 142 individuals with IC (Chapter 6) demonstrated 
that, overall, 73% and 28% of the variance in walking intentions and objective walking ability 
(6MWD), respectively, was explained. Past walking behaviour was an important predictor in 
both models, and walking treatment cognitions defined as TPB constructs were better at 
explaining walking intention, whereas illness cognitions defined as CSM constructs explained 
6MWD. Attitude, subjective norm, and perceived behavioural control regarding walking, and 
perceived consequences of PAD, made independent contributions to explaining walking 
intention, and risk factor attributions, illness coherence, treatment control, and personal 
control over PAD were illness cognitions that contributed to explaining 6MWD.  
The aim of the first three studies was to evaluate and establish an evidence base for employing 
the TPB and CSM as frameworks for developing and evaluating the feasibility of a walking 
intervention for IC, and to identify suitable BCTs that could facilitate walking. A strength of this 
work was the use of mixed methods to establish an evidence base; however, a challenge of 
mixed-methods research involves the integration of findings, drawn from divergent methods 
and epistemologies. A pragmatic approach was employed, wherein qualitative or quantitative 
methods were distinct, but corresponding in their overarching goal, to inform the 
development of a walking intervention. The implications of key evidence from each phase of 





Figure 9.1 Translation of key findings to the development and execution of the feasibility 
study, and implications for future research 
 
BCTs, Behaviour-change techniques; CSM, Common Sense Model of Illness Representations; 
IC, intermittent claudication; TPB, theory of planned behaviour. 
9.1.4 Feasibility and acceptability studies of a physiotherapist-led behaviour-
change intervention targeting walking in people with IC 
The feasibility of an RCT informed by the TPB and CSM, and targeting walking in people with IC, 
was demonstrated in Chapters 7 and 8. One high-quality, effective intervention, informed by 
the CSM, provided a template for the current study (Cunningham et al., 2013; Cunningham et 
al., 2012); however, that study included only newly diagnosed individuals with IC, found no 
treatment effect on key theory-based constructs, did not report on treatment fidelity, and 
included a usual care control, which limits the interpretation of findings. In addition, the 
intervention was delivered by a researcher, so the feasibility of implementing the intervention 
in clinical practice was not demonstrated.  
Unlike previous research (Cunningham et al., 2013; Cunningham et al., 2012) the present study 
sampled the wider population of individuals with IC to include those who had undergone 
revascularisation, included an attention-control arm which supports the validity of findings, 




points. In addition, objective walking was assessed as the outcome, extending our knowledge 
of the applicability of the walking intervention among individuals with IC. A physiotherapist 
was trained to deliver the intervention, and affirmed the acceptability of this process 
(Chapter 8).  
Most feasibility criteria were achieved, demonstrating study retention (>60%), compliance to 
the intervention (>60%), utility of the MITI Code as a fidelity assessment tool, and a positive 
effect of the intervention on objective walking behaviour (Hedges g=0.39, 95% CI -0.47, 1.25). 
In addition, acceptability of the protocol was confirmed based on narrative accounts of 
participants and the physiotherapist in a nested qualitative study (Chapter 8). However, rates 
of missing baseline pedometer data and post-intervention questionnaire data were higher 
than expected. Reasons for missing data were explored further in the qualitative interviews. 
Participants reported the pedometers were comfortable and non-intrusive, but some 
individuals (e.g., 04C, 09C, and 21C) expressed difficulties in remembering to wear the device. 
In addition, while individuals felt equivocal about completing questionnaires, some forgot to 
complete these at home or reported returning them, although they were not received. 
Strategies to remind participants to wear their pedometer and to complete interim 
questionnaires at home (e.g., text reminders, use of incentives) should be employed in a 
definitive trial.  
Walking behaviour increased by approximately 60 minutes/week following the intervention, 
however, this is below recommendations to walk for at least 30 minutes on at least 
3 days/week (i.e., at least 90 minutes/week), and might explain the lack of improvement in 
6MWD, although the study was not powered to evaluate hypothesised effects. This contrasts 
with previous findings, in which a similar intervention increased walking by mean 1358.4 steps 
(approximately 95 minutes/week) (Cunningham et al., 2013; Cunningham et al., 2012); 
however, that study did not evaluate objective walking ability, so it is unclear whether 




addition, that study did not evaluate change in targeted cognitions. Risk factor attributions, 
illness coherence, treatment control, and personal control regarding PAD were CSM constructs 
associated with 6MWD, and which were targeted by the present behaviour-change 
intervention alongside other CSM variables, but only treatment control and coherence 
demonstrated positive changes following treatment, so other CSM variables may require 
additional emphasis in future interventions. 
9.2 Implications for management of individuals with IC 
Supervised centre-based exercise programmes are a key quality improvement area and a 
priority commissioning action identified by NICE (2012). Currently, there is a lack of available 
programmes for clinicians to refer people with IC, and the cost of initiating new programmes is 
a barrier (NICE, 2014b), despite evidence of the cost-effectiveness of exercise therapy for IC 
once a programme is in place. However, a potential threat to the effectiveness, and cost-
effectiveness, of supervised exercise therapy is adherence, which has not been demonstrated 
over the short- or long-term following discharge (Bermingham et al., 2013). Only 
approximately half of individuals adhered (e.g., attended ≥80% of session) to supervised 
exercise therapy, with nearly 40% dropping out within 4 weeks of initiating the programme 
(Guidon and McGee, 2013). However, that intervention provided exercise alone without BCTs, 
was available only on a twice-weekly predefined schedule without flexibility, and identified 
participants from patient records who may not have been actively seeking treatment for their 
IC. In addition to low participant attendance (i.e., adherence), the long-term effectiveness of 
supervised exercise therapy is unknown, as there is limited evidence that individuals maintain 
regular self-directed walking upon programme completion. Assuming no difference in long-
term adherence after 1 year, Bermingham et al. (2013) reported an Incremental Cost-
Effectiveness Ratio of £1608 per Quality-Adjusted Life Year (QALY) gained, which resulted in a 
25% likelihood that walking advice would be cost-effective at a willingness to pay £20,000 
compared with supervised exercise therapy. Simple walking advice is ineffective, and data 




effectiveness of supervised exercise therapy, and highlights the potential for lost expenditure 
on programmes that do not support adherence to walking behaviour. Until effective home-
based walking programmes are established, which support adherence to walking, it may be 
impossible to determine the cost–effectiveness of such programmes against alternative 
treatment options. The current research begins to address this gap by identifying BCTs that 
could facilitate regular self-directed walking, and employing a robust theoretical underpinning 
to the intervention development and evaluation, which is informed by in-depth narrative 
accounts of the experiences and beliefs of individuals with IC. In addition, this research 
extends the role of physiotherapists in IC management. Employing allied health professionals, 
such as physiotherapists, to deliver this brief intervention in participants’ homes, could 
minimise the cost of treatment compared with supervised exercise therapy, and facilitate 
commissioning within the NHS. In addition, participants reported a positive therapeutic 
alliance with the physiotherapist (Chapter 8), which may improve adherence to walking, also 
contributing to the cost–effectiveness of the intervention. 
Current NICE pathways for care recommend a supervised walking programme as a first-line 
treatment strategy for IC, which precedes medical and surgical management (NICE, 2012). 
However, there is scope for exercise therapy, particularly walking, to be included alongside 
other management strategies to improve long-term outcome, and support rehabilitation post-
revascularisation. The current research demonstrated the expanded role of a structured home-
based walking programme for individuals with long-standing IC, including those who had 
undergone revascularisation. Therefore, the pathway for management of individuals with IC 
should not terminate at medical and surgical management. Instead, a bi-directional pathway 
between walking and medical and surgical management may provide patients and clinicians 
with greater flexibility to facilitate the adoption of healthy lifestyle changes by providing 
structured home-based walking programmes before, alongside or after revascularisation 




Figure 9.2 Proposed bi-directional pathway between structured exercise therapy and medical 
or surgical management of IC 
 
National Institute for Health and Care Excellence (2015). Adapted from ‘Managing intermittent 
claudication in people with peripheral arterial disease’. Reproduced with permission. 
9.3 Implications of findings for physiotherapy practice 
Studies of home-based walking therapy for people with IC have reported delivery by a nurse, 
researcher, or psychologist (Galea et al., 2013; Al-Jundi et al., 2013). Exercise and physical 
activity prescription is a key management strategy for physiotherapists, and training in 
communication skills and BCTs are core components of pre-registration physiotherapy training, 
so qualified physiotherapists require minimal training to be able to deliver this intervention. 
This study demonstrated that training a physiotherapist in BCTs, including motivational 
interviewing, was feasible. Training was brief comprising a total of 15 hours of formal contact, 
including a 1 day course in motivational interviewing certified by the British Psychological 
Society, role play with feedback, and ongoing supervision of recorded sessions. These 
techniques have demonstrated effectiveness in training clinicians to deliver health psychology 
interventions (Perryman, 2014). The programme extends practice by providing an alternative 
















A physiotherapist was considered by participants as the appropriate healthcare professional to 
deliver the intervention, and a positive therapeutic alliance was established based on 
participant reports, which could support treatment adherence (Cohen, 2009). The 
physiotherapist confirmed the acceptability of the intervention and training, and offered areas 
for improvement, including greater structure for the booster telephone session, which should 
be incorporated to the intervention materials and training package. While this study 
demonstrated the feasibility of the training programme, it did not aim to evaluate the 
effectiveness. A full-scale trial is required to evaluate the clinical and cost-effectiveness of the 
intervention, and further research should be undertaken to evaluate the volume and content 
of training required to achieve competency prior to treatment delivery. 
9.4 Contributions to theoretical understanding of walking among 
people with IC 
The health behaviour change literature is dominated by a small number of theoretical 
frameworks, including the TPB and CSM (Painter et al., 2008). Many theories employ 
constructs and pathways that conceptually or statistically overlap, and there is potential to 
compare constructs, determine the most robust models, and to inform the development of 
new models (Sniehotta et al., 2013; Noar and Zimmerman, 2005). In addition, existing theories 
are incomplete, explaining only small to moderate variance in health behaviour (Armitage and 
Conner, 2001; Hagger and Orbell, 2003), and there is scope for extending theories if new 
variables can be identified that add to the predictive utility of a framework, such as the TPB 
(Ajzen, 1991).  
Cross-sectional data (Chapter 6) support the TPB for explaining walking intentions in people 
with IC, and expand our theoretical understanding of this domain by providing the first 
evidence that CSM variables account for objective walking ability unexplained by the TPB, and 
that this pathway is not directly mediated by intention. This contrasts with a previous study, 
which hypothesised that intention would mediate the effect of CSM constructs on self-




effect of either model on the outcome, and only perceived behavioural control and timeline 
cyclical emerged as independent predictors (Sniehotta et al., 2010). However, that sample was 
small, predominantly male, and psychometric properties for the measure of illness perceptions 
were low. In addition, physical activity was assessed by self-report. To date, no other studies 
have been identified which apply the TPB and CSM together to explain objectively measured 
physical activity. 
While the TPB suggests that intention is a prerequisite to behaviour, the present findings, and 
those of Sniehotta et al. (2010), are consistent with the wider literature demonstrating an 
“intention–behaviour gap” (Orbell and Sheeran, 1998). A number of factors have been 
explored as potential moderators of the intention–behaviour relationship (e.g., intention 
stability, anticipated regret, and conscientiousness); however, the evidence is inconclusive, 
and based primarily on healthy samples (Rhodes and Dickau, 2012b). It is possible that, in the 
context of walking in people with IC, TPB and CSM constructs interact so that intenders with 
positive illness cognitions are more likely to engage in walking. The cross-sectional study 
described in Chapter 6 was not designed or powered to evaluate this hypothesis, so future 
research could explore possible interactive effects of intentions and illness cognitions on 
walking.  
It may be that illness cognitions have an indirect effect on intention by contributing to the 
formation of attitude, subjective norm, and perceived behavioural control. Horne and 
Weinman (1999) suggested that beliefs about illness may influence choice of treatment, 
outcome expectations of treatment, and adherence. Illness cognitions determine beliefs about 
the necessity of and concerns about pharmacological treatment (Horne and Weinman, 2002); 
however,  this pathway has not been explored using treatment beliefs defined by the TPB, or 
in the context of walking treatment.  
Self-regulatory processes have also been proposed to bridge the gap between intention and 




(e.g., walking) contributes to a cognitive and emotional feedback loop which serves to achieve 
individual standards, or goals, for regulating a health threat (e.g., reduced symptoms, 
improved walking ability). Although the TPB is not explicitly a self-regulatory model, 
behavioural attempts provide a source of information, which, in turn, may contribute to 
changes in attitude, subjective norm, perceived behavioural control, and intention (Ajzen, 
2002b). Action planning and action control are self-regulatory processes which are proposed to 
act as moderators or mediators of the intention–behaviour relationship, and which were 
evaluated in the feasibility study (Chapter 7). These variables may be important mechanisms, 
which could be common to the TPB and CSM, and which may support the translation of 
intentions or illness cognitions to behaviour by facilitating automatic processing of decisions to 
walk. Therefore, action planning and action control should be considered in future research 
which combines these models to explain walking behaviour, and included in further 
evaluations of the current intervention.  
Findings suggest different contributions of the TPB and CSM toward understanding walking 
intention and objective walking ability in IC. While it might appear as though the TPB and CSM 
are divergent or incompatible, alternately it is possible that the models are underpinned by 
unique processes, and therefore each contributes independently to understanding walking. 
The TPB in particular is a general theory of behaviour, and proposes determinants that are 
proximal to enactment of a behaviour (e.g., walking). By contrast, the CSM models the 
schematic representation of illness, which encompasses behavioural coping responses (e.g., 
walking as treatment for IC), and, by explicitly accounting for illness cognitions, might better 
correspond with a disease-specific behavioural outcome, such as the 6MWD. In addition, the 
6MWD might represent a distal outcome of walking behaviour among individuals with IC, 
which is mediated by angiogenic or arteriogenic mechanisms (Chapter 1), and therefore not 




Figure 9.3 Proposed indirect pathway from behavioural determinants defined by the TPB to 
health outcome, defined as the 6MWD 
 
Adapted from Hardeman et al. (2005) with permission from Oxford University Press. 
TPB, Theory of Planned Behaviour; 6MWD, 6 Minute Walk Distance. 
Further investigation of how the models combine to explain walking may inform intervention 
development. For example, constructs from the TPB (e.g., attitude, subjective norm, perceived 
behavioural control) may be targeted in the motivational stage of behaviour change, to 
increase walking intentions, whereas CSM constructs may facilitate the translation of positive 
intentions to walking behaviour and improved walking ability. The current intervention 
incorporated TPB and CSM constructs simultaneously to form a health-behaviour link early in 
the intervention (Chapter 7), and further research is needed to evaluate whether CSM 
constructs should be emphasised during the later, volitional phase of behaviour-change, 
alongside self-regulatory processes (e.g., action planning and coping).  
9.5 Frameworks for behaviour-change and implementation to practice 
Despite limited empirical evidence for combining theoretical frameworks to explain and 
understand health behaviours, interventions often draw on multiple theories in their design 
(Davies et al., 2008; Darker et al., 2009), suggesting a discrepancy between the available 
theoretical evidence and implementation to practice, and a potential limitation of the available 
theoretical models. A key problem is the lack of explicit evidence for how to apply existing 
theories during intervention development to target modifiable constructs (e.g., cognitions). 
Frameworks which transcend theory provide a structure for characterising and designing 
behaviour-change interventions, and a practical starting point for overcoming the limitations 
of theory. The present research employed the MRC framework for developing and evaluating 
complex behaviour-change interventions (e.g., walking programmes for IC), which 




developing theory, modelling processes and outcomes) and 2) feasibility testing. The next 
stages in that process include 3) evaluation and 4) implementation to practice. Evaluation of 
treatment effectiveness, processes of change, and cost-effectiveness are necessary to justify 
the adoption of a novel intervention to practice, and can take place before or alongside 
implementation. MRC guidance outlines “potentially useful” (Craig et al., 2008) approaches to 
implementation, including stakeholder involvement, accounting for contextual factors, or 
multifaceted dissemination. However, implementation frameworks exist, which move beyond 
description of processes to propose determinants (e.g., the Theoretical Domains Framework) 
(Cane et al., 2012) or theories (e.g., Capability-Opportunity-Motivation-Behaviour [COM-B] 
Model) (Michie et al., 2011b) that can be applied during implementation (Nilsen, 2015). 
Behaviour-change is central to implementation, which requires healthcare professionals and 
patients to adopt and engage with a new treatment; however, implementation frameworks 
account for factors beyond human agency to include aspects of the context and system within 
which an intervention is provided (e.g., service provision, legislation, other treatment options). 
The next stages of this research should assess and evaluate factors influencing the capability, 
opportunity, and motivation of patients and healthcare professionals to engage with and 
adopt a new treatment to facilitate walking for IC, and to address potential barriers to 
implementation alongside an effectiveness evaluation. 
9.6 Continued intervention development and evaluation 
The feasibility study centred on refinements to an existing study protocol, including 
intervention delivery, process evaluation, and factors that might influence implementation to 
practice. However, core components of the treatment itself (e.g., the treatment script and 
BCTs employed) were adapted from previous research and should be updated based on the 





Table 9.1 Proposed refinements to a structured home-based behaviour-change intervention 
targeting walking among individuals with IC 
Refinements to the walking intervention based on 
findings from the current work 
Behaviour-change techniquesa 
Elicit participants’ previous treatment 
experiences including revascularisation in order 
to position walking as a therapeutic strategy in 
the appropriate context for the individual 
Framing/reframing 
Define the notion of “walking through pain” 
including the identification of barriers to walking 
to intensity and strategies for overcoming these 
Instruction on how to perform a 
behaviour 
Biofeedback 
Reduce negative emotions by providing coping 
strategies alongside recommendations for 
walking, particularly among individuals with high 
perceived consequences of IC  
Information about health consequences 
Salience of consequences 
Information about emotional 
consequences 
Reduce negative emotions 
Structure booster sessions to facilitate delivery 
and maximise opportunities for walking 
adherence and self-management  
Focus on past success 
Feedback on behaviour 
Review of goals 
Discrepancy between behaviour and goal 
Habit formation 
Generalisation of target behaviour 
aDefined according to the Behaviour Change Taxonomy (version 1) (Michie et al., 2013). 
This research engaged individuals with IC to determine the resonance and readability of 
intervention scripts and materials, and to evaluate the feasibility of pedometer outcome 
assessment (Chapter 6). Qualitative interviews provided rich data on the acceptability of the 
RCT and interventions. However, greater patient and public involvement in advance of a 






Therefore, the next stage of research should include the following: 
 Extended stakeholder involvement, including further guidance from patient experts, 
vascular specialists, and physiotherapists, to inform refinement of the intervention 
components and study protocol; 
 Development of a comprehensive training programme, incorporating evidence-based 
training techniques (Perryman, 2014), for dissemination to a wider group of clinicians 
delivering the intervention; 
 Preparation for a complete process evaluation (Moore et al., 2015), including the 
intervention implementation (e.g., fidelity, dose, and reach) and mechanisms for 
change (e.g., robust mediation analysis of proposed illness and treatment cognitions), 
to support interpretation of outcome data;  
 A cost–utility evaluation to support the commissioning of a structured home-based 
exercise programme, including a comparison of long-term (>6 month) outcomes; and 
 Application of an implementation framework to identify potential barriers to adoption 
of a novel intervention by healthcare professionals and patients, and to facilitate 
translation to practice. 
9.7 Methodological considerations 
This research addressed NICE recommendations to evaluate beliefs and attitudes of individuals 
with IC, in order to facilitate behaviour change and inform management strategies (NICE, 
2012). MRC guidance for developing and evaluating complex interventions were followed, 
including the use of mixed methods, which is a strength of this work. Simultaneously, our 
theoretical understanding of walking in IC was expanded, by testing constructs from the TPB 
and CSM as determinants of objective walking, supporting the role of the TPB as a robust 
framework in behaviour-change theory and practice, and demonstrating the scope for 




Limitations of this research included 1) the evolving Behaviour Change Taxonomy, which led to 
inconsistencies in reporting, and 2) challenges recruiting participants with IC, which meant 
complete data was not available in time to inform the intervention content, and are described 
below.  
9.7.1 Evolution of the Behaviour Change Taxonomy 
A Behaviour Change Taxonomy was employed to identify, evaluate, and report evidence 
underpinning the current research (Michie et al., 2013; Michie et al., 2011a). However, 
iterations of the taxonomy are reflected throughout this work, potentially contributing to 
discrepancies and loss of coherence. The evolved taxonomy has not simply reflected the 
addition of new components; instead existing BCTs have been relabelled or reclassified, which 
could contribute to discrepancies in reporting of this thesis. For example, the 26- and 40-item 
taxonomy defined motivational interviewing as a technique in its own right, and which is a BCT 
underpinning the current intervention. However, the most recent 96-item taxonomy describes 
motivational interviewing as a form of the technique, social support. However, reporting 
“motivational interviewing” provides a more specific account of the intervention content 
compared with “social support”. Second, while the Behaviour Change Taxonomy is informed 
by theory, it is not exhaustive, and does not provide explicit guidance for BCTs that map on to 
TPB and CSM constructs. Therefore, it is possible that walking treatment and illness cognitions 
salient to individuals with IC are not easily modified by the current armament of BCTs which 
have been identified and defined. In future, research should not apply the taxonomy as an 
exhaustive resource, and should contribute to the taxonomy development by identifying 
techniques that affect behaviour-change via processes consistent with the TPB and CSM.  
9.7.2 Recruitment of individuals with PAD 
Recruiting individuals with PAD to research is challenging (Guidon and McGee, 2013). The 
qualitative study included a predominantly White sample, despite attempts to purposively 
sample individuals from ethnic minorities. However, PAD prevalence is higher among people 




hypertension, are associated with Black and South Asian ethnicities (Bhopal et al., 2007; 
Meadows et al., 2009). In addition, rates of revascularisation differ by ethnicity (Ahmad et al., 
2013). Strategies for identifying and recruiting individuals from ethnic minorities are needed to 
facilitate research in this area, such as engaging with community or faith leaders, targeting 
primary care practices in areas servicing high concentrations of ethnic minorities, and ensuring 
translators are available for individuals who are not fluent in English.  
Second, recruitment to the cross-sectional study was slower than anticipated and required an 
extension of the study, and expansion to a new site. Records maintained between January 
2013 and July 2014 indicate a recruitment rate of 18% (n=116/624) of total individuals referred 
for suspected or confirmed IC. It is possible that individuals referred to a vascular surgeon are 
likely to have progressed PAD (e.g., critical limb ischaemia). Detection and awareness of PAD in 
primary care is an increasing priority (Burns et al., 2003; NICE, 2012), and future studies should 
consider identification of individuals with IC at an earlier stage in their care.  
9.8 Areas for future research 
Updated systematic review. Following publication of a systematic review, at least two RCTs 
reported behaviour-change interventions that were effective in increasing walking in people 
with IC (McDermott et al., 2013b; Tew et al., 2014). These recent studies incorporate 
behaviour-change theory or techniques explicitly, suggesting that health psychology is 
increasingly being used to inform the development of walking interventions for IC. An update 
of the systematic review may be required to synthesise new evidence in this area, potentially 
providing more conclusive evidence for effective components of behaviour-change 
interventions. 
Ongoing theory testing. Robust tests of theory, including larger studies with prospective 
longitudinal designs, are required that permit the evaluation of latent variables (e.g., structural 
equation modelling) in order to better understand the causal relationships between walking 




aspects of control, for example action planning and action control could be included in a 
combined model as proximal determinants of behaviour. Another opportunity for theory 
testing involves RCTs of interventions that include mediational analyses (Noar and Mehrotra, 
2011). A fully powered trial evaluating a home-based behaviour-change intervention and 
employing pre-, interim-, and post-intervention measures of TPB and CSM constructs would 
complement and extend the existing findings.  
Outcome development. Validated, disease-specific measures of self-reported walking 
behaviour should be developed and used, which reflect the frequency, duration, and intensity 
of walking activity, and should be coupled with objective walking assessment (e.g., pedometer 
and 6MWD) to ensure the reliability and validity of data on walking behaviour. The MCID 
should be established for primary clinical outcomes, including the 6MWD, to provide a 
benchmark for interventions designed to improve the health of individuals with IC. 
Intervention evaluation and implementation. A definitive trial of this intervention is needed to 
evaluate the effectiveness, cost-effectiveness, and provide a complete process evaluation 
reporting implementation (e.g., treatment fidelity, dose, and reach) and evaluating 
mechanisms of impact (e.g., participant accounts, hypothesised mediators) consistent with the 





9.9 Conclusions  
 Two high-quality studies supported self-monitoring, feedback on performance, and 
barrier identification with problem solving as effective BCTs applied to walking 
interventions for IC.   
 Walking is overlooked as a self-management strategy by people with IC, regardless of 
the perceived consequences of IC. A lack of tailored walking guidance, including 
information on purposeful walking exercise, walking to intensity, and outcomes of 
walking for IC could support individuals in achieving walking guidelines.   
 Walking treatment cognitions defined by the TPB explain walking intention among 
people with IC, whereas illness cognitions defined by the CSM explain objective 
walking ability. Attitude, subjective norm, and perceived behavioural control regarding 
walking treatment, and personal control, treatment control, coherence and risk factor 
attributions regarding PAD are salient cognitions. 
 An RCT which evaluated a physiotherapist-led home-based behaviour-change 
intervention targeting walking for IC, which was informed by the TPB and CSM, was 
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Appendix 1.2 Participant Information Sheet for a qualitative study exploring individual 
experiences of and beliefs about walking for IC 
         
 
Understanding illness and treatment beliefs of patients with PAD 
 
Participant Information Sheet (15 July 2011) 
 
You are being invited to take part in a research study. Before you decide it is important 
for you to understand why the research is being done and what it will involve. Please 
take time to read the following information carefully and discuss it with friends, relatives 
and your doctor if you wish. Ask us if there is anything that is not clear or if you would 
like more information. Take time to decide whether or not you wish to take part. Thank 
you for reading this. 
 
What is the purpose of the study? 
Peripheral arterial disease (PAD) can cause leg pain or discomfort, which limits the 
ability to walk and carry out everyday activities. Walking exercise can lead to 
improvements, but it can also be painful, and people with PAD often have difficulty 
keeping up regular walking on their own. A better understanding of the experiences of 
people with PAD could help us develop programmes that motivate people to walk more 
and improve overall health.  
 
Therefore, the first aim of this study is to learn more about the experiences, feelings 
and beliefs of people with PAD with regard to their illness, symptoms and walking 
exercise. The second aim of this study is to find out whether a brief questionnaire on 
beliefs about walking exercise is meaningful and appropriate for people with PAD.  
 
Why have I been chosen? 
You were invited to participate in this study because you have been diagnosed with 
PAD and experience symptoms of leg pain (‘claudication’) when you walk. We hope to 
include up to 17 participants with PAD in total. This study has been funded by the 
Dunhill Medical Trust, which is a registered UK charity. 
 
Do I have to take part? 
It is up to you to decide. We will describe the study and go through this information 
sheet, which we will then give to you. We will then ask you to sign a consent form to 
show you have agreed to take part. If you decide to take part you are still free to 
withdraw from the study at any time without giving a reason. This will not affect the 
standard of care you receive.  
 
What will happen to me if I take part? 
You will be asked to take part in an interview with the researcher (Melissa Galea). The 
interview will last approximately 60 minutes in total, and will include a discussion of 
your beliefs, feelings and experiences of having PAD, your symptoms and walking. You 
will also be asked to complete a brief questionnaire on your beliefs about walking 
exercise as a treatment for your condition. You will then discuss this questionnaire with 
the researcher, because we would like to know if it is suitable and applicable to people 
with PAD.  
 
The interview can take place at your home or at the Division of Health and Social Care 
Research (King’s College London, Guy’s Campus), depending on your preference. If 
you chose to be interviewed in your home, the researcher will visit your address at a 
mutually convenient time. If possible we would like to talk to you in a space that is 




What are the other possible disadvantages and risks of taking part? 
Taking part in this study involves discussing your illness, symptoms of leg pain and 
how you feel about walking. There is a chance that talking about some of these things 
may make you feel discouraged, uncomfortable or distressed. As a participant, you 
may choose not to respond to a question, or to end the interview at any point with no 
consequences.  
 
If you have concerns about any aspect of this study, you may contact the researchers 
who will do their best to answer your questions (contact Melissa Galea 0207 848 
6679).  
 
What are the possible benefits of taking part? 
By taking part in an interview, you may learn about your own thoughts and beliefs 
about your condition and its management through open discussion. The information we 
get from this study may help us to develop a programme that aims to help people with 
PAD to walk more by targeting important beliefs. It may also help develop a suitable 
questionnaire for PAD patients on beliefs about walking exercise as a treatment. 
 
What will happen if I don’t want to carry on with the study? 
You may withdraw from the study at any time without giving us a reason and we will 
destroy all your identifiable samples, but we would like to use the data (which will not 
be identifiable) collected up to your withdrawal in the final study analysis. 
 
What if something goes wrong? 
In the event that something does go wrong and you are harmed during the research 
and this is due to someone’s negligence then you may have grounds for a legal action 
for compensation but you may have to pay your legal costs.  
 
Regardless of this, if you have concerns about any aspect of the way you have been 
approached or treated during the course of this study you may wish to contact the 
hospital’s Patient Advice and Liaison Service (PALS) on 0207 188 8801. 
 
What will happen to the information that is collected from the study? 
Any information you provide during the course of the research and any information 
about you that leaves the hospital will be kept strictly confidential and anonymous and 
you will not be identified in any way by your responses to study questions. Records of 
any interviews will be transcribed and the tapes destroyed immediately.  
 
The results of the study will be published in medical journals and presented at medical 
conferences. Copies of the results can be obtained from the study organiser (Dr 
Lindsay Bearne) when the study is completed. 
 
What happens now? 
You will be contacted by the researcher (Melissa Galea) to discuss whether you would 
like to participate in this study. The researcher will be able to answer any questions you 
might still have about participating and an appointment for an interview made at a 
mutually convenient place and time. 
 
Thank you for taking the time to learn more about this study. If you have any questions 
please contact: 
 
Melissa Galea (0207 848 6679, melissa.galea@kcl.ac.uk) 
Dr Lindsay M Bearne (0207 848 6322, Lindsay.bearne@kcl.ac.uk) 
King’s College London, Division of Health and Social Care Research 




Appendix 1.3 Participant Consent Form for a qualitative study exploring individual experiences 
of and beliefs about walking for IC 
            
 
Understanding illness and treatment beliefs of patients with PAD 
 Consent Form  
Participant ID ____________ 
 
Researchers: Melissa Galea, Dr Lindsay M Bearne, Prof John A Weinman 
 
 Initial to 
confirm 
1. I confirm that I have read and understand the information sheet dated 
15 July 2011 for the above study. 
 
2. I have had the opportunity to consider the information, ask questions 
and have had these answered satisfactorily. 
 
3. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical 
care or legal rights being affected.  
 
 
4. I understand that the interview will be audio recorded, and consent to 
it being documented and transcribed. 
 
5. I understand that relevant sections of any of my medical notes and 
data collected during the study may be looked at by responsible 
individuals from King’s College London, from regulatory authorities or 
from the NHS Trust, where it is relevant to my taking part in this 
research. I give permission for these individuals to have access to my 
records.  
 





Name of participant Signature Date 
Name of person taking consent Signature Date 





Appendix 1.4 Participant Information Sheet for a cross-sectional observational study 
evaluating walking treatment and illness cognitions as determinants of walking intention and 
6MWD in people with IC 
           
 
 
Are patient beliefs associated with walking performance in PAD? 
 
Participant Information Sheet (15 July 2011) 
 
You are being invited to take part in a research study. Before you decide it is important 
for you to understand why the research is being done and what it will involve. Please 
take time to read the following information carefully and discuss it with friends, relatives 
and your doctor if you wish. Ask us if there is anything that is not clear or if you would 
like more information. Take time to decide whether or not you wish to take part. Thank 
you for reading this. 
 
What is the purpose of the study? 
Peripheral arterial disease (PAD) can cause leg pain or discomfort, which limits the 
ability to walk and carry out everyday activities. Walking exercise can lead to 
improvements, but it can also be painful, and people with PAD often have difficulty 
keeping up regular walking on their own. A better understanding of the experiences of 
people with PAD could help us develop programmes that motivate people to walk more 
and improve overall health. Therefore, the aim of this study is to determine if beliefs 
about illness and treatment held by people with PAD are associated with their ability to 
walk. We also hope to find out whether a brief questionnaire on beliefs about walking 
exercise is consistent over time in the results it provides.  
 
Why have I been chosen? 
You were invited to participate in this study because you have been diagnosed with 
PAD and experience symptoms of leg pain (‘claudication’) when you walk. We hope to 
include 202 participants with PAD in total. This study has been funded by the Dunhill 
Medical Trust, a registered UK charity. 
 
Do I have to take part? 
It is up to you to decide. We will describe the study and go through this information 
sheet, which we will then give to you. We will then ask you to sign a consent form to 
show you have agreed to take part. If you decide to take part you are still free to 
withdraw from the study at any time without giving a reason. This will not affect the 
standard of care you receive.  
 
What will happen to me if I take part? 
You will be asked to visit the Division of Health and Social Care Research (Guy’s 
Campus, King’s College London) for a session that will take approximately 90 minutes 
in total. First, you will be asked to complete a 6 Minute Walking Test. This involves 
walking at a moderate pace (your breath is raised but you can still hold a conversation) 
for up to 6 minutes around a track. During the walk, you will be asked to indicate the 
point when you begin to feel leg pain. We will also record if you must stop walking due 
to leg pain, if this occurs before 6 minutes. Upon completion of the test you will be able 
to sit and recover for 30-45 minutes. During this time, you will be asked to complete a 
set of 6 questionnaires which ask you about your beliefs about your condition and 
walking as a treatment. You can choose not to respond to a question if you feel it is 





In order to evaluate whether beliefs change over time, some participants will be given 
an envelope containing a brief questionnaire on beliefs about walking as a treatment 
for leg pain. If you receive this, you will be asked to take this home and, in one week’s 
time, to complete the questionnaire, and return it to the researcher in a pre-paid 
stamped envelope. 
 
What are the other possible disadvantages and risks of taking part? 
A 6 minute walking test might cause leg pain, fatigue or discomfort. You will be asked 
to walk up to a moderate level of discomfort, but you may choose to terminate the 
walking test or withdraw from the study altogether at any point with no consequences. 
Completing questionnaires about your beliefs about PAD may be tiring, and may cause 
you to feel worried or anxious. However, you can choose not to respond to any 
questions you feel inappropriate. If you have concerns about any aspect of this study, 
you may contact the researchers who will do their best to answer your questions 
(contact Melissa Galea 0207 848 6679).  
 
What are the possible benefits of taking part? 
By completing the questionnaires, you may learn about your own thoughts and beliefs 
about PAD and walking as a treatment. The walking test will provide you information on 
your walking ability in a safe and secure environment. The information we get from this 
study may help us to develop a programme that aims to help people with PAD to walk 
more by targeting important beliefs. It may also help develop a suitable questionnaire 
for PAD patients on beliefs about walking exercise as a treatment.  
 
What will happen if I don’t want to carry on with the study? 
You may withdraw from the study at any time without giving us a reason and we will 
destroy all your identifiable samples, but we would like to use the data (which will not 
be identifiable) collected up to your withdrawal in the final study analysis, if you do not 
object. 
 
What if something goes wrong? 
In the event that something does go wrong and you are harmed during the research 
and this is due to someone’s negligence then you may have grounds for a legal action 
for compensation but you may have to pay your legal costs. Regardless of this, if you 
have concerns about any aspect of the way you have been approached or treated 
during the course of this study you may wish to contact the hospital’s Patient Advice 
and Liaison Service (PALS) on 0207 188 8801. 
 
What will happen to the information that is collected from the study? 
Any information you provide during the course of the research and any information 
about you that leaves the hospital will be kept strictly confidential and anonymous and 
you will not be identified in any way by your responses to study questions. The results 
of the study will be published in medical journals and presented at medical 
conferences. Copies of the results can be obtained from the study organiser (Dr 
Lindsay Bearne) when the study is completed. 
 
What happens now? 
You will be contacted by the researcher (Melissa Galea) to discuss whether you would 
like to participate in this study. The researcher will be able to answer any questions you 
might still have about participating and an appointment made at a mutually convenient 
time.  
 
Thank you for taking the time to learn more about this study. If you have any questions 
please contact: 
 
Melissa Galea (0207 848 6679, melissa.galea@kcl.ac.uk) 
Dr Lindsay M Bearne (0207 848 6322, Lindsay.bearne@kcl.ac.uk) 
King’s College London, Division of Health and Social Care Research 
Guy’s Campus, London, SE1 1UL 
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Appendix 1.5 Participant Consent Form for a cross-sectional observational study evaluating 
walking treatment and illness cognitions as determinants of walking intention and 6MWD in 
people with IC 
           
 
 
Are patient beliefs associated with walking performance in PAD? 
 
Consent Form 
Participant ID ________ 
 
Researchers: Melissa Galea, Dr Lindsay M Bearne, Prof John A Weinman 
 
 Initial to 
confirm 
1. I confirm that I have read and understand the information sheet 
dated 15 July 2011 for the above study. 
 
2. I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
 
3. I understand that my participation is voluntary and that I am 
free to withdraw at any time, without giving any reason, without 
my medical care or legal rights being affected.  
 
4. I understand that relevant sections of any of my medical notes 
and data collected during the study, may be looked at by 
responsible individuals from King’s College London, from 
regulatory authorities or from the NHS Trust, where it is 
relevant to my taking part in this research. I give permission for 
these individuals to have access to my records.  
 





Name of participant Signature Date 
Name of person taking consent Signature Date 




Appendix 1.6 Ethical approval notice for a feasibility and acceptability study of an RCT of a 









Appendix 1.7 Participant Information Sheet for a feasibility and acceptability study of an RCT 
of a physiotherapist-led behaviour-change intervention targeting walking in people with IC  
           
 
Increasing Healthy Behaviour in People with Intermittent Claudication 
Participant Information Sheet (12 February 2014) 
You are being invited to take part in a research study. Before you decide it is important 
for you to understand why the research is being done and what it will involve. Please 
take time to read the following information carefully and discuss it with friends, relatives 
and your doctor if you wish. Ask us if there is anything that is not clear or if you would 
like more information. Take time to decide whether or not you wish to take part. Thank 
you for reading this. 
What is the purpose of the study? 
Peripheral arterial disease (PAD) can cause leg pain or discomfort, which limits the 
ability to walk and carry out everyday activities. Lifestyle changes, like increasing 
walking exercise and enjoying a healthier diet, can lead to improvements, but can be a 
challenge to begin and then keep up over the long-term. The aim of this study is to 
learn if a psychological intervention can improve healthy behaviours and physical ability 
in people with PAD. The intervention is designed to build a positive understanding of 
PAD and healthy behaviours and help individuals with PAD develop strategies to adopt 
lifestyle changes. This study has been funded by the Dunhill Medical Trust, a 
registered UK charity. 
Why have I been chosen? 
You were invited to participate in this study because you have been diagnosed with 
PAD and experience symptoms of leg pain (‘claudication’) when you walk. We hope to 
include 24 participants with PAD in total. 
Do I have to take part? 
It is up to you to decide. We will describe the study and go through this information 
sheet, which we will then give to you. We will then ask you to sign a consent form to 
show you have agreed to take part. If you decide to take part you are still free to 
withdraw from the study at any time without giving a reason. Whether you agree or 
decline will not affect the standard of care you receive.  
What will happen to me if I take part? 
Your involvement in this study will last 4 months. First, you will be asked to visit King’s 
College London, Guy’s Campus, London Bridge) for a 90 minute appointment. You will 
be asked to complete a 6 minute walking test along a flat indoor surface. During the 
walk, you will be able to stop and rest at any point, to relieve any leg pain or if you are 
tired. You will then be able to sit and recover while you complete a set of 
questionnaires that ask about your beliefs about PAD, walking as a treatment and 
dietary behavior. Then, you will be given a pedometer, which is a small device you can 
wear on your waistband and which counts the steps you take. You will be asked to take 
the pedometer home with you and wear this during the day for the next 6 days.Over the 
next 2 weeks a physiotherapist will visit you in your home on two separate occasions, 
to pick up the pedometer and to discuss your beliefs about PAD and to set goals and 
plans for healthy lifestyle changes. These visits will last 60 min and will take place at a 
time that is convenient for you. The physiotherapist will telephone you after 4 and then 
8 weeks to see how you are getting on with your goals and to help you address any 
problems or challenges in achieving your goals. At the end of the study, you will be 
asked to visit King’s College London for a second appointment where you will repeat 
the 6 Minute Walk Test, fill out a set of questionnaires and be given a pedometer to 
take home once again. You will also be given a postage paid envelope that you can 
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return the pedometer in once you are finished wearing it. You may be invited to 
volunteer and provide feedback on your experience of the intervention by telephone or 
a face to face interview which will take place at KCL or your home. The interview will 
last up to 45 minutes. Interviews will be audio recorded. The audio tapes will be 
transcribed then destroyed. Direct quotes from the interviews may be used in the write 
up of the study but these will be anonymised and not able to be traced back to the 
participant.  
What are the possible disadvantages and risks of taking part? 
A 6 minute walking test might cause leg pain, fatigue or discomfort. You will be asked 
to walk at a brisk pace, but will be able to stop and rest at any point during the 6 
Minutes. Completing questionnaires about your beliefs and health behaviours may be 
tiring, and may cause you to feel worried or anxious. However, you can choose not to 
respond to any questions you feel are inappropriate. If you have concerns about any 
aspect of this study, you may contact the researchers (Melissa N Galea Holmes 0207 
848 6679) who will do their best to answer your questions. 
What are the possible benefits of taking part? 
The physiotherapist visits will provide you with information about PAD and leg pain, 
and will help you build goals and plans to begin healthy lifestyle changes. By 
completing the questionnaires, you may learn about your own thoughts and beliefs 
about PAD and walking as a treatment. The 6 Minute Walk Test will provide information 
on your walking ability in a safe and secure environment. The information we get from 
this study will help us to develop a programme that aims to help people with PAD make 
healthy lifestyle changes. 
What will happen if I don’t want to carry on with the study? 
You may withdraw from the study at any time without giving us a reason and we will 
remove any personal information, like your name and phone number, from our records. 
But we would like to use any anonymous data collected up to your withdrawal in the 
final study analysis, if you do not object. 
What if something goes wrong? 
In the event that something does go wrong and you are harmed during the research 
and this is due to someone’s negligence then you may have grounds for a legal action 
for compensation but you may have to pay your legal costs. Regardless of this, if you 
have concerns about any aspect of the way you have been approached or treated 
during the course of this study you may wish to contact the hospital’s Patient Advice 
and Liaison Service (PALS) on 0207 188 8801. 
What will happen to the information that is collected from the study? 
Any information you provide during the course of the research and any information 
about you that leaves the hospital will be kept strictly confidential and anonymous and 
you will not be identified in any way by your responses to study questions. The results 
of the study will be published in medical journals and presented at medical 
conferences. Copies of the results can be obtained from the researcher (Melissa Galea 
Holmes) when the study is completed. Copies of your signed consent form will be filed 
into your medical notes and a copy of this information letter will be sent to your GP to 
inform them that you have taken part in the study.  
What happens now? 
You will be contacted by the researcher (Melissa Galea Holmes) to discuss whether 
you would like to participate in this study. The researcher will be able to answer any 
questions you might still have about participating and an appointment made at a 
mutually convenient time. Thank you for taking the time to learn more about this study. 
If you have any questions please contact: 
Melissa Galea (0207 848 6679, melissa.galea@kcl.ac.uk) 
Dr Lindsay M Bearne (0207 848 6322, Lindsay.bearne@kcl.ac.uk) 
King’s College London, Division of Health and Social Care Research 
Guy’s Campus, London, SE1 1UL  
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Appendix 1.8 Participant Consent Form for a feasibility and acceptability study of an RCT of a 
physiotherapist-led behaviour-change intervention targeting walking for people with IC  
           
 
 
Increasing Healthy Behaviour in People with Intermittent Claudication 
 
Consent Form 
Participant ID ________ 
 
Researchers: Melissa N Galea Holmes, Dr Lindsay M Bearne, Prof John A Weinman 
 
 Initial to 
confirm 
6. I confirm that I have read and understand the information sheet dated 
12 February 2014 for the above study. 
 
7. I have had the opportunity to consider the information, ask questions 
and have had these answered satisfactorily. 
 
8. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical 
care or legal rights being affected.  
 
9. I understand that relevant sections of any of my medical notes and 
data collected during the study, may be looked at by responsible 
individuals from King’s College London, from regulatory authorities or 
from the NHS Trust, where it is relevant to my taking part in this 
research. I give permission for these individuals to have access to my 
records.  
 
10. I consent for my GP to be informed about my participation in this 
study 
 
11. I consent to phone calls and interviews to be audio recorded and that 
direct anonymised quotes may be used 
 




Name of participant Signature Date 






Appendix 1.9 Sample letter provided to General Practitioners informing them of patient 
participation in a feasibility and acceptability study of an RCT of a physiotherapist-led 
behaviour-change intervention targeting walking for people with IC 




Dear M __________, 
 
RE: Patient Participation in a Research  
Study: Increasing Healthy Behaviour in People with Intermittent Claudication  
 
Patient name: ____________         DOB:  _____________________ 
Address: ________________   NHS Number: ______________ 
       
I am writing to inform you that your patient has been given information about a pilot 
intervention study which provides home-based support to increase healthy behaviours 
among individuals with intermittent claudication. [Patient Name] has met the inclusion 
criteria and has consented to take part. I enclose a copy of the participant information 
sheet. 
The study is part of a PhD project that is sponsored by King’s College London and 
Guy’s & St Thomas’ NHS Foundation Trust, and funded by the Dunhill Medical Trust 
(RTF 09/0110). 
Walking exercise is an important treatment strategy for individuals with intermittent 
claudication and peripheral arterial disease. However, update and adherence to 
walking advice is poor, and patients report a desire for clearer instructions and better 
support in order to adopt this lifestyle change. This study randomizes participants to 
either an intervention group, which receives two 60 min sessions and follow-up 
telephone consultations with a physiotherapist, who will support individuals to adopt a 
regimen of walking, or an attention-control group, which receives the same contact time 
during which the physiotherapist will provide information on dietary changes. 
Participants in both groups will also attend two laboratory assessments where they will 
complete a 6 Minute Walk Test and questionnaires on beliefs about walking exercise, 
illness perceptions and attitudes toward pain. A subsample of participants will also be 
invited to attend an interview where they will be asked to remark on their experience of 
the intervention programme. 
Should you have any questions regarding the study, or any concerns regarding your 
patient’s participation, then please do not hesitate to contact us. 
Yours sincerely, 
 
Dr Lindsay Bearne, Principal Investigator  
Mrs Melissa N Galea Holmes, PhD Investigator 
King’s College London  
Division of Health and Social Care Research 
Academic Department of Physiotherapy     
3.11 Shepherd's House  
Guy’s Campus   
London SE1 1UL   
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Baseline exercise  pain   ____ (Borg CR10) 
Baseline exercise  exertion ____ (Borg RPE) 
 
Lap counter: __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ 
 
Pain-Free Walking (if indicated by patient):  
Time: _________ 
Number of laps: ______ (60.96 meters)  
Final partial lap: ________ meters 
Total distance walked: _________ meters 
 
Maximal Walking (if  patient stopped during walk):  
Time: _________ 
Number of laps: ______ (60.96 meters)  
Final partial lap: ________ meters 
Total distance walked: _________ meters 
 
6-Min Walk Distance 
Number of laps: ______ (60.96 meters)  
Final partial lap: ________ meters 
Total distance walked in 6 minutes: _________ meters 
 
Post exercise  pain   ______ (Borg CR10) 
Post exercise  exertion ______ (Borg RPE) 
 
Stopped or paused before 6 minutes? No Yes   
Reason: _____________ 
Describe symptoms at end of exercise: ______________ 
 
 
Tech comments: ___________________________________________ 
_________________________________________________________ 
 
Date: __________  Patient ID ___________ 
 
Walk # ______                    Height: ______ metres 
 




Appendix 2.3 The Baltimore Activity Scale for Intermittent Claudication (BASIC) 
Please circle the appropriate letter (a, b, or c) that best 
describes your answer to each question. 
 
1. How far can you walk before you feel pain in your leg? 
 
a. Less than 100 metres. 
b. Between 100 and 200 metres. 
c. More than 200 metres. 
 
2. What happens when you feel the pain while you walk? 
 
a. Stop walking. 
b. Slow down. 
c. Continue walking at the same pace. 
 
3. How often do you walk at a fast pace? 
 




4. How often do you walk up and down stairs? 
 




5. How often do you walk up and down hills? 
 





SHORT LAST 7 DAYS SELF-ADMINISTERED version of the IPAQ. Revised August 2002. 
 
Appendix 2.4 International Physical Activity Questionnaire (IPAQ) 
We are interested in finding out about the kinds of physical activities that people 
do as part of their everyday lives. The questions will ask you about the time you 
spent being physically active in the last 7 days. Please answer each question 
even if you do not consider yourself to be an active person. Please think about 
the activities you do at work, as part of your house and yard work, to get from 
place to place, and in your spare time for recreation, exercise or sport. 
 
Think about all the vigorous activities that you did in the last 7 days. Vigorous 
physical activities refer to activities that take hard physical effort and make you 
breathe much harder than normal. Think only about those physical activities that 
you did for at least 10 minutes at a time. 
 
1. During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, digging, aerobics, or fast bicycling?  
 
_____ days per week  
 
   No vigorous physical activities  Skip to question 3 
 
 
2. How much time did you usually spend doing vigorous physical activities 
on one of those days? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
Think about all the moderate activities that you did in the last 7 days. 
Moderate activities refer to activities that take moderate physical effort and 
make you breathe somewhat harder than normal. Think only about those 
physical activities that you did for at least 10 minutes at a time. 
 
 
3. During the last 7 days, on how many days did you do moderate 
physical activities like carrying light loads, bicycling at a regular pace, or 
doubles tennis? Do not include walking. 
 
_____ days per week 
 









4. How much time did you usually spend doing moderate physical activities 
on one of those days? 
 
_____ hours per day 
_____ minutes per day 
 
  Don’t know/Not sure  
 
 
Think about the time you spent walking in the last 7 days. This includes at 
work and at home, walking to travel from place to place, and any other walking 
that you might do solely for recreation, sport, exercise, or leisure. 
 
5. During the last 7 days, on how many days did you walk for at least 10 
minutes at a time?  
 
_____ days per week 
  
   No walking    Skip to question 7 
 
 
6. How much time did you usually spend walking on one of those days? 
 
_____ hours per day 
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
The last question is about the time you spent sitting on weekdays during the 
last 7 days. Include time spent at work, at home, while doing course work and 
during leisure time. This may include time spent sitting at a desk, visiting 
friends, reading, or sitting or lying down to watch television. 
 
7. During the last 7 days, how much time did you spend sitting on a week 
day? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
 





Appendix 2.5 Theory of Planned Behaviour (TPB) Questionnaire 
Guidelines indicate that people with leg pain should complete at least 30 minutes of 
walking exercise on 3 or more days per week, walking through the pain until it 
reaches a moderate level.  
Walking for 30 minutes at once can be difficult, so this target can be met through 
several bouts of walking, each lasting at least 10 minutes. For example, you could 
walk for 10 minutes, stop and rest, walk another 10 minutes, and so on. Or you could 
walk for 15 minutes in the morning and 15 minutes later in the day.  
We would now like to ask about your personal views on the recommended walking 
exercise. For each question, circle the number that best represents how you feel. 









5 6 7 
completely 
agree 
Most people who are important to me think that I should do the 








5 6 7 
completely 
agree 























5 6 7 
completely 
agree 
If it were entirely up to me, I am confident that I would be able to do 








5 6 7 
completely 
agree 

















My spouse/significant other approves of me doing the recommended 








5 6 7 
completely 
agree 

























5 6 7 
completely 
agree 


























5 6 7 
completely 
agree 
Doing the recommended walking exercise would be… 
1 
enjoyable 




   5 6 7 
unenjoyable 
My closest friend or family member (other than my 









5 6 7 
completely 
agree 






























How much personal control do you believe you have over whether 




2 3 4 5 6 7 
absolutely 
no control 
How much do you feel that whether you do the recommended 













2 3 4 5 6 7 
definitely so 
 
For me to do the recommended walking exercise would be… 
1 
stressful 




   5 6 7 
relaxing 





2 3 4 5 6 7 
completely 
sure 
For me to do the recommended walking exercise would be… 
1 
harmful 




   5 6 7 
beneficial 
To what extent do you see yourself as being capable of doing the 




2 3 4 
 
5 6 7 
extremely 
incapable 
Doing the recommended walking exercise would be… 
1 
useless 









Appendix 2.6 Revised Illness Perception Questionnaire (IPQ-R) 
YOUR VIEWS ABOUT PERIPHERAL ARTERIAL DISEASE 
 
Listed below are a number of symptoms that you may or may not have 
experienced since your diagnosis with peripheral arterial disease 
(PAD). Please indicate (by circling Yes or No) whether you have 
experienced any of these symptoms since developing PAD, and then 




I have experienced this 
symptom since having 
PAD. 
This symptom is related to 
my PAD. 
Pain  Yes No Yes No 
Sore Throat  Yes No Yes No 
Nausea  Yes No Yes No 
Breathlessness  Yes No Yes No 
Weight Loss  Yes No Yes No 
Fatigue  Yes No Yes No 
Stiff Joints  Yes No Yes No 
Sore Eyes  Yes No Yes No 
Wheeziness  Yes No Yes No 
Headaches  Yes No Yes No 
Upset Stomach  Yes No Yes No 
Sleep Difficulties  Yes No Yes No 
Dizziness  Yes No Yes No 





We are interested in your own personal views of how you now see your 
current condition. Please indicate how much you agree or disagree 
with the following statements about your illness, that is, peripheral 
artery disease (PAD), by ticking the appropriate box. 
 












PAD has major consequences 
on my life 
     
My PAD is likely to be 
permanent rather than temporary 
     
When I think about my PAD I 
get upset 
     
My PAD will pass quickly      
My PAD makes me feel angry       
My PAD is a serious condition      
My PAD symptoms come and 
go in cycles  
     
My PAD does not have much 
effect on my life 
     
My PAD strongly affects the 
way others see me 
     
I have the power to influence 
my PAD 
     
Having this PAD makes me 
feel anxious  
     
My PAD will last a short time      
What I do can determine whether 
my PAD gets better or worse 
     
My PAD has serious financial 
consequences  
     
I get depressed when I think 
about my PAD  
     
There is a lot which I can do to 
control my PAD symptoms  
     
I expect to have PAD for the 
rest of my life  
     
My PAD causes difficulties for 
those who are close to me  
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I have a clear picture or 
understanding of my PAD 
     
Nothing I do will affect my 
PAD  
     
My PAD makes me feel afraid      
My walking exercise treatment 
can control my PAD 
     
There is nothing which can 
help my PAD 
     
My PAD will improve in time      
The course of my PAD 
depends on me 
     
I don’t understand my PAD      
There is very little that can be 
done to improve my PAD 
     
My PAD will last for a long 
time  
     
My PAD is a mystery to me       
The negative effects of my PAD 
can be prevented (avoided) by 
my walking exercise treatment  
     
The symptoms of my PAD are 
puzzling to me 
     
I go through cycles in which 
my PAD gets better and worse 
     
My PAD doesn’t make any 
sense to me  
     
My actions will have no effect 
on the outcome of my PAD  
     
My walking exercise treatment 
will be effective in curing my PAD  
     
My PAD does not worry me      
The symptoms of my PAD change 
a great deal from day to day  
     




We are interested in what you consider may have been the cause of your PAD. 
People are very different, and there are no correct or incorrect answers to the 
questions below. We would like to know your own views about the factors that 
caused your PAD rather than what others, including doctors or family, may have 
suggested to you. Below is a list of possible causes for your PAD. Please indicate 














Stress or worry      
Hereditary - it runs in my family      
A germ or virus      
Diet or eating habits      
Chance or bad luck      
Poor medical care in my past      
Pollution in the environment      
My own behaviour      
My mental attitude e.g. 
thinking about life negatively 
     
Family problems or worries      
Overwork      
My emotional state e.g. feeling 
down, lonely, anxious, empty 
     
Ageing      
Alcohol      
Smoking      
Accident or injury      
My personality      
Altered immunity      
 
Please list in rank-order the three most important factors that you now believe 
caused your peripheral arterial disease. You may use any of the items from the 
questions above, or you may have additional ideas of your own. 
 






Appendix 2.7 Revised Illness Perception Questionnaire (IPQ-R) 
Where 0 is ‘not at all confident’ and 10 is ‘extremely confident’, how confident are you that you 
can walk for at least 30 minutes, at least 3 times a week, walking until the claudication pain is 






1. The weather is bad 0 1 2 3 4 5 6 7 8 9 10 
2. The walk is uphill 0 1 2 3 4 5 6 7 8 9 10 
3. You are on your own 0 1 2 3 4 5 6 7 8 9 10 
4. You are with someone who walks quickly 0 1 2 3 4 5 6 7 8 9 10 
5. There is a flight of steps 0 1 2 3 4 5 6 7 8 9 10 
6. You are tired 0 1 2 3 4 5 6 7 8 9 10 











Appendix 2.8 Action Planning and Action Control Questionnaires 
For each question, circle the response that best applies to you: 
 
I have made a detailed plan regarding… 
 
 








(a) when to do my walking 
exercise 
 
1 2 3 4 
(b) where to do my walking 
exercise 
1 2 3 4 
(c) how to do my walking 
exercise 
1 2 3 4 
(d) how often to do my 
walking   exercise 
1 2 3 4 
 
 
During the last 3 months, I have… 
 








(a) constantly monitored 
myself to ensure I walked 
frequently enough 
1 2 3 4 
(b) tried to make sure that I 
walked for at least 30 
minutes until I reached a 
moderate level of leg pain 
1 2 3 4 
(c) had my walking exercise 
plan often on my mind 
1 2 3 4 
(d) always been aware of my 
agreed walking action plan 
1 2 3 4 
(e) really tried to walk for 
exercise regularly 
1 2 3 4 
(f) tried my best to follow 
through with my walking 
action plan  
1 2 3 4 
 SF-12v2™ Health Survey  1992-2002 by Health Assessment Lab, Medical Outcomes Trust and QualityMetric Incorporated. All 
rights reserved. 
SF-12® is a registered trademark of Medical Outcomes Trust. 
(IQOLA SF-12v2 Standard, English (United Kingdom) 8/02) 
Appendix 2.9 Medical Outcomes Survey Short Form-12, version 2 (SF-21v2) 




This survey asks for your views about your health. This information 
will help keep track of how you feel and how well you are able to do 
your usual activities. Thank you for completing this survey! 
 
For each of the following questions, please tick the one box that best 
describes your answer. 
 
1. In general, would you say your health is: 
2. The following questions are about activities you might do during 
a typical day. Does your health now limit you in these activities? 










    
 a Moderate activities, such as moving a table, pushing  
a vacuum cleaner, bowling, or playing golf ..........................  1 .............  2 .............  3 
 b Climbing several flights of stairs ...........................................  1 .............  2..............  3 
Excellent Very good Good Fair Poor 
     
  1   2   3   4   5 
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3. During the past 4 weeks, how much of the time have you had any 
of the following problems with your work or other regular daily 
activities as a result of your physical health?  










      
 a Accomplished less than you  
  would like .....................................  1 .............  2 .............  3 .............  4 .............  5 
 b Were limited in the kind of  
  work or other activities .................  1 .............  2 .............  3 .............  4 .............  5 
 
4. During the past 4 weeks, how much of the time have you had any 
of the following problems with your work or other regular daily 
activities as a result of any emotional problems (such as feeling 
depressed or anxious)? 
5. During the past 4 weeks, how much did pain interfere with your 
normal work (including both work outside the home and 
housework)?  
Not at all A little bit Moderately Quite a bit Extremely 
     
  1   2   3   4   5 
 
  










      
 a Accomplished less than you  
  would like .....................................  1 .............  2 .............  3 .............  4 .............  5 
 b Did work or other activities 
  less carefully than usual ................  1 .............  2 .............  3 .............  4 .............  5 
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6. These questions are about how you feel and how things have been 
with you during the past 4 weeks. For each question, please give 
the one answer that comes closest to the way you have been 
feeling. How much of the time during the past 4 weeks… 
7. During the past 4 weeks, , how much of the time has your 
physical health or emotional problems interfered with your social 











     







Thank you for completing these questions! 










      
 a  Have you felt calm and  
peaceful? .......................................  1 .............  2 .............  3 .............  4 .............  5 
 b  Did you have a lot of energy? .......  1 .............  2 .............  3 .............  4 .............  5 
 c  Have you felt downhearted  




Appendix 2.10 San Diego Claudication Questionnaire (SDCQ) 
The following questions relate to your leg symptoms. Please circle 
the appropriate number in response for each leg, right R and left L. 
 
 
1. Do you get pain, discomfort or numbness in your legs when 
you walk? 
 




2. Does this pain ever begin when you are standing still or 
sitting? 
 




3. In what part of the leg or buttock do you feel it? 
 
R L 
(A)  Includes calf/calves  1 1………Yes 
2 2………No 
(B)  Includes thigh/thighs  1 1………Yes 
2 2………No 
(C)  Includes buttock/buttocks 1 1………Yes 
2 2………No 
 
   
4. Do you get it when you walk uphill or hurry? 
 
R  L 
1 1………Yes 
2 2………No 
3 3………Never walk uphill or hurry 
 
5. Do you get it if you walk at an ordinary pace on the level? 
 









6. Does the pain ever disappear while you are still walking? 
 




7. What do you do if you get this pain while you are walking? 
 
R  L 
1 1………Stop or slow down 
2 2………Carry on 
 
8. What happens to it if you stand still? 
 
R  L 
1 1………Lessens or relieved  
2 2………Unchanged 
 
(A) If it is lessened or relieved, how soon? 
 
R  L 
1 1………10 minutes or less 






Appendix 2.11 Borg Category–Ratio 10 Scale for Pain (CR10) 
Instructions: Think of the three worst experiences of pain you have ever had. If 
you use 10 on the following scale as the worst pain you have ever experienced 
or can think of, how would you rate the intensity of pain or discomfort in your 
legs when you stopped walking?  
Start by looking at the verbal expressions and then chose a number. For 
example, if your pain was “Very slight,” chose 1, if “Moderate,” chose 3, and so 
on. You can also use half values (such as 1.5, 3.5 or decimals such as 0.4, 0.8, 
or 2.3).  
0 Nothing at all 
0.5 Just noticeable  
1 Very slight 
2 Slight 
3 Moderate  
4 Somewhat severe 
5 Severe  
6  
7 Very severe 
8  
9 Very, very severe 




Appendix 2.12 Borg Rating of Perceived Exertion (RPE) 
Instructions: While exercising we want you to rate your perception of exertion, 
that is, how heavy and strenuous the exercise feels to you. The perception of 
exertion depends mainly on the strain and fatigue in your muscles and on your 
feeling of breathlessness or aches in the chest.  
Look at this rating scale; we want you to use this scale from 6 to 20, where 6 
means ‘no exertion at all’ and 20 means ‘maximal exertion’. Try to appraise your 
feeling of exertion as honestly as possible, without thinking about what the 
actual physical load is. Look at the scale and the expressions and then give a 
number.  
6 No exertion at all 
7 Extremely light  
8  
9 Very light 
10   
11 Light 
12  
13 Somewhat hard 
14  
15 Hard (heavy) 
16  
17 Very hard 
18  
19 Extremely hard 
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Appendix 3.1 A representative search strategy conducted in Medline within the Ovid interface 
for a systematic review evaluating behaviour-change techniques targeting walking in 
individuals with IC  
intermittent claudication.mp. or Intermittent Claudication/ 
peripheral vascular disease.mp. or Peripheral Vascular Diseases/ 
peripheral arterial disease.mp. 
Arterial Occlusive Diseases/ or peripheral arterial occlusive disease.mp. 
claudication.mp. 
("peripheral arterial disease" or "peripheral vascular disease" or "peripheral arterial occlusive 
disease" or "claudication" or "peripheral occlusive arterial disease").ab,ti. 
Attitude/ or attitude.mp. 
self-efficacy.mp. or Self Efficacy/ 
"behavior and behavior mechanisms"/ or psychological theory/ or psychology, applied/ 
Cognition/ or cognition.mp. 
Beliefs/ 
motivation.mp. or Motivation/ 
Intention/ or intention.mp. 
Cognitive Therapy/ or Behavior Therapy/ 
intervention.mp. or Intervention Studies/ 
(attitud* or cognit* or belief* or percei* or percep* or "self ADJ efficacy" or "self-efficacy" or 
intention* or motivat*).ab,ti. 
Walking/ or walking.mp. 
exercise.mp. or Exercise/ or Exercise Therapy/ 
"physical activity".mp. 
(walk* OR exercise* or "physical activity").ab,ti 
Search terms reflect the disease, psychological interventions or variables, and outcome. ab.ti, 






Appendix 3.2 Full text screening criteria for a systematic review evaluating behaviour-change techniques targeting walking in individuals with IC 
Step Criterion Description Action 
             Study design
a
 
A Is the study an experimental 
design? 
Include a) RCTs; b) Quasi-randomised trials; c) non-randomised/quasi-experimental 
trials (e.g., allocation by patient/physician preference); or d) protocol report of any of 
the above designs.  
Yes: answer E 
No:  answer B 
B Is the study an observational design 
in which participants receive an 
intervention? 
Include a) controlled before-and-after study; b) concurrent cohort study; c) historical 
cohort study; d) case-control study; or e) before-and-after study. 
Yes: answer E 
No:  answer C 
C Is the study a non-intervention 
design? 
Include a) cross-sectional design; and b) prospective observational studies. Yes: answer F 
No:  answer D 
D Is the study a qualitative design? Include a) individual interview; and b) focus group studies. Yes: answer H 
No: exclude 
             Study methods 
E Does the treatment arm receive a 
behaviour-change intervention? 
See Michie et al (2011). 
Intervention can include any behaviour-change strategy and can be provided in 
isolation or in adjunct to an exercise training programme. 
Yes: answer G 
No: exclude  
F Are psychosocial variables included 
as a determinant? 
 Yes: answer G 
No: exclude  
G Is either walking behaviour or 
walking ability included as an 
outcome measure? 
Can be the primary or secondary outcome. Walking behaviour includes regular 
walking activity assessed by an objective (e.g., pedometer) or validated subjective 
(e.g., PASE) measure. Walking ability includes functional walking performance 
assessed by a validated method (e.g., 6 Minute Walk Test, Shuttle Walk Test, graded 
treadmill test), and may include measures of pain-free or maximal walking ability. 
Yes: Include  
No: exclude  
H Does the qualitative study describe 
patient beliefs that could influence 
walking behaviour or ability? 
 Yes: Include  
No: exclude  









Appendix 3.3 Data extraction tool applied to a study included in a systematic review evaluating behaviour-change techniques targeting walking in people with 
IC 
Outcome Extracted data 
Author (date) Collins et al. 2011 
Study code: 029 
Study design:  RCT 
Method of randomisation:  Permuted blocks with block sizes 2, 4, 6 or 8 
Concealment of allocation:  Yes 
Blinded:  No   Single X    Double      Triple      Unclear    NA  
A priori power calculation:  Yes 
Total number of patients randomised/enrolled:  n=145 
 Number identified/screened:  n=1756 
 Number eligible: n=145 (same as number randomised) 
 Number refused before randomisation:  NR 
 Number excluded before randomisation  n=1611 (1294 + 317) 
Notes: Two stages of screening (telephone and in-person), no refusals pre-randomisation. 
Number included in follow-up 1:  3 months, n=145 
Number included in follow-up 2 (if applicable):  6 months, n=126 
Number included in follow-up 3 (if applicable):  NA 
Attrition rate at final follow-up 13.1% 
Attendance/compliance, % NR 
“Intention to treat” analysis:  Yes 
Source of funding:   Not stated     Pharmaceutical     Other  X 
Description of funding source: American Diabetes Association 
Country: USA 
Setting/Location:  Home-based, some sessions at a walking centre. 
Number of centres:   Single-centre 
Description: IC and type I or II DM 
Number: 145 
Age:  66.5 years (SD 10.1) 
Sex:  Female n=45 (31%); Male n=100 (69%) 







Baseline maximal walking ability:  Mean 448 metres (SD 237.1) 
Baseline pain-free walking ability: Control: mean 166.1 metres (SD 169.6), Intervention: mean 149.1 metres (SD 147.0).  
Other: Baseline vasodilator use: Control n=19/73 (26%), Intervention n=6/72 (8%) 
Inclusion criteria:  Men/women aged >40 years, diagnosed with PAD (resting ABI<0.90, TBI≤0.70, or surgery for PAD), 
type I or II DM, exertional leg symptoms 
Exclusion criteria:  No intention to start exercising in next 6 months (i.e., pre-contemplators based on PAR-Q), no 
available phone, foot/lower leg amputation, CLI, lower extremity revascularisation <6 months before 
enrolment, MI <3 months before enrolment, significant coronary ischemia at low workload (treadmill 
test), systolic BP>180 mmHg or diastolic blood pressure >110 mmHg, diagnosis of life-threatening 
malignancy within past year, exercise tolerance limited by comorbid condition. 
Description of treatment(s):  Home-based exercise programme with weekly group training sessions 
Duration  6 months. Advice to walk 50 minutes/session. Advice to increase pedometer walking by 50 
steps/session. 
Frequency of sessions:  4 days/week (1 with group and 3 at home) 
Type/mode of exercise:  Walking, cycling, stretching, strength training. 
Intensity of exercise/pain threshold: NR 
Behaviour change component:  Home-based walking programme: 
1) Baseline one-on-one interaction with research coordinator guided by the PACE instrument: 
discussion on current stage of change (based on response to modified PACE part 1), and discussion 
of patient responses to relevant PACE part 2.  
2) Two 1-hour walking exercise sessions led by an experienced exercise instructor. “Served as 
reinforcement and facilitated treatment adherence.” Session 1: Group session designed to facilitate 
interaction among participants. Instructor asked participants to describe what they hoped to gain 
from walking exercise. Group discussion of strategies for staying in the walking programme. Session 
1: Practice walking session with one or more participants. Patients listened to an audiotaped 
instructional aid (AHA), then instructed on home walking and encouraged to attend weekly group 
walking class. 
3) Biweekly telephone calls for 6 months. Participants completed the PACE assessment and Exercise 
Behaviour Questionnaire (i.e., Stanford Patient Education Research Centre Exercise Behaviour 
Survey), discussed strategies for risk factor control and adherence to walking during past 2 weeks. 
Adverse events:  Assessed, but none reported by participants. 
Control/placebo (brief description of treatment):                        Attention control: Participants received twice-monthly phone calls with the research coordinator. 
Duration 10-15 min. Participants shared and discussed the information documented in calendars (see 
standard care) on blood glucose, BP, cholesterol, and smoking habits as applicable. The Exercise 
Behaviour Questionnaire (i.e., Stanford Patient Education Research Centre Exercise Behaviour 






AHA, American Heart Association; CLI, critical limb ischaemia; N, no; NA, not applicable; NR, not reported; PACE, PAtient-Centred assessment and  






Time points n Intervention Control p-value 
Maximal walking ability Gardner-Skinner 
graded exercise 
treadmill test. 
Baseline Intervention n=72 
Control n=73 
Mean 422.7 







3 months NR NR NR NR 
6 months Intervention n=61 
Control n=65 






Pain-free walking ability Gardner-Skinner 
graded exercise 
treadmill test. 
Baseline Intervention n=72 
Control n=73 






3 months NR NR NR NR 






Other:  NA  NA NA NA 
Walking behaviour NA Baseline NA NA NA NA 
3 months NA NA NA NA 
Self-reported walking ability NA NA NA NA NA NA 
Notes Attention control was not equivalent in frequency/duration of attention as the intervention group (e.g., bimonthly calls 





(max 11): 10 
External validity 
(max 3): 1 
Internal validity – bias 
(max 7): 5 
Internal validity – confounding 
(max 6): 5 
Power (max 
5): 0 
Total score (max 
27): 21 
Cochrane 









Blinding of participants/ 
personnel: Y 

















Appendix 3.4 Data extracted from studies included in a systematic review evaluating 










ability Daily walking 
behaviour Distance Speed 
Cunningham 
(2010) 
– – –  5274 ±3022 steps 
versus 3599 ±2850 






















∆3 ±76 min/day versus 









– –  – 
Christman 
(2003) 
8 ±6 minutes 
































Quirk (2012) – – – – Median (IQR) 330 
MET-minutes/week 
(0–1238) versus 396 
(0–1980); p=0.735. 
Data are presented as intervention versus control and represent mean ±standard deviation 
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Appendix 4.1 Questionnaire assessing demographic and clinical characteristics of participants 
in a qualitative study exploring the experiences of and beliefs about walking in people with IC  
 
Please complete all questions to the best of your ability.  
Age: ________ 
Gender:    Male  Female 
What is your marital or same-sex civil partnership status? 
 Never married or in a same-sex civil partnership 
 Married or in a same-sex civil partnership       
 Separated, but still legally married or in a same-sex civil partnership      
 Divorced or formerly in a same-sex civil partnership  
 Widowed or a surviving partner of a same-sex civil partnership 
Which of the following best describes your ethnic group or background? 
White       
 English/Welsh/Scottish/   Irish  
   Northern Irish/British   Gypsy or Irish Traveller 
Mixed/multiple ethnic   Asian/Asian British 
background     Indian        
 White and Black Caribbean     Pakistani  
 White and Black African   Bangladeshi       
 White and Asian        Chinese       
Black/African/ 
Caribbean/Black British  Other ethnic group 
 African       Arab       
 Caribbean          Any other ethnic group  
   (write in) __________ 
Smoking history (check the box that best applies to you): 
   I am currently a cigarette smoker 
   I used to smoke, but have NOT smoked a cigarette in the past 6 months 
   I have never been a cigarette smoker 
Are you, or have you ever been, diagnosed with: 
Diabetes mellitus     Yes   No     
Cholesterol    Yes   No     
High blood pressure  Yes   No     
Cardiovascular disease  Yes   No  
Renal disease      Yes   No  
Have you ever experienced a: 
Heart attack    Yes   No     
Stroke     Yes   No  
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The following questions relate to the symptoms of pain or discomfort in your 
legs. Please answer each question to the best of your ability. 
1. Which leg causes you the most severe pain or discomfort while you are 
walking? 
  Right leg       Left leg        Both are the same      Neither 
 
2. Approximately how long have you been experiencing this pain or 
discomfort? 
 Less than one year 
 One to two years 
 Greater than two years 
 
3. Where do you get this pain or discomfort?  Mark the place(s) with “x” on the 
diagram below.                                                   
                                                         
 
4. Are you on any medication which helps to treat or alleviate the pain or 
discomfort that you experience in your legs during walking? 
 Yes   No 
5. Do you have pain or discomfort caused by a condition other than the 
circulation in your legs (e.g. foot or back pain, arthritis, knee injury, etc.) that 
affects your ability to walk?  
 Yes  No 






Appendix 4.2 Walking subscale of the Physical Activity Scale for the Elderly (PASE) used to 
evaluating walking behaviour among participants with IC in a qualitative study exploring 
experiences of and beliefs about walking 
 
The following question is about how much walking you do. 
Please circle the responses that best describes your walking 
activity. 
 
1. Over the past 7 days, how often did you take a walk outside 
your home or yard for any reason? For example, for fun or 




[1.] SELDOM [2.] SOMETIMES [3.] OFTEN 
 (1–2 DAYS) (3–4 DAYS) (5–7 DAYS) 
Skip 1a.    
 
    
1a. On average, how many hours per day did you 
spend walking? 
  
[1.]  LESS THAN 1 
HOUR 
[2.]  1 BUT LESS THAN 2 
HOURS 
  
[3.]  2–4 HOURS 
[4.]  MORE THAN 4 
HOURS 









Appendix 4.3 Sample of transcribed data, field notes, and reflexive analysis of an interview 
with one participant in a qualitative study exploring experiences of and beliefs about walking 
for IC  
MG: Can you tell me about your condition? 
128B: My condition, em, was first diagnosed, em, at [Name of Hospital], and I had an 
angiogram, um, with the dye test, and, um they was – were – going to do the angioplasty, but 
then I was referred onto Mr [Name of Consultant], em, who, em, in turn carried out the 
procedure of the balloon procedure. Had that not have been a success I was going to have the 
stent. If that failed, I was going to have the bypass. But fortunately at the time, the balloon 
procedure was a success, for a short while only unfortunately. And then I was referred back 
and I had a further, um, er, um, er [slaps knee and bites bottom lip, trying to think of the 
correct word] test in November, which revealed, yes it was beginning to, the vessels were 
beginning to narrow again. Um, and I have an appointment now, waiting to go back to see Mr 
[Name of Consultant] from that day in November. 
MG: And what do you expect from that next appointment? 
128B: The next appointment? Um, it remains to be seen at this stage, because, meanwhile, I’ve 
been referred to the cardiac department, and Mr [Name of Consultant] was aware of that, and 
um, when I saw him in November he felt that it was wise to wait for the result of any tests that 
were carried out in the cardiac department before proceeding with the, um, vascular 
procedure – any vascular procedure that might have to take place. 
MG: And what are your thoughts on that? 
128B: Well, at this stage, since November, seeing Mr [Name of Consultant], I am still, um, 
persevering with my walking, um, in the hope that, um, the vessels, will, um, work for 
themselves, in other words, try not to have any further procedure if that’s possible. Um, at the 
same time, I know that I can, um, have the, well, I would have to have the stent if I could not 
succeed in getting the vessels working on their own through exercise. 
MG: And how do you feel about that possibility? 
128B: The stent? 
MG: Mmm. [Yes] 
128B: Well, so be it. Um, what is to be, will be. If I have to have the stent, then, you know, if 
it’s going to answer the problem, in the long term, then, um, that’s the road, you know, the 
avenue which we’ll have to take.  
MG: So, from that experience, how has that left you feeling about your condition? 
128B: Very mindful, of course, of any, you know, life – any life-threatening condition that could 
be. I realise more than ever that I can’t take it for granted, um, my health. And that I, I have to 
remain positive, and work toward, as far as possible, in trying to maintain and, um, if it has to 
be, correct the condition.  
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MG: You mentioned that you’re concerned about life-threatening possibilities. Um, can you 
explain that further to me? 
128B: Well, obviously, I have got, um, a cardiovascular condition as well. And um, it seems that 
um, I’m prime candidate for any, you know, um, setback, as far as having, um, heart attacks, or 
any, anything resulting from my present condition. Um, I’m very aware, for example, of trying 
to avoid contracting diabetes, and, whatever else you know it could cause, the condition I 
have. 
MG: The condition being…? 
128B: The blocked arteries. 
MG: In the…? [pauses waiting for response]  
128B: Yes, in the legs, the legs in particular. Because I realise that is the part of my body which 
we’re working on. 
MG: So, you’ve sort of described a number of different problems that you’re faced with at the 
moment. Do you think they are linked? 
128B: Um, the cardio and the vascular, the leg? Um, I really don’t know? I presume in some 
way, they must because it’s my body and, you know, the blockage is in my leg, and there 
appears to be some obstruction, um, calcium, in my um, arteries [pointing to chest], so you 
know, that being the case, it must be throughout my system somehow or another, so you 
know, I’m mindful of that.  
MG: How do you feel about your health in general right now? 
128B: Um, [smirks and points to wrist in a cast, rolling eyes], in general, well, mentally, I 
struggle to behave, to maintain a positive outlook. Um physically, um, I’m very conscious of 
movement, of keeping the body moving, and exercise and walking, and - apart from evening 
times of course, when I do relax and then fall asleep – but otherwise, throughout the day, for 
example hovering, housework general, and of course when the weather permits, gardening as 
a form of exercise. I’m fortunate enough to have a staircase that I’m up and down all day when 
I’m in the house, which I see as another form of exercise. 
MG: So, why is this so important to you, the movement? 
128B: Well, because I know it goes hand in hand with the condition that I have, and that it’s 
going to improve my condition. Well, it’s certainly not going to hinder it, you know, the more 
exercise I can carry out on a daily basis, um, it surely is the answer to helping to correct to 
some extent my condition.  
MG: And what has been your experience of that so far? 
128B: Of exercise? Um, yes, as a matter of fact, I find sometimes, walking the first 150 yards, 
after that it can be a bit of a struggle, but the more I persevere, the longer I walk, it seems to 
help overcome that pain that I experience in my calf, like a cramp experience. And the more I 
keep moving and have movement throughout my body, whatever I do, walking or any form of 
exercise, it is stimulating – it helps to stimulate the body. There’s no two ways about it, you 
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know, you hear people who do all sorts of running and athletes and all sorts, you know, 
without overdoing it, they feel refreshed. And I feel somewhat the same in my small way of 
what I can do.  
MG: And what is it like then to go for a walk? Can you tell me a bit more about that? 
128B: Well, mentally and physically, it’s um, it’s uplifting. If for example I have no reason to go 
out, for example, one day last week, it was beautiful the weather, so I just went for a walk, not 
for any particular reason, but just to go for a walk, to get the exercise. I was out for about 30 
min, 20 to 30 min, walking in my local area, not in parkland, but you know, where I live, and I 
did feel, you know, refreshed from doing that. And I felt that it was worthwhile, you know, um, 
and sometimes, um I will walk up to my local newsagent at  [Street Name] to buy my weekly 
paper, or in the other direction to another newsagent which is 20, 25, 30 minutes way and 
back again, and sometimes to my local village, [Street Name], and then perhaps I will get the 
bus home after doing a bit of shopping, but not weather permitting of course again, I don’t go 
out, of course when it’s tipping down. [End of excerpt] 
Field notes 
This interview was conducted in the participant’s home. Participant 128B had an unsuccessful 
angioplasty approximately 1 year ago. She is proactive in her health and well-being, and 
believes movement is essential. She actively manages her health through walking, diet and 
general activity and quit smoking last year after noticing a patient who had undergone 
amputation outside the hospital. She experiences anxiety and has had a stressful past 
following the loss of her son, and believes this is crucial to her health and finds ways to 
manage it through relaxation and humour. She feels she is responsible for her health and in 
control of the progress of her condition, and hopeful that she can improve her leg circulation 
or at least prevent it getting worse through lifestyle changes.  
Reflexive diary 
A good rapport was established quickly with the participant, who was very welcoming, open, 
and interested in getting to know the investigator (e.g., the participant asked the investigator 
questions about her professional work and personal life, and a conversation was easily 
initiated). The interview took place at the participant’s home, and the investigator was made 
to feel welcome, and treated as a warm guest (e.g., offered tea and cake). The participant was 
sharp with a sense of humour, which made the interview overall enjoyable for the investigator. 
The participant was also very candid and open in sharing her thoughts and feelings, and was 
also articulate and thoughtful in her responses, so probing was minimal and the investigator 
was able to allow the interview to flow naturally from the participant’s dialogue. The 
participant discussed her family extensively during the interview, including her deceased 
husband and son, pointing to family photos around the house, where relevant. She described 
her children as approximately the age of the investigator, and it may be that she was reminded 
of her family by the investigator’s age, gender, appearance or other qualities. At times, the 
participant became quite emotional, when describing her family life and her condition; this 
was unexpected, but not awkward or uncomfortable, possibly as a good rapport had been 
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Appendix 5.1 Self-report assessment of sociodemographic and clinical characteristics of 
participants with IC in a cross-sectional study evaluating walking treatment and illness 
cognitions as determinants of walking intention and 6MWD 
 
Please complete all questions to the best of your ability.  
 
Age: ________ 
Gender:    Male  Female 
 
What is your marital or same-sex civil partnership status? 
 
 Never married  
 Married  
 Separated, but still legally married  
 Divorced  
 Widowed  
 
Which of the following best describes your ethnic group or background? 
 
  White  
  Asian/Asian British 
  Black/African/Caribbean/Black British  
  Mixed/multiple ethnic background 
  Other ethnic group (please specify: __________) 
 
Smoking history (check the box that best applies to you): 
 
   I am currently a cigarette smoker 
   I have quit or cut down on smoking within the past 6 months  
   I used to smoke, but have not smoked a cigarette for at least 6 months 
   I have never been a cigarette smoker 
 
Are you, or have you ever been, diagnosed with: 
 
Diabetes mellitus     Yes   No     
Cholesterol    Yes   No     
High blood pressure  Yes   No     
Cardiovascular disease  Yes   No  
Kidney disease      Yes   No  
 
Have you ever experienced a: 
 
Heart attack    Yes   No     





Are you on any medication which helps to treat or alleviate the pain or 
discomfort that you experience in your legs during walking? 
 
Yes   No  
 
For how long have you had pain or discomfort in your legs when walking that is 
due to poor circulation? 
 
   <1 year 
   1 – 2 years 
   >2 years 
 
Do you have pain or discomfort caused by a condition other than the circulation 
in your legs (e.g. foot or back pain, arthritis, knee injury, etc.) that affects your 
ability to walk?  
 
Yes   No  
 




Appendix 5.2 Patterns and rates of missing data across variables among 29 participants with IC who had incomplete data in a cross-sectional study 










0                              
TPB                               
Attitude 0                              
SN 3.4 ● ● ● ● ●                         
PBC 0.7      ●                        
CSM                               
Intention 0                              
Identity 0                              
Coherence 0.7       ●                       
Personal 
control 
2.1 ●       ● ●                     
Treatment 
control 
0.7          ●                    
Acute TL  0.7        ●                      
Chronic TL 0                              
Consequences 0.7        ●                      
Emotion 0.7           ●                   
CA                               
Risk Factors 2.1            ● ● ●                
Psychological 5.5      ●         ● ● ● ● ● ● ●         
Accident / 
chance 
0.7                      ●        
Immunity 4.8                       ● ● ● ● ● ● ● 
6MWD                               
a
Item 5 on the International Physical Activity Questionnaire. CA, causal attributions; Con, control; CSM, Common Sense Model; PBC, 






Appendix 5.3 Frequencies of reported causal attributions among participants with IC in a 
cross-sectional study evaluating walking treatment and illness cognitions as determinants of 
walking intention and 6MWD 
Causal attribution n/total n Frequency, % 
Smoking 96/145 66.2 
Ageing 94/145 64.0 
My own behaviour 65/144 45.1 
Diet or eating habits 56/145 38.6 
Alcohol 42/144 29.2 
Stress 38/145 26.2 
Heredity  36/144 25.0 
Chance or bad luck 30/144 20.9 
My emotional state 29/145 20.0 
Overwork 21/144 14.6 
Mental attitude 20/145 13.8 
Family problems or worries 19/143 13.3 
Poor medical care in my past 17/145 11.8 
Accident or injury 16/145 11.0 
Pollution 15/143 10.5 
Altered immunity  9/141 6.4 
My personality 8/140 5.7 
Germ or virus 5/144 3.5 
Responses of ‘agree’ or ‘strongly agree’ were defined as affirmative responses of a causal 





Appendix 5.4 Skewness and kurtosis values for independent and dependent variables in the 
cross sectional study evaluating walking treatment and illness cognitions as determinants of 
walking intention and 6MWD 
Variable Skewness Kurtosis 
6MWD -0.487 0.40 
Intention -0.985a 0.212  
Past walking behaviour -0.552a   -1.223a  
Attitude -0.166  -0.325  
Subjective norm -0.682a   -0.235  
Perceived behavioural control -0.400  -0.438  
Identity 1.217a 1.740a 
Coherence -0.162 -0.601 
Consequences -0.097 0.124 
Personal control  -0.365 0.795a 
Treatment control  -0.171 0.593 
Acute timeline 0.063 -0.367 
Cyclical timeline  0.069 -0.472 
Emotional representation 0.119 -0.532 
Psychological attributions 0.398 0.075 
Risk factor attributions -0.236 0.120 
Immunity attributions 0.129 -0.425 
Accident/chance attributions  0.482a 0.250 






Appendix 5.6 Histogram illustrating the distribution of 6 Minute Walk Distance (6MWD) scores 
in a cross-sectional observational study evaluating walking treatment cognitions and illness 




Appendix 5.5 Histogram illustrating the distribution of walking intention scores before and after 
reflection and log transformation in a cross-sectional observational study evaluating walking 
treatment and illness cognitions as determinants of walking intention and 6MWD 
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Appendix 5.7 Histogram of the frequencies of standardised residual scores for a hierarchical 
multiple linear regression evaluating past walking behaviour, walking treatment cognitions, 
and illness cognitions as determinants of walking intention 
  
Appendix 5.8 Normal P-P plot of standardised residual scores for a hierarchical multiple linear 
regression evaluating past walking behaviour, walking treatment cognitions, and illness 
cognitions as determinants of walking intention 
 
  
Appendix 5.9  Scatterplot of the standardised residual and predicted scores for a hierarchical 
multiple linear regression evaluating past walking behaviour, walking treatment cognitions, 
and illness cognitions as determinants of walking intention 
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Appendix 5.10 Histogram of the frequencies of standardised residual scores for a hierarchical 
multiple linear regression evaluating past walking behaviour, walking treatment cognitions, 
and illness cognitions as determinants of 6MWD 
  
Appendix 5.11 Normal P-P plot of standardised residual scores for a hierarchical multiple linear 
regression evaluating past walking behaviour, walking treatment cognitions, and illness 
cognitions as determinants of 6MWD 
 
Appendix 5.12 Scatterplot of the standardised residual and predicted scores for a hierarchical 
multiple linear regression evaluating past walking behaviour, walking treatment cognitions, 
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aAdapted from Cunningham (2010) 
Appendix 6.1 Treatment script used in a feasibility study of an RCT of a physiotherapist-led 
behaviour-change intervention targeting walking for IC a 
Session 1 
Open with 3- 5 min general chat. Therapist introduces self, provides overview of session, small 
talk, getting to know one another, building trust and rapport. 
Can you tell me about your health, your leg pain? 
 How has it been affecting you? 
 What are your biggest problems/worries related to your health? 
 How could things in your life be different if you got to grips with these problems/worries? 
 What sort of things have you tried to address this so far? How has that gone for you? 
[aim is for therapist to identify/elicit value-based goals, barriers to achieving goals] 
 
Illness coherence and common sense model 
You mentioned [something about how the leg pain affects person] about your leg pain.  
 What sort of things have you tried or done to manage this problem? 
 How has this gone for you? 
 What do you think is going on when you walk? 
 
What is intermittent claudication? 
Your arteries carry blood from your lungs around your body to all your different muscles. The 
blood provides oxygen to the muscles to help them work properly. If your muscles do not get 
enough oxygen, then they start to hurt. The pain that you feel in your legs when you walk is 
because your leg muscles are not getting enough oxygen.  This is because you have a 
narrowing in one or more of the arteries supplying your leg, which slows down the flow of blood 






This pain is not a sign of damage to the muscles, but can make walking more difficult, and can 
affect your ability your work, hobbies and ability to do the everyday things you normally enjoy 
doing.  
 Would you like to talk about the impact your leg pain has had for you? 
 
What causes intermittent claudication? 
 Do you have any thoughts on what causes your leg pain? 
 
Narrowing of the arteries is usually the result of the build-up over many years of fatty plaques on 
the walls of the arteries, called atherosclerosis. When it happens in the legs it can cause leg 





 Do you have any thoughts on what might have caused you to develop the narrowing 
arteries causing your leg pain?  
 
Risk factors you can change 
There is no single factor which causes narrowing of the arteries, but I would like to assure you 
that there are some things which you can do to reduce the risk of continued narrowing or 
blockage: 
 
 Quitting tobacco smoking 
 Managing blood sugar or diabetes 
 Reduced cholesterol 
 Reduced blood pressure 
 Weight loss 
 Regular walking exercise 
 
[Therapist reviews risk factors relevant to the individual and current management] 
Walking as treatment for IC 
Have you had any treatments for your leg pain that you would like to discuss? 
Have you heard very much about walking as a treatment to improve your IC? 
 Can you tell me about any walking you do now?  
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 What it is like when you go for a walk? 
 
The benefits of walking for IC 
Time and again walking has been shown to have a drastic improvement in the symptoms 
people with IC experience. A regimen of walking can  
1. increase how far or long you can walk before you notice the pain, and 
2. increase how far or long you can walk before you need to stop and rest 
 
Regular walking can help you to continue to enjoy work and home activities we discussed 
earlier. Walking might even be better, in the long term, at improving your symptoms compared 
with other treatments like angioplasty or bypass, and comes with fewer risks. If you have had an 
angioplasty or bypass, or undergo this treatment in the future, walking could help with your long-
term recovery and maintaining your health and mobility.  
 
What are your thoughts about that? 
[Clinician addresses any doubts, concerns or questions as they arise] 
 
How does walking help? 
There are at least two ways that walking regularly could improve your symptoms. First, walking 
leads to changes in the muscles ability to take oxygen from the blood. Second, walking could 
encourage the blood to find other routes to the muscles and lead to ‘collateral blood flow’. In 
addition, regular walking can support your general health, and protect you from a heart attack or 
stroke. 
 
In order for walking to help your leg pain, it needs to be done regularly, and progressively, 
otherwise the benefits will be lost. Engaging in regular activity can be a challenge for most 
people, and especially for people with leg pain. 
[therapist reviews the current walking that patient described earlier] 
 
Based on what we know about walking, it is recommended that people with IC try and walk for a 
total of 30 minutes, on at least 3 days of the week. It is important that you “walk through the 
pain”. What I mean by this is that, during a walk, if you notice the pain, you should try and 
continue to walk through the pain until it reaches a “moderate” intensity, and then stop and 
rest for a few minutes before you continue on. [therapist presents 5-point rating of claudication 
pain to illustrate what is meant by moderate pain]. Some people may notice that their pain does 
not become moderate, and they can carry on walking without a need to rest. You should try and 
walk at a brisk pace that brings on pain within the first 3-5 minutes of walking. 
 
 Do you have any thoughts or questions so far? 
 What are you thinking about your current walking at this point? 
 How would you like to be in 4 months’ time? 
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 What would be the benefits of doing more walking? 
 What might be the challenges for you to do more walking? 
o In your neighbourhood, for yourself, regarding the walking guidelines? 
Rate on a scale from 0 to 10 (with 10 being the highest) how interested you are in making a 
change to your walking. 
 (Why did you not choose a higher number) 
 
Rate, again on a scale from 0 to 10, how confident you are that you can make the change. 
 (What would it take to get you to a higher number) 
 Is there anybody who could offer you support in making this change? 
 
We talked about very specific guidelines for walking, and for some people it is realistic to begin 
by doing less and progress slowly until the recommended walking is achieved. But I would like 
you to think about our talk today, and during our next session we can decide the best way 




Appendix 6.2 Attention-control script delivered in a feasibility study of an RCT evaluating a 
physiotherapist-led behaviour-change intervention targeting walking for IC  
The attention-control script is consistent with the treatment script up to the section titled, 
“Risk factors you can change”: 
Risk factors you can change 
There is no single factor which causes narrowing of the arteries, but I would like to assure you 
that there are some things which you can do to reduce the risk of continued narrowing or 
blockage: 
 
 Quitting tobacco smoking 
 Managing blood sugar or diabetes 
 Reduced cholesterol 
 Reduced blood pressure 
 Weight loss 
 
[Therapist reviews risk factors relevant to the individual and current management] 
 
How does diet help? 
A healthy diet does not require cutting out certain foods and following specific menus. In fact, 
healthy eating isn’t about cutting out foods – it’s about eating a wide variety of foods in the right 
amounts to give your body what it needs.  
Healthy eating helps you to maintain a healthy weight and reduces your risk of diabetes, high 
blood pressure and high cholesterol. It can also help reduce your risk of coronary heart disease 
and some cancers. If you already have arterial disease, eating well can help protect you from 
further problems.  
Healthy eating has many other benefits too. You may find that you sleep better, have more 
energy and better concentration – which all adds up. 
In order for your diet to make a difference you need to be consistent. You don’t need to always 
get the balance right at every meal, but try to get it right over a longer time, like a whole day or a 
week.  
Based on what we know about diet, it is recommended that people with IC try and reduce their 
intake of foods high in saturated fats and cholesterol, and incorporate a variety of fresh fruit, 
vegetables and lean protein sources.  
[Therapist reviews specific information provided by the British Heart Foundation] 
 
 Do you have any thoughts or questions so far? 
 What are you thinking about your current diet at this point? 
 How would you like to be in 4 months’ time? 
 What would be the benefits of changing your diet? 
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 What might be the challenges for you to change your diet? 
 
Rate on a scale from 0 to 10 (with 10 being the highest) how interested you are in making a 
change to your diet. 
 (Why did you not choose a higher number) 
 
Rate, again on a scale from 0 to 10, how confident you are that you can make the change. 
 (What would it take to get you to a higher number) 
 Is there anybody who could offer you support in making this change? 
 
We talked about very specific dietary guidelines, and for some people it is realistic to begin by 
making small changes. I would like you to think about our talk today, and during our next 
session we can decide the best way forward for you.
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aAdapted from Cunningham (2010) 
 
Appendix 6.3 Goal setting and problem solving worksheet used during Session 2 in the 
treatment and attention-control groups of a feasibility study of an RCT evaluating a 
physiotherapist-led behaviour-change intervention targeting walking for ICa 
During last week’s session, we talked about intermittent claudication, which is the word used to 
describe your leg pain. We talked about how blood is carried to your legs through your arteries, 
and how the arteries can become blocked, and cause this pain. 
Did you have any questions about that? 
We also discussed some of the factors that put you at risk of this problem, and things that you 
can do to improve your health, like walking for exercise. We covered some of the benefits of 
walking and a where you would like to be with your walking in 4 months. 
You mentioned [revisit any points the participant made with regard to a) where they would like to 
be; b) how interested they are in walking more; c) who might be able to support them etc.] 
This week, I would like to help you build a plan to make the changes that we discussed. 
The changes I want to make are: 
____________________________________________________________ 
The most important reasons why I want to make these changes are: 
____________________________________________________________ 
My specific goal is: 
____________________________________________________________________________ 
 
To achieve this goal: 
What am I going to do? 
Where am I going to do it? 
When am I going to do it? 
WITH whom am I going to do it? 
 










I will know my plan is working if: 
____________________________________________________________ 
[Participants are given a laminated copy of their action plan to take home where they can record 
their activity]
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aAdapted from Cunningham (2010) 
Appendix 6.4 Telephone booster session worksheet for the treatment and attention control 
groups of a feasibility study of an RCT evaluating a physiotherapist-led behaviour-change 
intervention targeting walking among individuals with ICa 
When we met, we discussed your goal to [patients specific goal] and we agreed on a plan for 
how you could achieve this goal.  
How is it going with your plan? 
 Identify attempts and successes and reinforce these efforts 
 Reinforce values underlying goals and check these are still salient  
 Discuss any aspects of the plan that have been difficult to achieve 
 Revise goals and plans if necessary 
 Revisit strategies for addressing barriers 
 Discuss new barrier and strategies to overcome these 
 
Is there anything else you would like to discuss? 
Is there any other way that I can help you today? 
[Remind participant of next booster call] 
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Appendix 6.5 Acceptability of the plan and script of a behaviour-change intervention targeting 
walking among individuals with IC 
Participant Intervention structure 
110B Some individuals might prefer to go to a centre, but home visits could be more 
helpful because the physiotherapist can see the context where the person is 
walking and give advice. 
113B Would prefer to go to a centre, did not specify a reason why. 
115B Likes the idea and would prefer someone to come to her home and likes the idea. 
116B Would be embarrassed to have someone at his home because it is untidy. 
117B Has no need for physiotherapy, he can do it himself: “What more could I know 
about walking?” 
123B Having a physiotherapist visit the home is a fantastic idea, it saves a lot of hassle, 
especially for people who have a lot of trouble walking or leaving the house. 
However, it might be less relevant or appropriate for her because she has other 
pain problems, like back pain, that limit her, and not just claudication. 
 Intervention script 
110B Was confused or interested by the text: “You may worry that walking will harm your 
legs because of the cramping pain you experience when you walk. There is no 
evidence that this is the case. In fact, lots of research has shown that walking more 
will help improve how far you can walk before the pain comes on.” Patient wonders 
what causes it then, if pain is not causing the problem. Unsure of the meaning of 
“metabolism”. 
113B Unsure of the meaning of the word “atherosclerosis”. Already aware of information 
on risk factors, and blocked arteries. 
115B She is surprised to see the risk factors do not include “diet”, although obesity is 
shown. 
116B Already aware of information about IC, provided by vascular specialist. This would 
have been more helpful at an earlier stage. Unsure of the meaning and 
pronunciation of “atherosclerosis”, although acknowledges that the script explains 
this later on. Wonders where obesity fits into it, and how you define or determine if 
you are obese. 
117B The material is really helpful and informative, and novel. Does not understand the 
word “atherosclerosis”, otherwise the text is very clear and positive to read. 
123B Already aware risk factors presented, but it would be great for someone who is 
newly diagnosed. The list of risk factors are important to discuss with the 
physiotherapist, she would want as much information as possible on what she 
should/should not do with relevance to risk factors she has. She would want to 
know what sort of exercises help, and to be shown exactly what to do as far as she 
is able to exercise. 
124B Already knew most of this, but it is nice to have it confirmed. Would want to know 
the best kind of exercise to do, and the regularity of it. And if there are any drugs 
he could take to alleviate the pain. 
127B Not particularly useful for him, as he is already aware of his problems and risk 
factors, and already does a lot of walking. But for others, it might be useful. 
 Intervention diagram 
110B Helps to see what is happening inside of the body. He had never really imagined 
this before. Prompted the patient wonder just how exercise would clear the 
blockage. He wanted more information on how the two were linked.  
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113B Needs interpreting, diagram is a little bit complex for the ordinary person. Would 
like to know which arteries in my legs are actually blocked. The diagram of a 
blocked artery is familiar, but it is helpful to see it. 
115B A bit “frightening” to look at! But at least you learn something. Patient relates 
image to her own bypass and is able to locate the place where she has had a 
bypass. 
116B Useful and can make sense of them, especially the furring of the artery as he has 
high cholesterol. 
117B Helpful to see, maybe move some of the text to the left side to spread it out. 
Diagram of the blocked artery is not useful at all on its own: there needs to be 
explanatory text around it and perhaps also a cross-sectional diagram showing the 
space remaining where the blood can flow through. 
123B Very interesting, wanted to see where she gets her pain, and can see how 
collateral vessels would develop here. The blocked artery is quite frightening, clear 
message of what is happening in the body. It is clear to see the narrowing and how 
little blood could pass through – helps to understand why you have the pain. 
124B Provides much more detail of the problem, and helps to make sense of the pain 
and what causes it. Patient can relate to this, and it is just how he imagined it. 
127B Shows where the blood circulates, but the writing is too small, able to understand 
the image, quite a lot of writing. Blocked artery: looks like a pipe-line, should be 
“uglier”, maybe larger and in colour to have more of an impact on the patient. 
Participants were n=6 male, mean age 60 years (range 56–78), mean 6 Minute Walk Distance 




Appendix 6.6 Self-report assessment of sociodemographic and clinical characteristics of 
participants with IC in a feasibility study of an RCT evaluating a physiotherapist-led behaviour-
change intervention targeting walking 
Please complete all questions to the best of your ability.  
 
Age: ________ 
Gender:    Male  Female 
 
What is your marital or same-sex civil partnership status? 
 
 Never married  
 Married  
 Separated, but still legally married  
 Divorced  
 Widowed  
 
Which of the following best describes your ethnic group or background? 
 
  White  
  Asian/Asian British 
  Black/African/Caribbean/Black British  
  Mixed/multiple ethnic background 
  Other ethnic group (please specify: __________) 
 
Smoking history (check the box that best applies to you): 
 
   I am currently a cigarette smoker 
   I have quit or cut down on smoking within the past 6 months  
   I used to smoke, but have not smoked a cigarette for at least 6 months 
   I have never been a cigarette smoker 
 
Are you, or have you ever been, diagnosed with: 
 
Diabetes mellitus     Yes   No     
Cholesterol    Yes   No     
High blood pressure  Yes   No     
Cardiovascular disease  Yes   No  
Kidney disease      Yes   No  
 
Have you ever experienced a: 
 
Heart attack    Yes   No     





Are you on any medication which helps to treat or alleviate the pain or 
discomfort that you experience in your legs during walking? 
 
Yes   No  
 
For how long have you had pain or discomfort in your legs when walking that is 
due to poor circulation? 
 
   <1 year 
   1 – 2 years 
   >2 years 
 
Do you have pain or discomfort caused by a condition other than the circulation 
in your legs (e.g. foot or back pain, arthritis, knee injury, etc.) that affects your 
ability to walk?  
Yes   No  
 
If you answered, “Yes”, write down what this condition is here: _____________ 
 
Have you received medical advice on how far or how long to walk because of 
your intermittent claudication? 
 
Yes   No  
 
In the past 3 years, have you taken part in an exercise programme at a centre 
in your community or at your hospital? 
 









Appendix 6.7 Patterns of missing data across participants in the treatment and attention-control groups in a feasibility study of an RCT of a behaviour-change 





1 3 4 5 6 8 9 14 17 18 21 24 2 7 10 11 12 13 15 26 19 20 22 23 
Baseline    
Attitude 4.5                 ●        
Subjective norm 4.5                 ●        
PBC 9.0                ● ●        
Intention 4.5                 ●        
Identity 0                         
Coherence 0                         
Personal control 0                         
Treatment control 0                         
Timeline acute 0                         
Timeline cyclical 0                         
Consequences 0                         
Emotion 0                         
Risk factors
a
 0                         
Personality
a
 0                         
Accident/chance
a
 4.5                 ●        
Immunity
a
 0                         
Barrier self-efficacy 0                         
SF-12v2 MCS 0                         
SF-12v2 PCS 0                         
BASIC 0                         
6MWD 0                         
6-Day Step Count 36.4   ●  ● ●      ●  ●   ● ●   ● ●   
Post-Intervention                          
Attitude 22.7       ● ● ●          ●  ●  ●  
Subjective norm 31.8      ● ● ● ●     ●     ●  ●  ●  
PBC 22.7       ● ● ●          ●  ●  ●  
Intention 22.7       ● ● ●          ●  ●  ●  
Identity 18.2        ● ●          ●  ●  ●  
Coherence 22.7        ● ●   ●       ●  ●  ●  
Personal control 22.7        ● ●   ●       ●  ●  ●  
Treatment control 22.7        ● ●   ●       ●  ●  ●  







Timeline cyclical 22.7        ● ●   ●       ●  ●  ●  
Consequences 22.7        ● ●   ●       ●  ●  ●  
Emotion 22.7        ● ●   ●       ●  ●  ● ● 
Risk factors
a
 31.8        ● ●  ●     ●  ● ●  ●  ●  
Personality
a
 18.2        ● ●          ●  ●  ●  
Accident/chance
a
 18.2        ● ●          ●  ●  ●  
Immunity
a
 18.2        ● ●          ●  ●  ●  
Barrier self-efficacy 22.7       ● ● ●          ●  ●  ●  
Action planning 18.2        ● ●          ●  ●  ●  
Action control 22.7 ●       ● ● ●         ●  ●  ●  
Follow-up   
Attitude 0                     ●   ● 
Subjective norm 0                     ●   ● 
PBC 0                     ●   ● 
Intention 0                     ●   ● 
Identity 0                     ●   ● 
Coherence 0                     ●   ● 
Personal control 0                     ●   ● 
Treatment control 0                     ●   ● 
Timeline acute 0                     ●   ● 
Timeline cyclical 0                     ●   ● 
Consequences 0                     ●   ● 
Emotion 0                     ●   ● 
Risk factors
a
 0                     ●   ● 
Personality
a
 0                     ●   ● 
Accident/chance
a
 0                     ●   ● 
Immunity
a
 0                     ●   ● 
Barrier self-efficacy 0                     ●   ● 
SF-12v2 MCS 4.5                     ●  ● ● 
SF-12v2 PCS 4.5                     ●  ● ● 
BASIC 0                     ●   ● 
6MWD 0                     ●   ● 
6-Day Step Count 9.1 ●             ●       ●   ● 
a
Causal attributions. BASIC, Baltimore Activity Scale for Intermittent Claudication; CA, Causal attribution; MDR, missing data rate (excluding participants 19 and 23 who were lost to  
follow-up; n=22); PBC, perceived behavioural control; MCS, Mental Component Summary; PCS, Physical Component Summary; SF-12v2, Medical Outcomes Survey Short Form-12  








Appendix 6.8 Change in 6MWD and objective walking behaviour among participants with IC in a feasibility study of an RCT of a behaviour-change intervention 
targeting walking 
 








Appendix 6.9 Box plot illustrating median (IQR) change scores for 6MWD and three outliers for 
data reflecting 6MWD in the attention-control group of a feasibility study of an RCT evaluating 
a physiotherapist-led behaviour-change intervention targeting walking for IC 
 
